{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Benchmarks"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Initialize"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 69,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2021-01-05T11:03:09.852316Z",
     "start_time": "2021-01-05T11:03:07.701Z"
    },
    "tags": []
   },
   "outputs": [],
   "source": [
    "#library(Rmisc)\n",
    "library(dtplyr)\n",
    "library(tidyverse)\n",
    "library(glue)\n",
    "library(arrow)\n",
    "library(patchwork)\n",
    "library(data.table)\n",
    "library(\"jsonlite\")\n",
    "library(ggthemes)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 70,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2021-01-05T11:03:10.491477Z",
     "start_time": "2021-01-05T11:03:10.445Z"
    },
    "tags": []
   },
   "outputs": [],
   "source": [
    "base_path = \"/home/jakobs\"\n",
    "\n",
    "project_path = glue(\"{base_path}/data\")\n",
    "experiment = '231117'\n",
    "experiment_path = glue(\"{project_path}/{experiment}\")\n",
    "\n",
    "endpoints_md = endpoint_defs = arrow::read_feather(glue(\"{base_path}/data/endpoints_epic_md.feather\")) %>% filter(n_epic>=100)\n",
    "endpoints = endpoint_defs$endpoint"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 71,
   "metadata": {
    "tags": []
   },
   "outputs": [],
   "source": [
    "base_size = 8\n",
    "title_size = 10\n",
    "facet_size = 9\n",
    "geom_text_size=3\n",
    "theme_set(theme_classic(base_size = base_size) + \n",
    "          theme(strip.background = element_blank(), plot.title=element_text(size=title_size, hjust=0), \n",
    "                strip.text.x = element_text(size = facet_size),axis.title=element_text(size=10), axis.text=element_text(size=8, color=\"black\"),\n",
    "                legend.position=\"bottom\", axis.line = element_line(size = 0.2), axis.ticks=element_line(size=0.2), panel.grid.major.y=element_line()))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 72,
   "metadata": {
    "tags": []
   },
   "outputs": [],
   "source": [
    "endpoint_map = endpoint_defs$phecode_string\n",
    "names(endpoint_map) =  endpoint_defs$endpoint\n",
    "endpoint_order = endpoints"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 73,
   "metadata": {
    "tags": []
   },
   "outputs": [],
   "source": [
    "endpoint_selection = c(\n",
    "    # generally very important\n",
    "    \"phecode_202\", # Diabetes mellitus\n",
    "    \"phecode_401\",\t#Hypertension\"  \n",
    "    \"phecode_404\", # Ischemic heart disease   \n",
    "    \"phecode_404-1\", # Myocardial infarction [Heart attack]\n",
    "    \"phecode_431-11\", # Cerebral infarction [Ischemic stroke]\n",
    "    \"phecode_424\", # Heart failure\n",
    "\n",
    "    \n",
    "    \"phecode_059-1\", # COVID 19\n",
    "    \"phecode_468\", # Pneumonia\n",
    "    \"phecode_474\", # Chronic obstructive pulmonary disease [COPD]\n",
    "      \n",
    "    \"phecode_286-2\", #\tMajor depressive disorder\n",
    "    \"phecode_324-11\", #Parkinson's Disease\n",
    "    \"phecode_328\", # Dementias and cerebral degeneration\n",
    "\n",
    "    \n",
    "    \"phecode_164\", # Anemia\n",
    "    \"phecode_726-1\", # Osteoporosis\n",
    "    \"phecode_371\", # Cataract\n",
    "    \"phecode_374-42\", # Diabetic retinopathy\n",
    "    \"phecode_374-5\", # Macular degeneration\n",
    "    \"phecode_375-1\", # Glaucoma\n",
    "    \n",
    "    \n",
    "    \"phecode_103\", # Malignant neoplasm of the skin\n",
    "    \"phecode_101\", # Malignant neoplasm of the digestive organs\n",
    "    \"phecode_102\", # LUNG CANCER\n",
    "    \n",
    "    \"phecode_583\", # Chronic kidney disease    \n",
    "    \"phecode_542\", # Chronic liver disease and sequelae    \n",
    "    \"OMOP_4306655\" # All-Cause Death\n",
    "    \n",
    "    # also generally important and relevant\n",
    "    #\"phecode_440-3\", # Pulmonary embolism\n",
    "    #\"phecode_468-1\",\t#Viral pneumonia\n",
    "#     \"phecode_460-2\",\t#Acute lower respiratory infection\n",
    "    #\"phecode_388\" # Blindness and low vision\n",
    "      # generally important and fun to check\n",
    "   # \"phecode_374-3\", # Retinal vascular changes and occlusions\n",
    "    #\"phecode_665\", # Psoriasis\n",
    "#     \"phecode_121\", # Leukemia\n",
    "    # important for eye\n",
    "#     \"phecode_705-1\", # Rheumatoid arthritis\n",
    ")\n",
    "\n",
    "endpoints_common = c(\n",
    "   'phecode_164', #Anemia\n",
    " 'phecode_705-1', #Rheumatoid arthritis\n",
    " 'phecode_328', #Dementias and cerebral degeneration\n",
    " 'phecode_328-1', #Alzheimer's disease\n",
    " 'phecode_401', #Hypertension\n",
    " 'phecode_202', #Diabetes mellitus\n",
    " 'phecode_416-21', #Atrial fibrillation\n",
    " 'phecode_404-1', #Myocardial infarction [Heart attack]\n",
    " 'phecode_424', #Heart failure\n",
    " 'phecode_468', #Pneumonia\n",
    " 'phecode_474', #Chronic obstructive pulmonary disease [COPD]\n",
    " 'phecode_583', #Chronic kidney disease\n",
    " 'OMOP_4306655' #All-Cause Death\n",
    "    )\n",
    "    \n",
    "endpoints_cardio = c(\n",
    "    'phecode_438-11',   #  \"Abdominal aortic aneurysm\",\n",
    "    'phecode_440-3',#  \"Pulmonary embolism\", # intervention\n",
    "    'phecode_413-21',#  \"Aortic stenosis\", # intervention\n",
    "    'phecode_400'#  \"Rheumatic fever and chronic rheumatic heart diseases\",\t\n",
    ")\n",
    "\n",
    "endpoints_eye= c(\n",
    "    'phecode_374-5', #Macular degeneration\n",
    " 'phecode_374-51', #Age-related macular degeneration\n",
    " 'phecode_374-42', #Diabetic retinopathy\n",
    " 'phecode_371', #Cataract\n",
    " 'phecode_388', #Blindness and low vision\n",
    " 'phecode_367-5', #Uveitis\n",
    " 'phecode_389-1' #Ocular pain\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 74,
   "metadata": {
    "tags": []
   },
   "outputs": [],
   "source": [
    "endpoint_defs = endpoint_defs %>% \n",
    "    mutate(name = phecode_string) %>%\n",
    "    mutate(name = \n",
    "           case_when( \n",
    "               phecode_string == \"Myocardial infarction [Heart attack]\"~\"Myocardial infarction\",\n",
    "               phecode_string == \"Cerebral infarction [Ischemic stroke]\"~\"Ischemic stroke\",\n",
    "               phecode_string == \"Chronic obstructive pulmonary disease [COPD]\"~\"Chronic obstructive pulmonary disease\",\n",
    "               phecode_string == \"Mitral valve insufficiency\"~\"Mitral insufficiency\",\n",
    "               phecode_string == \"Parkinson's disease (Primary)\"~\"Parkinson's disease\",\n",
    "               phecode_string == \"Suicide ideation and attempt or self harm\"~\"Suicide attempt\",\n",
    "               phecode_string == \"Ischemic heart disease\"~\"Coronary heart disease\",\n",
    "               phecode_string == \"Chronic kidney disease\"~\"Chronic kidney disease\",\n",
    "               phecode_string == \"Rheumatic fever and chronic rheumatic heart diseases\"~\"Rheumatic heart disease\",\n",
    "               phecode_string == \"Abdominal aortic aneurysm\"~\"Abdominal aortic aneurysm\",\n",
    "                  TRUE ~ name)\n",
    "           )\n",
    "            \n",
    "endpoint_map = endpoint_defs$name\n",
    "names(endpoint_map) =  endpoint_defs$endpoint\n",
    "#endpoint_order = (endpoint_defs %>% arrange(as.numeric(phecode)))$endpoint\n",
    "endpoint_order = endpoint_selection"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Load data"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Load Benchmarks"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 75,
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "\u001b[1m\u001b[22mJoining with `by = join_by(endpoint)`\n"
     ]
    }
   ],
   "source": [
    "#today = substr(Sys.time(), 0, 10) # YYYY-MM-DD\n",
    "today = '231117'\n",
    "name = glue(\"benchmarks_{today}\")\n",
    "benchmark_endpoints = arrow::read_feather(glue(\"{experiment_path}/{name}.feather\")) %>% left_join(endpoints_md) "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 76,
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "\u001b[1m\u001b[22m`summarise()` has grouped output by 'endpoint'. You can override using the `.groups` argument.\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<table class=\"dataframe\">\n",
       "<caption>A tibble: 7 × 2</caption>\n",
       "<thead>\n",
       "\t<tr><th scope=col>score</th><th scope=col>mean(cindex)</th></tr>\n",
       "\t<tr><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;dbl&gt;</th></tr>\n",
       "</thead>\n",
       "<tbody>\n",
       "\t<tr><td>Retina        </td><td>0.5695564</td></tr>\n",
       "\t<tr><td>Age+Sex       </td><td>0.5929907</td></tr>\n",
       "\t<tr><td>SCORE2        </td><td>0.5943669</td></tr>\n",
       "\t<tr><td>ASCVD         </td><td>0.5959851</td></tr>\n",
       "\t<tr><td>SCORE2+Retina </td><td>0.6038248</td></tr>\n",
       "\t<tr><td>ASCVD+Retina  </td><td>0.6052626</td></tr>\n",
       "\t<tr><td>Age+Sex+Retina</td><td>0.6060296</td></tr>\n",
       "</tbody>\n",
       "</table>\n"
      ],
      "text/latex": [
       "A tibble: 7 × 2\n",
       "\\begin{tabular}{ll}\n",
       " score & mean(cindex)\\\\\n",
       " <chr> & <dbl>\\\\\n",
       "\\hline\n",
       "\t Retina         & 0.5695564\\\\\n",
       "\t Age+Sex        & 0.5929907\\\\\n",
       "\t SCORE2         & 0.5943669\\\\\n",
       "\t ASCVD          & 0.5959851\\\\\n",
       "\t SCORE2+Retina  & 0.6038248\\\\\n",
       "\t ASCVD+Retina   & 0.6052626\\\\\n",
       "\t Age+Sex+Retina & 0.6060296\\\\\n",
       "\\end{tabular}\n"
      ],
      "text/markdown": [
       "\n",
       "A tibble: 7 × 2\n",
       "\n",
       "| score &lt;chr&gt; | mean(cindex) &lt;dbl&gt; |\n",
       "|---|---|\n",
       "| Retina         | 0.5695564 |\n",
       "| Age+Sex        | 0.5929907 |\n",
       "| SCORE2         | 0.5943669 |\n",
       "| ASCVD          | 0.5959851 |\n",
       "| SCORE2+Retina  | 0.6038248 |\n",
       "| ASCVD+Retina   | 0.6052626 |\n",
       "| Age+Sex+Retina | 0.6060296 |\n",
       "\n"
      ],
      "text/plain": [
       "  score          mean(cindex)\n",
       "1 Retina         0.5695564   \n",
       "2 Age+Sex        0.5929907   \n",
       "3 SCORE2         0.5943669   \n",
       "4 ASCVD          0.5959851   \n",
       "5 SCORE2+Retina  0.6038248   \n",
       "6 ASCVD+Retina   0.6052626   \n",
       "7 Age+Sex+Retina 0.6060296   "
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "benchmark_endpoints %>% group_by(endpoint, score)  %>% summarise(cindex=mean(cindex)) %>% group_by(score) %>% summarise(mean(cindex)) %>% arrange(`mean(cindex)`)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 77,
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "\u001b[1m\u001b[22m`summarise()` has grouped output by 'endpoint'. You can override using the `.groups` argument.\n"
     ]
    }
   ],
   "source": [
    "endpoints_sorted = (benchmark_endpoints %>% \n",
    "    filter(score == \"Age+Sex+Retina\") %>% \n",
    "    group_by(endpoint, score) %>% \n",
    "    summarise(cindex=mean(cindex, na.rm=TRUE)) %>% \n",
    "    arrange(cindex) %>% ungroup())$endpoint"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 78,
   "metadata": {
    "tags": []
   },
   "outputs": [],
   "source": [
    "categories_sorted = (endpoint_defs %>% distinct(phecode_category))$phecode_category"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# CALCULATE THE FREQ of significant!"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 79,
   "metadata": {
    "tags": []
   },
   "outputs": [],
   "source": [
    "plot_width = 10; plot_height=2.5; plot_res = 320\n",
    "options(repr.plot.width = plot_width, repr.plot.height = plot_height, repr.plot.res=plot_res)\n",
    "\n",
    "scores_plot = c(\"Age+Sex\", \"Age+Sex+Retina\")#, \"AgeSexRetina\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 80,
   "metadata": {
    "tags": []
   },
   "outputs": [],
   "source": [
    "options(repr.matrix.max.rows=1500, repr.matrix.max.cols=200)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 81,
   "metadata": {
    "tags": []
   },
   "outputs": [],
   "source": [
    "library(ggdist)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 82,
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[1] 173\n",
      "nrows with positive lower q of delta: 59\n",
      "nrows with negative lower q of delta: 114\n",
      "nrows with positive delta: 117\n",
      "nrows with negative delta: 56"
     ]
    }
   ],
   "source": [
    "table_2_pre = benchmark_endpoints %>% \n",
    "    filter(score %in% scores_plot) %>% \n",
    "    mutate(score = factor(score, levels=scores_plot)) %>%\n",
    "    mutate(endpoint = factor(endpoint, levels=endpoints_sorted)) %>%\n",
    "    group_by(endpoint, score, phecode_string, phecode_category) %>%\n",
    "    pivot_wider(names_from=score, values_from=cindex) %>% \n",
    "    mutate(id = row_number()) %>%\n",
    "    mutate(delta = `Age+Sex+Retina`-`Age+Sex`) %>%\n",
    "    group_by(endpoint, phecode_string, phecode_category) %>%\n",
    "    median_qi(delta) %>% filter(endpoint %in% endpoints_md$endpoint)\n",
    "    #mutate(posdelta = case_when(delta>=0 ~ \"pos\", delta < 0 ~\"neg\"))\n",
    "#table_2_pre %>% head()\n",
    "print(nrow(table_2_pre))\n",
    "\n",
    "cat(\"nrows with positive lower q of delta:\", nrow(table_2_pre %>% filter(.lower > 0)))\n",
    "cat(\"\\nnrows with negative lower q of delta:\", nrow(table_2_pre %>% filter(.lower <= 0)))\n",
    "cat(\"\\nnrows with positive delta:\", nrow(table_2_pre %>% filter(delta > 0)))\n",
    "cat(\"\\nnrows with negative delta:\", nrow(table_2_pre %>% filter(delta <= 0)))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 83,
   "metadata": {
    "tags": []
   },
   "outputs": [],
   "source": [
    "table_2_significant = table_2_pre %>%\n",
    "    filter(delta > 0) %>%\n",
    "    filter(.lower > 0) %>%\n",
    "    arrange(endpoint)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "tags": []
   },
   "source": [
    "table_2_pre %>%\n",
    "    filter(delta > 0) %>%\n",
    "    filter(.lower > 0) %>%\n",
    "    arrange(endpoint) %>% \n",
    "    mutate_if(is.numeric, round, 3) %>%\n",
    "    write_csv(glue(\"outputs/SupplTable2_SignificantEndpoints_CropRatio-{crop_ratio}.csv\"))"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "execution": {
     "iopub.execute_input": "2022-11-30T14:21:35.048497Z",
     "iopub.status.busy": "2022-11-30T14:21:35.047303Z",
     "iopub.status.idle": "2022-11-30T14:21:35.089659Z",
     "shell.execute_reply": "2022-11-30T14:21:35.088017Z"
    },
    "tags": []
   },
   "source": [
    "table_2_pre %>%\n",
    "    arrange(endpoint) %>% \n",
    "    mutate_if(is.numeric, round, 3) %>%\n",
    "    write_csv(glue(\"outputs/SupplTable2_DeltasAllEndpoints_CropRatio-{crop_ratio}.csv\"))"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "execution": {
     "iopub.execute_input": "2022-11-30T14:21:35.093105Z",
     "iopub.status.busy": "2022-11-30T14:21:35.091887Z",
     "iopub.status.idle": "2022-11-30T14:21:35.106192Z",
     "shell.execute_reply": "2022-11-30T14:21:35.104788Z"
    }
   },
   "source": [
    "glue(\"outputs/SupplTable2_SignificantEndpoints_CropRatio-{crop_ratio}.csv\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 84,
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "\u001b[1m\u001b[22mJoining with `by = join_by(phecode_category)`\n",
      "\u001b[1m\u001b[22m`mutate_if()` ignored the following grouping variables:\n",
      "\u001b[36m•\u001b[39m Column `phecode_category`\n"
     ]
    }
   ],
   "source": [
    "og_counts = table_2_pre %>% group_by(phecode_category) %>% count() %>% select(phecode_category, n) %>% rename(N_total = n)\n",
    "tmp = table_2_significant %>% group_by(phecode_category) %>% count() %>% left_join(og_counts) %>% mutate(Percent_Significant=n/ N_total) \n",
    "#%>%        unite(s, n, N_total, sep = \"/\", remove=FALSE)\n",
    "tmp %>%  \n",
    "mutate_if(is.numeric, round, 3) %>%\n",
    "write_csv(glue(\"outputs/SupplTable2_RatioOfSignificantEndpoints.csv\"))"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "tags": []
   },
   "source": [
    "## delta c-idx with negative values"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 85,
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "\u001b[1m\u001b[22m`summarise()` has grouped output by 'endpoint', 'phecode_string'. You can override using the `.groups` argument.\n"
     ]
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAADIAAAAMgCAIAAABusm8oAAAACXBIWXMAADE2AAAxNgGa50Ig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\nAElFTkSuQmCC",
      "text/plain": [
       "plot without title"
      ]
     },
     "metadata": {
      "image/png": {
       "height": 400,
       "width": 1600
      }
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "geom.text.size = 1\n",
    "\n",
    "temp = benchmark_endpoints %>% \n",
    "    filter(score %in% scores_plot) %>% \n",
    "    mutate(score = factor(score, levels=scores_plot)) %>%\n",
    "    mutate(endpoint = factor(endpoint, levels=endpoints_sorted)) %>%\n",
    "    ungroup() %>%\n",
    "    pivot_wider(names_from=score, values_from=cindex) %>% \n",
    "    mutate(id = row_number()) %>%\n",
    "    mutate(delta = `Age+Sex+Retina`-`Age+Sex`) %>%\n",
    "    group_by(endpoint, phecode_string, phecode_category) %>%\n",
    "    summarise(delta = median(delta)) %>%\n",
    "    mutate(pos = case_when(delta>=0 ~ \"pos\", delta < 0 ~\"neg\")) %>%\n",
    "    mutate(endpoint = fct_reorder(endpoint, delta)) %>%\n",
    "    mutate(highlight = case_when(endpoint %in% endpoint_selection ~ \"YES\", TRUE ~ \"NO\")) %>%# %>% filter(endpoint %in% endpoint_sample)\n",
    "    mutate(phecode_category = factor(phecode_category, levels=categories_sorted))\n",
    "\n",
    "endpoint_order = (temp %>% arrange(delta))$endpoint\n",
    "\n",
    "temp = temp %>% mutate(endpoint = factor(endpoint, levels=endpoint_order)) %>% ungroup() %>% arrange(endpoint) %>% group_by(phecode_category) %>% mutate(endpoint = row_number())\n",
    "\n",
    "ggplot(temp) +\n",
    "    geom_ribbon(aes(x=endpoint, ymin=0, ymax=delta), fill=\"black\", alpha=0.2)+\n",
    "    geom_point(aes(x=endpoint, y=delta, color=highlight, size=highlight, alpha=highlight)) +\n",
    "    geom_text(data=temp %>% filter(highlight==\"YES\"), aes(x=endpoint, y=delta+0.045, label=\"↓\"), color=\"black\", size=5, alpha=0.7) +\n",
    "#     geom_text(data=tmp,\n",
    "#               mapping = aes(x = -Inf, y = -Inf, label =s),\n",
    "#               hjust   = -0.1, \n",
    "#               vjust   = -13) + \n",
    "    #geom_segment(aes(x=endpoint, xend=endpoint, y=0, yend=delta, color=highlight, size=highlight), alpha=0.5)+#+\n",
    "    labs(x=\"Endpoints\", y=glue(\"Delta C-Index\"))+\n",
    "    scale_color_manual(values=c(\"NO\"=\"black\", \"YES\"=\"firebrick\"))+\n",
    "    scale_alpha_manual(values=c(\"NO\"=0.1, \"YES\"=1))+\n",
    "    scale_size_manual(values=c(\"NO\"=0.01, \"YES\"=1))+\n",
    "    #scale_colour_manual(values = c(\"pos\"=\"forestgreen\", \"neg\" = \"firebrick\")) + \n",
    "    #coord_polar() +\n",
    "    coord_cartesian(ylim=c(-0.1, 0.1), clip = \"off\")+\n",
    "    scale_y_continuous(expand=c(0, 0))+\n",
    "    scale_x_discrete(expand=expansion(add=20))+\n",
    "    facet_grid(~phecode_category, scales=\"free_x\", space=\"free_x\")+#, switch=TRUE)+\n",
    "    #facet_grid2(~phecode_category, scales = \"free\", independent = \"all\") + \n",
    "    theme(axis.title.x=element_blank(),\n",
    "        axis.text.x=element_blank(),\n",
    "        axis.ticks.x=element_blank(),\n",
    "        panel.grid.major=element_blank(), \n",
    "         strip.text = element_text(angle=270)) + \n",
    "    theme(legend.position=\"none\") \n",
    "    \n",
    "    #geom_ribbon(aes(x=id, ymin=AgeSex, ymax=`Age+Sex+Retina`), fill=\"red\", alpha=0.2)\n",
    "#geom_violin(size=0.1)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## delta c-idx with positive values (negative set to 0)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 86,
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "\u001b[1m\u001b[22m`summarise()` has grouped output by 'endpoint', 'phecode_string'. You can override using the `.groups` argument.\n"
     ]
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAADIAAAAMgCAIAAABusm8oAAAACXBIWXMAADE2AAAxNgGa50Ig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",
      "text/plain": [
       "plot without title"
      ]
     },
     "metadata": {
      "image/png": {
       "height": 400,
       "width": 1600
      }
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "plot_width = 10; plot_height=2.5; plot_res = 320\n",
    "options(repr.plot.width = plot_width, repr.plot.height = plot_height, repr.plot.res=plot_res)\n",
    "\n",
    "scores_plot = c(\"Age+Sex\", \"Age+Sex+Retina\")#, \"AgeSexRetina\")\n",
    "\n",
    "temp_pos = benchmark_endpoints %>% \n",
    "    filter(score %in% scores_plot) %>% \n",
    "    mutate(score = factor(score, levels=scores_plot)) %>%\n",
    "    mutate(endpoint = factor(endpoint, levels=endpoints_sorted)) %>%\n",
    "    ungroup() %>%\n",
    "    pivot_wider(names_from=score, values_from=cindex) %>% \n",
    "    mutate(id = row_number()) %>%\n",
    "    mutate(delta = `Age+Sex+Retina`-`Age+Sex`) %>% filter(endpoint %in% endpoints_md$endpoint)\n",
    "\n",
    "temp_pos = temp_pos %>%\n",
    "    group_by(endpoint, phecode_string, phecode_category) %>%\n",
    "    summarise(delta = median(delta)) %>%\n",
    "    mutate(pos = case_when(delta>=0 ~ \"pos\", delta < 0 ~\"neg\")) %>%\n",
    "    mutate(endpoint = fct_reorder(endpoint, delta)) %>%\n",
    "    mutate(highlight = case_when(endpoint %in% endpoint_selection ~ \"YES\", TRUE ~ \"NO\")) %>%# %>% filter(endpoint %in% endpoint_sample)\n",
    "    mutate(phecode_category = factor(phecode_category, levels=categories_sorted))\n",
    "\n",
    "endpoint_order = (temp_pos %>% arrange(delta))$endpoint\n",
    "\n",
    "temp_pos = temp_pos %>% mutate(endpoint = factor(endpoint, levels=endpoint_order)) %>% ungroup() %>% arrange(endpoint) %>% group_by(phecode_category) %>% mutate(endpoint = row_number())\n",
    "\n",
    "fig3a = ggplot(temp_pos) +\n",
    "    geom_ribbon(aes(x=endpoint, ymin=0, ymax=delta), fill=\"black\", alpha=0.2)+\n",
    "    geom_point(aes(x=endpoint, y=delta, color=highlight, size=highlight, alpha=highlight)) +\n",
    "    #geom_text(data=temp_pos %>% filter(highlight==\"YES\"), aes(x=endpoint, y=delta+0.015, label=\"↓\"), color=\"black\", size=5, alpha=0.7) +\n",
    "    #geom_segment(aes(x=endpoint, xend=endpoint, y=0, yend=delta, color=highlight, size=highlight), alpha=0.5)+#+\n",
    "    labs(x=\"Endpoints\", y=glue(\"Delta C-Index\"))+\n",
    "    scale_color_manual(values=c(\"NO\"=\"black\", \"YES\"=\"firebrick\"))+\n",
    "    scale_alpha_manual(values=c(\"NO\"=0.1, \"YES\"=1))+\n",
    "    scale_size_manual(values=c(\"NO\"=0.01, \"YES\"=1))+\n",
    "    #scale_colour_manual(values = c(\"pos\"=\"forestgreen\", \"neg\" = \"firebrick\")) + \n",
    "    #coord_polar() +\n",
    "    coord_cartesian(ylim=c(NA, 0.1), clip = \"off\")+\n",
    "    scale_y_continuous(expand=c(0, 0))+\n",
    "    scale_x_discrete(expand=expansion(add=2))+\n",
    "    facet_grid(~phecode_category, scales=\"free_x\", space=\"free_x\")+#, switch=TRUE)+\n",
    "    #facet_grid2(~phecode_category, scales = \"free\", independent = \"all\") + \n",
    "    theme(axis.title.x=element_blank(),\n",
    "        axis.text.x=element_blank(),\n",
    "        axis.ticks.x=element_blank(),\n",
    "        panel.grid.major=element_blank(), \n",
    "         strip.text = element_text(angle=270)) + \n",
    "    theme(legend.position=\"none\") \n",
    "    \n",
    "fig3a    \n",
    "#geom_ribbon(aes(x=id, ymin=AgeSex, ymax=`Age+Sex+Retina`), fill=\"red\", alpha=0.2)\n",
    "#geom_violin(size=0.1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 87,
   "metadata": {
    "tags": []
   },
   "outputs": [],
   "source": [
    "plot_name = \"SupplFigure3a_EPIC_Discrimination_PhenomeWide\"\n",
    "fig3a %>% ggsave(filename=glue(\"outputs/{plot_name}.pdf\"), device=\"pdf\", width=plot_width, height=plot_height, dpi=plot_res, limitsize=FALSE)\n",
    "fig3a %>% ggsave(filename=glue(\"outputs/{plot_name}.png\"), device=\"png\", width=plot_width, height=plot_height, dpi=plot_res, limitsize=FALSE)\n",
    "temp_pos %>% write_csv(glue(\"outputs/SupplFigure3a.csv\"))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 88,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<table class=\"dataframe\">\n",
       "<caption>A data.table: 752 × 6</caption>\n",
       "<thead>\n",
       "\t<tr><th scope=col>phecode_category</th><th scope=col>endpoint</th><th scope=col>phecode_string</th><th scope=col>Age+Sex</th><th scope=col>Age+Sex+Retina</th><th scope=col>delta</th></tr>\n",
       "\t<tr><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th></tr>\n",
       "</thead>\n",
       "<tbody>\n",
       "\t<tr><td>Blood         </td><td>phecode_168-1  </td><td>Hypo-coagulability                                                             </td><td>0.655 (0.613, 0.691)</td><td>0.486 (0.438, 0.547)</td><td>-0.166 (-0.212, -0.104)</td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_552-1  </td><td>Cholangitis                                                                    </td><td>0.599 (0.575, 0.642)</td><td>0.566 (0.539, 0.612)</td><td>-0.035 (-0.049, -0.013)</td></tr>\n",
       "\t<tr><td>Blood         </td><td>phecode_180    </td><td>Other disorders involving the immune mechanism                                 </td><td>0.635 (0.612, 0.676)</td><td>0.602 (0.574, 0.647)</td><td>-0.032 (-0.057, -0.008)</td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_721-6  </td><td>Baker's cyst [popliteal cyst]                                                  </td><td>0.627 (0.59, 0.665) </td><td>0.596 (0.561, 0.632)</td><td>-0.031 (-0.058, -0.012)</td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_520-15 </td><td>Incisional hernia                                                              </td><td>0.585 (0.543, 0.618)</td><td>0.552 (0.521, 0.583)</td><td>-0.031 (-0.067, 0.005) </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_702    </td><td>Infective and reactive arthropathies                                           </td><td>0.574 (0.542, 0.6)  </td><td>0.544 (0.509, 0.573)</td><td>-0.03 (-0.054, 0.001)  </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_430-1  </td><td>Nontraumatic subarachnoid hemorrhage                                           </td><td>0.643 (0.596, 0.675)</td><td>0.61 (0.569, 0.651) </td><td>-0.03 (-0.055, 0)      </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_329-1  </td><td>Memory loss                                                                    </td><td>0.615 (0.583, 0.657)</td><td>0.588 (0.544, 0.629)</td><td>-0.027 (-0.055, -0.005)</td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_532-4  </td><td>Volvulus                                                                       </td><td>0.596 (0.554, 0.63) </td><td>0.573 (0.527, 0.6)  </td><td>-0.027 (-0.042, -0.005)</td></tr>\n",
       "\t<tr><td>Hearing       </td><td>phecode_397-1  </td><td>Tinnitus                                                                       </td><td>0.591 (0.557, 0.624)</td><td>0.564 (0.536, 0.595)</td><td>-0.026 (-0.055, 0)     </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_324-3  </td><td>Dystonia                                                                       </td><td>0.589 (0.557, 0.623)</td><td>0.567 (0.521, 0.602)</td><td>-0.026 (-0.054, 0)     </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_601-12 </td><td>Chronic prostatitis                                                            </td><td>0.624 (0.584, 0.653)</td><td>0.597 (0.558, 0.627)</td><td>-0.025 (-0.041, -0.006)</td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_423    </td><td>Abnormal cardiac sounds                                                        </td><td>0.648 (0.621, 0.668)</td><td>0.624 (0.596, 0.649)</td><td>-0.024 (-0.039, -0.009)</td></tr>\n",
       "\t<tr><td>Hearing       </td><td>phecode_397    </td><td>Other hearing abnormality                                                      </td><td>0.579 (0.551, 0.618)</td><td>0.558 (0.527, 0.593)</td><td>-0.024 (-0.046, 0.002) </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_704    </td><td>Systemic vasculitis                                                            </td><td>0.695 (0.658, 0.727)</td><td>0.672 (0.636, 0.702)</td><td>-0.024 (-0.035, -0.008)</td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_506    </td><td>Diseases of salivary glands                                                    </td><td>0.572 (0.533, 0.616)</td><td>0.549 (0.498, 0.593)</td><td>-0.024 (-0.05, 0.014)  </td></tr>\n",
       "\t<tr><td>Endo          </td><td>phecode_200-22 </td><td>Uninodular goiter [single thyroid nodule]                                      </td><td>0.642 (0.597, 0.674)</td><td>0.619 (0.583, 0.653)</td><td>-0.023 (-0.047, 0.002) </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_625    </td><td>Pain and other symptoms associated with female genital organs                  </td><td>0.647 (0.605, 0.677)</td><td>0.623 (0.582, 0.66) </td><td>-0.023 (-0.038, -0.007)</td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_504-32 </td><td>Chronic periodontitis                                                          </td><td>0.554 (0.515, 0.604)</td><td>0.534 (0.487, 0.569)</td><td>-0.023 (-0.057, 0.013) </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_423-1  </td><td>Cardiac murmurs                                                                </td><td>0.644 (0.621, 0.671)</td><td>0.623 (0.594, 0.647)</td><td>-0.023 (-0.043, -0.007)</td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_360    </td><td>Inflammation of eyelids                                                        </td><td>0.492 (0.465, 0.519)</td><td>0.471 (0.441, 0.493)</td><td>-0.022 (-0.04, 0.001)  </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_530-3  </td><td>Rectal prolapse                                                                </td><td>0.694 (0.656, 0.727)</td><td>0.669 (0.634, 0.705)</td><td>-0.022 (-0.041, -0.005)</td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_494    </td><td>Voice disturbance                                                              </td><td>0.621 (0.574, 0.659)</td><td>0.601 (0.572, 0.638)</td><td>-0.021 (-0.047, 0.008) </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_522-7  </td><td>Ulceration of the lower GI tract                                               </td><td>0.536 (0.513, 0.568)</td><td>0.517 (0.485, 0.551)</td><td>-0.021 (-0.053, 0.007) </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_123    </td><td>Multiple myeloma and malignant plasma cell neoplasms                           </td><td>0.69 (0.648, 0.721) </td><td>0.668 (0.624, 0.703)</td><td>-0.021 (-0.046, 0.002) </td></tr>\n",
       "\t<tr><td>Blood         </td><td>phecode_180-3  </td><td>Paraproteinemias                                                               </td><td>0.675 (0.637, 0.71) </td><td>0.655 (0.615, 0.692)</td><td>-0.02 (-0.043, 0.006)  </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_710-3  </td><td>Acquired deformities of the knee                                               </td><td>0.599 (0.577, 0.63) </td><td>0.579 (0.548, 0.607)</td><td>-0.02 (-0.036, -0.006) </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_122-22 </td><td>Diffuse large B-cell lymphoma*                                                 </td><td>0.656 (0.621, 0.698)</td><td>0.636 (0.601, 0.667)</td><td>-0.02 (-0.041, 0.003)  </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_610    </td><td>Benign mammary dysplasias                                                      </td><td>0.416 (0.381, 0.461)</td><td>0.401 (0.357, 0.438)</td><td>-0.02 (-0.038, 0.01)   </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_139-61 </td><td>Hemangioma                                                                     </td><td>0.55 (0.512, 0.578) </td><td>0.525 (0.488, 0.566)</td><td>-0.02 (-0.043, 0)      </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_363-7  </td><td>Stenosis and insufficiency of lacrimal passages                                </td><td>0.643 (0.608, 0.681)</td><td>0.625 (0.582, 0.664)</td><td>-0.019 (-0.034, -0.007)</td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_139-6  </td><td>Hemangioma and lymphangioma                                                    </td><td>0.55 (0.512, 0.581) </td><td>0.529 (0.496, 0.566)</td><td>-0.019 (-0.041, 0.008) </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_124    </td><td>Myeloproliferative disorder                                                    </td><td>0.677 (0.646, 0.71) </td><td>0.656 (0.625, 0.687)</td><td>-0.018 (-0.037, -0.006)</td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_438-12 </td><td>Thoracic aneurysm                                                              </td><td>0.659 (0.625, 0.688)</td><td>0.643 (0.605, 0.676)</td><td>-0.018 (-0.052, 0.02)  </td></tr>\n",
       "\t<tr><td>Blood         </td><td>phecode_180-31 </td><td>Monoclonal gammopathy                                                          </td><td>0.685 (0.641, 0.726)</td><td>0.667 (0.628, 0.708)</td><td>-0.018 (-0.044, 0.014) </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_109-3  </td><td>Malignant neoplasm of brain                                                    </td><td>0.604 (0.567, 0.636)</td><td>0.581 (0.544, 0.616)</td><td>-0.018 (-0.051, 0.008) </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_123-1  </td><td>Multiple myeloma                                                               </td><td>0.675 (0.633, 0.713)</td><td>0.657 (0.61, 0.698) </td><td>-0.017 (-0.041, 0.012) </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_413-22 </td><td>Aortic insufficiency                                                           </td><td>0.69 (0.67, 0.712)  </td><td>0.673 (0.654, 0.698)</td><td>-0.017 (-0.027, -0.003)</td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_328-7  </td><td>Vascular dementia                                                              </td><td>0.805 (0.778, 0.828)</td><td>0.788 (0.76, 0.816) </td><td>-0.017 (-0.037, 0.002) </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_603    </td><td>Disorders and symptoms of testis                                               </td><td>0.538 (0.51, 0.564) </td><td>0.521 (0.491, 0.547)</td><td>-0.017 (-0.039, 0.006) </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_349    </td><td>Disorder of nervous system                                                     </td><td>0.577 (0.547, 0.623)</td><td>0.568 (0.51, 0.611) </td><td>-0.016 (-0.06, 0.019)  </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_530-1  </td><td>Anal fissure                                                                   </td><td>0.544 (0.509, 0.581)</td><td>0.529 (0.493, 0.566)</td><td>-0.016 (-0.031, 0.002) </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_121-2  </td><td>Chronic leukemia                                                               </td><td>0.724 (0.696, 0.751)</td><td>0.709 (0.672, 0.738)</td><td>-0.016 (-0.031, -0.002)</td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_109    </td><td>Malignant neoplasm of the eye, brain and other parts of central nervous system </td><td>0.572 (0.54, 0.608) </td><td>0.556 (0.524, 0.588)</td><td>-0.016 (-0.038, 0.01)  </td></tr>\n",
       "\t<tr><td>Endo          </td><td>phecode_200-23 </td><td>Multinodular goiter                                                            </td><td>0.689 (0.648, 0.719)</td><td>0.673 (0.632, 0.71) </td><td>-0.016 (-0.035, 0.003) </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_679-4  </td><td>Pruritus                                                                       </td><td>0.574 (0.53, 0.621) </td><td>0.563 (0.505, 0.602)</td><td>-0.016 (-0.05, 0.02)   </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_529-2  </td><td>Abdominal distension and flatulence                                            </td><td>0.529 (0.504, 0.553)</td><td>0.514 (0.487, 0.537)</td><td>-0.015 (-0.033, 0.001) </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_148-2  </td><td>Benign neoplasm of meninges (Meningioma)                                       </td><td>0.663 (0.629, 0.709)</td><td>0.648 (0.612, 0.69) </td><td>-0.015 (-0.038, 0.004) </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_121    </td><td>Leukemia                                                                       </td><td>0.693 (0.665, 0.72) </td><td>0.68 (0.649, 0.701) </td><td>-0.015 (-0.026, -0.003)</td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_601    </td><td>Inflammatory diseases of prostate                                              </td><td>0.652 (0.627, 0.672)</td><td>0.637 (0.609, 0.658)</td><td>-0.015 (-0.022, -0.006)</td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_106-2  </td><td>Malignant neoplasm of the uterus                                               </td><td>0.581 (0.556, 0.613)</td><td>0.567 (0.538, 0.6)  </td><td>-0.014 (-0.03, -0.001) </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_466    </td><td>Tonsillitis and adenoiditis                                                    </td><td>0.573 (0.533, 0.611)</td><td>0.556 (0.519, 0.59) </td><td>-0.014 (-0.033, 0.004) </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_601-1  </td><td>Prostatitis                                                                    </td><td>0.65 (0.625, 0.671) </td><td>0.636 (0.61, 0.658) </td><td>-0.014 (-0.021, -0.003)</td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_608    </td><td>Other disorders of male genital organs                                         </td><td>0.526 (0.5, 0.554)  </td><td>0.512 (0.486, 0.544)</td><td>-0.014 (-0.039, 0.01)  </td></tr>\n",
       "\t<tr><td>Stat          </td><td>phecode_990    </td><td>Family history of digestive disorders                                          </td><td>0.582 (0.546, 0.612)</td><td>0.568 (0.538, 0.601)</td><td>-0.014 (-0.039, 0.011) </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_106-21 </td><td>Malignant neoplasm of endometrium                                              </td><td>0.587 (0.558, 0.611)</td><td>0.574 (0.546, 0.594)</td><td>-0.013 (-0.027, 0.002) </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_710    </td><td>Acquired deformities of limbs                                                  </td><td>0.616 (0.596, 0.643)</td><td>0.605 (0.581, 0.626)</td><td>-0.013 (-0.025, 0.001) </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_603-1  </td><td>Hydrocele                                                                      </td><td>0.557 (0.527, 0.593)</td><td>0.545 (0.513, 0.581)</td><td>-0.013 (-0.041, 0.019) </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_356-2  </td><td>Aphasia and dysphasia                                                          </td><td>0.675 (0.638, 0.709)</td><td>0.664 (0.621, 0.702)</td><td>-0.013 (-0.034, 0.019) </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_139-54 </td><td>Testicular limpoma                                                             </td><td>0.567 (0.529, 0.611)</td><td>0.554 (0.518, 0.599)</td><td>-0.012 (-0.017, -0.006)</td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_532-1  </td><td>Intestinal fistula                                                             </td><td>0.596 (0.562, 0.623)</td><td>0.582 (0.543, 0.612)</td><td>-0.012 (-0.037, 0.009) </td></tr>\n",
       "\t<tr><td>Hearing       </td><td>phecode_390    </td><td>Disorders of external ear                                                      </td><td>0.593 (0.554, 0.632)</td><td>0.58 (0.546, 0.621) </td><td>-0.012 (-0.028, 0.005) </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_120-1  </td><td>Myeloid                                                                        </td><td>0.693 (0.673, 0.715)</td><td>0.682 (0.66, 0.706) </td><td>-0.012 (-0.021, -0.002)</td></tr>\n",
       "\t<tr><td>Hearing       </td><td>phecode_394-21 </td><td>Paroxysmal vertigo                                                             </td><td>0.665 (0.625, 0.704)</td><td>0.653 (0.617, 0.689)</td><td>-0.012 (-0.032, 0.01)  </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_346    </td><td>Brain damage and brain death                                                   </td><td>0.596 (0.551, 0.637)</td><td>0.587 (0.536, 0.619)</td><td>-0.012 (-0.048, 0.024) </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_628    </td><td>Ovarian cyst                                                                   </td><td>0.586 (0.56, 0.618) </td><td>0.575 (0.551, 0.606)</td><td>-0.011 (-0.021, 0.001) </td></tr>\n",
       "\t<tr><td>ID            </td><td>phecode_009    </td><td>Pseudomonas                                                                    </td><td>0.652 (0.625, 0.678)</td><td>0.639 (0.614, 0.666)</td><td>-0.011 (-0.035, 0.007) </td></tr>\n",
       "\t<tr><td>Blood         </td><td>phecode_172    </td><td>Other disorders of white blood cells                                           </td><td>0.598 (0.55, 0.672) </td><td>0.591 (0.536, 0.649)</td><td>-0.011 (-0.044, 0.019) </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_135    </td><td>Benign neoplasm of the head and neck                                           </td><td>0.593 (0.577, 0.615)</td><td>0.582 (0.565, 0.606)</td><td>-0.011 (-0.019, -0.001)</td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_144-1  </td><td>Benign neoplasms of external female genital organs and cervix                  </td><td>0.554 (0.515, 0.588)</td><td>0.546 (0.511, 0.57) </td><td>-0.011 (-0.032, 0.018) </td></tr>\n",
       "\t<tr><td>Mental        </td><td>phecode_288-4  </td><td>Phobic disorders                                                               </td><td>0.651 (0.621, 0.677)</td><td>0.639 (0.611, 0.667)</td><td>-0.011 (-0.024, 0.006) </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_121-21 </td><td>Chronic lymphoid leukemia                                                      </td><td>0.725 (0.695, 0.751)</td><td>0.717 (0.68, 0.745) </td><td>-0.01 (-0.027, 0.004)  </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_500    </td><td>Disorders of tooth develoment                                                  </td><td>0.59 (0.553, 0.628) </td><td>0.583 (0.551, 0.61) </td><td>-0.01 (-0.026, 0.005)  </td></tr>\n",
       "\t<tr><td>ID            </td><td>phecode_011    </td><td>Klebsiella                                                                     </td><td>0.669 (0.636, 0.7)  </td><td>0.66 (0.628, 0.69)  </td><td>-0.01 (-0.041, 0.021)  </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_503-5  </td><td>Periapical abscess                                                             </td><td>0.454 (0.411, 0.487)</td><td>0.445 (0.402, 0.49) </td><td>-0.01 (-0.043, 0.033)  </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_712    </td><td>Other specific joint derangements                                              </td><td>0.547 (0.523, 0.565)</td><td>0.537 (0.518, 0.556)</td><td>-0.01 (-0.02, 0.004)   </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_719    </td><td>Disorders of muscle                                                            </td><td>0.57 (0.539, 0.596) </td><td>0.56 (0.532, 0.581) </td><td>-0.01 (-0.025, 0.009)  </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_500-4  </td><td>Disturbances in tooth eruption                                                 </td><td>0.588 (0.552, 0.631)</td><td>0.577 (0.537, 0.621)</td><td>-0.01 (-0.027, 0.007)  </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_721-2  </td><td>Ganglion cyst                                                                  </td><td>0.543 (0.515, 0.57) </td><td>0.533 (0.508, 0.558)</td><td>-0.01 (-0.028, 0.011)  </td></tr>\n",
       "\t<tr><td>Signs/Symptoms</td><td>phecode_841-13 </td><td>Allergy to sulfonamides                                                        </td><td>0.687 (0.666, 0.716)</td><td>0.678 (0.652, 0.703)</td><td>-0.01 (-0.02, 0.002)   </td></tr>\n",
       "\t<tr><td>Mental        </td><td>phecode_308-7  </td><td>Restlessness and agitation*                                                    </td><td>0.654 (0.603, 0.696)</td><td>0.641 (0.595, 0.683)</td><td>-0.009 (-0.038, 0.011) </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_602    </td><td>Other disorders of prostate                                                    </td><td>0.656 (0.637, 0.682)</td><td>0.647 (0.626, 0.673)</td><td>-0.009 (-0.024, 0.008) </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_416-5  </td><td>Premature depolarization [Premature beats]                                     </td><td>0.667 (0.639, 0.691)</td><td>0.659 (0.629, 0.679)</td><td>-0.009 (-0.018, 0)     </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_556-3  </td><td>Abdominal or pelvic swelling, mass, or lump                                    </td><td>0.601 (0.568, 0.636)</td><td>0.593 (0.551, 0.628)</td><td>-0.009 (-0.035, 0.017) </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_416-52 </td><td>Ventricular premature depolarization*                                          </td><td>0.654 (0.62, 0.681) </td><td>0.645 (0.613, 0.67) </td><td>-0.009 (-0.019, 0.002) </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_149    </td><td>Benign neoplasm of the endocrine glands                                        </td><td>0.593 (0.569, 0.616)</td><td>0.583 (0.554, 0.607)</td><td>-0.009 (-0.03, 0.011)  </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_614-1  </td><td>Pelvic peritoneal adhesions, female (postoperative) (postinfection)            </td><td>0.545 (0.507, 0.587)</td><td>0.536 (0.506, 0.569)</td><td>-0.009 (-0.031, 0.016) </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_596-3  </td><td>Diverticulum of bladder                                                        </td><td>0.72 (0.691, 0.756) </td><td>0.714 (0.677, 0.745)</td><td>-0.009 (-0.015, -0.003)</td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_500-41 </td><td>Impacted teeth*                                                                </td><td>0.576 (0.548, 0.611)</td><td>0.566 (0.531, 0.606)</td><td>-0.009 (-0.025, 0.011) </td></tr>\n",
       "\t<tr><td>Endo          </td><td>phecode_208-21 </td><td>Primary hyperparathyroidism                                                    </td><td>0.634 (0.608, 0.666)</td><td>0.627 (0.597, 0.656)</td><td>-0.008 (-0.032, 0.016) </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_381    </td><td>Strabismus                                                                     </td><td>0.596 (0.57, 0.634) </td><td>0.586 (0.555, 0.618)</td><td>-0.008 (-0.037, 0.014) </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_520-14 </td><td>Ventral hernia                                                                 </td><td>0.57 (0.547, 0.587) </td><td>0.561 (0.539, 0.581)</td><td>-0.008 (-0.025, 0.01)  </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_144-3  </td><td>Benign neoplasms of the ovary                                                  </td><td>0.49 (0.449, 0.529) </td><td>0.479 (0.449, 0.524)</td><td>-0.008 (-0.048, 0.03)  </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_592-12 </td><td>Chronic cystitis                                                               </td><td>0.55 (0.507, 0.589) </td><td>0.542 (0.509, 0.577)</td><td>-0.008 (-0.038, 0.02)  </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_622-2  </td><td>Mucous polyp of cervix                                                         </td><td>0.553 (0.521, 0.587)</td><td>0.543 (0.516, 0.574)</td><td>-0.008 (-0.041, 0.021) </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_624    </td><td>Symptoms involving female genital tract                                        </td><td>0.56 (0.534, 0.581) </td><td>0.551 (0.522, 0.578)</td><td>-0.008 (-0.026, 0.015) </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_488-8  </td><td>Mouth breathing*                                                               </td><td>0.57 (0.536, 0.611) </td><td>0.558 (0.523, 0.596)</td><td>-0.008 (-0.035, 0.021) </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_410    </td><td>Inflammation of the heart [Carditis]                                           </td><td>0.656 (0.622, 0.685)</td><td>0.647 (0.62, 0.678) </td><td>-0.008 (-0.032, 0.017) </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_708-12 </td><td>Primary osteoarthritis of knee, lower leg                                      </td><td>0.633 (0.617, 0.649)</td><td>0.626 (0.606, 0.642)</td><td>-0.007 (-0.014, 0.001) </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_514-3  </td><td>Ileus                                                                          </td><td>0.694 (0.664, 0.731)</td><td>0.682 (0.648, 0.723)</td><td>-0.007 (-0.03, 0.008)  </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_416-12 </td><td>Ventricular tachycardia                                                        </td><td>0.723 (0.689, 0.749)</td><td>0.715 (0.688, 0.746)</td><td>-0.007 (-0.02, 0.007)  </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_148    </td><td>Benign neoplasm of the eye, brain and other parts of central nervous system    </td><td>0.634 (0.6, 0.661)  </td><td>0.626 (0.598, 0.654)</td><td>-0.007 (-0.024, 0.014) </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_431-2  </td><td>Transient cerebral ischemic attacks                                            </td><td>0.71 (0.693, 0.737) </td><td>0.703 (0.688, 0.728)</td><td>-0.007 (-0.017, 0.003) </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_685-82 </td><td>Generalized hyperhidrosis                                                      </td><td>0.527 (0.485, 0.574)</td><td>0.52 (0.462, 0.565) </td><td>-0.007 (-0.056, 0.029) </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_628-2  </td><td>Corpus luteum cyst or hematoma                                                 </td><td>0.563 (0.536, 0.585)</td><td>0.554 (0.525, 0.582)</td><td>-0.007 (-0.023, 0.007) </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_599    </td><td>Other symptoms/disorders or the urinary system                                 </td><td>0.652 (0.636, 0.669)</td><td>0.645 (0.63, 0.66)  </td><td>-0.007 (-0.013, -0.002)</td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_417-1  </td><td>Palpitations                                                                   </td><td>0.583 (0.569, 0.599)</td><td>0.575 (0.562, 0.591)</td><td>-0.007 (-0.014, -0.002)</td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_433-2  </td><td>Occlusion and stenosis of precerebral arteries                                 </td><td>0.769 (0.748, 0.793)</td><td>0.763 (0.741, 0.784)</td><td>-0.007 (-0.02, 0.01)   </td></tr>\n",
       "\t<tr><td>Endo          </td><td>phecode_209    </td><td>Disorders of the pituitary gland and its hypothalamic control                  </td><td>0.613 (0.571, 0.646)</td><td>0.604 (0.569, 0.644)</td><td>-0.007 (-0.036, 0.019) </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_120-21 </td><td>Mature B-cell                                                                  </td><td>0.686 (0.666, 0.705)</td><td>0.679 (0.663, 0.7)  </td><td>-0.007 (-0.017, 0.004) </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_122-2  </td><td>Non-Hodgkin lymphoma                                                           </td><td>0.665 (0.64, 0.685) </td><td>0.659 (0.636, 0.678)</td><td>-0.006 (-0.017, 0.007) </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_120    </td><td>Hemo onc - by cell of origin                                                   </td><td>0.668 (0.654, 0.683)</td><td>0.662 (0.648, 0.679)</td><td>-0.006 (-0.012, -0.001)</td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_120-2  </td><td>Lymphoid                                                                       </td><td>0.674 (0.66, 0.692) </td><td>0.669 (0.65, 0.685) </td><td>-0.006 (-0.016, 0.003) </td></tr>\n",
       "\t<tr><td>Endo          </td><td>phecode_200-3  </td><td>Thyrotoxicosis [hyperthyroidism]                                               </td><td>0.63 (0.607, 0.653) </td><td>0.623 (0.599, 0.653)</td><td>-0.006 (-0.02, 0.006)  </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_416-11 </td><td>Supraventricular tachycardia                                                   </td><td>0.624 (0.602, 0.646)</td><td>0.618 (0.595, 0.642)</td><td>-0.006 (-0.02, 0.006)  </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_101-8  </td><td>Malignant neoplasm of the pancreas                                             </td><td>0.678 (0.645, 0.703)</td><td>0.673 (0.635, 0.697)</td><td>-0.006 (-0.028, 0.009) </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_144-13 </td><td>Benign neoplasms of the cervix                                                 </td><td>0.565 (0.533, 0.602)</td><td>0.557 (0.524, 0.595)</td><td>-0.005 (-0.028, 0.016) </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_708-11 </td><td>Primary osteoarthritis of hip, pelvic region and thigh                         </td><td>0.61 (0.59, 0.626)  </td><td>0.603 (0.587, 0.622)</td><td>-0.005 (-0.014, 0.002) </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_324-1  </td><td>Parkinsonism                                                                   </td><td>0.732 (0.709, 0.748)</td><td>0.726 (0.705, 0.743)</td><td>-0.005 (-0.012, 0.003) </td></tr>\n",
       "\t<tr><td>Hearing       </td><td>phecode_396-2  </td><td>Sensorineural hearing loss                                                     </td><td>0.636 (0.613, 0.667)</td><td>0.629 (0.608, 0.662)</td><td>-0.005 (-0.019, 0.009) </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_324-11 </td><td>Parkinson's disease (Primary)                                                  </td><td>0.735 (0.721, 0.753)</td><td>0.731 (0.714, 0.746)</td><td>-0.005 (-0.011, 0.001) </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_714    </td><td>Deforming dorsopathies                                                         </td><td>0.696 (0.671, 0.715)</td><td>0.689 (0.67, 0.714) </td><td>-0.005 (-0.015, 0.005) </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_433-21 </td><td>Carotid artery stenosis                                                        </td><td>0.767 (0.749, 0.794)</td><td>0.761 (0.742, 0.792)</td><td>-0.005 (-0.022, 0.008) </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_622-1  </td><td>Polyp of corpus uteri                                                          </td><td>0.523 (0.508, 0.537)</td><td>0.52 (0.501, 0.533) </td><td>-0.005 (-0.016, 0.006) </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_618-11 </td><td>Cystocele                                                                      </td><td>0.585 (0.565, 0.602)</td><td>0.579 (0.562, 0.596)</td><td>-0.005 (-0.011, 0.003) </td></tr>\n",
       "\t<tr><td>ID            </td><td>phecode_095    </td><td>Sequela of infection                                                           </td><td>0.536 (0.502, 0.574)</td><td>0.529 (0.499, 0.566)</td><td>-0.005 (-0.026, 0.021) </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_622    </td><td>Polyp of female genital organs                                                 </td><td>0.534 (0.517, 0.553)</td><td>0.53 (0.515, 0.547) </td><td>-0.005 (-0.017, 0.009) </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_471-2  </td><td>Deviated nasal septum                                                          </td><td>0.617 (0.591, 0.649)</td><td>0.613 (0.584, 0.646)</td><td>-0.005 (-0.01, 0.002)  </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_460-1  </td><td>Acute upper respiratory infection                                              </td><td>0.523 (0.5, 0.544)  </td><td>0.518 (0.494, 0.535)</td><td>-0.004 (-0.025, 0.012) </td></tr>\n",
       "\t<tr><td>Blood         </td><td>phecode_170-1  </td><td>Neutropenia                                                                    </td><td>0.623 (0.605, 0.638)</td><td>0.619 (0.599, 0.633)</td><td>-0.004 (-0.015, 0.007) </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_473    </td><td>Other diseases of upper respiratory tract                                      </td><td>0.531 (0.499, 0.578)</td><td>0.529 (0.484, 0.573)</td><td>-0.004 (-0.037, 0.02)  </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_685-8  </td><td>Hyperhidrosis                                                                  </td><td>0.524 (0.487, 0.572)</td><td>0.524 (0.46, 0.573) </td><td>-0.004 (-0.044, 0.032) </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_106    </td><td>Gynecological malignant neoplasms                                              </td><td>0.58 (0.564, 0.602) </td><td>0.574 (0.56, 0.601) </td><td>-0.004 (-0.014, 0.004) </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_594-4  </td><td>Frequency of urination and polyuria                                            </td><td>0.631 (0.611, 0.655)</td><td>0.626 (0.605, 0.652)</td><td>-0.004 (-0.009, 0.002) </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_328-1  </td><td>Alzheimer's disease                                                            </td><td>0.812 (0.793, 0.829)</td><td>0.808 (0.788, 0.826)</td><td>-0.004 (-0.009, 0)     </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_503    </td><td>Diseases of pulp and periapical tissues                                        </td><td>0.435 (0.404, 0.465)</td><td>0.432 (0.402, 0.47) </td><td>-0.004 (-0.036, 0.029) </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_676-2  </td><td>Scar conditions and fibrosis of skin                                           </td><td>0.533 (0.503, 0.556)</td><td>0.526 (0.497, 0.552)</td><td>-0.004 (-0.026, 0.023) </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_416-7  </td><td>Sinoatrial node dysfunction                                                    </td><td>0.736 (0.704, 0.771)</td><td>0.73 (0.703, 0.765) </td><td>-0.004 (-0.016, 0.007) </td></tr>\n",
       "\t<tr><td>Blood         </td><td>phecode_170    </td><td>Decreased white blood cell count                                               </td><td>0.624 (0.606, 0.641)</td><td>0.62 (0.597, 0.636) </td><td>-0.004 (-0.018, 0.006) </td></tr>\n",
       "\t<tr><td>Blood         </td><td>phecode_162    </td><td>Aplastic anemia                                                                </td><td>0.664 (0.634, 0.7)  </td><td>0.66 (0.629, 0.699) </td><td>-0.004 (-0.033, 0.024) </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_416-43 </td><td>Right bundle branch block                                                      </td><td>0.706 (0.694, 0.724)</td><td>0.702 (0.687, 0.721)</td><td>-0.004 (-0.009, 0.001) </td></tr>\n",
       "\t<tr><td>Signs/Symptoms</td><td>phecode_814    </td><td>Jaundice (not of newborn)                                                      </td><td>0.599 (0.562, 0.627)</td><td>0.595 (0.554, 0.623)</td><td>-0.004 (-0.03, 0.028)  </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_510-8  </td><td>Barrett's esophagus                                                            </td><td>0.657 (0.643, 0.666)</td><td>0.653 (0.64, 0.662) </td><td>-0.004 (-0.008, 0)     </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_108-5  </td><td>Malignant neoplasm of the bladder                                              </td><td>0.743 (0.721, 0.764)</td><td>0.739 (0.718, 0.764)</td><td>-0.004 (-0.009, 0.004) </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_416-71 </td><td>Sick sinus syndrome*                                                           </td><td>0.73 (0.697, 0.765) </td><td>0.726 (0.7, 0.762)  </td><td>-0.004 (-0.015, 0.01)  </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_471    </td><td>Other disorders of nose and nasal sinuses                                      </td><td>0.573 (0.555, 0.592)</td><td>0.57 (0.551, 0.589) </td><td>-0.003 (-0.013, 0.005) </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_518    </td><td>Appendicitis                                                                   </td><td>0.55 (0.529, 0.578) </td><td>0.546 (0.526, 0.571)</td><td>-0.003 (-0.02, 0.017)  </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_596-1  </td><td>Bladder neck obstruction                                                       </td><td>0.793 (0.772, 0.822)</td><td>0.791 (0.769, 0.818)</td><td>-0.003 (-0.011, 0.004) </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_614    </td><td>Inflammatory diseases of female pelvic organs                                  </td><td>0.537 (0.513, 0.562)</td><td>0.535 (0.5, 0.561)  </td><td>-0.003 (-0.021, 0.009) </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_504-3  </td><td>Periodontitis                                                                  </td><td>0.542 (0.501, 0.587)</td><td>0.537 (0.499, 0.576)</td><td>-0.003 (-0.037, 0.025) </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_139-53 </td><td>Lipoma of other skin subcutaneous tissue                                       </td><td>0.516 (0.493, 0.549)</td><td>0.513 (0.484, 0.536)</td><td>-0.003 (-0.017, 0.012) </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_413-6  </td><td>Heart valve replaced                                                           </td><td>0.726 (0.706, 0.75) </td><td>0.723 (0.702, 0.744)</td><td>-0.003 (-0.012, 0.006) </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_362    </td><td>Other disorders of the eyelids                                                 </td><td>0.582 (0.555, 0.605)</td><td>0.579 (0.551, 0.603)</td><td>-0.003 (-0.015, 0.008) </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_136-2  </td><td>Benign neoplasm of stomach                                                     </td><td>0.629 (0.617, 0.641)</td><td>0.626 (0.614, 0.637)</td><td>-0.003 (-0.006, 0)     </td></tr>\n",
       "\t<tr><td>ID            </td><td>phecode_089-3  </td><td>Fungal infections                                                              </td><td>0.649 (0.635, 0.663)</td><td>0.647 (0.626, 0.665)</td><td>-0.003 (-0.015, 0.012) </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_626-14 </td><td>Irregular menstrual bleeding                                                   </td><td>0.863 (0.851, 0.874)</td><td>0.86 (0.846, 0.873) </td><td>-0.003 (-0.011, 0.005) </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_101-6  </td><td>Malignant neoplasm of the liver and intrahepatic bile ducts                    </td><td>0.729 (0.698, 0.762)</td><td>0.727 (0.682, 0.764)</td><td>-0.003 (-0.028, 0.019) </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_619-3  </td><td>Noninflammatory disorders of cervix                                            </td><td>0.5 (0.465, 0.527)  </td><td>0.496 (0.46, 0.533) </td><td>-0.003 (-0.024, 0.018) </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_627    </td><td>Menopausal and postmenopausal disorders                                        </td><td>0.655 (0.643, 0.666)</td><td>0.652 (0.639, 0.664)</td><td>-0.003 (-0.006, 0.001) </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_122    </td><td>Lymphoma                                                                       </td><td>0.663 (0.642, 0.68) </td><td>0.659 (0.638, 0.678)</td><td>-0.003 (-0.012, 0.007) </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_101-1  </td><td>Malignant neoplasm of the esophagus                                            </td><td>0.725 (0.701, 0.754)</td><td>0.723 (0.699, 0.753)</td><td>-0.003 (-0.018, 0.012) </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_417-3  </td><td>Bradycardia*                                                                   </td><td>0.687 (0.675, 0.703)</td><td>0.684 (0.674, 0.703)</td><td>-0.003 (-0.007, 0.004) </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_386-2  </td><td>Diplopia                                                                       </td><td>0.578 (0.535, 0.618)</td><td>0.578 (0.536, 0.611)</td><td>-0.003 (-0.026, 0.027) </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_116-3  </td><td>Secondary malignant neoplasm of digestive systems                              </td><td>0.635 (0.611, 0.655)</td><td>0.632 (0.606, 0.654)</td><td>-0.003 (-0.016, 0.011) </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_440-3  </td><td>Pulmonary embolism                                                             </td><td>0.634 (0.617, 0.649)</td><td>0.633 (0.617, 0.648)</td><td>-0.002 (-0.01, 0.009)  </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_592-1  </td><td>Cystitis                                                                       </td><td>0.618 (0.597, 0.641)</td><td>0.615 (0.595, 0.637)</td><td>-0.002 (-0.015, 0.014) </td></tr>\n",
       "\t<tr><td>Endo          </td><td>phecode_208    </td><td>Disorders of parathyroid gland                                                 </td><td>0.642 (0.614, 0.668)</td><td>0.64 (0.612, 0.666) </td><td>-0.002 (-0.021, 0.015) </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_705-3  </td><td>Polymyalgia rheumatica                                                         </td><td>0.738 (0.72, 0.751) </td><td>0.735 (0.716, 0.751)</td><td>-0.002 (-0.008, 0.003) </td></tr>\n",
       "\t<tr><td>ID            </td><td>phecode_070    </td><td>Candidiasis                                                                    </td><td>0.645 (0.628, 0.665)</td><td>0.643 (0.624, 0.66) </td><td>-0.002 (-0.013, 0.011) </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_513-3  </td><td>Duodenal ulcer                                                                 </td><td>0.623 (0.601, 0.65) </td><td>0.623 (0.601, 0.644)</td><td>-0.002 (-0.015, 0.012) </td></tr>\n",
       "\t<tr><td>Cong          </td><td>phecode_773    </td><td>Congenital malformation of kidney                                              </td><td>0.592 (0.532, 0.631)</td><td>0.588 (0.538, 0.631)</td><td>-0.002 (-0.033, 0.023) </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_618-12 </td><td>Rectocele                                                                      </td><td>0.566 (0.542, 0.587)</td><td>0.564 (0.542, 0.583)</td><td>-0.002 (-0.01, 0.011)  </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_618-1  </td><td>Prolapse of vaginal walls                                                      </td><td>0.58 (0.568, 0.595) </td><td>0.578 (0.566, 0.594)</td><td>-0.002 (-0.009, 0.003) </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_105    </td><td>Malignant neoplasm of the breast                                               </td><td>0.765 (0.759, 0.773)</td><td>0.764 (0.758, 0.771)</td><td>-0.002 (-0.003, -0.001)</td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_676    </td><td>Hypertrophic conditions of skin                                                </td><td>0.505 (0.486, 0.531)</td><td>0.505 (0.483, 0.524)</td><td>-0.002 (-0.021, 0.019) </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_594-1  </td><td>Retention of urine                                                             </td><td>0.734 (0.726, 0.743)</td><td>0.732 (0.724, 0.741)</td><td>-0.002 (-0.004, 0)     </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_328-9  </td><td>Dementia NOS                                                                   </td><td>0.783 (0.768, 0.805)</td><td>0.78 (0.764, 0.798) </td><td>-0.002 (-0.01, 0.005)  </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_416-42 </td><td>Left bundle branch block                                                       </td><td>0.729 (0.71, 0.746) </td><td>0.726 (0.709, 0.743)</td><td>-0.002 (-0.009, 0.004) </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_615    </td><td>Endometriosis                                                                  </td><td>0.703 (0.673, 0.741)</td><td>0.7 (0.676, 0.736)  </td><td>-0.002 (-0.012, 0.01)  </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_592    </td><td>Cystitis and urethritis                                                        </td><td>0.622 (0.599, 0.646)</td><td>0.619 (0.598, 0.642)</td><td>-0.002 (-0.012, 0.008) </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_626-1  </td><td>Irregular menstrual cycle/bleeding                                             </td><td>0.847 (0.836, 0.861)</td><td>0.847 (0.835, 0.858)</td><td>-0.002 (-0.008, 0.004) </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_438-1  </td><td>Aortic aneurysm and ectasia                                                    </td><td>0.793 (0.777, 0.813)</td><td>0.792 (0.776, 0.814)</td><td>-0.002 (-0.01, 0.006)  </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_101-4  </td><td>Malignant neoplasm of the colon and rectum                                     </td><td>0.683 (0.672, 0.696)</td><td>0.682 (0.669, 0.695)</td><td>-0.002 (-0.007, 0.003) </td></tr>\n",
       "\t<tr><td>Endo          </td><td>phecode_208-2  </td><td>Hyperparathyroidism                                                            </td><td>0.637 (0.613, 0.667)</td><td>0.636 (0.604, 0.665)</td><td>-0.002 (-0.016, 0.014) </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_532    </td><td>Other disorders of the intestines                                              </td><td>0.559 (0.541, 0.573)</td><td>0.557 (0.539, 0.571)</td><td>-0.001 (-0.015, 0.01)  </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_618    </td><td>Genital prolapse                                                               </td><td>0.588 (0.575, 0.603)</td><td>0.586 (0.575, 0.599)</td><td>-0.001 (-0.006, 0.003) </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_328    </td><td>Dementias and cerebral degeneration                                            </td><td>0.788 (0.779, 0.803)</td><td>0.787 (0.777, 0.801)</td><td>-0.001 (-0.009, 0.004) </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_101-41 </td><td>Malignant neoplasm of the colon                                                </td><td>0.685 (0.671, 0.7)  </td><td>0.682 (0.669, 0.7)  </td><td>-0.001 (-0.006, 0.005) </td></tr>\n",
       "\t<tr><td>Signs/Symptoms</td><td>phecode_840    </td><td>Allergy                                                                        </td><td>0.563 (0.549, 0.576)</td><td>0.562 (0.552, 0.573)</td><td>-0.001 (-0.007, 0.004) </td></tr>\n",
       "\t<tr><td>Signs/Symptoms</td><td>phecode_808    </td><td>Syncope and collapse                                                           </td><td>0.637 (0.626, 0.648)</td><td>0.636 (0.624, 0.646)</td><td>-0.001 (-0.005, 0.004) </td></tr>\n",
       "\t<tr><td>Mental        </td><td>phecode_290    </td><td>Reaction to severe stress, and adjustment disorders                            </td><td>0.632 (0.595, 0.675)</td><td>0.635 (0.597, 0.674)</td><td>-0.001 (-0.034, 0.044) </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_593    </td><td>Hematuria                                                                      </td><td>0.646 (0.633, 0.658)</td><td>0.646 (0.633, 0.658)</td><td>-0.001 (-0.004, 0.002) </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_594    </td><td>Abnormality of urination                                                       </td><td>0.661 (0.655, 0.67) </td><td>0.661 (0.654, 0.668)</td><td>-0.001 (-0.004, 0.002) </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_517    </td><td>Gastrointestinal angiodysplasia                                                </td><td>0.703 (0.672, 0.73) </td><td>0.703 (0.665, 0.729)</td><td>-0.001 (-0.024, 0.021) </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_709-21 </td><td>Hallux valgus (Bunion)                                                         </td><td>0.695 (0.684, 0.704)</td><td>0.693 (0.682, 0.704)</td><td>-0.001 (-0.006, 0.003) </td></tr>\n",
       "\t<tr><td>Blood         </td><td>phecode_174-2  </td><td>Splenomegaly                                                                   </td><td>0.648 (0.606, 0.696)</td><td>0.645 (0.593, 0.686)</td><td>-0.001 (-0.06, 0.053)  </td></tr>\n",
       "\t<tr><td>Hearing       </td><td>phecode_394-2  </td><td>Vertigo                                                                        </td><td>0.625 (0.597, 0.658)</td><td>0.624 (0.589, 0.66) </td><td>-0.001 (-0.031, 0.023) </td></tr>\n",
       "\t<tr><td>Blood         </td><td>phecode_174    </td><td>Diseases of spleen                                                             </td><td>0.605 (0.577, 0.641)</td><td>0.602 (0.574, 0.636)</td><td>-0.001 (-0.033, 0.032) </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_416-1  </td><td>Paroxysmal tachycardia                                                         </td><td>0.642 (0.63, 0.659) </td><td>0.641 (0.627, 0.658)</td><td>-0.001 (-0.012, 0.01)  </td></tr>\n",
       "\t<tr><td>Metab         </td><td>phecode_256-2  </td><td>Hyposmolality and/or hyponatremia                                              </td><td>0.693 (0.678, 0.705)</td><td>0.692 (0.677, 0.704)</td><td>-0.001 (-0.009, 0.006) </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_404-11 </td><td>Acute myocardial infarction                                                    </td><td>0.703 (0.694, 0.715)</td><td>0.702 (0.693, 0.714)</td><td>-0.001 (-0.006, 0.005) </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_132    </td><td>Sequelae of cancer                                                             </td><td>0.739 (0.727, 0.752)</td><td>0.737 (0.725, 0.751)</td><td>-0.001 (-0.005, 0.003) </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_107    </td><td>Malignant neoplasm of male genitalia                                           </td><td>0.686 (0.676, 0.698)</td><td>0.685 (0.674, 0.697)</td><td>-0.001 (-0.003, 0.001) </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_406-1  </td><td>Pulmonary hypertension                                                         </td><td>0.74 (0.717, 0.76)  </td><td>0.739 (0.713, 0.765)</td><td>-0.001 (-0.016, 0.016) </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_107-2  </td><td>Malignant neoplasm of the prostate                                             </td><td>0.691 (0.681, 0.7)  </td><td>0.69 (0.68, 0.698)  </td><td>-0.001 (-0.002, 0.001) </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_627-4  </td><td>Menorrhagia/Excessive and frequent menstruation                                </td><td>0.875 (0.869, 0.882)</td><td>0.875 (0.867, 0.881)</td><td>-0.001 (-0.003, 0.002) </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_416-21 </td><td>Atrial fibrillation                                                            </td><td>0.699 (0.69, 0.712) </td><td>0.699 (0.689, 0.712)</td><td>-0.001 (-0.006, 0.005) </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_708-1  </td><td>Primary osteoarthritis                                                         </td><td>0.606 (0.593, 0.617)</td><td>0.605 (0.594, 0.615)</td><td>-0.001 (-0.005, 0.004) </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_416-41 </td><td>Atrioventricular block                                                         </td><td>0.76 (0.748, 0.773) </td><td>0.759 (0.746, 0.771)</td><td>0 (-0.005, 0.002)      </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_510    </td><td>Diseases of esophagus                                                          </td><td>0.599 (0.592, 0.606)</td><td>0.599 (0.591, 0.606)</td><td>0 (-0.004, 0.005)      </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_600    </td><td>Benign prostatic hyperplasia                                                   </td><td>0.693 (0.685, 0.7)  </td><td>0.693 (0.685, 0.7)  </td><td>0 (-0.002, 0.001)      </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_101-42 </td><td>Malignant neoplasm of the rectum                                               </td><td>0.683 (0.647, 0.712)</td><td>0.68 (0.652, 0.709) </td><td>0 (-0.01, 0.008)       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_520-11 </td><td>Inguinal hernia                                                                </td><td>0.799 (0.791, 0.804)</td><td>0.799 (0.791, 0.804)</td><td>0 (0, 0)               </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_520-1  </td><td>Hernia of the abdominal wall                                                   </td><td>0.724 (0.717, 0.732)</td><td>0.724 (0.717, 0.732)</td><td>0 (-0.001, 0.001)      </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_135-5  </td><td>Benign neoplasm of the paranasal sinus and nasal cavity                        </td><td>0.62 (0.588, 0.649) </td><td>0.62 (0.596, 0.645) </td><td>0 (-0.01, 0.012)       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_552-2  </td><td>Obstruction of bile duct                                                       </td><td>0.648 (0.618, 0.673)</td><td>0.647 (0.611, 0.676)</td><td>0 (-0.019, 0.019)      </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_471-5  </td><td>Nasal polyps                                                                   </td><td>0.617 (0.591, 0.653)</td><td>0.618 (0.595, 0.644)</td><td>0 (-0.014, 0.014)      </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_416-211</td><td>Paroxysmal atrial fibrillation*                                                </td><td>0.697 (0.683, 0.709)</td><td>0.697 (0.682, 0.71) </td><td>0 (-0.007, 0.006)      </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_116-4  </td><td>Secondary malignant neoplasm of liver                                          </td><td>0.665 (0.65, 0.679) </td><td>0.664 (0.65, 0.681) </td><td>0 (-0.007, 0.007)      </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_413-11 </td><td>Mitral valve insufficiency                                                     </td><td>0.696 (0.682, 0.713)</td><td>0.696 (0.677, 0.713)</td><td>0 (-0.007, 0.008)      </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_101    </td><td>Malignant neoplasm of the digestive organs                                     </td><td>0.675 (0.665, 0.684)</td><td>0.676 (0.666, 0.682)</td><td>0 (-0.004, 0.004)      </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_626    </td><td>Disorders of menstruation and other abnormal bleeding from female genital tract</td><td>0.798 (0.78, 0.815) </td><td>0.8 (0.779, 0.815)  </td><td>0 (-0.005, 0.005)      </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_444-11 </td><td>Varicose veins of lower extremities                                            </td><td>0.579 (0.565, 0.593)</td><td>0.578 (0.565, 0.593)</td><td>0 (-0.008, 0.01)       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_604    </td><td>Disorders of penis                                                             </td><td>0.568 (0.541, 0.588)</td><td>0.566 (0.54, 0.593) </td><td>0 (-0.021, 0.021)      </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_529-3  </td><td>Fecal incontinence                                                             </td><td>0.638 (0.611, 0.656)</td><td>0.637 (0.62, 0.657) </td><td>0.001 (-0.015, 0.015)  </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_400    </td><td>Rheumatic fever and chronic rheumatic heart diseases                           </td><td>0.72 (0.709, 0.731) </td><td>0.721 (0.707, 0.734)</td><td>0.001 (-0.005, 0.008)  </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_552    </td><td>Other diseases of biliary tract                                                </td><td>0.616 (0.591, 0.642)</td><td>0.615 (0.594, 0.636)</td><td>0.001 (-0.015, 0.011)  </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_136-42 </td><td>Benign neoplasm of rectum and anus                                             </td><td>0.59 (0.579, 0.599) </td><td>0.591 (0.578, 0.6)  </td><td>0.001 (-0.004, 0.005)  </td></tr>\n",
       "\t<tr><td>Hearing       </td><td>phecode_391-1  </td><td>Otitis media                                                                   </td><td>0.541 (0.493, 0.577)</td><td>0.541 (0.512, 0.572)</td><td>0.001 (-0.032, 0.045)  </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_668-4  </td><td>Dermatitis due to substances taken internally                                  </td><td>0.509 (0.461, 0.556)</td><td>0.511 (0.459, 0.551)</td><td>0.001 (-0.054, 0.053)  </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_446-2  </td><td>Orthostatic hypotension                                                        </td><td>0.707 (0.688, 0.721)</td><td>0.708 (0.691, 0.722)</td><td>0.001 (-0.009, 0.013)  </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_413-32 </td><td>Tricuspid value insufficiency*                                                 </td><td>0.703 (0.682, 0.735)</td><td>0.707 (0.682, 0.741)</td><td>0.001 (-0.014, 0.027)  </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_416-212</td><td>Persistent atrial fibrillation*                                                </td><td>0.679 (0.652, 0.707)</td><td>0.68 (0.655, 0.72)  </td><td>0.001 (-0.02, 0.022)   </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_438-11 </td><td>Abdominal aortic aneurysm                                                      </td><td>0.845 (0.826, 0.858)</td><td>0.845 (0.829, 0.862)</td><td>0.001 (-0.01, 0.012)   </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_116    </td><td>Secondary malignant neoplasm                                                   </td><td>0.656 (0.649, 0.666)</td><td>0.657 (0.648, 0.667)</td><td>0.001 (-0.004, 0.006)  </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_514-2  </td><td>Intestinal obstruction                                                         </td><td>0.606 (0.58, 0.625) </td><td>0.607 (0.585, 0.626)</td><td>0.001 (-0.012, 0.015)  </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_520    </td><td>Hernia                                                                         </td><td>0.624 (0.619, 0.63) </td><td>0.625 (0.62, 0.631) </td><td>0.001 (-0.001, 0.003)  </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_416-4  </td><td>Heart block                                                                    </td><td>0.73 (0.722, 0.74)  </td><td>0.732 (0.722, 0.74) </td><td>0.001 (-0.002, 0.004)  </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_480    </td><td>Pulmonary edema                                                                </td><td>0.673 (0.642, 0.707)</td><td>0.672 (0.638, 0.712)</td><td>0.001 (-0.022, 0.028)  </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_709-24 </td><td>Hammer toe                                                                     </td><td>0.706 (0.682, 0.722)</td><td>0.707 (0.684, 0.724)</td><td>0.001 (-0.005, 0.008)  </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_144-2  </td><td>Benign neoplasms of the uterus                                                 </td><td>0.61 (0.597, 0.621) </td><td>0.611 (0.598, 0.624)</td><td>0.001 (-0.005, 0.006)  </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_580-3  </td><td>Nephrotic syndrome                                                             </td><td>0.539 (0.495, 0.58) </td><td>0.54 (0.5, 0.581)   </td><td>0.001 (-0.033, 0.03)   </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_400-2  </td><td>Chronic rheumatic heart diseases                                               </td><td>0.721 (0.711, 0.733)</td><td>0.723 (0.71, 0.734) </td><td>0.001 (-0.007, 0.007)  </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_130    </td><td>Cancer (solid tumor, excluding BCC)                                            </td><td>0.644 (0.64, 0.648) </td><td>0.645 (0.642, 0.649)</td><td>0.001 (0, 0.003)       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_103-1  </td><td>Melanomas of skin                                                              </td><td>0.592 (0.574, 0.613)</td><td>0.593 (0.574, 0.616)</td><td>0.001 (-0.012, 0.013)  </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_670    </td><td>Seborrheic keratosis                                                           </td><td>0.615 (0.591, 0.637)</td><td>0.617 (0.594, 0.638)</td><td>0.001 (-0.007, 0.011)  </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_136    </td><td>Benign neoplasm of the digestive organs                                        </td><td>0.587 (0.581, 0.594)</td><td>0.588 (0.582, 0.595)</td><td>0.001 (-0.001, 0.003)  </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_403    </td><td>Angina pectoris                                                                </td><td>0.682 (0.676, 0.69) </td><td>0.684 (0.676, 0.692)</td><td>0.001 (-0.003, 0.007)  </td></tr>\n",
       "\t<tr><td>Metab         </td><td>phecode_230-3  </td><td>Anorexia                                                                       </td><td>0.644 (0.616, 0.677)</td><td>0.649 (0.615, 0.678)</td><td>0.001 (-0.018, 0.028)  </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_619    </td><td>Noninflammatory female genital disorders                                       </td><td>0.496 (0.48, 0.512) </td><td>0.499 (0.48, 0.513) </td><td>0.001 (-0.008, 0.013)  </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_510-2  </td><td>Esophagitis                                                                    </td><td>0.585 (0.578, 0.595)</td><td>0.586 (0.579, 0.595)</td><td>0.001 (-0.004, 0.007)  </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_594-2  </td><td>Dysuria                                                                        </td><td>0.588 (0.55, 0.619) </td><td>0.592 (0.558, 0.621)</td><td>0.001 (-0.024, 0.028)  </td></tr>\n",
       "\t<tr><td>Endo          </td><td>phecode_200-13 </td><td>Postprocedural hypothyroidism                                                  </td><td>0.663 (0.638, 0.683)</td><td>0.663 (0.639, 0.69) </td><td>0.001 (-0.009, 0.013)  </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_112    </td><td>Malignant neoplasm of other and ill-defined sites                              </td><td>0.656 (0.649, 0.663)</td><td>0.657 (0.65, 0.665) </td><td>0.001 (-0.001, 0.003)  </td></tr>\n",
       "\t<tr><td>Endo          </td><td>phecode_200-2  </td><td>Goiter                                                                         </td><td>0.661 (0.638, 0.679)</td><td>0.661 (0.642, 0.681)</td><td>0.002 (-0.01, 0.01)    </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_144    </td><td>Gynecological benign neoplasms                                                 </td><td>0.6 (0.588, 0.611)  </td><td>0.601 (0.588, 0.611)</td><td>0.002 (-0.005, 0.007)  </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_722    </td><td>Fasciopathy                                                                    </td><td>0.675 (0.657, 0.689)</td><td>0.676 (0.656, 0.69) </td><td>0.002 (-0.003, 0.007)  </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_722-4  </td><td>Palmar fascial fibromatosis [Dupuytren]                                        </td><td>0.717 (0.704, 0.736)</td><td>0.719 (0.704, 0.735)</td><td>0.002 (-0.003, 0.006)  </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_523    </td><td>Diverticular disease [Bowel diverticulosis]                                    </td><td>0.629 (0.624, 0.634)</td><td>0.631 (0.626, 0.635)</td><td>0.002 (0, 0.004)       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_709    </td><td>Acquired deformities of fingers and toes                                       </td><td>0.671 (0.66, 0.682) </td><td>0.672 (0.663, 0.683)</td><td>0.002 (-0.002, 0.006)  </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_557    </td><td>Gastrointestinal hemorrhage                                                    </td><td>0.551 (0.541, 0.561)</td><td>0.552 (0.542, 0.56) </td><td>0.002 (-0.006, 0.008)  </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_530    </td><td>Disease of anus and rectum                                                     </td><td>0.565 (0.55, 0.58)  </td><td>0.567 (0.552, 0.58) </td><td>0.002 (-0.008, 0.011)  </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_478    </td><td>Aspiration pneumonia                                                           </td><td>0.736 (0.713, 0.756)</td><td>0.736 (0.711, 0.754)</td><td>0.002 (-0.016, 0.017)  </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_523-2  </td><td>Diverticula of colon                                                           </td><td>0.629 (0.623, 0.634)</td><td>0.631 (0.626, 0.636)</td><td>0.002 (0, 0.003)       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_116-1  </td><td>Secondary malignancy of lymph nodes                                            </td><td>0.614 (0.603, 0.628)</td><td>0.615 (0.604, 0.626)</td><td>0.002 (-0.008, 0.009)  </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_529    </td><td>Symptoms involving digestive system                                            </td><td>0.592 (0.586, 0.598)</td><td>0.594 (0.589, 0.599)</td><td>0.002 (-0.002, 0.005)  </td></tr>\n",
       "\t<tr><td>Hearing       </td><td>phecode_394    </td><td>Disorders of vestibular function                                               </td><td>0.632 (0.608, 0.66) </td><td>0.635 (0.609, 0.662)</td><td>0.002 (-0.014, 0.017)  </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_139    </td><td>Benign sarcoma-related cancers                                                 </td><td>0.541 (0.521, 0.553)</td><td>0.542 (0.523, 0.555)</td><td>0.002 (-0.006, 0.009)  </td></tr>\n",
       "\t<tr><td>Endo          </td><td>phecode_200    </td><td>Disorders of thyroid gland                                                     </td><td>0.669 (0.66, 0.677) </td><td>0.67 (0.663, 0.68)  </td><td>0.002 (0, 0.004)       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_709-2  </td><td>Acquired deformities of toe                                                    </td><td>0.674 (0.663, 0.685)</td><td>0.676 (0.668, 0.686)</td><td>0.002 (-0.002, 0.006)  </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_618-2  </td><td>Uterine/Uterovaginal prolapse                                                  </td><td>0.585 (0.569, 0.606)</td><td>0.588 (0.571, 0.607)</td><td>0.002 (-0.01, 0.015)   </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_413-2  </td><td>Aortic valve disorders                                                         </td><td>0.744 (0.733, 0.756)</td><td>0.746 (0.734, 0.758)</td><td>0.002 (-0.005, 0.007)  </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_469    </td><td>Bronchitis                                                                     </td><td>0.607 (0.583, 0.633)</td><td>0.609 (0.589, 0.637)</td><td>0.002 (-0.015, 0.022)  </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_714-3  </td><td>Scoliosis                                                                      </td><td>0.718 (0.696, 0.739)</td><td>0.72 (0.698, 0.743) </td><td>0.002 (-0.009, 0.011)  </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_514-1  </td><td>Esophageal obstruction (Stricture and stenosis of esophagus)                   </td><td>0.628 (0.611, 0.645)</td><td>0.628 (0.612, 0.649)</td><td>0.002 (-0.01, 0.011)   </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_431    </td><td>Stroke and transient cerebral ischemic attacks                                 </td><td>0.703 (0.691, 0.711)</td><td>0.705 (0.695, 0.715)</td><td>0.002 (-0.004, 0.01)   </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_597    </td><td>Other disorders of urethra and urinary tract                                   </td><td>0.624 (0.599, 0.64) </td><td>0.627 (0.603, 0.644)</td><td>0.002 (-0.005, 0.011)  </td></tr>\n",
       "\t<tr><td>Metab         </td><td>phecode_232-27 </td><td>Vitamin B12 deficiency                                                         </td><td>0.606 (0.577, 0.64) </td><td>0.61 (0.571, 0.638) </td><td>0.003 (-0.035, 0.04)   </td></tr>\n",
       "\t<tr><td>Endo          </td><td>phecode_200-1  </td><td>Hypothyroidism                                                                 </td><td>0.672 (0.663, 0.678)</td><td>0.674 (0.665, 0.682)</td><td>0.003 (0.001, 0.005)   </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_136-4  </td><td>Benign neoplasm of colon, rectum, anus and anal canal                          </td><td>0.588 (0.582, 0.593)</td><td>0.59 (0.584, 0.596) </td><td>0.003 (0, 0.005)       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_556    </td><td>Other symptoms involving the digestive system and abdomen                      </td><td>0.599 (0.582, 0.614)</td><td>0.602 (0.583, 0.618)</td><td>0.003 (-0.009, 0.012)  </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_727    </td><td>Other disorders of bone                                                        </td><td>0.645 (0.629, 0.659)</td><td>0.647 (0.632, 0.661)</td><td>0.003 (-0.003, 0.01)   </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_685    </td><td>Disorders of sweat glands                                                      </td><td>0.558 (0.51, 0.588) </td><td>0.553 (0.514, 0.597)</td><td>0.003 (-0.033, 0.039)  </td></tr>\n",
       "\t<tr><td>Endo          </td><td>phecode_200-14 </td><td>Hypothyroidism, not specified as secondary                                     </td><td>0.671 (0.664, 0.68) </td><td>0.674 (0.667, 0.682)</td><td>0.003 (0, 0.005)       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_136-41 </td><td>Benign neoplasm of the colon                                                   </td><td>0.602 (0.597, 0.609)</td><td>0.605 (0.599, 0.611)</td><td>0.003 (0.001, 0.006)   </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_436    </td><td>Atherosclerosis [ASCVD]                                                        </td><td>0.714 (0.705, 0.72) </td><td>0.716 (0.709, 0.723)</td><td>0.003 (-0.001, 0.005)  </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_520-2  </td><td>Diaphragmatic hernia [Hiatal hernia]                                           </td><td>0.608 (0.602, 0.613)</td><td>0.61 (0.604, 0.617) </td><td>0.003 (0, 0.006)       </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_353    </td><td>Symptoms and signs involving general sensations and perceptions                </td><td>0.623 (0.595, 0.659)</td><td>0.627 (0.593, 0.655)</td><td>0.003 (-0.033, 0.031)  </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_585    </td><td>Kidney stone disease                                                           </td><td>0.643 (0.63, 0.656) </td><td>0.646 (0.631, 0.658)</td><td>0.003 (-0.004, 0.011)  </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_591    </td><td>Urinary tract infection                                                        </td><td>0.662 (0.654, 0.672)</td><td>0.666 (0.657, 0.676)</td><td>0.003 (-0.002, 0.01)   </td></tr>\n",
       "\t<tr><td>ID            </td><td>phecode_092    </td><td>Bacteremia, Sepsis, and SIRS                                                   </td><td>0.674 (0.663, 0.682)</td><td>0.677 (0.667, 0.686)</td><td>0.003 (-0.002, 0.009)  </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_406    </td><td>Chronic pulmonary heart disease                                                </td><td>0.735 (0.712, 0.758)</td><td>0.74 (0.716, 0.765) </td><td>0.003 (-0.017, 0.022)  </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_108    </td><td>Malignant neoplasm of the urinary tract                                        </td><td>0.719 (0.706, 0.735)</td><td>0.723 (0.71, 0.737) </td><td>0.003 (-0.001, 0.009)  </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_144-21 </td><td>Leiomyoma of uterus                                                            </td><td>0.67 (0.654, 0.685) </td><td>0.674 (0.658, 0.69) </td><td>0.003 (-0.003, 0.01)   </td></tr>\n",
       "\t<tr><td>Signs/Symptoms</td><td>phecode_840-8  </td><td>Allergies related to other diseases/symptoms                                   </td><td>0.456 (0.438, 0.474)</td><td>0.459 (0.44, 0.478) </td><td>0.003 (-0.009, 0.018)  </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_476    </td><td>Bronchiectasis                                                                 </td><td>0.7 (0.685, 0.718)  </td><td>0.705 (0.688, 0.721)</td><td>0.003 (-0.005, 0.012)  </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_416    </td><td>Cardiac arrhythmia and conduction disorders                                    </td><td>0.719 (0.713, 0.725)</td><td>0.723 (0.717, 0.728)</td><td>0.003 (0.002, 0.005)   </td></tr>\n",
       "\t<tr><td>Signs/Symptoms</td><td>phecode_829    </td><td>Nonspecific findings on examination of blood                                   </td><td>0.701 (0.694, 0.709)</td><td>0.705 (0.698, 0.713)</td><td>0.003 (0.001, 0.006)   </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_413-1  </td><td>Mitral valve disorders                                                         </td><td>0.708 (0.697, 0.718)</td><td>0.712 (0.699, 0.723)</td><td>0.003 (-0.003, 0.009)  </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_723-2  </td><td>Rotator cuff tear or rupture                                                   </td><td>0.573 (0.558, 0.592)</td><td>0.576 (0.564, 0.596)</td><td>0.003 (-0.007, 0.012)  </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_331-6  </td><td>Migraine                                                                       </td><td>0.596 (0.582, 0.614)</td><td>0.599 (0.585, 0.622)</td><td>0.003 (-0.005, 0.012)  </td></tr>\n",
       "\t<tr><td>Signs/Symptoms</td><td>phecode_841-1  </td><td>Allergy to other anti-infective agents                                         </td><td>0.592 (0.587, 0.599)</td><td>0.595 (0.59, 0.601) </td><td>0.003 (0.001, 0.006)   </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_410-2  </td><td>Endocarditis                                                                   </td><td>0.675 (0.638, 0.712)</td><td>0.677 (0.645, 0.717)</td><td>0.004 (-0.017, 0.024)  </td></tr>\n",
       "\t<tr><td>Signs/Symptoms</td><td>phecode_841    </td><td>Drug and medical agent allergy                                                 </td><td>0.588 (0.583, 0.595)</td><td>0.592 (0.586, 0.598)</td><td>0.004 (0.001, 0.007)   </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_103-3  </td><td>Carcinoma in situ of skin                                                      </td><td>0.732 (0.699, 0.755)</td><td>0.733 (0.704, 0.76) </td><td>0.004 (-0.005, 0.013)  </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_726    </td><td>Osteoporosis and low bone density                                              </td><td>0.756 (0.745, 0.766)</td><td>0.76 (0.75, 0.769)  </td><td>0.004 (0.001, 0.005)   </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_404-2  </td><td>Coronary atherosclerosis [Atherosclerotic heart disease]                       </td><td>0.712 (0.704, 0.718)</td><td>0.715 (0.708, 0.722)</td><td>0.004 (0.001, 0.007)   </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_416-2  </td><td>Atrial fibrillation and flutter                                                </td><td>0.739 (0.734, 0.746)</td><td>0.743 (0.737, 0.749)</td><td>0.004 (0.001, 0.006)   </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_726-1  </td><td>Osteoporosis                                                                   </td><td>0.762 (0.755, 0.771)</td><td>0.766 (0.758, 0.774)</td><td>0.004 (0.002, 0.006)   </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_627-3  </td><td>Postmenopausal atrophic vaginitis                                              </td><td>0.497 (0.467, 0.525)</td><td>0.5 (0.472, 0.53)   </td><td>0.004 (-0.023, 0.025)  </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_438    </td><td>Aneurysm or ectasia                                                            </td><td>0.71 (0.693, 0.726) </td><td>0.714 (0.696, 0.734)</td><td>0.004 (-0.004, 0.012)  </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_413    </td><td>Heart valve disorders                                                          </td><td>0.719 (0.71, 0.729) </td><td>0.723 (0.714, 0.734)</td><td>0.004 (-0.002, 0.008)  </td></tr>\n",
       "\t<tr><td>Signs/Symptoms</td><td>phecode_841-12 </td><td>Allergy to antibiotic agent (excluding penicillin)                             </td><td>0.636 (0.626, 0.648)</td><td>0.64 (0.629, 0.651) </td><td>0.004 (-0.003, 0.009)  </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_116-6  </td><td>Secondary malignancy of bone                                                   </td><td>0.687 (0.672, 0.7)  </td><td>0.69 (0.677, 0.703) </td><td>0.004 (-0.003, 0.01)   </td></tr>\n",
       "\t<tr><td>ID            </td><td>phecode_092-2  </td><td>Sepsis                                                                         </td><td>0.671 (0.66, 0.682) </td><td>0.675 (0.664, 0.684)</td><td>0.004 (-0.005, 0.011)  </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_431-12 </td><td>Hemorrhagic stroke                                                             </td><td>0.658 (0.633, 0.686)</td><td>0.662 (0.638, 0.682)</td><td>0.004 (-0.013, 0.018)  </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_430    </td><td>Nontraumatic Intracranial hemorrhage                                           </td><td>0.659 (0.643, 0.685)</td><td>0.664 (0.642, 0.688)</td><td>0.004 (-0.006, 0.018)  </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_529-5  </td><td>Constipation                                                                   </td><td>0.632 (0.624, 0.639)</td><td>0.635 (0.629, 0.642)</td><td>0.004 (-0.001, 0.009)  </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_431-1  </td><td>Stroke                                                                         </td><td>0.706 (0.692, 0.716)</td><td>0.71 (0.697, 0.723) </td><td>0.004 (-0.004, 0.011)  </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_522-1  </td><td>Inflammatory bowel disease                                                     </td><td>0.535 (0.515, 0.554)</td><td>0.538 (0.521, 0.56) </td><td>0.004 (-0.018, 0.022)  </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_420    </td><td>Cardiac arrest                                                                 </td><td>0.727 (0.711, 0.748)</td><td>0.731 (0.709, 0.756)</td><td>0.004 (-0.013, 0.021)  </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_554-2  </td><td>Cyst and pseudocyst of pancreas                                                </td><td>0.606 (0.559, 0.649)</td><td>0.604 (0.561, 0.651)</td><td>0.004 (-0.036, 0.034)  </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_404    </td><td>Ischemic heart disease                                                         </td><td>0.703 (0.697, 0.708)</td><td>0.707 (0.701, 0.713)</td><td>0.005 (0.002, 0.007)   </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_327    </td><td>Other degenerative diseases of nervous system                                  </td><td>0.698 (0.674, 0.722)</td><td>0.702 (0.673, 0.73) </td><td>0.005 (-0.012, 0.022)  </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_545    </td><td>Nonspecific abnormal results of function study of liver                        </td><td>0.609 (0.596, 0.626)</td><td>0.614 (0.603, 0.625)</td><td>0.005 (-0.008, 0.014)  </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_330-3  </td><td>Convulsions                                                                    </td><td>0.586 (0.562, 0.61) </td><td>0.588 (0.56, 0.617) </td><td>0.005 (-0.02, 0.027)   </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_511    </td><td>Gastro-esophageal reflux disease                                               </td><td>0.571 (0.566, 0.577)</td><td>0.576 (0.571, 0.582)</td><td>0.005 (0.001, 0.008)   </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_596    </td><td>Other disorders of bladder                                                     </td><td>0.644 (0.632, 0.657)</td><td>0.648 (0.636, 0.66) </td><td>0.005 (0, 0.009)       </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_324    </td><td>Extrapyramidal and movement disorders                                          </td><td>0.655 (0.643, 0.67) </td><td>0.66 (0.649, 0.677) </td><td>0.005 (-0.002, 0.016)  </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_522-11 </td><td>Crohn's disease                                                                </td><td>0.45 (0.422, 0.477) </td><td>0.454 (0.425, 0.49) </td><td>0.005 (-0.025, 0.033)  </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_426    </td><td>Other heart disorders in diseases NEC                                          </td><td>0.71 (0.695, 0.723) </td><td>0.713 (0.698, 0.729)</td><td>0.005 (-0.007, 0.014)  </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_514    </td><td>Gastrointestinal obstruction                                                   </td><td>0.624 (0.61, 0.636) </td><td>0.628 (0.613, 0.64) </td><td>0.005 (-0.004, 0.014)  </td></tr>\n",
       "\t<tr><td>Signs/Symptoms</td><td>phecode_848    </td><td>Nonspecific abnormal findings of other body structures                         </td><td>0.551 (0.516, 0.594)</td><td>0.556 (0.523, 0.594)</td><td>0.005 (-0.027, 0.031)  </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_678    </td><td>Other skin and connective tissue disorders                                     </td><td>0.596 (0.58, 0.612) </td><td>0.601 (0.582, 0.617)</td><td>0.005 (-0.002, 0.012)  </td></tr>\n",
       "\t<tr><td>Stat          </td><td>phecode_981    </td><td>Family history of malignant neoplasm                                           </td><td>0.515 (0.503, 0.525)</td><td>0.519 (0.508, 0.53) </td><td>0.005 (-0.002, 0.012)  </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_708-7  </td><td>Generalized osteoarthritis                                                     </td><td>0.632 (0.621, 0.642)</td><td>0.636 (0.625, 0.649)</td><td>0.005 (-0.002, 0.014)  </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_522    </td><td>Gastrointestinal inflammation                                                  </td><td>0.577 (0.571, 0.583)</td><td>0.583 (0.576, 0.589)</td><td>0.005 (0.002, 0.009)   </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_708    </td><td>Osteoarthritis                                                                 </td><td>0.637 (0.633, 0.642)</td><td>0.643 (0.638, 0.647)</td><td>0.005 (0.004, 0.007)   </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_557-2  </td><td>Blood in stool                                                                 </td><td>0.66 (0.639, 0.68)  </td><td>0.664 (0.644, 0.687)</td><td>0.006 (-0.008, 0.015)  </td></tr>\n",
       "\t<tr><td>Endo          </td><td>phecode_204    </td><td>Elevated blood glucose level                                                   </td><td>0.639 (0.601, 0.662)</td><td>0.643 (0.611, 0.669)</td><td>0.006 (-0.016, 0.031)  </td></tr>\n",
       "\t<tr><td>Hearing       </td><td>phecode_394-1  </td><td>Meniere disease                                                                </td><td>0.592 (0.56, 0.624) </td><td>0.599 (0.562, 0.629)</td><td>0.006 (-0.021, 0.031)  </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_100    </td><td>Malignant neoplasm of the head and neck                                        </td><td>0.613 (0.585, 0.644)</td><td>0.619 (0.583, 0.646)</td><td>0.006 (-0.012, 0.026)  </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_673    </td><td>Skin changes due to chronic exposure to nonionizing radiation                  </td><td>0.679 (0.661, 0.695)</td><td>0.685 (0.667, 0.702)</td><td>0.006 (0.002, 0.01)    </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_597-1  </td><td>Urethral stricture                                                             </td><td>0.648 (0.628, 0.667)</td><td>0.653 (0.635, 0.676)</td><td>0.006 (-0.004, 0.012)  </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_431-11 </td><td>Cerebral infarction [Ischemic stroke]                                          </td><td>0.721 (0.708, 0.728)</td><td>0.726 (0.715, 0.736)</td><td>0.006 (-0.003, 0.014)  </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_673-1  </td><td>Actinic keratosis                                                              </td><td>0.683 (0.669, 0.702)</td><td>0.689 (0.674, 0.708)</td><td>0.006 (0.001, 0.011)   </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_680    </td><td>Epidermal thickening                                                           </td><td>0.58 (0.55, 0.605)  </td><td>0.584 (0.553, 0.613)</td><td>0.006 (-0.027, 0.026)  </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_703    </td><td>Chrystal arthropathies                                                         </td><td>0.765 (0.755, 0.774)</td><td>0.77 (0.76, 0.779)  </td><td>0.006 (0.001, 0.011)   </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_721-1  </td><td>Synovitis and tenosynovitis                                                    </td><td>0.554 (0.538, 0.573)</td><td>0.561 (0.542, 0.573)</td><td>0.006 (-0.01, 0.021)   </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_404-1  </td><td>Myocardial infarction [Heart attack]                                           </td><td>0.722 (0.715, 0.732)</td><td>0.728 (0.721, 0.738)</td><td>0.006 (0.001, 0.01)    </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_705    </td><td>Rheumatoid arthritis and other inflammatory polyarthropathies                  </td><td>0.654 (0.644, 0.667)</td><td>0.659 (0.646, 0.673)</td><td>0.006 (0.001, 0.01)    </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_522-9  </td><td>Gastritis                                                                      </td><td>0.579 (0.571, 0.588)</td><td>0.585 (0.578, 0.595)</td><td>0.006 (0.001, 0.011)   </td></tr>\n",
       "\t<tr><td>ID            </td><td>phecode_015-2  </td><td>Clostridium difficile                                                          </td><td>0.65 (0.607, 0.687) </td><td>0.655 (0.621, 0.699)</td><td>0.006 (-0.025, 0.045)  </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_334-2  </td><td>Facial nerve disorders and weakness                                            </td><td>0.547 (0.514, 0.581)</td><td>0.551 (0.52, 0.583) </td><td>0.006 (-0.027, 0.038)  </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_116-2  </td><td>Secondary malignancy of respiratory organs                                     </td><td>0.637 (0.621, 0.652)</td><td>0.642 (0.63, 0.661) </td><td>0.006 (-0.004, 0.017)  </td></tr>\n",
       "\t<tr><td>Hearing       </td><td>phecode_396    </td><td>Hearing impairment                                                             </td><td>0.678 (0.666, 0.69) </td><td>0.684 (0.672, 0.697)</td><td>0.006 (0.002, 0.011)   </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_708-8  </td><td>Secondary osteoarthritis                                                       </td><td>0.573 (0.544, 0.607)</td><td>0.579 (0.556, 0.611)</td><td>0.006 (-0.014, 0.03)   </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_468-8  </td><td>Bronchopneumonia                                                               </td><td>0.699 (0.662, 0.734)</td><td>0.705 (0.667, 0.739)</td><td>0.006 (-0.015, 0.03)   </td></tr>\n",
       "\t<tr><td>Metab         </td><td>phecode_256-5  </td><td>Hypokalemia [Hypopotassemia]                                                   </td><td>0.647 (0.633, 0.664)</td><td>0.654 (0.64, 0.674) </td><td>0.006 (-0.004, 0.018)  </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_334    </td><td>Disorders of other cranial nerves                                              </td><td>0.558 (0.532, 0.586)</td><td>0.564 (0.538, 0.587)</td><td>0.007 (-0.018, 0.026)  </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_444    </td><td>Venous insufficiency                                                           </td><td>0.592 (0.581, 0.606)</td><td>0.599 (0.588, 0.61) </td><td>0.007 (-0.003, 0.016)  </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_439    </td><td>Hemorrhoids                                                                    </td><td>0.505 (0.496, 0.514)</td><td>0.512 (0.503, 0.521)</td><td>0.007 (0.001, 0.014)   </td></tr>\n",
       "\t<tr><td>ID            </td><td>phecode_015    </td><td>Clostridium                                                                    </td><td>0.64 (0.61, 0.675)  </td><td>0.649 (0.614, 0.692)</td><td>0.007 (-0.027, 0.052)  </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_583    </td><td>Chronic kidney disease                                                         </td><td>0.721 (0.713, 0.73) </td><td>0.728 (0.719, 0.737)</td><td>0.007 (0.001, 0.012)   </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_703-11 </td><td>Gout                                                                           </td><td>0.769 (0.76, 0.779) </td><td>0.776 (0.767, 0.786)</td><td>0.007 (0.002, 0.012)   </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_413-21 </td><td>Aortic stenosis                                                                </td><td>0.756 (0.745, 0.771)</td><td>0.764 (0.749, 0.779)</td><td>0.007 (-0.003, 0.016)  </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_513    </td><td>Peptic ulcer                                                                   </td><td>0.598 (0.589, 0.613)</td><td>0.606 (0.594, 0.622)</td><td>0.007 (-0.003, 0.017)  </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_413-3  </td><td>Tricuspid valve disorders                                                      </td><td>0.727 (0.714, 0.738)</td><td>0.733 (0.72, 0.746) </td><td>0.007 (0, 0.015)       </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_484    </td><td>Pneumothorax and air leak                                                      </td><td>0.639 (0.609, 0.669)</td><td>0.648 (0.615, 0.681)</td><td>0.007 (-0.023, 0.044)  </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_444-1  </td><td>Varicose veins                                                                 </td><td>0.584 (0.573, 0.596)</td><td>0.591 (0.578, 0.602)</td><td>0.007 (-0.001, 0.017)  </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_703-1  </td><td>Hyperuricemia                                                                  </td><td>0.769 (0.761, 0.78) </td><td>0.777 (0.768, 0.787)</td><td>0.007 (0.003, 0.013)   </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_411    </td><td>Other diseases of pericardium                                                  </td><td>0.654 (0.625, 0.677)</td><td>0.661 (0.639, 0.684)</td><td>0.007 (-0.009, 0.026)  </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_446    </td><td>Hypotension                                                                    </td><td>0.662 (0.652, 0.673)</td><td>0.669 (0.658, 0.68) </td><td>0.008 (0, 0.014)       </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_334-21 </td><td>Bell's palsy                                                                   </td><td>0.553 (0.51, 0.579) </td><td>0.554 (0.534, 0.59) </td><td>0.008 (-0.03, 0.046)   </td></tr>\n",
       "\t<tr><td>Stat          </td><td>phecode_988    </td><td>Family history of cardiovascular disease                                       </td><td>0.573 (0.564, 0.582)</td><td>0.58 (0.569, 0.59)  </td><td>0.008 (0.002, 0.014)   </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_726-2  </td><td>Pathologic fracture                                                            </td><td>0.724 (0.698, 0.754)</td><td>0.731 (0.7, 0.756)  </td><td>0.008 (-0.006, 0.022)  </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_724-52 </td><td>Osteophyte*                                                                    </td><td>0.559 (0.544, 0.58) </td><td>0.568 (0.551, 0.588)</td><td>0.008 (-0.006, 0.022)  </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_425    </td><td>Cardiomegaly                                                                   </td><td>0.693 (0.682, 0.707)</td><td>0.701 (0.691, 0.714)</td><td>0.008 (-0.001, 0.017)  </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_554-1  </td><td>Pancreatitis                                                                   </td><td>0.581 (0.556, 0.608)</td><td>0.591 (0.561, 0.612)</td><td>0.008 (-0.016, 0.031)  </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_528    </td><td>Nausea and vomiting                                                            </td><td>0.601 (0.591, 0.609)</td><td>0.609 (0.599, 0.616)</td><td>0.008 (0.002, 0.013)   </td></tr>\n",
       "\t<tr><td>Blood         </td><td>phecode_177-4  </td><td>Lymphedema                                                                     </td><td>0.66 (0.628, 0.692) </td><td>0.668 (0.637, 0.687)</td><td>0.008 (-0.024, 0.029)  </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_528-2  </td><td>Vomiting                                                                       </td><td>0.6 (0.591, 0.609)  </td><td>0.608 (0.6, 0.616)  </td><td>0.008 (0.002, 0.013)   </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_709-22 </td><td>Hallux rigidus                                                                 </td><td>0.589 (0.553, 0.618)</td><td>0.594 (0.564, 0.632)</td><td>0.008 (-0.011, 0.026)  </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_522-8  </td><td>Duodenitis                                                                     </td><td>0.603 (0.588, 0.62) </td><td>0.611 (0.597, 0.624)</td><td>0.008 (-0.002, 0.019)  </td></tr>\n",
       "\t<tr><td>Metab         </td><td>phecode_230-21 </td><td>Abnormal weight loss                                                           </td><td>0.628 (0.616, 0.64) </td><td>0.637 (0.625, 0.648)</td><td>0.009 (0, 0.015)       </td></tr>\n",
       "\t<tr><td>Metab         </td><td>phecode_230    </td><td>Malnutrition and underweight                                                   </td><td>0.627 (0.618, 0.637)</td><td>0.636 (0.626, 0.646)</td><td>0.009 (0.002, 0.014)   </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_528-1  </td><td>Nausea                                                                         </td><td>0.6 (0.59, 0.609)   </td><td>0.609 (0.599, 0.618)</td><td>0.009 (0.004, 0.016)   </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_414-2  </td><td>Dilated cardiomyopathy*                                                        </td><td>0.668 (0.624, 0.714)</td><td>0.673 (0.634, 0.724)</td><td>0.009 (-0.012, 0.025)  </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_463-2  </td><td>Allergic rhinitis                                                              </td><td>0.444 (0.429, 0.469)</td><td>0.455 (0.432, 0.473)</td><td>0.009 (-0.011, 0.027)  </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_527    </td><td>Abdominal pain                                                                 </td><td>0.547 (0.541, 0.554)</td><td>0.556 (0.548, 0.562)</td><td>0.009 (0.005, 0.013)   </td></tr>\n",
       "\t<tr><td>Signs/Symptoms</td><td>phecode_841-4  </td><td>Allergy to analgesic agent                                                     </td><td>0.602 (0.591, 0.616)</td><td>0.609 (0.601, 0.625)</td><td>0.009 (0.001, 0.015)   </td></tr>\n",
       "\t<tr><td>Signs/Symptoms</td><td>phecode_841-11 </td><td>Penicillin allergy                                                             </td><td>0.577 (0.57, 0.585) </td><td>0.586 (0.579, 0.595)</td><td>0.009 (0.005, 0.013)   </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_417    </td><td>Abnormalities of heart beat                                                    </td><td>0.595 (0.585, 0.605)</td><td>0.605 (0.595, 0.613)</td><td>0.009 (0.003, 0.015)   </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_711-1  </td><td>Derangement of meniscus                                                        </td><td>0.522 (0.509, 0.531)</td><td>0.53 (0.517, 0.542) </td><td>0.009 (-0.003, 0.019)  </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_437    </td><td>Vascular insufficiency of intestine                                            </td><td>0.669 (0.638, 0.699)</td><td>0.681 (0.645, 0.712)</td><td>0.009 (-0.018, 0.037)  </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_586-2  </td><td>Cyst of kidney                                                                 </td><td>0.66 (0.64, 0.679)  </td><td>0.668 (0.65, 0.696) </td><td>0.009 (-0.001, 0.024)  </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_329    </td><td>Symptoms and signs involving cognitive functions and awareness                 </td><td>0.704 (0.695, 0.714)</td><td>0.714 (0.702, 0.725)</td><td>0.009 (0.002, 0.017)   </td></tr>\n",
       "\t<tr><td>ID            </td><td>phecode_061    </td><td>Influenza virus                                                                </td><td>0.614 (0.583, 0.643)</td><td>0.624 (0.591, 0.659)</td><td>0.009 (-0.014, 0.031)  </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_108-4  </td><td>Malignant neoplasm of the kidney                                               </td><td>0.669 (0.641, 0.693)</td><td>0.68 (0.653, 0.708) </td><td>0.01 (-0.009, 0.032)   </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_712-1  </td><td>Loose body in joint                                                            </td><td>0.507 (0.469, 0.534)</td><td>0.511 (0.478, 0.553)</td><td>0.01 (-0.022, 0.042)   </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_103    </td><td>Malignant neoplasm of the skin                                                 </td><td>0.662 (0.655, 0.671)</td><td>0.671 (0.665, 0.681)</td><td>0.01 (0.007, 0.013)    </td></tr>\n",
       "\t<tr><td>Metab         </td><td>phecode_230-2  </td><td>Abnormal loss of weight and underweight                                        </td><td>0.627 (0.615, 0.641)</td><td>0.637 (0.625, 0.65) </td><td>0.01 (0.003, 0.017)    </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_101-2  </td><td>Malignant neoplasm of stomach                                                  </td><td>0.676 (0.636, 0.709)</td><td>0.686 (0.652, 0.716)</td><td>0.01 (-0.009, 0.032)   </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_706    </td><td>Other inflammatory spondylopathies                                             </td><td>0.61 (0.587, 0.629) </td><td>0.621 (0.6, 0.638)  </td><td>0.01 (-0.005, 0.027)   </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_715-1  </td><td>Spondylosis                                                                    </td><td>0.639 (0.629, 0.649)</td><td>0.649 (0.64, 0.659) </td><td>0.01 (0.004, 0.015)    </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_430-2  </td><td>Nontraumatic intracerebral hemorrhage                                          </td><td>0.69 (0.664, 0.721) </td><td>0.701 (0.675, 0.734)</td><td>0.01 (-0.008, 0.026)   </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_336-5  </td><td>Mononeuritis of lower limb                                                     </td><td>0.606 (0.579, 0.638)</td><td>0.619 (0.586, 0.641)</td><td>0.01 (-0.016, 0.03)    </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_556-8  </td><td>Nonspecific abnormal findings in stool contents                                </td><td>0.591 (0.575, 0.608)</td><td>0.6 (0.582, 0.618)  </td><td>0.01 (-0.004, 0.023)   </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_526-12 </td><td>Intestinal infection due to C. difficile                                       </td><td>0.647 (0.613, 0.686)</td><td>0.659 (0.621, 0.69) </td><td>0.01 (-0.015, 0.052)   </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_512    </td><td>Dysphagia                                                                      </td><td>0.57 (0.558, 0.581) </td><td>0.58 (0.569, 0.592) </td><td>0.01 (0.002, 0.02)     </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_447    </td><td>Nonspecific low blood-pressure reading                                         </td><td>0.63 (0.608, 0.658) </td><td>0.64 (0.614, 0.67)  </td><td>0.01 (-0.005, 0.027)   </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_354    </td><td>Dizziness and giddiness                                                        </td><td>0.598 (0.585, 0.615)</td><td>0.607 (0.595, 0.625)</td><td>0.01 (0, 0.02)         </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_424-1  </td><td>Left heart failure                                                             </td><td>0.733 (0.714, 0.747)</td><td>0.744 (0.73, 0.76)  </td><td>0.01 (0.003, 0.022)    </td></tr>\n",
       "\t<tr><td>ID            </td><td>phecode_089    </td><td>Infections                                                                     </td><td>0.612 (0.604, 0.618)</td><td>0.622 (0.614, 0.629)</td><td>0.011 (0.005, 0.017)   </td></tr>\n",
       "\t<tr><td>Signs/Symptoms</td><td>phecode_819    </td><td>General symptoms and other findings                                            </td><td>0.689 (0.683, 0.696)</td><td>0.701 (0.694, 0.707)</td><td>0.011 (0.006, 0.016)   </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_724-5  </td><td>Exostosis                                                                      </td><td>0.554 (0.533, 0.567)</td><td>0.562 (0.546, 0.581)</td><td>0.011 (-0.005, 0.024)  </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_363    </td><td>Disorders of lacrimal system                                                   </td><td>0.667 (0.648, 0.689)</td><td>0.678 (0.659, 0.699)</td><td>0.011 (0.001, 0.019)   </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_721    </td><td>Synoviopathy and bursopathy                                                    </td><td>0.556 (0.546, 0.568)</td><td>0.567 (0.556, 0.578)</td><td>0.011 (0.003, 0.018)   </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_419    </td><td>Presence of cardiac device                                                     </td><td>0.741 (0.726, 0.754)</td><td>0.752 (0.739, 0.764)</td><td>0.011 (0.004, 0.019)   </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_513-2  </td><td>Gastric ulcer                                                                  </td><td>0.588 (0.57, 0.602) </td><td>0.598 (0.585, 0.613)</td><td>0.011 (-0.004, 0.024)  </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_668    </td><td>Dermatitis [eczema]                                                            </td><td>0.552 (0.534, 0.57) </td><td>0.564 (0.547, 0.58) </td><td>0.011 (-0.001, 0.024)  </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_440    </td><td>Embolism and thrombosis                                                        </td><td>0.633 (0.622, 0.642)</td><td>0.644 (0.635, 0.654)</td><td>0.011 (0.004, 0.019)   </td></tr>\n",
       "\t<tr><td>Signs/Symptoms</td><td>phecode_815    </td><td>Symptoms and signs concerning food and fluid intake                            </td><td>0.713 (0.688, 0.745)</td><td>0.726 (0.689, 0.756)</td><td>0.011 (-0.016, 0.033)  </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_504    </td><td>Periodontal diseases                                                           </td><td>0.494 (0.467, 0.525)</td><td>0.503 (0.471, 0.548)</td><td>0.011 (-0.024, 0.039)  </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_581-31 </td><td>Hydronephrosis                                                                 </td><td>0.618 (0.6, 0.637)  </td><td>0.629 (0.611, 0.647)</td><td>0.011 (-0.002, 0.02)   </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_448-1  </td><td>Raynaud's syndrome                                                             </td><td>0.608 (0.586, 0.63) </td><td>0.617 (0.602, 0.643)</td><td>0.011 (-0.003, 0.026)  </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_108-41 </td><td>Malignant neoplasm of kidney, except pelvis                                    </td><td>0.671 (0.646, 0.701)</td><td>0.681 (0.653, 0.713)</td><td>0.011 (-0.007, 0.027)  </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_594-3  </td><td>Urinary incontinence                                                           </td><td>0.626 (0.612, 0.638)</td><td>0.637 (0.621, 0.648)</td><td>0.011 (0.002, 0.02)    </td></tr>\n",
       "\t<tr><td>ID            </td><td>phecode_089-1  </td><td>Bacterial infections                                                           </td><td>0.625 (0.616, 0.635)</td><td>0.636 (0.628, 0.644)</td><td>0.011 (0.004, 0.017)   </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_581-3  </td><td>Obstructive and reflux uropathy                                                </td><td>0.623 (0.604, 0.641)</td><td>0.634 (0.614, 0.648)</td><td>0.011 (-0.002, 0.022)  </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_483    </td><td>Pleural effusion                                                               </td><td>0.68 (0.667, 0.69)  </td><td>0.691 (0.682, 0.704)</td><td>0.011 (0.004, 0.018)   </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_353-1  </td><td>Hallucinations                                                                 </td><td>0.631 (0.585, 0.669)</td><td>0.642 (0.603, 0.676)</td><td>0.011 (-0.027, 0.047)  </td></tr>\n",
       "\t<tr><td>Blood         </td><td>phecode_181    </td><td>Autoimmune disease                                                             </td><td>0.575 (0.566, 0.587)</td><td>0.586 (0.576, 0.597)</td><td>0.012 (0.004, 0.02)    </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_487-1  </td><td>Epistaxis                                                                      </td><td>0.643 (0.622, 0.667)</td><td>0.655 (0.636, 0.677)</td><td>0.012 (-0.002, 0.025)  </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_523-4  </td><td>Diverticulitis                                                                 </td><td>0.608 (0.567, 0.651)</td><td>0.622 (0.577, 0.665)</td><td>0.012 (-0.025, 0.049)  </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_554-11 </td><td>Acute pancreatitis                                                             </td><td>0.57 (0.545, 0.599) </td><td>0.584 (0.556, 0.61) </td><td>0.012 (-0.009, 0.032)  </td></tr>\n",
       "\t<tr><td>Metab         </td><td>phecode_239    </td><td>Hyperlipidemia                                                                 </td><td>0.682 (0.678, 0.686)</td><td>0.694 (0.691, 0.698)</td><td>0.012 (0.009, 0.014)   </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_401-1  </td><td>Essential hypertension                                                         </td><td>0.663 (0.66, 0.667) </td><td>0.675 (0.672, 0.679)</td><td>0.012 (0.01, 0.014)    </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_558    </td><td>Abnormal findings on diagnostic imaging of the digestive tract                 </td><td>0.578 (0.56, 0.599) </td><td>0.589 (0.572, 0.609)</td><td>0.012 (-0.004, 0.026)  </td></tr>\n",
       "\t<tr><td>Metab         </td><td>phecode_239-11 </td><td>Pure hypercholesterolemia                                                      </td><td>0.682 (0.678, 0.688)</td><td>0.695 (0.69, 0.699) </td><td>0.012 (0.01, 0.015)    </td></tr>\n",
       "\t<tr><td>Metab         </td><td>phecode_239-1  </td><td>Hypercholesterolemia                                                           </td><td>0.682 (0.677, 0.686)</td><td>0.694 (0.69, 0.698) </td><td>0.012 (0.01, 0.014)    </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_715-3  </td><td>Spondylolisthesis                                                              </td><td>0.667 (0.644, 0.687)</td><td>0.678 (0.654, 0.701)</td><td>0.012 (-0.004, 0.024)  </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_401    </td><td>Hypertension                                                                   </td><td>0.664 (0.659, 0.667)</td><td>0.676 (0.672, 0.679)</td><td>0.012 (0.01, 0.014)    </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_715    </td><td>Non-inflammatory spondylopathy                                                 </td><td>0.639 (0.63, 0.646) </td><td>0.65 (0.642, 0.659) </td><td>0.012 (0.007, 0.017)   </td></tr>\n",
       "\t<tr><td>Metab         </td><td>phecode_256    </td><td>Disorders of fluid, electrolyte and acid-base balance                          </td><td>0.673 (0.666, 0.682)</td><td>0.686 (0.676, 0.694)</td><td>0.012 (0.006, 0.018)   </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_139-5  </td><td>Lipoma                                                                         </td><td>0.539 (0.52, 0.56)  </td><td>0.552 (0.535, 0.571)</td><td>0.013 (0.003, 0.021)   </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_516    </td><td>Other diseases of stomach and duodenum                                         </td><td>0.571 (0.556, 0.588)</td><td>0.586 (0.567, 0.601)</td><td>0.013 (0.001, 0.026)   </td></tr>\n",
       "\t<tr><td>Stat          </td><td>phecode_983    </td><td>Family history of other endocrine and metabolic diseases                       </td><td>0.506 (0.457, 0.545)</td><td>0.515 (0.466, 0.552)</td><td>0.013 (-0.039, 0.057)  </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_705-1  </td><td>Rheumatoid arthritis                                                           </td><td>0.626 (0.612, 0.642)</td><td>0.64 (0.625, 0.657) </td><td>0.013 (0.006, 0.02)    </td></tr>\n",
       "\t<tr><td>Death         </td><td>OMOP_4306655   </td><td>All-Cause Death                                                                </td><td>0.708 (0.701, 0.715)</td><td>0.721 (0.715, 0.728)</td><td>0.013 (0.009, 0.017)   </td></tr>\n",
       "\t<tr><td>Signs/Symptoms</td><td>phecode_812    </td><td>Edema                                                                          </td><td>0.655 (0.64, 0.667) </td><td>0.666 (0.651, 0.681)</td><td>0.013 (-0.002, 0.022)  </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_723-1  </td><td>Adhesive capsulitis of shoulder                                                </td><td>0.551 (0.522, 0.578)</td><td>0.565 (0.535, 0.596)</td><td>0.013 (-0.009, 0.031)  </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_463-21 </td><td>Seasonal allergic rhinitis                                                     </td><td>0.447 (0.428, 0.465)</td><td>0.46 (0.44, 0.476)  </td><td>0.013 (-0.003, 0.033)  </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_360-4  </td><td>Blepharitis                                                                    </td><td>0.629 (0.598, 0.666)</td><td>0.641 (0.604, 0.681)</td><td>0.013 (-0.015, 0.038)  </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_356    </td><td>Speech disturbance                                                             </td><td>0.647 (0.621, 0.667)</td><td>0.658 (0.64, 0.682) </td><td>0.013 (-0.003, 0.028)  </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_424    </td><td>Heart failure                                                                  </td><td>0.744 (0.737, 0.754)</td><td>0.759 (0.75, 0.769) </td><td>0.014 (0.008, 0.02)    </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_361    </td><td>Disorders of eyelid function                                                   </td><td>0.681 (0.661, 0.698)</td><td>0.694 (0.675, 0.713)</td><td>0.014 (0.003, 0.023)   </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_465    </td><td>Pharyngitis                                                                    </td><td>0.479 (0.445, 0.508)</td><td>0.493 (0.461, 0.522)</td><td>0.014 (-0.022, 0.052)  </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_586    </td><td>Other disorders of the kidney and ureters                                      </td><td>0.66 (0.646, 0.676) </td><td>0.675 (0.661, 0.691)</td><td>0.014 (0.005, 0.025)   </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_374-3  </td><td>Retinal vascular changes and occlusions                                        </td><td>0.683 (0.655, 0.7)  </td><td>0.698 (0.67, 0.714) </td><td>0.014 (-0.002, 0.03)   </td></tr>\n",
       "\t<tr><td>Blood         </td><td>phecode_169-1  </td><td>Thrombocytopenia                                                               </td><td>0.658 (0.642, 0.676)</td><td>0.672 (0.648, 0.691)</td><td>0.014 (-0.001, 0.024)  </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_326    </td><td>Demyelinating diseases of the central nervous system                           </td><td>0.593 (0.551, 0.625)</td><td>0.608 (0.572, 0.643)</td><td>0.014 (-0.001, 0.039)  </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_700-2  </td><td>Sicca syndrome [Sjogren syndrome]                                              </td><td>0.749 (0.716, 0.791)</td><td>0.766 (0.738, 0.803)</td><td>0.015 (-0.008, 0.038)  </td></tr>\n",
       "\t<tr><td>Blood         </td><td>phecode_169    </td><td>Platelet defects                                                               </td><td>0.654 (0.633, 0.673)</td><td>0.669 (0.651, 0.685)</td><td>0.015 (-0.001, 0.029)  </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_479-6  </td><td>Pulmonary collapse [Atelectasis]                                               </td><td>0.644 (0.629, 0.658)</td><td>0.658 (0.643, 0.674)</td><td>0.015 (0.003, 0.026)   </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_440-1  </td><td>Venous thromboembolism                                                         </td><td>0.588 (0.575, 0.607)</td><td>0.604 (0.588, 0.619)</td><td>0.015 (0.003, 0.027)   </td></tr>\n",
       "\t<tr><td>Blood         </td><td>phecode_168    </td><td>Coagulation defects, purpura and other hemorrhagic conditions                  </td><td>0.584 (0.553, 0.604)</td><td>0.597 (0.57, 0.625) </td><td>0.015 (-0.006, 0.037)  </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_515    </td><td>Heartburn and epigastric pain                                                  </td><td>0.516 (0.49, 0.546) </td><td>0.53 (0.504, 0.563) </td><td>0.015 (-0.004, 0.042)  </td></tr>\n",
       "\t<tr><td>Mental        </td><td>phecode_283-8  </td><td>Other problems related to lifestyle                                            </td><td>0.563 (0.549, 0.575)</td><td>0.578 (0.564, 0.587)</td><td>0.015 (0.007, 0.021)   </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_707    </td><td>Other arthropathies                                                            </td><td>0.652 (0.648, 0.658)</td><td>0.668 (0.662, 0.674)</td><td>0.015 (0.011, 0.018)   </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_711    </td><td>Disorder of patella                                                            </td><td>0.515 (0.505, 0.527)</td><td>0.531 (0.521, 0.543)</td><td>0.015 (0.004, 0.029)   </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_475    </td><td>Asthma                                                                         </td><td>0.54 (0.533, 0.545) </td><td>0.555 (0.548, 0.561)</td><td>0.015 (0.009, 0.022)   </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_513-1  </td><td>Esophageal ulcer                                                               </td><td>0.594 (0.576, 0.621)</td><td>0.61 (0.588, 0.63)  </td><td>0.016 (0.001, 0.028)   </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_525    </td><td>Intestinal malabsorption                                                       </td><td>0.533 (0.512, 0.561)</td><td>0.549 (0.519, 0.573)</td><td>0.016 (-0.008, 0.029)  </td></tr>\n",
       "\t<tr><td>Hearing       </td><td>phecode_395-1  </td><td>Labyrinthitis                                                                  </td><td>0.535 (0.476, 0.578)</td><td>0.551 (0.498, 0.61) </td><td>0.016 (-0.013, 0.061)  </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_682-11 </td><td>Sebaceous cyst [Epidermal cyst]                                                </td><td>0.503 (0.469, 0.535)</td><td>0.515 (0.478, 0.548)</td><td>0.016 (-0.021, 0.048)  </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_721-11 </td><td>Trigger finger                                                                 </td><td>0.575 (0.553, 0.593)</td><td>0.591 (0.568, 0.615)</td><td>0.016 (-0.01, 0.032)   </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_550-1  </td><td>Gallstones [Cholelithiasis]                                                    </td><td>0.556 (0.546, 0.567)</td><td>0.573 (0.561, 0.582)</td><td>0.016 (0.006, 0.024)   </td></tr>\n",
       "\t<tr><td>Signs/Symptoms</td><td>phecode_841-3  </td><td>Allergy to narcotic agent                                                      </td><td>0.606 (0.587, 0.622)</td><td>0.622 (0.606, 0.639)</td><td>0.016 (0.006, 0.024)   </td></tr>\n",
       "\t<tr><td>Mental        </td><td>phecode_288    </td><td>Anxiety disorders                                                              </td><td>0.58 (0.572, 0.591) </td><td>0.597 (0.588, 0.606)</td><td>0.016 (0.009, 0.022)   </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_546    </td><td>Other disorders of liver                                                       </td><td>0.619 (0.606, 0.638)</td><td>0.637 (0.618, 0.656)</td><td>0.016 (0.002, 0.032)   </td></tr>\n",
       "\t<tr><td>Signs/Symptoms</td><td>phecode_810    </td><td>Shock                                                                          </td><td>0.726 (0.689, 0.759)</td><td>0.739 (0.707, 0.769)</td><td>0.017 (-0.014, 0.044)  </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_351-3  </td><td>Paresthesia of skin*                                                           </td><td>0.466 (0.44, 0.498) </td><td>0.484 (0.461, 0.512)</td><td>0.017 (-0.01, 0.046)   </td></tr>\n",
       "\t<tr><td>Metab         </td><td>phecode_256-7  </td><td>Volume depletion                                                               </td><td>0.67 (0.656, 0.682) </td><td>0.686 (0.676, 0.7)  </td><td>0.017 (0.007, 0.027)   </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_509    </td><td>Diseases of tongue                                                             </td><td>0.508 (0.476, 0.532)</td><td>0.524 (0.489, 0.56) </td><td>0.017 (-0.009, 0.041)  </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_361-1  </td><td>Entropion and trichiasis of eyelid                                             </td><td>0.728 (0.689, 0.761)</td><td>0.744 (0.714, 0.775)</td><td>0.017 (-0.003, 0.035)  </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_336-1  </td><td>Carpal tunnel syndrome                                                         </td><td>0.572 (0.556, 0.587)</td><td>0.589 (0.573, 0.6)  </td><td>0.017 (0.005, 0.027)   </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_481    </td><td>Interstitial pulmonary diseases                                                </td><td>0.73 (0.712, 0.751) </td><td>0.747 (0.726, 0.771)</td><td>0.017 (0.003, 0.029)   </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_584    </td><td>Renal failure                                                                  </td><td>0.702 (0.675, 0.724)</td><td>0.719 (0.693, 0.743)</td><td>0.017 (-0.002, 0.037)  </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_440-13 </td><td>Phlebitis and thrombophlebitis                                                 </td><td>0.589 (0.573, 0.606)</td><td>0.608 (0.59, 0.622) </td><td>0.017 (0.01, 0.028)    </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_341    </td><td>Cerebral palsy and other paralytic syndromes                                   </td><td>0.662 (0.643, 0.687)</td><td>0.679 (0.662, 0.698)</td><td>0.017 (-0.001, 0.031)  </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_594-32 </td><td>Stress incontinence                                                            </td><td>0.691 (0.675, 0.706)</td><td>0.707 (0.696, 0.721)</td><td>0.018 (0.004, 0.031)   </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_116-5  </td><td>Secondary malignancy of brain/spine                                            </td><td>0.622 (0.6, 0.65)   </td><td>0.641 (0.618, 0.663)</td><td>0.018 (-0.007, 0.039)  </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_724    </td><td>Other symptoms and disorders of the soft tissue                                </td><td>0.567 (0.557, 0.578)</td><td>0.586 (0.577, 0.597)</td><td>0.018 (0.011, 0.026)   </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_106-3  </td><td>Malignant neoplasm of the ovary                                                </td><td>0.598 (0.562, 0.632)</td><td>0.615 (0.584, 0.646)</td><td>0.018 (0, 0.04)        </td></tr>\n",
       "\t<tr><td>Signs/Symptoms</td><td>phecode_805    </td><td>Fever of unknown origin                                                        </td><td>0.569 (0.555, 0.581)</td><td>0.586 (0.57, 0.6)   </td><td>0.018 (0.005, 0.028)   </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_414    </td><td>Cardiomyopathy                                                                 </td><td>0.672 (0.655, 0.692)</td><td>0.69 (0.673, 0.712) </td><td>0.018 (0.003, 0.028)   </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_329-9  </td><td>Delirium                                                                       </td><td>0.752 (0.732, 0.765)</td><td>0.768 (0.757, 0.784)</td><td>0.018 (0.006, 0.032)   </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_440-2  </td><td>Arterial embolism and thrombosis                                               </td><td>0.704 (0.681, 0.728)</td><td>0.722 (0.699, 0.744)</td><td>0.018 (0.004, 0.033)   </td></tr>\n",
       "\t<tr><td>Blood         </td><td>phecode_160-2  </td><td>Megaloblastic anemia                                                           </td><td>0.654 (0.624, 0.677)</td><td>0.671 (0.643, 0.704)</td><td>0.019 (-0.007, 0.041)  </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_716-3  </td><td>Spinal disc displacement (herniation)                                          </td><td>0.551 (0.535, 0.567)</td><td>0.57 (0.556, 0.589) </td><td>0.019 (0.007, 0.031)   </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_700    </td><td>Diffuse diseases of connective tissue                                          </td><td>0.662 (0.635, 0.685)</td><td>0.68 (0.653, 0.707) </td><td>0.019 (-0.003, 0.038)  </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_674    </td><td>Disorders of pigmentation                                                      </td><td>0.503 (0.471, 0.531)</td><td>0.519 (0.486, 0.556)</td><td>0.019 (-0.016, 0.052)  </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_526    </td><td>Intestinal infection                                                           </td><td>0.591 (0.582, 0.599)</td><td>0.609 (0.6, 0.618)  </td><td>0.019 (0.011, 0.026)   </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_463    </td><td>Rhinitis and nasal congestion                                                  </td><td>0.452 (0.437, 0.469)</td><td>0.47 (0.457, 0.489) </td><td>0.019 (0.004, 0.035)   </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_468    </td><td>Pneumonia                                                                      </td><td>0.674 (0.667, 0.681)</td><td>0.693 (0.686, 0.701)</td><td>0.019 (0.013, 0.024)   </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_487    </td><td>Hemorrhage from respiratory passages                                           </td><td>0.623 (0.604, 0.64) </td><td>0.643 (0.626, 0.661)</td><td>0.019 (0.007, 0.03)    </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_335    </td><td>Nerve root and plexus disorders                                                </td><td>0.559 (0.54, 0.572) </td><td>0.577 (0.563, 0.592)</td><td>0.019 (0.005, 0.033)   </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_715-4  </td><td>Spinal stenosis                                                                </td><td>0.648 (0.636, 0.661)</td><td>0.669 (0.653, 0.682)</td><td>0.019 (0.011, 0.03)    </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_581    </td><td>Renal tubulo-interstitial diseases                                             </td><td>0.577 (0.56, 0.598) </td><td>0.597 (0.584, 0.616)</td><td>0.019 (0.007, 0.032)   </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_336    </td><td>Mononeuropathies                                                               </td><td>0.556 (0.546, 0.568)</td><td>0.576 (0.566, 0.583)</td><td>0.02 (0.009, 0.027)    </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_550    </td><td>Disorders of the gallbladder                                                   </td><td>0.555 (0.546, 0.568)</td><td>0.575 (0.565, 0.586)</td><td>0.02 (0.009, 0.029)    </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_728    </td><td>Chondropathies                                                                 </td><td>0.492 (0.464, 0.517)</td><td>0.511 (0.475, 0.541)</td><td>0.02 (-0.004, 0.043)   </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_348    </td><td>Other diseases of spinal cord                                                  </td><td>0.619 (0.594, 0.641)</td><td>0.637 (0.614, 0.668)</td><td>0.02 (-0.001, 0.043)   </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_468-9  </td><td>Lobar pneumonia*                                                               </td><td>0.679 (0.669, 0.689)</td><td>0.699 (0.688, 0.709)</td><td>0.02 (0.012, 0.028)    </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_522-12 </td><td>Ulcerative colitis                                                             </td><td>0.534 (0.503, 0.555)</td><td>0.553 (0.526, 0.58) </td><td>0.02 (0, 0.042)        </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_433    </td><td>Other cerebrovascular disease                                                  </td><td>0.733 (0.721, 0.745)</td><td>0.753 (0.742, 0.764)</td><td>0.02 (0.012, 0.027)    </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_350    </td><td>Other symptoms involving nervous system                                        </td><td>0.697 (0.683, 0.708)</td><td>0.718 (0.705, 0.729)</td><td>0.02 (0.012, 0.029)    </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_554    </td><td>Diseases of the pancreas                                                       </td><td>0.593 (0.575, 0.612)</td><td>0.612 (0.592, 0.633)</td><td>0.02 (0.003, 0.034)    </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_718    </td><td>Back pain                                                                      </td><td>0.583 (0.574, 0.593)</td><td>0.603 (0.594, 0.612)</td><td>0.021 (0.013, 0.028)   </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_336-55 </td><td>Lesion of plantar nerve                                                        </td><td>0.606 (0.579, 0.638)</td><td>0.629 (0.599, 0.65) </td><td>0.021 (-0.008, 0.045)  </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_468-1  </td><td>Viral pneumonia                                                                </td><td>0.637 (0.607, 0.666)</td><td>0.656 (0.626, 0.695)</td><td>0.021 (-0.016, 0.067)  </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_361-4  </td><td>Blepharochalasis                                                               </td><td>0.612 (0.567, 0.648)</td><td>0.63 (0.595, 0.668) </td><td>0.021 (-0.008, 0.05)   </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_149-3  </td><td>Benign neoplasm of the parathyroid gland                                       </td><td>0.626 (0.592, 0.656)</td><td>0.649 (0.607, 0.676)</td><td>0.021 (-0.004, 0.047)  </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_348-2  </td><td>Myelopathies                                                                   </td><td>0.61 (0.58, 0.642)  </td><td>0.629 (0.603, 0.66) </td><td>0.021 (-0.012, 0.052)  </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_627-1  </td><td>Postmenopausal bleeding                                                        </td><td>0.425 (0.406, 0.441)</td><td>0.445 (0.426, 0.46) </td><td>0.021 (0.008, 0.036)   </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_479    </td><td>Pulmonary insufficiency and acute respiratory distress syndrome                </td><td>0.656 (0.643, 0.671)</td><td>0.677 (0.663, 0.692)</td><td>0.021 (0.011, 0.029)   </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_582    </td><td>Acute kidney failure                                                           </td><td>0.704 (0.695, 0.712)</td><td>0.726 (0.718, 0.734)</td><td>0.022 (0.015, 0.028)   </td></tr>\n",
       "\t<tr><td>ID            </td><td>phecode_003    </td><td>Escherichia coli                                                               </td><td>0.628 (0.616, 0.644)</td><td>0.651 (0.637, 0.663)</td><td>0.022 (0.011, 0.036)   </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_713    </td><td>Symptoms related to joints                                                     </td><td>0.578 (0.565, 0.592)</td><td>0.6 (0.587, 0.61)   </td><td>0.022 (0.013, 0.03)    </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_386-4  </td><td>Visual field defects                                                           </td><td>0.646 (0.601, 0.689)</td><td>0.668 (0.622, 0.718)</td><td>0.022 (-0.023, 0.056)  </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_402    </td><td>Elevated blood pressure reading without diagnosis of hypertension              </td><td>0.577 (0.554, 0.602)</td><td>0.599 (0.572, 0.628)</td><td>0.022 (0.004, 0.043)   </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_603-5  </td><td>Orchitis and epididymitis                                                      </td><td>0.434 (0.381, 0.475)</td><td>0.463 (0.423, 0.502)</td><td>0.022 (-0.02, 0.088)   </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_341-2  </td><td>Hemiplegia and hemiparesis                                                     </td><td>0.673 (0.648, 0.697)</td><td>0.695 (0.673, 0.719)</td><td>0.022 (0.003, 0.039)   </td></tr>\n",
       "\t<tr><td>Metab         </td><td>phecode_247    </td><td>Disorders of mineral metabolism and mineral deficiencies                       </td><td>0.603 (0.595, 0.611)</td><td>0.626 (0.616, 0.635)</td><td>0.022 (0.015, 0.028)   </td></tr>\n",
       "\t<tr><td>Blood         </td><td>phecode_164    </td><td>Anemia                                                                         </td><td>0.605 (0.598, 0.611)</td><td>0.627 (0.62, 0.634) </td><td>0.023 (0.015, 0.029)   </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_361-3  </td><td>Ptosis of eyelid                                                               </td><td>0.657 (0.633, 0.681)</td><td>0.68 (0.656, 0.701) </td><td>0.023 (0.004, 0.045)   </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_448    </td><td>Peripheral vascular disease                                                    </td><td>0.656 (0.64, 0.671) </td><td>0.679 (0.664, 0.693)</td><td>0.023 (0.013, 0.035)   </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_463-1  </td><td>Chronic rhinitis                                                               </td><td>0.541 (0.486, 0.581)</td><td>0.56 (0.516, 0.609) </td><td>0.023 (-0.017, 0.064)  </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_331    </td><td>Headache                                                                       </td><td>0.567 (0.559, 0.58) </td><td>0.59 (0.582, 0.603) </td><td>0.023 (0.014, 0.032)   </td></tr>\n",
       "\t<tr><td>ID            </td><td>phecode_089-2  </td><td>Viral infections                                                               </td><td>0.564 (0.553, 0.576)</td><td>0.588 (0.575, 0.601)</td><td>0.024 (0.01, 0.034)    </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_665-2  </td><td>Psoriatic arthropathy                                                          </td><td>0.506 (0.443, 0.542)</td><td>0.53 (0.485, 0.566) </td><td>0.024 (-0.019, 0.068)  </td></tr>\n",
       "\t<tr><td>Mental        </td><td>phecode_283    </td><td>Other behavioral problems                                                      </td><td>0.549 (0.537, 0.56) </td><td>0.573 (0.564, 0.585)</td><td>0.024 (0.014, 0.034)   </td></tr>\n",
       "\t<tr><td>Hearing       </td><td>phecode_391    </td><td>Disorders of the middle ear                                                    </td><td>0.524 (0.499, 0.549)</td><td>0.547 (0.524, 0.573)</td><td>0.024 (-0.009, 0.051)  </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_491    </td><td>Pleurisy                                                                       </td><td>0.687 (0.66, 0.721) </td><td>0.712 (0.69, 0.737) </td><td>0.024 (0.01, 0.037)    </td></tr>\n",
       "\t<tr><td>Signs/Symptoms</td><td>phecode_800    </td><td>Chest pain                                                                     </td><td>0.528 (0.52, 0.536) </td><td>0.553 (0.546, 0.561)</td><td>0.024 (0.017, 0.032)   </td></tr>\n",
       "\t<tr><td>Metab         </td><td>phecode_247-5  </td><td>Disorders of calcium metabolism                                                </td><td>0.64 (0.618, 0.663) </td><td>0.667 (0.642, 0.69) </td><td>0.024 (0.004, 0.044)   </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_557-8  </td><td>Hemorrhage of rectum and anus                                                  </td><td>0.472 (0.458, 0.484)</td><td>0.496 (0.477, 0.51) </td><td>0.025 (0.007, 0.038)   </td></tr>\n",
       "\t<tr><td>Signs/Symptoms</td><td>phecode_801    </td><td>Cough                                                                          </td><td>0.561 (0.542, 0.575)</td><td>0.586 (0.567, 0.598)</td><td>0.025 (0.007, 0.043)   </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_350-5  </td><td>Repeated falls*                                                                </td><td>0.734 (0.725, 0.744)</td><td>0.757 (0.748, 0.769)</td><td>0.025 (0.016, 0.031)   </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_433-1  </td><td>Occlusion and stenosis of cerebral arteries                                    </td><td>0.722 (0.701, 0.746)</td><td>0.748 (0.722, 0.77) </td><td>0.025 (0.008, 0.044)   </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_331-8  </td><td>Headache NOS                                                                   </td><td>0.558 (0.544, 0.57) </td><td>0.582 (0.568, 0.597)</td><td>0.025 (0.015, 0.037)   </td></tr>\n",
       "\t<tr><td>Metab         </td><td>phecode_247-7  </td><td>Disorders of iron metabolism                                                   </td><td>0.586 (0.576, 0.597)</td><td>0.611 (0.601, 0.621)</td><td>0.025 (0.016, 0.032)   </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_387-3  </td><td>Astigmatism                                                                    </td><td>0.674 (0.661, 0.688)</td><td>0.7 (0.685, 0.713)  </td><td>0.025 (0.014, 0.036)   </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_716    </td><td>Intervertebral disc disorder                                                   </td><td>0.551 (0.538, 0.565)</td><td>0.577 (0.565, 0.588)</td><td>0.026 (0.013, 0.036)   </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_550-2  </td><td>Cholecystitis                                                                  </td><td>0.559 (0.535, 0.585)</td><td>0.586 (0.562, 0.614)</td><td>0.026 (0.002, 0.056)   </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_411-2  </td><td>Pericardial effusion (noninflammatory)*                                        </td><td>0.652 (0.618, 0.677)</td><td>0.674 (0.647, 0.704)</td><td>0.026 (0.003, 0.039)   </td></tr>\n",
       "\t<tr><td>Signs/Symptoms</td><td>phecode_809    </td><td>Pain                                                                           </td><td>0.579 (0.567, 0.59) </td><td>0.606 (0.593, 0.615)</td><td>0.026 (0.016, 0.037)   </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_369-4  </td><td>Corneal degenerations                                                          </td><td>0.73 (0.707, 0.751) </td><td>0.758 (0.737, 0.78) </td><td>0.026 (0.006, 0.046)   </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_667    </td><td>Erythematous conditions                                                        </td><td>0.576 (0.525, 0.616)</td><td>0.597 (0.553, 0.647)</td><td>0.026 (-0.022, 0.069)  </td></tr>\n",
       "\t<tr><td>Signs/Symptoms</td><td>phecode_809-3  </td><td>Pain in limb                                                                   </td><td>0.565 (0.55, 0.579) </td><td>0.59 (0.578, 0.607) </td><td>0.027 (0.015, 0.037)   </td></tr>\n",
       "\t<tr><td>Mental        </td><td>phecode_288-2  </td><td>Panic disorder [episodic paroxysmal anxiety]                                   </td><td>0.561 (0.533, 0.59) </td><td>0.589 (0.559, 0.622)</td><td>0.027 (-0.005, 0.069)  </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_524    </td><td>Functional intestinal disorder                                                 </td><td>0.579 (0.568, 0.589)</td><td>0.606 (0.595, 0.619)</td><td>0.027 (0.021, 0.034)   </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_488-1  </td><td>Dyspnea [Shortness of breath]                                                  </td><td>0.606 (0.595, 0.618)</td><td>0.633 (0.623, 0.643)</td><td>0.027 (0.017, 0.037)   </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_679    </td><td>Skin symptoms                                                                  </td><td>0.572 (0.556, 0.59) </td><td>0.598 (0.583, 0.617)</td><td>0.027 (0.01, 0.047)    </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_660    </td><td>Infection of the skin                                                          </td><td>0.577 (0.568, 0.588)</td><td>0.604 (0.592, 0.615)</td><td>0.027 (0.016, 0.037)   </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_462-2  </td><td>Chronic sinusitis                                                              </td><td>0.531 (0.509, 0.551)</td><td>0.558 (0.534, 0.585)</td><td>0.027 (0.005, 0.053)   </td></tr>\n",
       "\t<tr><td>Blood         </td><td>phecode_160    </td><td>Nutritional anemias                                                            </td><td>0.6 (0.589, 0.608)  </td><td>0.628 (0.618, 0.636)</td><td>0.028 (0.02, 0.035)    </td></tr>\n",
       "\t<tr><td>Blood         </td><td>phecode_164-1  </td><td>Microcytic anemia                                                              </td><td>0.592 (0.582, 0.606)</td><td>0.619 (0.612, 0.631)</td><td>0.028 (0.018, 0.038)   </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_347    </td><td>Other disorders of the brain and CNS                                           </td><td>0.58 (0.535, 0.621) </td><td>0.607 (0.573, 0.639)</td><td>0.028 (-0.004, 0.065)  </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_460    </td><td>Acute respiratory infection                                                    </td><td>0.629 (0.619, 0.638)</td><td>0.656 (0.647, 0.664)</td><td>0.028 (0.019, 0.035)   </td></tr>\n",
       "\t<tr><td>Metab         </td><td>phecode_247-4  </td><td>Disorders of magnesium metabolism                                              </td><td>0.661 (0.633, 0.689)</td><td>0.687 (0.658, 0.712)</td><td>0.028 (0.006, 0.042)   </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_417-2  </td><td>Tachycardia                                                                    </td><td>0.585 (0.566, 0.602)</td><td>0.613 (0.593, 0.63) </td><td>0.028 (0.008, 0.038)   </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_660-6  </td><td>Cellulitis and abscess                                                         </td><td>0.575 (0.563, 0.586)</td><td>0.604 (0.592, 0.614)</td><td>0.028 (0.02, 0.039)    </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_401-3  </td><td>Hypertensive chronic kidney disease                                            </td><td>0.703 (0.672, 0.745)</td><td>0.731 (0.696, 0.759)</td><td>0.028 (-0.005, 0.053)  </td></tr>\n",
       "\t<tr><td>Metab         </td><td>phecode_232-4  </td><td>Vitamin D deficiency                                                           </td><td>0.6 (0.58, 0.621)   </td><td>0.629 (0.612, 0.648)</td><td>0.028 (0.013, 0.043)   </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_718-2  </td><td>Cervicalgia                                                                    </td><td>0.604 (0.578, 0.633)</td><td>0.634 (0.608, 0.662)</td><td>0.028 (0.009, 0.053)   </td></tr>\n",
       "\t<tr><td>Blood         </td><td>phecode_164-2  </td><td>Macrocytic anemia                                                              </td><td>0.649 (0.622, 0.674)</td><td>0.679 (0.647, 0.706)</td><td>0.028 (0.006, 0.052)   </td></tr>\n",
       "\t<tr><td>Blood         </td><td>phecode_160-1  </td><td>Iron deficiency anemia                                                         </td><td>0.591 (0.581, 0.601)</td><td>0.62 (0.609, 0.628) </td><td>0.029 (0.019, 0.038)   </td></tr>\n",
       "\t<tr><td>Metab         </td><td>phecode_247-72 </td><td>Iron deficiency                                                                </td><td>0.59 (0.58, 0.601)  </td><td>0.619 (0.609, 0.628)</td><td>0.029 (0.021, 0.038)   </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_665    </td><td>Psoriasis                                                                      </td><td>0.581 (0.559, 0.6)  </td><td>0.609 (0.588, 0.631)</td><td>0.029 (0.009, 0.051)   </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_479-3  </td><td>Respiratory failure                                                            </td><td>0.671 (0.649, 0.688)</td><td>0.697 (0.68, 0.722) </td><td>0.029 (0.013, 0.044)   </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_718-1  </td><td>Radiculopathy                                                                  </td><td>0.557 (0.533, 0.579)</td><td>0.586 (0.561, 0.615)</td><td>0.029 (0.005, 0.055)   </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_713-3  </td><td>Pain in joint                                                                  </td><td>0.581 (0.569, 0.596)</td><td>0.61 (0.597, 0.624) </td><td>0.029 (0.018, 0.036)   </td></tr>\n",
       "\t<tr><td>Hearing       </td><td>phecode_395    </td><td>Other diseases of inner ear                                                    </td><td>0.526 (0.499, 0.574)</td><td>0.556 (0.519, 0.598)</td><td>0.029 (-0.008, 0.056)  </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_555    </td><td>Ascites                                                                        </td><td>0.637 (0.611, 0.657)</td><td>0.665 (0.642, 0.692)</td><td>0.029 (0.012, 0.049)   </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_377    </td><td>Hemorrhage of the eye                                                          </td><td>0.588 (0.557, 0.629)</td><td>0.616 (0.577, 0.672)</td><td>0.029 (-0.038, 0.094)  </td></tr>\n",
       "\t<tr><td>Metab         </td><td>phecode_256-4  </td><td>Hyperkalemia [Hyperpotassemia]                                                 </td><td>0.698 (0.68, 0.714) </td><td>0.725 (0.709, 0.747)</td><td>0.029 (0.013, 0.046)   </td></tr>\n",
       "\t<tr><td>Stat          </td><td>phecode_979    </td><td>Transplated organ                                                              </td><td>0.563 (0.531, 0.591)</td><td>0.594 (0.556, 0.631)</td><td>0.029 (-0.011, 0.077)  </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_325-2  </td><td>Abnormality of gait and mobility                                               </td><td>0.683 (0.671, 0.697)</td><td>0.713 (0.703, 0.73) </td><td>0.03 (0.02, 0.041)     </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_486    </td><td>Other respiratory disorders                                                    </td><td>0.651 (0.633, 0.665)</td><td>0.681 (0.662, 0.698)</td><td>0.03 (0.014, 0.042)    </td></tr>\n",
       "\t<tr><td>Signs/Symptoms</td><td>phecode_807    </td><td>Malaise and fatigue                                                            </td><td>0.591 (0.571, 0.61) </td><td>0.622 (0.606, 0.641)</td><td>0.03 (0.019, 0.043)    </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_330    </td><td>Epilepsy, recurrent seizures, convulsions                                      </td><td>0.572 (0.554, 0.589)</td><td>0.602 (0.588, 0.617)</td><td>0.03 (0.013, 0.047)    </td></tr>\n",
       "\t<tr><td>Mental        </td><td>phecode_284    </td><td>Suicide ideation and attempt or self harm                                      </td><td>0.561 (0.53, 0.595) </td><td>0.594 (0.56, 0.635) </td><td>0.03 (-0.008, 0.068)   </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_488    </td><td>Abnormalities of breathing                                                     </td><td>0.587 (0.576, 0.597)</td><td>0.617 (0.607, 0.628)</td><td>0.03 (0.021, 0.04)     </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_448-9  </td><td>Peripheral vascular disease NOS [includes PAD]                                 </td><td>0.755 (0.74, 0.771) </td><td>0.785 (0.767, 0.798)</td><td>0.03 (0.014, 0.046)    </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_138-2  </td><td>Melanocytic nevi*                                                              </td><td>0.513 (0.489, 0.539)</td><td>0.548 (0.526, 0.566)</td><td>0.03 (0.013, 0.061)    </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_325    </td><td>Symptoms and signs related to movement disorders                               </td><td>0.673 (0.66, 0.687) </td><td>0.704 (0.692, 0.718)</td><td>0.03 (0.022, 0.039)    </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_535    </td><td>Intestinal or peritoneal adhesions                                             </td><td>0.552 (0.534, 0.564)</td><td>0.582 (0.565, 0.597)</td><td>0.03 (0.018, 0.044)    </td></tr>\n",
       "\t<tr><td>Metab         </td><td>phecode_256-6  </td><td>Fluid overload                                                                 </td><td>0.723 (0.699, 0.741)</td><td>0.752 (0.731, 0.774)</td><td>0.03 (0.011, 0.046)    </td></tr>\n",
       "\t<tr><td>ID            </td><td>phecode_096    </td><td>Contact or exposure to infectious agent                                        </td><td>0.596 (0.497, 0.701)</td><td>0.627 (0.507, 0.734)</td><td>0.031 (-0.07, 0.137)   </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_468-2  </td><td>Bacterial pneumonia                                                            </td><td>0.643 (0.617, 0.669)</td><td>0.672 (0.647, 0.714)</td><td>0.031 (0.011, 0.056)   </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_721-5  </td><td>Bursitis                                                                       </td><td>0.499 (0.481, 0.52) </td><td>0.533 (0.51, 0.55)  </td><td>0.031 (0.012, 0.058)   </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_679-1  </td><td>Rash and other nonspecific skin eruption                                       </td><td>0.59 (0.564, 0.609) </td><td>0.621 (0.601, 0.64) </td><td>0.031 (0.014, 0.05)    </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_525-1  </td><td>Celiac disease                                                                 </td><td>0.522 (0.496, 0.549)</td><td>0.552 (0.521, 0.576)</td><td>0.031 (0.002, 0.053)   </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_580    </td><td>Glomerular diseases                                                            </td><td>0.659 (0.633, 0.689)</td><td>0.69 (0.661, 0.719) </td><td>0.031 (0.011, 0.052)   </td></tr>\n",
       "\t<tr><td>Blood         </td><td>phecode_177-2  </td><td>Enlargement of lymph nodes [Lymphadenopathy]                                   </td><td>0.58 (0.565, 0.597) </td><td>0.612 (0.593, 0.634)</td><td>0.031 (0.014, 0.046)   </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_465-1  </td><td>Acute Pharyngitis                                                              </td><td>0.467 (0.434, 0.504)</td><td>0.5 (0.457, 0.534)  </td><td>0.031 (-0.013, 0.061)  </td></tr>\n",
       "\t<tr><td>Metab         </td><td>phecode_232    </td><td>Vitamin deficiencies                                                           </td><td>0.608 (0.595, 0.625)</td><td>0.64 (0.627, 0.652) </td><td>0.032 (0.021, 0.043)   </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_707-8  </td><td>Polyarthritis                                                                  </td><td>0.421 (0.389, 0.453)</td><td>0.454 (0.423, 0.484)</td><td>0.032 (0.014, 0.047)   </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_508    </td><td>Diseases of lips                                                               </td><td>0.49 (0.435, 0.53)  </td><td>0.521 (0.465, 0.561)</td><td>0.032 (-0.006, 0.072)  </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_526-1  </td><td>Bacterial enteritis                                                            </td><td>0.567 (0.539, 0.585)</td><td>0.594 (0.574, 0.614)</td><td>0.032 (0.013, 0.051)   </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_443-1  </td><td>Stricture of artery [Arterial stenosis]                                        </td><td>0.72 (0.688, 0.757) </td><td>0.752 (0.726, 0.787)</td><td>0.032 (-0.002, 0.062)  </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_526-2  </td><td>Viral enteritis                                                                </td><td>0.568 (0.544, 0.613)</td><td>0.602 (0.571, 0.633)</td><td>0.033 (-0.002, 0.071)  </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_686-1  </td><td>Pressure ulcer                                                                 </td><td>0.718 (0.702, 0.734)</td><td>0.749 (0.738, 0.765)</td><td>0.033 (0.021, 0.045)   </td></tr>\n",
       "\t<tr><td>Mental        </td><td>phecode_299    </td><td>Mental disorder, not otherwise specified                                       </td><td>0.631 (0.587, 0.665)</td><td>0.663 (0.631, 0.695)</td><td>0.033 (-0.002, 0.064)  </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_460-2  </td><td>Acute lower respiratory infection                                              </td><td>0.645 (0.635, 0.655)</td><td>0.678 (0.669, 0.687)</td><td>0.033 (0.024, 0.04)    </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_723    </td><td>Enthesopathy/Enthesitis/Tendinopathy                                           </td><td>0.506 (0.491, 0.517)</td><td>0.539 (0.527, 0.55) </td><td>0.033 (0.021, 0.045)   </td></tr>\n",
       "\t<tr><td>Metab         </td><td>phecode_232-2  </td><td>Vitamin B group deficiency                                                     </td><td>0.628 (0.607, 0.649)</td><td>0.663 (0.649, 0.683)</td><td>0.033 (0.02, 0.05)     </td></tr>\n",
       "\t<tr><td>Blood         </td><td>phecode_177    </td><td>Abnormality of the lymph nodes                                                 </td><td>0.588 (0.576, 0.601)</td><td>0.621 (0.608, 0.635)</td><td>0.033 (0.021, 0.045)   </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_520-13 </td><td>Umbilical hernia                                                               </td><td>0.638 (0.617, 0.656)</td><td>0.67 (0.656, 0.688) </td><td>0.034 (0.021, 0.045)   </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_702-3  </td><td>Enteropathic arthropathies                                                     </td><td>0.497 (0.458, 0.532)</td><td>0.532 (0.499, 0.562)</td><td>0.034 (-0.006, 0.081)  </td></tr>\n",
       "\t<tr><td>ID            </td><td>phecode_004    </td><td>Streptococcus                                                                  </td><td>0.593 (0.571, 0.615)</td><td>0.627 (0.606, 0.649)</td><td>0.034 (0.016, 0.056)   </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_443    </td><td>Other specified disorders of arteries and arterioles                           </td><td>0.698 (0.678, 0.73) </td><td>0.735 (0.709, 0.763)</td><td>0.034 (0.009, 0.059)   </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_462    </td><td>Sinusitis                                                                      </td><td>0.519 (0.498, 0.541)</td><td>0.552 (0.528, 0.579)</td><td>0.034 (0.008, 0.059)   </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_524-1  </td><td>Irritable bowel syndrome                                                       </td><td>0.567 (0.556, 0.579)</td><td>0.602 (0.589, 0.613)</td><td>0.035 (0.028, 0.043)   </td></tr>\n",
       "\t<tr><td>Mental        </td><td>phecode_284-29 </td><td>Intentional self-harm*                                                         </td><td>0.554 (0.524, 0.598)</td><td>0.593 (0.56, 0.625) </td><td>0.035 (-0.003, 0.075)  </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_686    </td><td>Chronic ulcer of skin                                                          </td><td>0.706 (0.69, 0.72)  </td><td>0.74 (0.726, 0.758) </td><td>0.035 (0.022, 0.044)   </td></tr>\n",
       "\t<tr><td>Metab         </td><td>phecode_256-1  </td><td>Hyperosmolality and/or hypernatremia                                           </td><td>0.67 (0.632, 0.702) </td><td>0.708 (0.666, 0.744)</td><td>0.035 (0.012, 0.071)   </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_682-1  </td><td>Cutaneous cyst                                                                 </td><td>0.455 (0.43, 0.476) </td><td>0.49 (0.468, 0.507) </td><td>0.036 (0.015, 0.062)   </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_724-1  </td><td>Myalgia                                                                        </td><td>0.61 (0.592, 0.632) </td><td>0.647 (0.627, 0.667)</td><td>0.037 (0.025, 0.047)   </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_386    </td><td>Visual disturbances                                                            </td><td>0.591 (0.573, 0.608)</td><td>0.626 (0.609, 0.645)</td><td>0.037 (0.02, 0.048)    </td></tr>\n",
       "\t<tr><td>Signs/Symptoms</td><td>phecode_835    </td><td>Cytology and pathology findings                                                </td><td>0.44 (0.406, 0.492) </td><td>0.474 (0.428, 0.521)</td><td>0.037 (-0.006, 0.076)  </td></tr>\n",
       "\t<tr><td>ID            </td><td>phecode_002    </td><td>Staphylococcus                                                                 </td><td>0.629 (0.617, 0.652)</td><td>0.668 (0.652, 0.686)</td><td>0.038 (0.021, 0.051)   </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_507    </td><td>Lesions of mouth                                                               </td><td>0.351 (0.331, 0.374)</td><td>0.39 (0.367, 0.412) </td><td>0.038 (0.021, 0.054)   </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_557-1  </td><td>Hematemesis                                                                    </td><td>0.629 (0.605, 0.654)</td><td>0.666 (0.642, 0.688)</td><td>0.038 (0.014, 0.06)    </td></tr>\n",
       "\t<tr><td>Metab         </td><td>phecode_256-3  </td><td>Mixed disorder of acid-base balance                                            </td><td>0.657 (0.636, 0.68) </td><td>0.694 (0.676, 0.714)</td><td>0.038 (0.018, 0.055)   </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_326-1  </td><td>Multiple sclerosis                                                             </td><td>0.568 (0.528, 0.604)</td><td>0.608 (0.566, 0.64) </td><td>0.039 (0.016, 0.069)   </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_614-5  </td><td>Inflammatory disease of cervix, vagina, and vulva                              </td><td>0.439 (0.397, 0.478)</td><td>0.479 (0.431, 0.518)</td><td>0.039 (0.009, 0.077)   </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_537    </td><td>Abnormality of the peritoneum                                                  </td><td>0.539 (0.511, 0.569)</td><td>0.576 (0.546, 0.603)</td><td>0.039 (-0.002, 0.064)  </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_355    </td><td>Coma and other alteration of consciousness                                     </td><td>0.597 (0.563, 0.625)</td><td>0.634 (0.596, 0.666)</td><td>0.039 (0.009, 0.073)   </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_102    </td><td>Malignant neoplasm of the thoracic and respiratory organs                      </td><td>0.674 (0.659, 0.686)</td><td>0.713 (0.699, 0.725)</td><td>0.039 (0.027, 0.049)   </td></tr>\n",
       "\t<tr><td>Metab         </td><td>phecode_247-3  </td><td>Disorder of phosphorus metabolism                                              </td><td>0.631 (0.603, 0.653)</td><td>0.67 (0.644, 0.701) </td><td>0.04 (0.014, 0.065)    </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_344-1  </td><td>Hydrocephalus                                                                  </td><td>0.631 (0.588, 0.666)</td><td>0.667 (0.626, 0.709)</td><td>0.04 (-0.006, 0.084)   </td></tr>\n",
       "\t<tr><td>Signs/Symptoms</td><td>phecode_800-2  </td><td>Precordial pain                                                                </td><td>0.509 (0.496, 0.522)</td><td>0.549 (0.535, 0.564)</td><td>0.04 (0.024, 0.056)    </td></tr>\n",
       "\t<tr><td>Metab         </td><td>phecode_244    </td><td>Disorders of lipoprotein metabolism and other lipidemias                       </td><td>0.602 (0.573, 0.635)</td><td>0.644 (0.606, 0.684)</td><td>0.04 (0.015, 0.071)    </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_104    </td><td>Malignant sarcoma-related cancers                                              </td><td>0.52 (0.487, 0.55)  </td><td>0.559 (0.524, 0.593)</td><td>0.04 (0.009, 0.07)     </td></tr>\n",
       "\t<tr><td>Stat          </td><td>phecode_997    </td><td>Family history of other condition                                              </td><td>0.697 (0.681, 0.716)</td><td>0.737 (0.72, 0.759) </td><td>0.04 (0.026, 0.054)    </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_502    </td><td>Other diseases of teeth and supporting structures                              </td><td>0.489 (0.47, 0.508) </td><td>0.532 (0.511, 0.552)</td><td>0.041 (0.021, 0.063)   </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_374-5  </td><td>Macular degeneration                                                           </td><td>0.742 (0.73, 0.754) </td><td>0.785 (0.772, 0.793)</td><td>0.041 (0.033, 0.05)    </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_472    </td><td>Diseases of vocal cords and larynx, not elsewhere classified                   </td><td>0.582 (0.552, 0.608)</td><td>0.62 (0.6, 0.656)   </td><td>0.041 (0, 0.068)       </td></tr>\n",
       "\t<tr><td>Blood         </td><td>phecode_168-2  </td><td>Hyper-coagulability                                                            </td><td>0.514 (0.477, 0.557)</td><td>0.557 (0.52, 0.605) </td><td>0.042 (0.01, 0.083)    </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_540    </td><td>Hepatitis                                                                      </td><td>0.546 (0.513, 0.576)</td><td>0.588 (0.552, 0.622)</td><td>0.042 (0.011, 0.066)   </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_713-2  </td><td>Effusion of joint                                                              </td><td>0.577 (0.551, 0.609)</td><td>0.619 (0.594, 0.653)</td><td>0.043 (0.015, 0.071)   </td></tr>\n",
       "\t<tr><td>Metab         </td><td>phecode_256-31 </td><td>Acidosis                                                                       </td><td>0.655 (0.632, 0.675)</td><td>0.696 (0.676, 0.716)</td><td>0.043 (0.02, 0.064)    </td></tr>\n",
       "\t<tr><td>ID            </td><td>phecode_002-1  </td><td>Staphylococcus aureus                                                          </td><td>0.617 (0.589, 0.642)</td><td>0.66 (0.635, 0.687) </td><td>0.044 (0.022, 0.061)   </td></tr>\n",
       "\t<tr><td>Mental        </td><td>phecode_284-2  </td><td>Suicide and self-inflicted harm                                                </td><td>0.554 (0.525, 0.593)</td><td>0.598 (0.565, 0.631)</td><td>0.044 (0.001, 0.083)   </td></tr>\n",
       "\t<tr><td>Mental        </td><td>phecode_308    </td><td>Signs and symptoms involving emotional state                                   </td><td>0.562 (0.53, 0.592) </td><td>0.605 (0.582, 0.63) </td><td>0.044 (0.01, 0.076)    </td></tr>\n",
       "\t<tr><td>ID            </td><td>phecode_052-3  </td><td>Varicella zoster virus                                                         </td><td>0.545 (0.508, 0.587)</td><td>0.591 (0.542, 0.636)</td><td>0.044 (-0.003, 0.083)  </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_723-6  </td><td>Impingement syndrome of shoulder*                                              </td><td>0.48 (0.466, 0.501) </td><td>0.523 (0.51, 0.542) </td><td>0.044 (0.028, 0.062)   </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_674-2  </td><td>Hypepigmentation                                                               </td><td>0.492 (0.444, 0.545)</td><td>0.535 (0.501, 0.58) </td><td>0.045 (-0.011, 0.1)    </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_542-4  </td><td>Portal hypertension                                                            </td><td>0.631 (0.597, 0.664)</td><td>0.676 (0.623, 0.717)</td><td>0.045 (0.005, 0.082)   </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_344    </td><td>Disorders of the circulation of the cerebrospinal fluid                        </td><td>0.553 (0.516, 0.587)</td><td>0.597 (0.562, 0.633)</td><td>0.045 (0.009, 0.083)   </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_619-2  </td><td>Disorders of uterus, NEC                                                       </td><td>0.412 (0.383, 0.43) </td><td>0.458 (0.428, 0.479)</td><td>0.046 (0.024, 0.068)   </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_682-12 </td><td>Pilar and trichodermal cyst                                                    </td><td>0.453 (0.434, 0.477)</td><td>0.501 (0.478, 0.526)</td><td>0.046 (0.022, 0.074)   </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_495    </td><td>Abnormal findings on diagnostic imaging of lung                                </td><td>0.63 (0.611, 0.649) </td><td>0.679 (0.658, 0.694)</td><td>0.047 (0.033, 0.066)   </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_474    </td><td>Chronic obstructive pulmonary disease [COPD]                                   </td><td>0.681 (0.673, 0.69) </td><td>0.728 (0.718, 0.736)</td><td>0.047 (0.039, 0.054)   </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_367    </td><td>Inflammation of the eye                                                        </td><td>0.592 (0.571, 0.617)</td><td>0.639 (0.613, 0.663)</td><td>0.048 (0.014, 0.067)   </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_487-3  </td><td>Hemoptysis                                                                     </td><td>0.582 (0.554, 0.604)</td><td>0.624 (0.6, 0.653)  </td><td>0.048 (0.022, 0.068)   </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_375-1  </td><td>Glaucoma                                                                       </td><td>0.708 (0.697, 0.72) </td><td>0.757 (0.746, 0.77) </td><td>0.048 (0.039, 0.058)   </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_102-1  </td><td>Malignant neoplasm of the of bronchus and lung                                 </td><td>0.676 (0.663, 0.692)</td><td>0.724 (0.711, 0.738)</td><td>0.049 (0.036, 0.06)    </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_330-1  </td><td>Epilepsy                                                                       </td><td>0.541 (0.522, 0.564)</td><td>0.591 (0.57, 0.612) </td><td>0.049 (0.026, 0.069)   </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_718-5  </td><td>Sciatica                                                                       </td><td>0.591 (0.568, 0.618)</td><td>0.639 (0.616, 0.661)</td><td>0.049 (0.029, 0.07)    </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_542-3  </td><td>Hepatic failure                                                                </td><td>0.643 (0.611, 0.677)</td><td>0.696 (0.66, 0.727) </td><td>0.049 (0.015, 0.079)   </td></tr>\n",
       "\t<tr><td>ID            </td><td>phecode_059    </td><td>Coronavirus                                                                    </td><td>0.644 (0.599, 0.683)</td><td>0.69 (0.651, 0.732) </td><td>0.05 (0.008, 0.086)    </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_324-4  </td><td>Tremor                                                                         </td><td>0.647 (0.616, 0.672)</td><td>0.693 (0.669, 0.721)</td><td>0.051 (0.028, 0.08)    </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_474-1  </td><td>Emphysema                                                                      </td><td>0.695 (0.679, 0.714)</td><td>0.748 (0.726, 0.762)</td><td>0.051 (0.033, 0.072)   </td></tr>\n",
       "\t<tr><td>ID            </td><td>phecode_052-32 </td><td>Herpes zoster                                                                  </td><td>0.554 (0.51, 0.596) </td><td>0.604 (0.566, 0.653)</td><td>0.052 (0.004, 0.093)   </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_682    </td><td>Other follicular disorders                                                     </td><td>0.456 (0.439, 0.473)</td><td>0.507 (0.486, 0.523)</td><td>0.052 (0.03, 0.071)    </td></tr>\n",
       "\t<tr><td>Metab         </td><td>phecode_248    </td><td>Disorders of plasma-protein metabolism, NEC                                    </td><td>0.617 (0.582, 0.66) </td><td>0.67 (0.617, 0.716) </td><td>0.052 (0.012, 0.085)   </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_718-4  </td><td>Low back pain                                                                  </td><td>0.533 (0.512, 0.548)</td><td>0.585 (0.565, 0.597)</td><td>0.053 (0.038, 0.071)   </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_375    </td><td>Abnormal intraocular pressure                                                  </td><td>0.697 (0.688, 0.706)</td><td>0.75 (0.739, 0.758) </td><td>0.053 (0.044, 0.063)   </td></tr>\n",
       "\t<tr><td>Mental        </td><td>phecode_280-1  </td><td>Alcohol use disorders                                                          </td><td>0.622 (0.605, 0.635)</td><td>0.675 (0.658, 0.688)</td><td>0.053 (0.04, 0.064)    </td></tr>\n",
       "\t<tr><td>ID            </td><td>phecode_098    </td><td>Carrier or suspected carrier of infectious diseases                            </td><td>0.559 (0.538, 0.583)</td><td>0.61 (0.586, 0.637) </td><td>0.054 (0.029, 0.076)   </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_613    </td><td>Other nonmalignant breast conditions                                           </td><td>0.445 (0.4, 0.485)  </td><td>0.5 (0.461, 0.532)  </td><td>0.055 (0.014, 0.089)   </td></tr>\n",
       "\t<tr><td>Mental        </td><td>phecode_280    </td><td>Substance related disorders                                                    </td><td>0.616 (0.603, 0.628)</td><td>0.67 (0.652, 0.685) </td><td>0.055 (0.042, 0.068)   </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_664    </td><td>Papulosquamous disorders                                                       </td><td>0.554 (0.514, 0.598)</td><td>0.612 (0.553, 0.647)</td><td>0.055 (0.011, 0.097)   </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_686-2  </td><td>Non-pressure chronic ulcer                                                     </td><td>0.7 (0.676, 0.723)  </td><td>0.753 (0.736, 0.777)</td><td>0.056 (0.033, 0.076)   </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_537-1  </td><td>Peritonitis                                                                    </td><td>0.503 (0.476, 0.528)</td><td>0.556 (0.529, 0.588)</td><td>0.056 (0.022, 0.088)   </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_138    </td><td>Benign neoplasm of the skin                                                    </td><td>0.469 (0.452, 0.486)</td><td>0.525 (0.51, 0.538) </td><td>0.057 (0.037, 0.071)   </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_619-4  </td><td>Noninflammatory disorders of vagina                                            </td><td>0.445 (0.397, 0.49) </td><td>0.501 (0.451, 0.54) </td><td>0.057 (0.01, 0.103)    </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_337    </td><td>Polyneuropathies                                                               </td><td>0.62 (0.602, 0.643) </td><td>0.679 (0.66, 0.697) </td><td>0.058 (0.04, 0.075)    </td></tr>\n",
       "\t<tr><td>Blood         </td><td>phecode_164-6  </td><td>Anemia secondary to chronic diseases and conditions                            </td><td>0.631 (0.594, 0.675)</td><td>0.687 (0.655, 0.724)</td><td>0.058 (0.019, 0.09)    </td></tr>\n",
       "\t<tr><td>Mental        </td><td>phecode_286    </td><td>Mood [affective] disorders                                                     </td><td>0.543 (0.532, 0.55) </td><td>0.6 (0.592, 0.608)  </td><td>0.058 (0.051, 0.064)   </td></tr>\n",
       "\t<tr><td>ID            </td><td>phecode_056    </td><td>Human papillomavirus                                                           </td><td>0.407 (0.368, 0.448)</td><td>0.465 (0.418, 0.512)</td><td>0.059 (0.025, 0.095)   </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_681    </td><td>Localized swelling, mass and lump of skin and subcutaneous tissue              </td><td>0.503 (0.474, 0.53) </td><td>0.56 (0.535, 0.582) </td><td>0.059 (0.027, 0.086)   </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_619-5  </td><td>Noninflammatory disorders of vulva and perineum                                </td><td>0.404 (0.36, 0.447) </td><td>0.458 (0.428, 0.496)</td><td>0.059 (0.011, 0.109)   </td></tr>\n",
       "\t<tr><td>Mental        </td><td>phecode_286-2  </td><td>Major depressive disorder                                                      </td><td>0.545 (0.538, 0.552)</td><td>0.605 (0.597, 0.611)</td><td>0.059 (0.052, 0.069)   </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_374    </td><td>Disorders of the retina                                                        </td><td>0.678 (0.669, 0.686)</td><td>0.737 (0.728, 0.747)</td><td>0.06 (0.052, 0.069)    </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_583-1  </td><td>End stage renal disease [CDK, stage 5]                                         </td><td>0.7 (0.674, 0.728)  </td><td>0.76 (0.74, 0.789)  </td><td>0.06 (0.033, 0.081)    </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_333    </td><td>Sleep disorders                                                                </td><td>0.556 (0.544, 0.567)</td><td>0.616 (0.603, 0.63) </td><td>0.061 (0.047, 0.074)   </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_336-2  </td><td>Lesion of median, ulnar, radial nerve                                          </td><td>0.517 (0.49, 0.546) </td><td>0.578 (0.544, 0.604)</td><td>0.061 (0.037, 0.088)   </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_371    </td><td>Cataract                                                                       </td><td>0.739 (0.734, 0.744)</td><td>0.801 (0.796, 0.804)</td><td>0.062 (0.057, 0.065)   </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_333-1  </td><td>Sleep apnea                                                                    </td><td>0.561 (0.547, 0.579)</td><td>0.624 (0.614, 0.641)</td><td>0.063 (0.052, 0.076)   </td></tr>\n",
       "\t<tr><td>Mental        </td><td>phecode_280-11 </td><td>Alcohol abuse                                                                  </td><td>0.632 (0.617, 0.654)</td><td>0.697 (0.677, 0.715)</td><td>0.064 (0.05, 0.083)    </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_376-2  </td><td>Vitreous opacities                                                             </td><td>0.659 (0.629, 0.686)</td><td>0.724 (0.708, 0.744)</td><td>0.065 (0.036, 0.098)   </td></tr>\n",
       "\t<tr><td>Mental        </td><td>phecode_286-1  </td><td>Bipolar disorder                                                               </td><td>0.504 (0.464, 0.543)</td><td>0.568 (0.534, 0.61) </td><td>0.066 (0.028, 0.105)   </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_376    </td><td>Disorders of vitreous body                                                     </td><td>0.659 (0.636, 0.683)</td><td>0.724 (0.703, 0.745)</td><td>0.066 (0.04, 0.091)    </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_371-3  </td><td>Nuclear cataract                                                               </td><td>0.742 (0.737, 0.751)</td><td>0.81 (0.804, 0.817) </td><td>0.067 (0.061, 0.073)   </td></tr>\n",
       "\t<tr><td>ID            </td><td>phecode_059-1  </td><td>COVID-19*                                                                      </td><td>0.627 (0.583, 0.673)</td><td>0.691 (0.659, 0.732)</td><td>0.068 (0.017, 0.11)    </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_371-31 </td><td>Age-related nuclear cataract                                                   </td><td>0.742 (0.735, 0.749)</td><td>0.81 (0.805, 0.817) </td><td>0.068 (0.062, 0.075)   </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_542-1  </td><td>Fibrosis and cirrhosis of liver                                                </td><td>0.638 (0.61, 0.667) </td><td>0.706 (0.675, 0.737)</td><td>0.069 (0.04, 0.092)    </td></tr>\n",
       "\t<tr><td>Mental        </td><td>phecode_280-13 </td><td>Alcoholic liver disease                                                        </td><td>0.68 (0.646, 0.711) </td><td>0.75 (0.717, 0.78)  </td><td>0.07 (0.035, 0.102)    </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_369    </td><td>Noninflammatory disorders of the cornea                                        </td><td>0.698 (0.676, 0.721)</td><td>0.768 (0.751, 0.789)</td><td>0.07 (0.054, 0.086)    </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_375-12 </td><td>Angle-Closure Glaucoma                                                         </td><td>0.681 (0.638, 0.718)</td><td>0.753 (0.714, 0.793)</td><td>0.071 (0.031, 0.108)   </td></tr>\n",
       "\t<tr><td>ID            </td><td>phecode_052    </td><td>Herpesvirus                                                                    </td><td>0.544 (0.511, 0.575)</td><td>0.613 (0.583, 0.651)</td><td>0.071 (0.033, 0.106)   </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_355-2  </td><td>Alteration of consciousness                                                    </td><td>0.587 (0.546, 0.625)</td><td>0.66 (0.617, 0.697) </td><td>0.071 (0.023, 0.113)   </td></tr>\n",
       "\t<tr><td>Endo          </td><td>phecode_202    </td><td>Diabetes mellitus                                                              </td><td>0.635 (0.627, 0.641)</td><td>0.706 (0.7, 0.712)  </td><td>0.072 (0.065, 0.078)   </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_351    </td><td>Disturbances of skin sensation                                                 </td><td>0.451 (0.432, 0.472)</td><td>0.521 (0.5, 0.544)  </td><td>0.072 (0.042, 0.099)   </td></tr>\n",
       "\t<tr><td>Mental        </td><td>phecode_281-1  </td><td>Substance abuse                                                                </td><td>0.62 (0.598, 0.641) </td><td>0.692 (0.673, 0.707)</td><td>0.072 (0.055, 0.087)   </td></tr>\n",
       "\t<tr><td>Endo          </td><td>phecode_202-2  </td><td>Type 2 diabetes                                                                </td><td>0.636 (0.631, 0.643)</td><td>0.71 (0.705, 0.715) </td><td>0.073 (0.068, 0.079)   </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_418    </td><td>Abnormal results of cardiovascular function studies                            </td><td>0.541 (0.506, 0.569)</td><td>0.612 (0.58, 0.641) </td><td>0.074 (0.046, 0.109)   </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_540-1  </td><td>Chronic hepatitis                                                              </td><td>0.531 (0.499, 0.573)</td><td>0.615 (0.579, 0.658)</td><td>0.084 (0.047, 0.122)   </td></tr>\n",
       "\t<tr><td>Endo          </td><td>phecode_211    </td><td>Disorders of adrenal glands                                                    </td><td>0.527 (0.491, 0.56) </td><td>0.611 (0.576, 0.661)</td><td>0.085 (0.046, 0.138)   </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_542    </td><td>Chronic liver disease and sequelae                                             </td><td>0.565 (0.551, 0.58) </td><td>0.652 (0.642, 0.668)</td><td>0.089 (0.068, 0.106)   </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_388    </td><td>Blindness and low vision                                                       </td><td>0.617 (0.589, 0.652)</td><td>0.709 (0.676, 0.751)</td><td>0.092 (0.05, 0.128)    </td></tr>\n",
       "\t<tr><td>Metab         </td><td>phecode_236-1  </td><td>Obesity                                                                        </td><td>0.523 (0.515, 0.529)</td><td>0.615 (0.608, 0.622)</td><td>0.093 (0.084, 0.103)   </td></tr>\n",
       "\t<tr><td>Metab         </td><td>phecode_236    </td><td>Overweight and obesity                                                         </td><td>0.523 (0.516, 0.529)</td><td>0.618 (0.611, 0.624)</td><td>0.095 (0.086, 0.102)   </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_387    </td><td>Disorders of refraction and accommodation                                      </td><td>0.677 (0.666, 0.69) </td><td>0.776 (0.765, 0.786)</td><td>0.097 (0.084, 0.109)   </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_366    </td><td>Noninflammatory disorders of conjunctiva                                       </td><td>0.549 (0.513, 0.589)</td><td>0.649 (0.607, 0.705)</td><td>0.098 (0.057, 0.136)   </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_360-2  </td><td>Chalazion                                                                      </td><td>0.318 (0.287, 0.347)</td><td>0.417 (0.382, 0.459)</td><td>0.099 (0.074, 0.127)   </td></tr>\n",
       "\t<tr><td>Mental        </td><td>phecode_280-12 </td><td>Alcohol dependence                                                             </td><td>0.607 (0.584, 0.633)</td><td>0.709 (0.684, 0.729)</td><td>0.101 (0.071, 0.127)   </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_375-11 </td><td>Open angle glaucoma                                                            </td><td>0.711 (0.687, 0.732)</td><td>0.814 (0.795, 0.833)</td><td>0.103 (0.085, 0.121)   </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_542-2  </td><td>Fatty liver disease (FLD)                                                      </td><td>0.525 (0.506, 0.549)</td><td>0.63 (0.611, 0.648) </td><td>0.105 (0.077, 0.13)    </td></tr>\n",
       "\t<tr><td>Mental        </td><td>phecode_287    </td><td>Psychotic disorder                                                             </td><td>0.491 (0.446, 0.539)</td><td>0.602 (0.559, 0.638)</td><td>0.106 (0.059, 0.141)   </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_688    </td><td>Granulomatous disorder of the skin                                             </td><td>0.431 (0.404, 0.464)</td><td>0.54 (0.505, 0.566) </td><td>0.107 (0.067, 0.138)   </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_501    </td><td>Dental caries                                                                  </td><td>0.427 (0.41, 0.447) </td><td>0.536 (0.518, 0.552)</td><td>0.108 (0.091, 0.128)   </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_688-1  </td><td>Sarcoidosis                                                                    </td><td>0.447 (0.402, 0.474)</td><td>0.563 (0.521, 0.613)</td><td>0.119 (0.072, 0.169)   </td></tr>\n",
       "\t<tr><td>Mental        </td><td>phecode_281    </td><td>Substance abuse, dependence, and withdrawl                                     </td><td>0.539 (0.531, 0.547)</td><td>0.665 (0.657, 0.672)</td><td>0.126 (0.116, 0.135)   </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_386-1  </td><td>Amblyopia                                                                      </td><td>0.646 (0.618, 0.684)</td><td>0.77 (0.731, 0.798) </td><td>0.126 (0.089, 0.155)   </td></tr>\n",
       "\t<tr><td>Endo          </td><td>phecode_205    </td><td>Hypoglycemia                                                                   </td><td>0.669 (0.646, 0.696)</td><td>0.797 (0.771, 0.815)</td><td>0.128 (0.101, 0.155)   </td></tr>\n",
       "\t<tr><td>Mental        </td><td>phecode_282-1  </td><td>Current tobacco use and nicotine dependence                                    </td><td>0.53 (0.521, 0.539) </td><td>0.66 (0.652, 0.667) </td><td>0.129 (0.119, 0.141)   </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_374-1  </td><td>Retinal detachments and breaks                                                 </td><td>0.598 (0.574, 0.623)</td><td>0.727 (0.708, 0.75) </td><td>0.129 (0.1, 0.154)     </td></tr>\n",
       "\t<tr><td>Mental        </td><td>phecode_282    </td><td>Nicotine dependence (current and history of)                                   </td><td>0.53 (0.519, 0.537) </td><td>0.66 (0.653, 0.665) </td><td>0.129 (0.122, 0.14)    </td></tr>\n",
       "\t<tr><td>Mental        </td><td>phecode_283-4  </td><td>Patient's noncompliance with medical treatment and regimen                     </td><td>0.53 (0.498, 0.569) </td><td>0.666 (0.635, 0.694)</td><td>0.133 (0.097, 0.172)   </td></tr>\n",
       "\t<tr><td>Mental        </td><td>phecode_281-2  </td><td>Substance dependence                                                           </td><td>0.528 (0.518, 0.535)</td><td>0.666 (0.661, 0.673)</td><td>0.138 (0.132, 0.146)   </td></tr>\n",
       "\t<tr><td>Endo          </td><td>phecode_202-1  </td><td>Type 1 diabetes                                                                </td><td>0.583 (0.563, 0.618)</td><td>0.728 (0.709, 0.752)</td><td>0.145 (0.12, 0.171)    </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_374-4  </td><td>Retinal disorders in diseases classified elsewhere                             </td><td>0.685 (0.655, 0.704)</td><td>0.836 (0.822, 0.853)</td><td>0.153 (0.135, 0.179)   </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_716-2  </td><td>Degenerative disc disease                                                      </td><td>0.325 (0.288, 0.373)</td><td>0.488 (0.443, 0.535)</td><td>0.156 (0.117, 0.201)   </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_337-8  </td><td>Polyneuropathy in diseases classified elsewhere                                </td><td>0.629 (0.594, 0.67) </td><td>0.805 (0.779, 0.829)</td><td>0.175 (0.139, 0.204)   </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_387-2  </td><td>Myopia                                                                         </td><td>0.609 (0.59, 0.633) </td><td>0.869 (0.858, 0.884)</td><td>0.259 (0.239, 0.281)   </td></tr>\n",
       "\t<tr><td>Blood         </td><td>phecode_165    </td><td>Hemoglobinopathies                                                             </td><td>0.602 (0.551, 0.656)</td><td>0.868 (0.84, 0.905) </td><td>0.265 (0.21, 0.324)    </td></tr>\n",
       "</tbody>\n",
       "</table>\n"
      ],
      "text/latex": [
       "A data.table: 752 × 6\n",
       "\\begin{tabular}{llllll}\n",
       " phecode\\_category & endpoint & phecode\\_string & Age+Sex & Age+Sex+Retina & delta\\\\\n",
       " <chr> & <chr> & <chr> & <chr> & <chr> & <chr>\\\\\n",
       "\\hline\n",
       "\t Blood          & phecode\\_168-1   & Hypo-coagulability                                                              & 0.655 (0.613, 0.691) & 0.486 (0.438, 0.547) & -0.166 (-0.212, -0.104)\\\\\n",
       "\t GI             & phecode\\_552-1   & Cholangitis                                                                     & 0.599 (0.575, 0.642) & 0.566 (0.539, 0.612) & -0.035 (-0.049, -0.013)\\\\\n",
       "\t Blood          & phecode\\_180     & Other disorders involving the immune mechanism                                  & 0.635 (0.612, 0.676) & 0.602 (0.574, 0.647) & -0.032 (-0.057, -0.008)\\\\\n",
       "\t Musc/Skel      & phecode\\_721-6   & Baker's cyst {[}popliteal cyst{]}                                                   & 0.627 (0.59, 0.665)  & 0.596 (0.561, 0.632) & -0.031 (-0.058, -0.012)\\\\\n",
       "\t GI             & phecode\\_520-15  & Incisional hernia                                                               & 0.585 (0.543, 0.618) & 0.552 (0.521, 0.583) & -0.031 (-0.067, 0.005) \\\\\n",
       "\t Musc/Skel      & phecode\\_702     & Infective and reactive arthropathies                                            & 0.574 (0.542, 0.6)   & 0.544 (0.509, 0.573) & -0.03 (-0.054, 0.001)  \\\\\n",
       "\t Cardio         & phecode\\_430-1   & Nontraumatic subarachnoid hemorrhage                                            & 0.643 (0.596, 0.675) & 0.61 (0.569, 0.651)  & -0.03 (-0.055, 0)      \\\\\n",
       "\t Neuro          & phecode\\_329-1   & Memory loss                                                                     & 0.615 (0.583, 0.657) & 0.588 (0.544, 0.629) & -0.027 (-0.055, -0.005)\\\\\n",
       "\t GI             & phecode\\_532-4   & Volvulus                                                                        & 0.596 (0.554, 0.63)  & 0.573 (0.527, 0.6)   & -0.027 (-0.042, -0.005)\\\\\n",
       "\t Hearing        & phecode\\_397-1   & Tinnitus                                                                        & 0.591 (0.557, 0.624) & 0.564 (0.536, 0.595) & -0.026 (-0.055, 0)     \\\\\n",
       "\t Neuro          & phecode\\_324-3   & Dystonia                                                                        & 0.589 (0.557, 0.623) & 0.567 (0.521, 0.602) & -0.026 (-0.054, 0)     \\\\\n",
       "\t Genitourinary  & phecode\\_601-12  & Chronic prostatitis                                                             & 0.624 (0.584, 0.653) & 0.597 (0.558, 0.627) & -0.025 (-0.041, -0.006)\\\\\n",
       "\t Cardio         & phecode\\_423     & Abnormal cardiac sounds                                                         & 0.648 (0.621, 0.668) & 0.624 (0.596, 0.649) & -0.024 (-0.039, -0.009)\\\\\n",
       "\t Hearing        & phecode\\_397     & Other hearing abnormality                                                       & 0.579 (0.551, 0.618) & 0.558 (0.527, 0.593) & -0.024 (-0.046, 0.002) \\\\\n",
       "\t Musc/Skel      & phecode\\_704     & Systemic vasculitis                                                             & 0.695 (0.658, 0.727) & 0.672 (0.636, 0.702) & -0.024 (-0.035, -0.008)\\\\\n",
       "\t GI             & phecode\\_506     & Diseases of salivary glands                                                     & 0.572 (0.533, 0.616) & 0.549 (0.498, 0.593) & -0.024 (-0.05, 0.014)  \\\\\n",
       "\t Endo           & phecode\\_200-22  & Uninodular goiter {[}single thyroid nodule{]}                                       & 0.642 (0.597, 0.674) & 0.619 (0.583, 0.653) & -0.023 (-0.047, 0.002) \\\\\n",
       "\t Genitourinary  & phecode\\_625     & Pain and other symptoms associated with female genital organs                   & 0.647 (0.605, 0.677) & 0.623 (0.582, 0.66)  & -0.023 (-0.038, -0.007)\\\\\n",
       "\t GI             & phecode\\_504-32  & Chronic periodontitis                                                           & 0.554 (0.515, 0.604) & 0.534 (0.487, 0.569) & -0.023 (-0.057, 0.013) \\\\\n",
       "\t Cardio         & phecode\\_423-1   & Cardiac murmurs                                                                 & 0.644 (0.621, 0.671) & 0.623 (0.594, 0.647) & -0.023 (-0.043, -0.007)\\\\\n",
       "\t Eye            & phecode\\_360     & Inflammation of eyelids                                                         & 0.492 (0.465, 0.519) & 0.471 (0.441, 0.493) & -0.022 (-0.04, 0.001)  \\\\\n",
       "\t GI             & phecode\\_530-3   & Rectal prolapse                                                                 & 0.694 (0.656, 0.727) & 0.669 (0.634, 0.705) & -0.022 (-0.041, -0.005)\\\\\n",
       "\t Resp           & phecode\\_494     & Voice disturbance                                                               & 0.621 (0.574, 0.659) & 0.601 (0.572, 0.638) & -0.021 (-0.047, 0.008) \\\\\n",
       "\t GI             & phecode\\_522-7   & Ulceration of the lower GI tract                                                & 0.536 (0.513, 0.568) & 0.517 (0.485, 0.551) & -0.021 (-0.053, 0.007) \\\\\n",
       "\t Neoplasms      & phecode\\_123     & Multiple myeloma and malignant plasma cell neoplasms                            & 0.69 (0.648, 0.721)  & 0.668 (0.624, 0.703) & -0.021 (-0.046, 0.002) \\\\\n",
       "\t Blood          & phecode\\_180-3   & Paraproteinemias                                                                & 0.675 (0.637, 0.71)  & 0.655 (0.615, 0.692) & -0.02 (-0.043, 0.006)  \\\\\n",
       "\t Musc/Skel      & phecode\\_710-3   & Acquired deformities of the knee                                                & 0.599 (0.577, 0.63)  & 0.579 (0.548, 0.607) & -0.02 (-0.036, -0.006) \\\\\n",
       "\t Neoplasms      & phecode\\_122-22  & Diffuse large B-cell lymphoma*                                                  & 0.656 (0.621, 0.698) & 0.636 (0.601, 0.667) & -0.02 (-0.041, 0.003)  \\\\\n",
       "\t Genitourinary  & phecode\\_610     & Benign mammary dysplasias                                                       & 0.416 (0.381, 0.461) & 0.401 (0.357, 0.438) & -0.02 (-0.038, 0.01)   \\\\\n",
       "\t Neoplasms      & phecode\\_139-61  & Hemangioma                                                                      & 0.55 (0.512, 0.578)  & 0.525 (0.488, 0.566) & -0.02 (-0.043, 0)      \\\\\n",
       "\t Eye            & phecode\\_363-7   & Stenosis and insufficiency of lacrimal passages                                 & 0.643 (0.608, 0.681) & 0.625 (0.582, 0.664) & -0.019 (-0.034, -0.007)\\\\\n",
       "\t Neoplasms      & phecode\\_139-6   & Hemangioma and lymphangioma                                                     & 0.55 (0.512, 0.581)  & 0.529 (0.496, 0.566) & -0.019 (-0.041, 0.008) \\\\\n",
       "\t Neoplasms      & phecode\\_124     & Myeloproliferative disorder                                                     & 0.677 (0.646, 0.71)  & 0.656 (0.625, 0.687) & -0.018 (-0.037, -0.006)\\\\\n",
       "\t Cardio         & phecode\\_438-12  & Thoracic aneurysm                                                               & 0.659 (0.625, 0.688) & 0.643 (0.605, 0.676) & -0.018 (-0.052, 0.02)  \\\\\n",
       "\t Blood          & phecode\\_180-31  & Monoclonal gammopathy                                                           & 0.685 (0.641, 0.726) & 0.667 (0.628, 0.708) & -0.018 (-0.044, 0.014) \\\\\n",
       "\t Neoplasms      & phecode\\_109-3   & Malignant neoplasm of brain                                                     & 0.604 (0.567, 0.636) & 0.581 (0.544, 0.616) & -0.018 (-0.051, 0.008) \\\\\n",
       "\t Neoplasms      & phecode\\_123-1   & Multiple myeloma                                                                & 0.675 (0.633, 0.713) & 0.657 (0.61, 0.698)  & -0.017 (-0.041, 0.012) \\\\\n",
       "\t Cardio         & phecode\\_413-22  & Aortic insufficiency                                                            & 0.69 (0.67, 0.712)   & 0.673 (0.654, 0.698) & -0.017 (-0.027, -0.003)\\\\\n",
       "\t Neuro          & phecode\\_328-7   & Vascular dementia                                                               & 0.805 (0.778, 0.828) & 0.788 (0.76, 0.816)  & -0.017 (-0.037, 0.002) \\\\\n",
       "\t Genitourinary  & phecode\\_603     & Disorders and symptoms of testis                                                & 0.538 (0.51, 0.564)  & 0.521 (0.491, 0.547) & -0.017 (-0.039, 0.006) \\\\\n",
       "\t Neuro          & phecode\\_349     & Disorder of nervous system                                                      & 0.577 (0.547, 0.623) & 0.568 (0.51, 0.611)  & -0.016 (-0.06, 0.019)  \\\\\n",
       "\t GI             & phecode\\_530-1   & Anal fissure                                                                    & 0.544 (0.509, 0.581) & 0.529 (0.493, 0.566) & -0.016 (-0.031, 0.002) \\\\\n",
       "\t Neoplasms      & phecode\\_121-2   & Chronic leukemia                                                                & 0.724 (0.696, 0.751) & 0.709 (0.672, 0.738) & -0.016 (-0.031, -0.002)\\\\\n",
       "\t Neoplasms      & phecode\\_109     & Malignant neoplasm of the eye, brain and other parts of central nervous system  & 0.572 (0.54, 0.608)  & 0.556 (0.524, 0.588) & -0.016 (-0.038, 0.01)  \\\\\n",
       "\t Endo           & phecode\\_200-23  & Multinodular goiter                                                             & 0.689 (0.648, 0.719) & 0.673 (0.632, 0.71)  & -0.016 (-0.035, 0.003) \\\\\n",
       "\t Derm           & phecode\\_679-4   & Pruritus                                                                        & 0.574 (0.53, 0.621)  & 0.563 (0.505, 0.602) & -0.016 (-0.05, 0.02)   \\\\\n",
       "\t GI             & phecode\\_529-2   & Abdominal distension and flatulence                                             & 0.529 (0.504, 0.553) & 0.514 (0.487, 0.537) & -0.015 (-0.033, 0.001) \\\\\n",
       "\t Neoplasms      & phecode\\_148-2   & Benign neoplasm of meninges (Meningioma)                                        & 0.663 (0.629, 0.709) & 0.648 (0.612, 0.69)  & -0.015 (-0.038, 0.004) \\\\\n",
       "\t Neoplasms      & phecode\\_121     & Leukemia                                                                        & 0.693 (0.665, 0.72)  & 0.68 (0.649, 0.701)  & -0.015 (-0.026, -0.003)\\\\\n",
       "\t Genitourinary  & phecode\\_601     & Inflammatory diseases of prostate                                               & 0.652 (0.627, 0.672) & 0.637 (0.609, 0.658) & -0.015 (-0.022, -0.006)\\\\\n",
       "\t Neoplasms      & phecode\\_106-2   & Malignant neoplasm of the uterus                                                & 0.581 (0.556, 0.613) & 0.567 (0.538, 0.6)   & -0.014 (-0.03, -0.001) \\\\\n",
       "\t Resp           & phecode\\_466     & Tonsillitis and adenoiditis                                                     & 0.573 (0.533, 0.611) & 0.556 (0.519, 0.59)  & -0.014 (-0.033, 0.004) \\\\\n",
       "\t Genitourinary  & phecode\\_601-1   & Prostatitis                                                                     & 0.65 (0.625, 0.671)  & 0.636 (0.61, 0.658)  & -0.014 (-0.021, -0.003)\\\\\n",
       "\t Genitourinary  & phecode\\_608     & Other disorders of male genital organs                                          & 0.526 (0.5, 0.554)   & 0.512 (0.486, 0.544) & -0.014 (-0.039, 0.01)  \\\\\n",
       "\t Stat           & phecode\\_990     & Family history of digestive disorders                                           & 0.582 (0.546, 0.612) & 0.568 (0.538, 0.601) & -0.014 (-0.039, 0.011) \\\\\n",
       "\t Neoplasms      & phecode\\_106-21  & Malignant neoplasm of endometrium                                               & 0.587 (0.558, 0.611) & 0.574 (0.546, 0.594) & -0.013 (-0.027, 0.002) \\\\\n",
       "\t Musc/Skel      & phecode\\_710     & Acquired deformities of limbs                                                   & 0.616 (0.596, 0.643) & 0.605 (0.581, 0.626) & -0.013 (-0.025, 0.001) \\\\\n",
       "\t Genitourinary  & phecode\\_603-1   & Hydrocele                                                                       & 0.557 (0.527, 0.593) & 0.545 (0.513, 0.581) & -0.013 (-0.041, 0.019) \\\\\n",
       "\t Neuro          & phecode\\_356-2   & Aphasia and dysphasia                                                           & 0.675 (0.638, 0.709) & 0.664 (0.621, 0.702) & -0.013 (-0.034, 0.019) \\\\\n",
       "\t Neoplasms      & phecode\\_139-54  & Testicular limpoma                                                              & 0.567 (0.529, 0.611) & 0.554 (0.518, 0.599) & -0.012 (-0.017, -0.006)\\\\\n",
       "\t GI             & phecode\\_532-1   & Intestinal fistula                                                              & 0.596 (0.562, 0.623) & 0.582 (0.543, 0.612) & -0.012 (-0.037, 0.009) \\\\\n",
       "\t Hearing        & phecode\\_390     & Disorders of external ear                                                       & 0.593 (0.554, 0.632) & 0.58 (0.546, 0.621)  & -0.012 (-0.028, 0.005) \\\\\n",
       "\t Neoplasms      & phecode\\_120-1   & Myeloid                                                                         & 0.693 (0.673, 0.715) & 0.682 (0.66, 0.706)  & -0.012 (-0.021, -0.002)\\\\\n",
       "\t Hearing        & phecode\\_394-21  & Paroxysmal vertigo                                                              & 0.665 (0.625, 0.704) & 0.653 (0.617, 0.689) & -0.012 (-0.032, 0.01)  \\\\\n",
       "\t Neuro          & phecode\\_346     & Brain damage and brain death                                                    & 0.596 (0.551, 0.637) & 0.587 (0.536, 0.619) & -0.012 (-0.048, 0.024) \\\\\n",
       "\t Genitourinary  & phecode\\_628     & Ovarian cyst                                                                    & 0.586 (0.56, 0.618)  & 0.575 (0.551, 0.606) & -0.011 (-0.021, 0.001) \\\\\n",
       "\t ID             & phecode\\_009     & Pseudomonas                                                                     & 0.652 (0.625, 0.678) & 0.639 (0.614, 0.666) & -0.011 (-0.035, 0.007) \\\\\n",
       "\t Blood          & phecode\\_172     & Other disorders of white blood cells                                            & 0.598 (0.55, 0.672)  & 0.591 (0.536, 0.649) & -0.011 (-0.044, 0.019) \\\\\n",
       "\t Neoplasms      & phecode\\_135     & Benign neoplasm of the head and neck                                            & 0.593 (0.577, 0.615) & 0.582 (0.565, 0.606) & -0.011 (-0.019, -0.001)\\\\\n",
       "\t Neoplasms      & phecode\\_144-1   & Benign neoplasms of external female genital organs and cervix                   & 0.554 (0.515, 0.588) & 0.546 (0.511, 0.57)  & -0.011 (-0.032, 0.018) \\\\\n",
       "\t Mental         & phecode\\_288-4   & Phobic disorders                                                                & 0.651 (0.621, 0.677) & 0.639 (0.611, 0.667) & -0.011 (-0.024, 0.006) \\\\\n",
       "\t Neoplasms      & phecode\\_121-21  & Chronic lymphoid leukemia                                                       & 0.725 (0.695, 0.751) & 0.717 (0.68, 0.745)  & -0.01 (-0.027, 0.004)  \\\\\n",
       "\t GI             & phecode\\_500     & Disorders of tooth develoment                                                   & 0.59 (0.553, 0.628)  & 0.583 (0.551, 0.61)  & -0.01 (-0.026, 0.005)  \\\\\n",
       "\t ID             & phecode\\_011     & Klebsiella                                                                      & 0.669 (0.636, 0.7)   & 0.66 (0.628, 0.69)   & -0.01 (-0.041, 0.021)  \\\\\n",
       "\t GI             & phecode\\_503-5   & Periapical abscess                                                              & 0.454 (0.411, 0.487) & 0.445 (0.402, 0.49)  & -0.01 (-0.043, 0.033)  \\\\\n",
       "\t Musc/Skel      & phecode\\_712     & Other specific joint derangements                                               & 0.547 (0.523, 0.565) & 0.537 (0.518, 0.556) & -0.01 (-0.02, 0.004)   \\\\\n",
       "\t Musc/Skel      & phecode\\_719     & Disorders of muscle                                                             & 0.57 (0.539, 0.596)  & 0.56 (0.532, 0.581)  & -0.01 (-0.025, 0.009)  \\\\\n",
       "\t GI             & phecode\\_500-4   & Disturbances in tooth eruption                                                  & 0.588 (0.552, 0.631) & 0.577 (0.537, 0.621) & -0.01 (-0.027, 0.007)  \\\\\n",
       "\t Musc/Skel      & phecode\\_721-2   & Ganglion cyst                                                                   & 0.543 (0.515, 0.57)  & 0.533 (0.508, 0.558) & -0.01 (-0.028, 0.011)  \\\\\n",
       "\t Signs/Symptoms & phecode\\_841-13  & Allergy to sulfonamides                                                         & 0.687 (0.666, 0.716) & 0.678 (0.652, 0.703) & -0.01 (-0.02, 0.002)   \\\\\n",
       "\t Mental         & phecode\\_308-7   & Restlessness and agitation*                                                     & 0.654 (0.603, 0.696) & 0.641 (0.595, 0.683) & -0.009 (-0.038, 0.011) \\\\\n",
       "\t Genitourinary  & phecode\\_602     & Other disorders of prostate                                                     & 0.656 (0.637, 0.682) & 0.647 (0.626, 0.673) & -0.009 (-0.024, 0.008) \\\\\n",
       "\t Cardio         & phecode\\_416-5   & Premature depolarization {[}Premature beats{]}                                      & 0.667 (0.639, 0.691) & 0.659 (0.629, 0.679) & -0.009 (-0.018, 0)     \\\\\n",
       "\t GI             & phecode\\_556-3   & Abdominal or pelvic swelling, mass, or lump                                     & 0.601 (0.568, 0.636) & 0.593 (0.551, 0.628) & -0.009 (-0.035, 0.017) \\\\\n",
       "\t Cardio         & phecode\\_416-52  & Ventricular premature depolarization*                                           & 0.654 (0.62, 0.681)  & 0.645 (0.613, 0.67)  & -0.009 (-0.019, 0.002) \\\\\n",
       "\t Neoplasms      & phecode\\_149     & Benign neoplasm of the endocrine glands                                         & 0.593 (0.569, 0.616) & 0.583 (0.554, 0.607) & -0.009 (-0.03, 0.011)  \\\\\n",
       "\t Genitourinary  & phecode\\_614-1   & Pelvic peritoneal adhesions, female (postoperative) (postinfection)             & 0.545 (0.507, 0.587) & 0.536 (0.506, 0.569) & -0.009 (-0.031, 0.016) \\\\\n",
       "\t Genitourinary  & phecode\\_596-3   & Diverticulum of bladder                                                         & 0.72 (0.691, 0.756)  & 0.714 (0.677, 0.745) & -0.009 (-0.015, -0.003)\\\\\n",
       "\t GI             & phecode\\_500-41  & Impacted teeth*                                                                 & 0.576 (0.548, 0.611) & 0.566 (0.531, 0.606) & -0.009 (-0.025, 0.011) \\\\\n",
       "\t Endo           & phecode\\_208-21  & Primary hyperparathyroidism                                                     & 0.634 (0.608, 0.666) & 0.627 (0.597, 0.656) & -0.008 (-0.032, 0.016) \\\\\n",
       "\t Eye            & phecode\\_381     & Strabismus                                                                      & 0.596 (0.57, 0.634)  & 0.586 (0.555, 0.618) & -0.008 (-0.037, 0.014) \\\\\n",
       "\t GI             & phecode\\_520-14  & Ventral hernia                                                                  & 0.57 (0.547, 0.587)  & 0.561 (0.539, 0.581) & -0.008 (-0.025, 0.01)  \\\\\n",
       "\t Neoplasms      & phecode\\_144-3   & Benign neoplasms of the ovary                                                   & 0.49 (0.449, 0.529)  & 0.479 (0.449, 0.524) & -0.008 (-0.048, 0.03)  \\\\\n",
       "\t Genitourinary  & phecode\\_592-12  & Chronic cystitis                                                                & 0.55 (0.507, 0.589)  & 0.542 (0.509, 0.577) & -0.008 (-0.038, 0.02)  \\\\\n",
       "\t Genitourinary  & phecode\\_622-2   & Mucous polyp of cervix                                                          & 0.553 (0.521, 0.587) & 0.543 (0.516, 0.574) & -0.008 (-0.041, 0.021) \\\\\n",
       "\t Genitourinary  & phecode\\_624     & Symptoms involving female genital tract                                         & 0.56 (0.534, 0.581)  & 0.551 (0.522, 0.578) & -0.008 (-0.026, 0.015) \\\\\n",
       "\t Resp           & phecode\\_488-8   & Mouth breathing*                                                                & 0.57 (0.536, 0.611)  & 0.558 (0.523, 0.596) & -0.008 (-0.035, 0.021) \\\\\n",
       "\t Cardio         & phecode\\_410     & Inflammation of the heart {[}Carditis{]}                                            & 0.656 (0.622, 0.685) & 0.647 (0.62, 0.678)  & -0.008 (-0.032, 0.017) \\\\\n",
       "\t Musc/Skel      & phecode\\_708-12  & Primary osteoarthritis of knee, lower leg                                       & 0.633 (0.617, 0.649) & 0.626 (0.606, 0.642) & -0.007 (-0.014, 0.001) \\\\\n",
       "\t GI             & phecode\\_514-3   & Ileus                                                                           & 0.694 (0.664, 0.731) & 0.682 (0.648, 0.723) & -0.007 (-0.03, 0.008)  \\\\\n",
       "\t Cardio         & phecode\\_416-12  & Ventricular tachycardia                                                         & 0.723 (0.689, 0.749) & 0.715 (0.688, 0.746) & -0.007 (-0.02, 0.007)  \\\\\n",
       "\t Neoplasms      & phecode\\_148     & Benign neoplasm of the eye, brain and other parts of central nervous system     & 0.634 (0.6, 0.661)   & 0.626 (0.598, 0.654) & -0.007 (-0.024, 0.014) \\\\\n",
       "\t Cardio         & phecode\\_431-2   & Transient cerebral ischemic attacks                                             & 0.71 (0.693, 0.737)  & 0.703 (0.688, 0.728) & -0.007 (-0.017, 0.003) \\\\\n",
       "\t Derm           & phecode\\_685-82  & Generalized hyperhidrosis                                                       & 0.527 (0.485, 0.574) & 0.52 (0.462, 0.565)  & -0.007 (-0.056, 0.029) \\\\\n",
       "\t Genitourinary  & phecode\\_628-2   & Corpus luteum cyst or hematoma                                                  & 0.563 (0.536, 0.585) & 0.554 (0.525, 0.582) & -0.007 (-0.023, 0.007) \\\\\n",
       "\t Genitourinary  & phecode\\_599     & Other symptoms/disorders or the urinary system                                  & 0.652 (0.636, 0.669) & 0.645 (0.63, 0.66)   & -0.007 (-0.013, -0.002)\\\\\n",
       "\t Cardio         & phecode\\_417-1   & Palpitations                                                                    & 0.583 (0.569, 0.599) & 0.575 (0.562, 0.591) & -0.007 (-0.014, -0.002)\\\\\n",
       "\t Cardio         & phecode\\_433-2   & Occlusion and stenosis of precerebral arteries                                  & 0.769 (0.748, 0.793) & 0.763 (0.741, 0.784) & -0.007 (-0.02, 0.01)   \\\\\n",
       "\t Endo           & phecode\\_209     & Disorders of the pituitary gland and its hypothalamic control                   & 0.613 (0.571, 0.646) & 0.604 (0.569, 0.644) & -0.007 (-0.036, 0.019) \\\\\n",
       "\t Neoplasms      & phecode\\_120-21  & Mature B-cell                                                                   & 0.686 (0.666, 0.705) & 0.679 (0.663, 0.7)   & -0.007 (-0.017, 0.004) \\\\\n",
       "\t Neoplasms      & phecode\\_122-2   & Non-Hodgkin lymphoma                                                            & 0.665 (0.64, 0.685)  & 0.659 (0.636, 0.678) & -0.006 (-0.017, 0.007) \\\\\n",
       "\t Neoplasms      & phecode\\_120     & Hemo onc - by cell of origin                                                    & 0.668 (0.654, 0.683) & 0.662 (0.648, 0.679) & -0.006 (-0.012, -0.001)\\\\\n",
       "\t Neoplasms      & phecode\\_120-2   & Lymphoid                                                                        & 0.674 (0.66, 0.692)  & 0.669 (0.65, 0.685)  & -0.006 (-0.016, 0.003) \\\\\n",
       "\t Endo           & phecode\\_200-3   & Thyrotoxicosis {[}hyperthyroidism{]}                                                & 0.63 (0.607, 0.653)  & 0.623 (0.599, 0.653) & -0.006 (-0.02, 0.006)  \\\\\n",
       "\t Cardio         & phecode\\_416-11  & Supraventricular tachycardia                                                    & 0.624 (0.602, 0.646) & 0.618 (0.595, 0.642) & -0.006 (-0.02, 0.006)  \\\\\n",
       "\t Neoplasms      & phecode\\_101-8   & Malignant neoplasm of the pancreas                                              & 0.678 (0.645, 0.703) & 0.673 (0.635, 0.697) & -0.006 (-0.028, 0.009) \\\\\n",
       "\t Neoplasms      & phecode\\_144-13  & Benign neoplasms of the cervix                                                  & 0.565 (0.533, 0.602) & 0.557 (0.524, 0.595) & -0.005 (-0.028, 0.016) \\\\\n",
       "\t Musc/Skel      & phecode\\_708-11  & Primary osteoarthritis of hip, pelvic region and thigh                          & 0.61 (0.59, 0.626)   & 0.603 (0.587, 0.622) & -0.005 (-0.014, 0.002) \\\\\n",
       "\t Neuro          & phecode\\_324-1   & Parkinsonism                                                                    & 0.732 (0.709, 0.748) & 0.726 (0.705, 0.743) & -0.005 (-0.012, 0.003) \\\\\n",
       "\t Hearing        & phecode\\_396-2   & Sensorineural hearing loss                                                      & 0.636 (0.613, 0.667) & 0.629 (0.608, 0.662) & -0.005 (-0.019, 0.009) \\\\\n",
       "\t Neuro          & phecode\\_324-11  & Parkinson's disease (Primary)                                                   & 0.735 (0.721, 0.753) & 0.731 (0.714, 0.746) & -0.005 (-0.011, 0.001) \\\\\n",
       "\t Musc/Skel      & phecode\\_714     & Deforming dorsopathies                                                          & 0.696 (0.671, 0.715) & 0.689 (0.67, 0.714)  & -0.005 (-0.015, 0.005) \\\\\n",
       "\t Cardio         & phecode\\_433-21  & Carotid artery stenosis                                                         & 0.767 (0.749, 0.794) & 0.761 (0.742, 0.792) & -0.005 (-0.022, 0.008) \\\\\n",
       "\t Genitourinary  & phecode\\_622-1   & Polyp of corpus uteri                                                           & 0.523 (0.508, 0.537) & 0.52 (0.501, 0.533)  & -0.005 (-0.016, 0.006) \\\\\n",
       "\t Genitourinary  & phecode\\_618-11  & Cystocele                                                                       & 0.585 (0.565, 0.602) & 0.579 (0.562, 0.596) & -0.005 (-0.011, 0.003) \\\\\n",
       "\t ID             & phecode\\_095     & Sequela of infection                                                            & 0.536 (0.502, 0.574) & 0.529 (0.499, 0.566) & -0.005 (-0.026, 0.021) \\\\\n",
       "\t Genitourinary  & phecode\\_622     & Polyp of female genital organs                                                  & 0.534 (0.517, 0.553) & 0.53 (0.515, 0.547)  & -0.005 (-0.017, 0.009) \\\\\n",
       "\t Resp           & phecode\\_471-2   & Deviated nasal septum                                                           & 0.617 (0.591, 0.649) & 0.613 (0.584, 0.646) & -0.005 (-0.01, 0.002)  \\\\\n",
       "\t Resp           & phecode\\_460-1   & Acute upper respiratory infection                                               & 0.523 (0.5, 0.544)   & 0.518 (0.494, 0.535) & -0.004 (-0.025, 0.012) \\\\\n",
       "\t Blood          & phecode\\_170-1   & Neutropenia                                                                     & 0.623 (0.605, 0.638) & 0.619 (0.599, 0.633) & -0.004 (-0.015, 0.007) \\\\\n",
       "\t Resp           & phecode\\_473     & Other diseases of upper respiratory tract                                       & 0.531 (0.499, 0.578) & 0.529 (0.484, 0.573) & -0.004 (-0.037, 0.02)  \\\\\n",
       "\t Derm           & phecode\\_685-8   & Hyperhidrosis                                                                   & 0.524 (0.487, 0.572) & 0.524 (0.46, 0.573)  & -0.004 (-0.044, 0.032) \\\\\n",
       "\t Neoplasms      & phecode\\_106     & Gynecological malignant neoplasms                                               & 0.58 (0.564, 0.602)  & 0.574 (0.56, 0.601)  & -0.004 (-0.014, 0.004) \\\\\n",
       "\t Genitourinary  & phecode\\_594-4   & Frequency of urination and polyuria                                             & 0.631 (0.611, 0.655) & 0.626 (0.605, 0.652) & -0.004 (-0.009, 0.002) \\\\\n",
       "\t Neuro          & phecode\\_328-1   & Alzheimer's disease                                                             & 0.812 (0.793, 0.829) & 0.808 (0.788, 0.826) & -0.004 (-0.009, 0)     \\\\\n",
       "\t GI             & phecode\\_503     & Diseases of pulp and periapical tissues                                         & 0.435 (0.404, 0.465) & 0.432 (0.402, 0.47)  & -0.004 (-0.036, 0.029) \\\\\n",
       "\t Derm           & phecode\\_676-2   & Scar conditions and fibrosis of skin                                            & 0.533 (0.503, 0.556) & 0.526 (0.497, 0.552) & -0.004 (-0.026, 0.023) \\\\\n",
       "\t Cardio         & phecode\\_416-7   & Sinoatrial node dysfunction                                                     & 0.736 (0.704, 0.771) & 0.73 (0.703, 0.765)  & -0.004 (-0.016, 0.007) \\\\\n",
       "\t Blood          & phecode\\_170     & Decreased white blood cell count                                                & 0.624 (0.606, 0.641) & 0.62 (0.597, 0.636)  & -0.004 (-0.018, 0.006) \\\\\n",
       "\t Blood          & phecode\\_162     & Aplastic anemia                                                                 & 0.664 (0.634, 0.7)   & 0.66 (0.629, 0.699)  & -0.004 (-0.033, 0.024) \\\\\n",
       "\t Cardio         & phecode\\_416-43  & Right bundle branch block                                                       & 0.706 (0.694, 0.724) & 0.702 (0.687, 0.721) & -0.004 (-0.009, 0.001) \\\\\n",
       "\t Signs/Symptoms & phecode\\_814     & Jaundice (not of newborn)                                                       & 0.599 (0.562, 0.627) & 0.595 (0.554, 0.623) & -0.004 (-0.03, 0.028)  \\\\\n",
       "\t GI             & phecode\\_510-8   & Barrett's esophagus                                                             & 0.657 (0.643, 0.666) & 0.653 (0.64, 0.662)  & -0.004 (-0.008, 0)     \\\\\n",
       "\t Neoplasms      & phecode\\_108-5   & Malignant neoplasm of the bladder                                               & 0.743 (0.721, 0.764) & 0.739 (0.718, 0.764) & -0.004 (-0.009, 0.004) \\\\\n",
       "\t Cardio         & phecode\\_416-71  & Sick sinus syndrome*                                                            & 0.73 (0.697, 0.765)  & 0.726 (0.7, 0.762)   & -0.004 (-0.015, 0.01)  \\\\\n",
       "\t Resp           & phecode\\_471     & Other disorders of nose and nasal sinuses                                       & 0.573 (0.555, 0.592) & 0.57 (0.551, 0.589)  & -0.003 (-0.013, 0.005) \\\\\n",
       "\t GI             & phecode\\_518     & Appendicitis                                                                    & 0.55 (0.529, 0.578)  & 0.546 (0.526, 0.571) & -0.003 (-0.02, 0.017)  \\\\\n",
       "\t Genitourinary  & phecode\\_596-1   & Bladder neck obstruction                                                        & 0.793 (0.772, 0.822) & 0.791 (0.769, 0.818) & -0.003 (-0.011, 0.004) \\\\\n",
       "\t Genitourinary  & phecode\\_614     & Inflammatory diseases of female pelvic organs                                   & 0.537 (0.513, 0.562) & 0.535 (0.5, 0.561)   & -0.003 (-0.021, 0.009) \\\\\n",
       "\t GI             & phecode\\_504-3   & Periodontitis                                                                   & 0.542 (0.501, 0.587) & 0.537 (0.499, 0.576) & -0.003 (-0.037, 0.025) \\\\\n",
       "\t Neoplasms      & phecode\\_139-53  & Lipoma of other skin subcutaneous tissue                                        & 0.516 (0.493, 0.549) & 0.513 (0.484, 0.536) & -0.003 (-0.017, 0.012) \\\\\n",
       "\t Cardio         & phecode\\_413-6   & Heart valve replaced                                                            & 0.726 (0.706, 0.75)  & 0.723 (0.702, 0.744) & -0.003 (-0.012, 0.006) \\\\\n",
       "\t Eye            & phecode\\_362     & Other disorders of the eyelids                                                  & 0.582 (0.555, 0.605) & 0.579 (0.551, 0.603) & -0.003 (-0.015, 0.008) \\\\\n",
       "\t Neoplasms      & phecode\\_136-2   & Benign neoplasm of stomach                                                      & 0.629 (0.617, 0.641) & 0.626 (0.614, 0.637) & -0.003 (-0.006, 0)     \\\\\n",
       "\t ID             & phecode\\_089-3   & Fungal infections                                                               & 0.649 (0.635, 0.663) & 0.647 (0.626, 0.665) & -0.003 (-0.015, 0.012) \\\\\n",
       "\t Genitourinary  & phecode\\_626-14  & Irregular menstrual bleeding                                                    & 0.863 (0.851, 0.874) & 0.86 (0.846, 0.873)  & -0.003 (-0.011, 0.005) \\\\\n",
       "\t Neoplasms      & phecode\\_101-6   & Malignant neoplasm of the liver and intrahepatic bile ducts                     & 0.729 (0.698, 0.762) & 0.727 (0.682, 0.764) & -0.003 (-0.028, 0.019) \\\\\n",
       "\t Genitourinary  & phecode\\_619-3   & Noninflammatory disorders of cervix                                             & 0.5 (0.465, 0.527)   & 0.496 (0.46, 0.533)  & -0.003 (-0.024, 0.018) \\\\\n",
       "\t Genitourinary  & phecode\\_627     & Menopausal and postmenopausal disorders                                         & 0.655 (0.643, 0.666) & 0.652 (0.639, 0.664) & -0.003 (-0.006, 0.001) \\\\\n",
       "\t Neoplasms      & phecode\\_122     & Lymphoma                                                                        & 0.663 (0.642, 0.68)  & 0.659 (0.638, 0.678) & -0.003 (-0.012, 0.007) \\\\\n",
       "\t Neoplasms      & phecode\\_101-1   & Malignant neoplasm of the esophagus                                             & 0.725 (0.701, 0.754) & 0.723 (0.699, 0.753) & -0.003 (-0.018, 0.012) \\\\\n",
       "\t Cardio         & phecode\\_417-3   & Bradycardia*                                                                    & 0.687 (0.675, 0.703) & 0.684 (0.674, 0.703) & -0.003 (-0.007, 0.004) \\\\\n",
       "\t Eye            & phecode\\_386-2   & Diplopia                                                                        & 0.578 (0.535, 0.618) & 0.578 (0.536, 0.611) & -0.003 (-0.026, 0.027) \\\\\n",
       "\t Neoplasms      & phecode\\_116-3   & Secondary malignant neoplasm of digestive systems                               & 0.635 (0.611, 0.655) & 0.632 (0.606, 0.654) & -0.003 (-0.016, 0.011) \\\\\n",
       "\t Cardio         & phecode\\_440-3   & Pulmonary embolism                                                              & 0.634 (0.617, 0.649) & 0.633 (0.617, 0.648) & -0.002 (-0.01, 0.009)  \\\\\n",
       "\t Genitourinary  & phecode\\_592-1   & Cystitis                                                                        & 0.618 (0.597, 0.641) & 0.615 (0.595, 0.637) & -0.002 (-0.015, 0.014) \\\\\n",
       "\t Endo           & phecode\\_208     & Disorders of parathyroid gland                                                  & 0.642 (0.614, 0.668) & 0.64 (0.612, 0.666)  & -0.002 (-0.021, 0.015) \\\\\n",
       "\t Musc/Skel      & phecode\\_705-3   & Polymyalgia rheumatica                                                          & 0.738 (0.72, 0.751)  & 0.735 (0.716, 0.751) & -0.002 (-0.008, 0.003) \\\\\n",
       "\t ID             & phecode\\_070     & Candidiasis                                                                     & 0.645 (0.628, 0.665) & 0.643 (0.624, 0.66)  & -0.002 (-0.013, 0.011) \\\\\n",
       "\t GI             & phecode\\_513-3   & Duodenal ulcer                                                                  & 0.623 (0.601, 0.65)  & 0.623 (0.601, 0.644) & -0.002 (-0.015, 0.012) \\\\\n",
       "\t Cong           & phecode\\_773     & Congenital malformation of kidney                                               & 0.592 (0.532, 0.631) & 0.588 (0.538, 0.631) & -0.002 (-0.033, 0.023) \\\\\n",
       "\t Genitourinary  & phecode\\_618-12  & Rectocele                                                                       & 0.566 (0.542, 0.587) & 0.564 (0.542, 0.583) & -0.002 (-0.01, 0.011)  \\\\\n",
       "\t Genitourinary  & phecode\\_618-1   & Prolapse of vaginal walls                                                       & 0.58 (0.568, 0.595)  & 0.578 (0.566, 0.594) & -0.002 (-0.009, 0.003) \\\\\n",
       "\t Neoplasms      & phecode\\_105     & Malignant neoplasm of the breast                                                & 0.765 (0.759, 0.773) & 0.764 (0.758, 0.771) & -0.002 (-0.003, -0.001)\\\\\n",
       "\t Derm           & phecode\\_676     & Hypertrophic conditions of skin                                                 & 0.505 (0.486, 0.531) & 0.505 (0.483, 0.524) & -0.002 (-0.021, 0.019) \\\\\n",
       "\t Genitourinary  & phecode\\_594-1   & Retention of urine                                                              & 0.734 (0.726, 0.743) & 0.732 (0.724, 0.741) & -0.002 (-0.004, 0)     \\\\\n",
       "\t Neuro          & phecode\\_328-9   & Dementia NOS                                                                    & 0.783 (0.768, 0.805) & 0.78 (0.764, 0.798)  & -0.002 (-0.01, 0.005)  \\\\\n",
       "\t Cardio         & phecode\\_416-42  & Left bundle branch block                                                        & 0.729 (0.71, 0.746)  & 0.726 (0.709, 0.743) & -0.002 (-0.009, 0.004) \\\\\n",
       "\t Genitourinary  & phecode\\_615     & Endometriosis                                                                   & 0.703 (0.673, 0.741) & 0.7 (0.676, 0.736)   & -0.002 (-0.012, 0.01)  \\\\\n",
       "\t Genitourinary  & phecode\\_592     & Cystitis and urethritis                                                         & 0.622 (0.599, 0.646) & 0.619 (0.598, 0.642) & -0.002 (-0.012, 0.008) \\\\\n",
       "\t Genitourinary  & phecode\\_626-1   & Irregular menstrual cycle/bleeding                                              & 0.847 (0.836, 0.861) & 0.847 (0.835, 0.858) & -0.002 (-0.008, 0.004) \\\\\n",
       "\t Cardio         & phecode\\_438-1   & Aortic aneurysm and ectasia                                                     & 0.793 (0.777, 0.813) & 0.792 (0.776, 0.814) & -0.002 (-0.01, 0.006)  \\\\\n",
       "\t Neoplasms      & phecode\\_101-4   & Malignant neoplasm of the colon and rectum                                      & 0.683 (0.672, 0.696) & 0.682 (0.669, 0.695) & -0.002 (-0.007, 0.003) \\\\\n",
       "\t Endo           & phecode\\_208-2   & Hyperparathyroidism                                                             & 0.637 (0.613, 0.667) & 0.636 (0.604, 0.665) & -0.002 (-0.016, 0.014) \\\\\n",
       "\t GI             & phecode\\_532     & Other disorders of the intestines                                               & 0.559 (0.541, 0.573) & 0.557 (0.539, 0.571) & -0.001 (-0.015, 0.01)  \\\\\n",
       "\t Genitourinary  & phecode\\_618     & Genital prolapse                                                                & 0.588 (0.575, 0.603) & 0.586 (0.575, 0.599) & -0.001 (-0.006, 0.003) \\\\\n",
       "\t Neuro          & phecode\\_328     & Dementias and cerebral degeneration                                             & 0.788 (0.779, 0.803) & 0.787 (0.777, 0.801) & -0.001 (-0.009, 0.004) \\\\\n",
       "\t Neoplasms      & phecode\\_101-41  & Malignant neoplasm of the colon                                                 & 0.685 (0.671, 0.7)   & 0.682 (0.669, 0.7)   & -0.001 (-0.006, 0.005) \\\\\n",
       "\t Signs/Symptoms & phecode\\_840     & Allergy                                                                         & 0.563 (0.549, 0.576) & 0.562 (0.552, 0.573) & -0.001 (-0.007, 0.004) \\\\\n",
       "\t Signs/Symptoms & phecode\\_808     & Syncope and collapse                                                            & 0.637 (0.626, 0.648) & 0.636 (0.624, 0.646) & -0.001 (-0.005, 0.004) \\\\\n",
       "\t Mental         & phecode\\_290     & Reaction to severe stress, and adjustment disorders                             & 0.632 (0.595, 0.675) & 0.635 (0.597, 0.674) & -0.001 (-0.034, 0.044) \\\\\n",
       "\t Genitourinary  & phecode\\_593     & Hematuria                                                                       & 0.646 (0.633, 0.658) & 0.646 (0.633, 0.658) & -0.001 (-0.004, 0.002) \\\\\n",
       "\t Genitourinary  & phecode\\_594     & Abnormality of urination                                                        & 0.661 (0.655, 0.67)  & 0.661 (0.654, 0.668) & -0.001 (-0.004, 0.002) \\\\\n",
       "\t GI             & phecode\\_517     & Gastrointestinal angiodysplasia                                                 & 0.703 (0.672, 0.73)  & 0.703 (0.665, 0.729) & -0.001 (-0.024, 0.021) \\\\\n",
       "\t Musc/Skel      & phecode\\_709-21  & Hallux valgus (Bunion)                                                          & 0.695 (0.684, 0.704) & 0.693 (0.682, 0.704) & -0.001 (-0.006, 0.003) \\\\\n",
       "\t Blood          & phecode\\_174-2   & Splenomegaly                                                                    & 0.648 (0.606, 0.696) & 0.645 (0.593, 0.686) & -0.001 (-0.06, 0.053)  \\\\\n",
       "\t Hearing        & phecode\\_394-2   & Vertigo                                                                         & 0.625 (0.597, 0.658) & 0.624 (0.589, 0.66)  & -0.001 (-0.031, 0.023) \\\\\n",
       "\t Blood          & phecode\\_174     & Diseases of spleen                                                              & 0.605 (0.577, 0.641) & 0.602 (0.574, 0.636) & -0.001 (-0.033, 0.032) \\\\\n",
       "\t Cardio         & phecode\\_416-1   & Paroxysmal tachycardia                                                          & 0.642 (0.63, 0.659)  & 0.641 (0.627, 0.658) & -0.001 (-0.012, 0.01)  \\\\\n",
       "\t Metab          & phecode\\_256-2   & Hyposmolality and/or hyponatremia                                               & 0.693 (0.678, 0.705) & 0.692 (0.677, 0.704) & -0.001 (-0.009, 0.006) \\\\\n",
       "\t Cardio         & phecode\\_404-11  & Acute myocardial infarction                                                     & 0.703 (0.694, 0.715) & 0.702 (0.693, 0.714) & -0.001 (-0.006, 0.005) \\\\\n",
       "\t Neoplasms      & phecode\\_132     & Sequelae of cancer                                                              & 0.739 (0.727, 0.752) & 0.737 (0.725, 0.751) & -0.001 (-0.005, 0.003) \\\\\n",
       "\t Neoplasms      & phecode\\_107     & Malignant neoplasm of male genitalia                                            & 0.686 (0.676, 0.698) & 0.685 (0.674, 0.697) & -0.001 (-0.003, 0.001) \\\\\n",
       "\t Cardio         & phecode\\_406-1   & Pulmonary hypertension                                                          & 0.74 (0.717, 0.76)   & 0.739 (0.713, 0.765) & -0.001 (-0.016, 0.016) \\\\\n",
       "\t Neoplasms      & phecode\\_107-2   & Malignant neoplasm of the prostate                                              & 0.691 (0.681, 0.7)   & 0.69 (0.68, 0.698)   & -0.001 (-0.002, 0.001) \\\\\n",
       "\t Genitourinary  & phecode\\_627-4   & Menorrhagia/Excessive and frequent menstruation                                 & 0.875 (0.869, 0.882) & 0.875 (0.867, 0.881) & -0.001 (-0.003, 0.002) \\\\\n",
       "\t Cardio         & phecode\\_416-21  & Atrial fibrillation                                                             & 0.699 (0.69, 0.712)  & 0.699 (0.689, 0.712) & -0.001 (-0.006, 0.005) \\\\\n",
       "\t Musc/Skel      & phecode\\_708-1   & Primary osteoarthritis                                                          & 0.606 (0.593, 0.617) & 0.605 (0.594, 0.615) & -0.001 (-0.005, 0.004) \\\\\n",
       "\t Cardio         & phecode\\_416-41  & Atrioventricular block                                                          & 0.76 (0.748, 0.773)  & 0.759 (0.746, 0.771) & 0 (-0.005, 0.002)      \\\\\n",
       "\t GI             & phecode\\_510     & Diseases of esophagus                                                           & 0.599 (0.592, 0.606) & 0.599 (0.591, 0.606) & 0 (-0.004, 0.005)      \\\\\n",
       "\t Genitourinary  & phecode\\_600     & Benign prostatic hyperplasia                                                    & 0.693 (0.685, 0.7)   & 0.693 (0.685, 0.7)   & 0 (-0.002, 0.001)      \\\\\n",
       "\t Neoplasms      & phecode\\_101-42  & Malignant neoplasm of the rectum                                                & 0.683 (0.647, 0.712) & 0.68 (0.652, 0.709)  & 0 (-0.01, 0.008)       \\\\\n",
       "\t GI             & phecode\\_520-11  & Inguinal hernia                                                                 & 0.799 (0.791, 0.804) & 0.799 (0.791, 0.804) & 0 (0, 0)               \\\\\n",
       "\t GI             & phecode\\_520-1   & Hernia of the abdominal wall                                                    & 0.724 (0.717, 0.732) & 0.724 (0.717, 0.732) & 0 (-0.001, 0.001)      \\\\\n",
       "\t Neoplasms      & phecode\\_135-5   & Benign neoplasm of the paranasal sinus and nasal cavity                         & 0.62 (0.588, 0.649)  & 0.62 (0.596, 0.645)  & 0 (-0.01, 0.012)       \\\\\n",
       "\t GI             & phecode\\_552-2   & Obstruction of bile duct                                                        & 0.648 (0.618, 0.673) & 0.647 (0.611, 0.676) & 0 (-0.019, 0.019)      \\\\\n",
       "\t Resp           & phecode\\_471-5   & Nasal polyps                                                                    & 0.617 (0.591, 0.653) & 0.618 (0.595, 0.644) & 0 (-0.014, 0.014)      \\\\\n",
       "\t Cardio         & phecode\\_416-211 & Paroxysmal atrial fibrillation*                                                 & 0.697 (0.683, 0.709) & 0.697 (0.682, 0.71)  & 0 (-0.007, 0.006)      \\\\\n",
       "\t Neoplasms      & phecode\\_116-4   & Secondary malignant neoplasm of liver                                           & 0.665 (0.65, 0.679)  & 0.664 (0.65, 0.681)  & 0 (-0.007, 0.007)      \\\\\n",
       "\t Cardio         & phecode\\_413-11  & Mitral valve insufficiency                                                      & 0.696 (0.682, 0.713) & 0.696 (0.677, 0.713) & 0 (-0.007, 0.008)      \\\\\n",
       "\t Neoplasms      & phecode\\_101     & Malignant neoplasm of the digestive organs                                      & 0.675 (0.665, 0.684) & 0.676 (0.666, 0.682) & 0 (-0.004, 0.004)      \\\\\n",
       "\t Genitourinary  & phecode\\_626     & Disorders of menstruation and other abnormal bleeding from female genital tract & 0.798 (0.78, 0.815)  & 0.8 (0.779, 0.815)   & 0 (-0.005, 0.005)      \\\\\n",
       "\t Cardio         & phecode\\_444-11  & Varicose veins of lower extremities                                             & 0.579 (0.565, 0.593) & 0.578 (0.565, 0.593) & 0 (-0.008, 0.01)       \\\\\n",
       "\t Genitourinary  & phecode\\_604     & Disorders of penis                                                              & 0.568 (0.541, 0.588) & 0.566 (0.54, 0.593)  & 0 (-0.021, 0.021)      \\\\\n",
       "\t GI             & phecode\\_529-3   & Fecal incontinence                                                              & 0.638 (0.611, 0.656) & 0.637 (0.62, 0.657)  & 0.001 (-0.015, 0.015)  \\\\\n",
       "\t Cardio         & phecode\\_400     & Rheumatic fever and chronic rheumatic heart diseases                            & 0.72 (0.709, 0.731)  & 0.721 (0.707, 0.734) & 0.001 (-0.005, 0.008)  \\\\\n",
       "\t GI             & phecode\\_552     & Other diseases of biliary tract                                                 & 0.616 (0.591, 0.642) & 0.615 (0.594, 0.636) & 0.001 (-0.015, 0.011)  \\\\\n",
       "\t Neoplasms      & phecode\\_136-42  & Benign neoplasm of rectum and anus                                              & 0.59 (0.579, 0.599)  & 0.591 (0.578, 0.6)   & 0.001 (-0.004, 0.005)  \\\\\n",
       "\t Hearing        & phecode\\_391-1   & Otitis media                                                                    & 0.541 (0.493, 0.577) & 0.541 (0.512, 0.572) & 0.001 (-0.032, 0.045)  \\\\\n",
       "\t Derm           & phecode\\_668-4   & Dermatitis due to substances taken internally                                   & 0.509 (0.461, 0.556) & 0.511 (0.459, 0.551) & 0.001 (-0.054, 0.053)  \\\\\n",
       "\t Cardio         & phecode\\_446-2   & Orthostatic hypotension                                                         & 0.707 (0.688, 0.721) & 0.708 (0.691, 0.722) & 0.001 (-0.009, 0.013)  \\\\\n",
       "\t Cardio         & phecode\\_413-32  & Tricuspid value insufficiency*                                                  & 0.703 (0.682, 0.735) & 0.707 (0.682, 0.741) & 0.001 (-0.014, 0.027)  \\\\\n",
       "\t Cardio         & phecode\\_416-212 & Persistent atrial fibrillation*                                                 & 0.679 (0.652, 0.707) & 0.68 (0.655, 0.72)   & 0.001 (-0.02, 0.022)   \\\\\n",
       "\t Cardio         & phecode\\_438-11  & Abdominal aortic aneurysm                                                       & 0.845 (0.826, 0.858) & 0.845 (0.829, 0.862) & 0.001 (-0.01, 0.012)   \\\\\n",
       "\t Neoplasms      & phecode\\_116     & Secondary malignant neoplasm                                                    & 0.656 (0.649, 0.666) & 0.657 (0.648, 0.667) & 0.001 (-0.004, 0.006)  \\\\\n",
       "\t GI             & phecode\\_514-2   & Intestinal obstruction                                                          & 0.606 (0.58, 0.625)  & 0.607 (0.585, 0.626) & 0.001 (-0.012, 0.015)  \\\\\n",
       "\t GI             & phecode\\_520     & Hernia                                                                          & 0.624 (0.619, 0.63)  & 0.625 (0.62, 0.631)  & 0.001 (-0.001, 0.003)  \\\\\n",
       "\t Cardio         & phecode\\_416-4   & Heart block                                                                     & 0.73 (0.722, 0.74)   & 0.732 (0.722, 0.74)  & 0.001 (-0.002, 0.004)  \\\\\n",
       "\t Resp           & phecode\\_480     & Pulmonary edema                                                                 & 0.673 (0.642, 0.707) & 0.672 (0.638, 0.712) & 0.001 (-0.022, 0.028)  \\\\\n",
       "\t Musc/Skel      & phecode\\_709-24  & Hammer toe                                                                      & 0.706 (0.682, 0.722) & 0.707 (0.684, 0.724) & 0.001 (-0.005, 0.008)  \\\\\n",
       "\t Neoplasms      & phecode\\_144-2   & Benign neoplasms of the uterus                                                  & 0.61 (0.597, 0.621)  & 0.611 (0.598, 0.624) & 0.001 (-0.005, 0.006)  \\\\\n",
       "\t Genitourinary  & phecode\\_580-3   & Nephrotic syndrome                                                              & 0.539 (0.495, 0.58)  & 0.54 (0.5, 0.581)    & 0.001 (-0.033, 0.03)   \\\\\n",
       "\t Cardio         & phecode\\_400-2   & Chronic rheumatic heart diseases                                                & 0.721 (0.711, 0.733) & 0.723 (0.71, 0.734)  & 0.001 (-0.007, 0.007)  \\\\\n",
       "\t Neoplasms      & phecode\\_130     & Cancer (solid tumor, excluding BCC)                                             & 0.644 (0.64, 0.648)  & 0.645 (0.642, 0.649) & 0.001 (0, 0.003)       \\\\\n",
       "\t Neoplasms      & phecode\\_103-1   & Melanomas of skin                                                               & 0.592 (0.574, 0.613) & 0.593 (0.574, 0.616) & 0.001 (-0.012, 0.013)  \\\\\n",
       "\t Derm           & phecode\\_670     & Seborrheic keratosis                                                            & 0.615 (0.591, 0.637) & 0.617 (0.594, 0.638) & 0.001 (-0.007, 0.011)  \\\\\n",
       "\t Neoplasms      & phecode\\_136     & Benign neoplasm of the digestive organs                                         & 0.587 (0.581, 0.594) & 0.588 (0.582, 0.595) & 0.001 (-0.001, 0.003)  \\\\\n",
       "\t Cardio         & phecode\\_403     & Angina pectoris                                                                 & 0.682 (0.676, 0.69)  & 0.684 (0.676, 0.692) & 0.001 (-0.003, 0.007)  \\\\\n",
       "\t Metab          & phecode\\_230-3   & Anorexia                                                                        & 0.644 (0.616, 0.677) & 0.649 (0.615, 0.678) & 0.001 (-0.018, 0.028)  \\\\\n",
       "\t Genitourinary  & phecode\\_619     & Noninflammatory female genital disorders                                        & 0.496 (0.48, 0.512)  & 0.499 (0.48, 0.513)  & 0.001 (-0.008, 0.013)  \\\\\n",
       "\t GI             & phecode\\_510-2   & Esophagitis                                                                     & 0.585 (0.578, 0.595) & 0.586 (0.579, 0.595) & 0.001 (-0.004, 0.007)  \\\\\n",
       "\t Genitourinary  & phecode\\_594-2   & Dysuria                                                                         & 0.588 (0.55, 0.619)  & 0.592 (0.558, 0.621) & 0.001 (-0.024, 0.028)  \\\\\n",
       "\t Endo           & phecode\\_200-13  & Postprocedural hypothyroidism                                                   & 0.663 (0.638, 0.683) & 0.663 (0.639, 0.69)  & 0.001 (-0.009, 0.013)  \\\\\n",
       "\t Neoplasms      & phecode\\_112     & Malignant neoplasm of other and ill-defined sites                               & 0.656 (0.649, 0.663) & 0.657 (0.65, 0.665)  & 0.001 (-0.001, 0.003)  \\\\\n",
       "\t Endo           & phecode\\_200-2   & Goiter                                                                          & 0.661 (0.638, 0.679) & 0.661 (0.642, 0.681) & 0.002 (-0.01, 0.01)    \\\\\n",
       "\t Neoplasms      & phecode\\_144     & Gynecological benign neoplasms                                                  & 0.6 (0.588, 0.611)   & 0.601 (0.588, 0.611) & 0.002 (-0.005, 0.007)  \\\\\n",
       "\t Musc/Skel      & phecode\\_722     & Fasciopathy                                                                     & 0.675 (0.657, 0.689) & 0.676 (0.656, 0.69)  & 0.002 (-0.003, 0.007)  \\\\\n",
       "\t Musc/Skel      & phecode\\_722-4   & Palmar fascial fibromatosis {[}Dupuytren{]}                                         & 0.717 (0.704, 0.736) & 0.719 (0.704, 0.735) & 0.002 (-0.003, 0.006)  \\\\\n",
       "\t GI             & phecode\\_523     & Diverticular disease {[}Bowel diverticulosis{]}                                     & 0.629 (0.624, 0.634) & 0.631 (0.626, 0.635) & 0.002 (0, 0.004)       \\\\\n",
       "\t Musc/Skel      & phecode\\_709     & Acquired deformities of fingers and toes                                        & 0.671 (0.66, 0.682)  & 0.672 (0.663, 0.683) & 0.002 (-0.002, 0.006)  \\\\\n",
       "\t GI             & phecode\\_557     & Gastrointestinal hemorrhage                                                     & 0.551 (0.541, 0.561) & 0.552 (0.542, 0.56)  & 0.002 (-0.006, 0.008)  \\\\\n",
       "\t GI             & phecode\\_530     & Disease of anus and rectum                                                      & 0.565 (0.55, 0.58)   & 0.567 (0.552, 0.58)  & 0.002 (-0.008, 0.011)  \\\\\n",
       "\t Resp           & phecode\\_478     & Aspiration pneumonia                                                            & 0.736 (0.713, 0.756) & 0.736 (0.711, 0.754) & 0.002 (-0.016, 0.017)  \\\\\n",
       "\t GI             & phecode\\_523-2   & Diverticula of colon                                                            & 0.629 (0.623, 0.634) & 0.631 (0.626, 0.636) & 0.002 (0, 0.003)       \\\\\n",
       "\t Neoplasms      & phecode\\_116-1   & Secondary malignancy of lymph nodes                                             & 0.614 (0.603, 0.628) & 0.615 (0.604, 0.626) & 0.002 (-0.008, 0.009)  \\\\\n",
       "\t GI             & phecode\\_529     & Symptoms involving digestive system                                             & 0.592 (0.586, 0.598) & 0.594 (0.589, 0.599) & 0.002 (-0.002, 0.005)  \\\\\n",
       "\t Hearing        & phecode\\_394     & Disorders of vestibular function                                                & 0.632 (0.608, 0.66)  & 0.635 (0.609, 0.662) & 0.002 (-0.014, 0.017)  \\\\\n",
       "\t Neoplasms      & phecode\\_139     & Benign sarcoma-related cancers                                                  & 0.541 (0.521, 0.553) & 0.542 (0.523, 0.555) & 0.002 (-0.006, 0.009)  \\\\\n",
       "\t Endo           & phecode\\_200     & Disorders of thyroid gland                                                      & 0.669 (0.66, 0.677)  & 0.67 (0.663, 0.68)   & 0.002 (0, 0.004)       \\\\\n",
       "\t Musc/Skel      & phecode\\_709-2   & Acquired deformities of toe                                                     & 0.674 (0.663, 0.685) & 0.676 (0.668, 0.686) & 0.002 (-0.002, 0.006)  \\\\\n",
       "\t Genitourinary  & phecode\\_618-2   & Uterine/Uterovaginal prolapse                                                   & 0.585 (0.569, 0.606) & 0.588 (0.571, 0.607) & 0.002 (-0.01, 0.015)   \\\\\n",
       "\t Cardio         & phecode\\_413-2   & Aortic valve disorders                                                          & 0.744 (0.733, 0.756) & 0.746 (0.734, 0.758) & 0.002 (-0.005, 0.007)  \\\\\n",
       "\t Resp           & phecode\\_469     & Bronchitis                                                                      & 0.607 (0.583, 0.633) & 0.609 (0.589, 0.637) & 0.002 (-0.015, 0.022)  \\\\\n",
       "\t Musc/Skel      & phecode\\_714-3   & Scoliosis                                                                       & 0.718 (0.696, 0.739) & 0.72 (0.698, 0.743)  & 0.002 (-0.009, 0.011)  \\\\\n",
       "\t GI             & phecode\\_514-1   & Esophageal obstruction (Stricture and stenosis of esophagus)                    & 0.628 (0.611, 0.645) & 0.628 (0.612, 0.649) & 0.002 (-0.01, 0.011)   \\\\\n",
       "\t Cardio         & phecode\\_431     & Stroke and transient cerebral ischemic attacks                                  & 0.703 (0.691, 0.711) & 0.705 (0.695, 0.715) & 0.002 (-0.004, 0.01)   \\\\\n",
       "\t Genitourinary  & phecode\\_597     & Other disorders of urethra and urinary tract                                    & 0.624 (0.599, 0.64)  & 0.627 (0.603, 0.644) & 0.002 (-0.005, 0.011)  \\\\\n",
       "\t Metab          & phecode\\_232-27  & Vitamin B12 deficiency                                                          & 0.606 (0.577, 0.64)  & 0.61 (0.571, 0.638)  & 0.003 (-0.035, 0.04)   \\\\\n",
       "\t Endo           & phecode\\_200-1   & Hypothyroidism                                                                  & 0.672 (0.663, 0.678) & 0.674 (0.665, 0.682) & 0.003 (0.001, 0.005)   \\\\\n",
       "\t Neoplasms      & phecode\\_136-4   & Benign neoplasm of colon, rectum, anus and anal canal                           & 0.588 (0.582, 0.593) & 0.59 (0.584, 0.596)  & 0.003 (0, 0.005)       \\\\\n",
       "\t GI             & phecode\\_556     & Other symptoms involving the digestive system and abdomen                       & 0.599 (0.582, 0.614) & 0.602 (0.583, 0.618) & 0.003 (-0.009, 0.012)  \\\\\n",
       "\t Musc/Skel      & phecode\\_727     & Other disorders of bone                                                         & 0.645 (0.629, 0.659) & 0.647 (0.632, 0.661) & 0.003 (-0.003, 0.01)   \\\\\n",
       "\t Derm           & phecode\\_685     & Disorders of sweat glands                                                       & 0.558 (0.51, 0.588)  & 0.553 (0.514, 0.597) & 0.003 (-0.033, 0.039)  \\\\\n",
       "\t Endo           & phecode\\_200-14  & Hypothyroidism, not specified as secondary                                      & 0.671 (0.664, 0.68)  & 0.674 (0.667, 0.682) & 0.003 (0, 0.005)       \\\\\n",
       "\t Neoplasms      & phecode\\_136-41  & Benign neoplasm of the colon                                                    & 0.602 (0.597, 0.609) & 0.605 (0.599, 0.611) & 0.003 (0.001, 0.006)   \\\\\n",
       "\t Cardio         & phecode\\_436     & Atherosclerosis {[}ASCVD{]}                                                         & 0.714 (0.705, 0.72)  & 0.716 (0.709, 0.723) & 0.003 (-0.001, 0.005)  \\\\\n",
       "\t GI             & phecode\\_520-2   & Diaphragmatic hernia {[}Hiatal hernia{]}                                            & 0.608 (0.602, 0.613) & 0.61 (0.604, 0.617)  & 0.003 (0, 0.006)       \\\\\n",
       "\t Neuro          & phecode\\_353     & Symptoms and signs involving general sensations and perceptions                 & 0.623 (0.595, 0.659) & 0.627 (0.593, 0.655) & 0.003 (-0.033, 0.031)  \\\\\n",
       "\t Genitourinary  & phecode\\_585     & Kidney stone disease                                                            & 0.643 (0.63, 0.656)  & 0.646 (0.631, 0.658) & 0.003 (-0.004, 0.011)  \\\\\n",
       "\t Genitourinary  & phecode\\_591     & Urinary tract infection                                                         & 0.662 (0.654, 0.672) & 0.666 (0.657, 0.676) & 0.003 (-0.002, 0.01)   \\\\\n",
       "\t ID             & phecode\\_092     & Bacteremia, Sepsis, and SIRS                                                    & 0.674 (0.663, 0.682) & 0.677 (0.667, 0.686) & 0.003 (-0.002, 0.009)  \\\\\n",
       "\t Cardio         & phecode\\_406     & Chronic pulmonary heart disease                                                 & 0.735 (0.712, 0.758) & 0.74 (0.716, 0.765)  & 0.003 (-0.017, 0.022)  \\\\\n",
       "\t Neoplasms      & phecode\\_108     & Malignant neoplasm of the urinary tract                                         & 0.719 (0.706, 0.735) & 0.723 (0.71, 0.737)  & 0.003 (-0.001, 0.009)  \\\\\n",
       "\t Neoplasms      & phecode\\_144-21  & Leiomyoma of uterus                                                             & 0.67 (0.654, 0.685)  & 0.674 (0.658, 0.69)  & 0.003 (-0.003, 0.01)   \\\\\n",
       "\t Signs/Symptoms & phecode\\_840-8   & Allergies related to other diseases/symptoms                                    & 0.456 (0.438, 0.474) & 0.459 (0.44, 0.478)  & 0.003 (-0.009, 0.018)  \\\\\n",
       "\t Resp           & phecode\\_476     & Bronchiectasis                                                                  & 0.7 (0.685, 0.718)   & 0.705 (0.688, 0.721) & 0.003 (-0.005, 0.012)  \\\\\n",
       "\t Cardio         & phecode\\_416     & Cardiac arrhythmia and conduction disorders                                     & 0.719 (0.713, 0.725) & 0.723 (0.717, 0.728) & 0.003 (0.002, 0.005)   \\\\\n",
       "\t Signs/Symptoms & phecode\\_829     & Nonspecific findings on examination of blood                                    & 0.701 (0.694, 0.709) & 0.705 (0.698, 0.713) & 0.003 (0.001, 0.006)   \\\\\n",
       "\t Cardio         & phecode\\_413-1   & Mitral valve disorders                                                          & 0.708 (0.697, 0.718) & 0.712 (0.699, 0.723) & 0.003 (-0.003, 0.009)  \\\\\n",
       "\t Musc/Skel      & phecode\\_723-2   & Rotator cuff tear or rupture                                                    & 0.573 (0.558, 0.592) & 0.576 (0.564, 0.596) & 0.003 (-0.007, 0.012)  \\\\\n",
       "\t Neuro          & phecode\\_331-6   & Migraine                                                                        & 0.596 (0.582, 0.614) & 0.599 (0.585, 0.622) & 0.003 (-0.005, 0.012)  \\\\\n",
       "\t Signs/Symptoms & phecode\\_841-1   & Allergy to other anti-infective agents                                          & 0.592 (0.587, 0.599) & 0.595 (0.59, 0.601)  & 0.003 (0.001, 0.006)   \\\\\n",
       "\t Cardio         & phecode\\_410-2   & Endocarditis                                                                    & 0.675 (0.638, 0.712) & 0.677 (0.645, 0.717) & 0.004 (-0.017, 0.024)  \\\\\n",
       "\t Signs/Symptoms & phecode\\_841     & Drug and medical agent allergy                                                  & 0.588 (0.583, 0.595) & 0.592 (0.586, 0.598) & 0.004 (0.001, 0.007)   \\\\\n",
       "\t Neoplasms      & phecode\\_103-3   & Carcinoma in situ of skin                                                       & 0.732 (0.699, 0.755) & 0.733 (0.704, 0.76)  & 0.004 (-0.005, 0.013)  \\\\\n",
       "\t Musc/Skel      & phecode\\_726     & Osteoporosis and low bone density                                               & 0.756 (0.745, 0.766) & 0.76 (0.75, 0.769)   & 0.004 (0.001, 0.005)   \\\\\n",
       "\t Cardio         & phecode\\_404-2   & Coronary atherosclerosis {[}Atherosclerotic heart disease{]}                        & 0.712 (0.704, 0.718) & 0.715 (0.708, 0.722) & 0.004 (0.001, 0.007)   \\\\\n",
       "\t Cardio         & phecode\\_416-2   & Atrial fibrillation and flutter                                                 & 0.739 (0.734, 0.746) & 0.743 (0.737, 0.749) & 0.004 (0.001, 0.006)   \\\\\n",
       "\t Musc/Skel      & phecode\\_726-1   & Osteoporosis                                                                    & 0.762 (0.755, 0.771) & 0.766 (0.758, 0.774) & 0.004 (0.002, 0.006)   \\\\\n",
       "\t Genitourinary  & phecode\\_627-3   & Postmenopausal atrophic vaginitis                                               & 0.497 (0.467, 0.525) & 0.5 (0.472, 0.53)    & 0.004 (-0.023, 0.025)  \\\\\n",
       "\t Cardio         & phecode\\_438     & Aneurysm or ectasia                                                             & 0.71 (0.693, 0.726)  & 0.714 (0.696, 0.734) & 0.004 (-0.004, 0.012)  \\\\\n",
       "\t Cardio         & phecode\\_413     & Heart valve disorders                                                           & 0.719 (0.71, 0.729)  & 0.723 (0.714, 0.734) & 0.004 (-0.002, 0.008)  \\\\\n",
       "\t Signs/Symptoms & phecode\\_841-12  & Allergy to antibiotic agent (excluding penicillin)                              & 0.636 (0.626, 0.648) & 0.64 (0.629, 0.651)  & 0.004 (-0.003, 0.009)  \\\\\n",
       "\t Neoplasms      & phecode\\_116-6   & Secondary malignancy of bone                                                    & 0.687 (0.672, 0.7)   & 0.69 (0.677, 0.703)  & 0.004 (-0.003, 0.01)   \\\\\n",
       "\t ID             & phecode\\_092-2   & Sepsis                                                                          & 0.671 (0.66, 0.682)  & 0.675 (0.664, 0.684) & 0.004 (-0.005, 0.011)  \\\\\n",
       "\t Cardio         & phecode\\_431-12  & Hemorrhagic stroke                                                              & 0.658 (0.633, 0.686) & 0.662 (0.638, 0.682) & 0.004 (-0.013, 0.018)  \\\\\n",
       "\t Cardio         & phecode\\_430     & Nontraumatic Intracranial hemorrhage                                            & 0.659 (0.643, 0.685) & 0.664 (0.642, 0.688) & 0.004 (-0.006, 0.018)  \\\\\n",
       "\t GI             & phecode\\_529-5   & Constipation                                                                    & 0.632 (0.624, 0.639) & 0.635 (0.629, 0.642) & 0.004 (-0.001, 0.009)  \\\\\n",
       "\t Cardio         & phecode\\_431-1   & Stroke                                                                          & 0.706 (0.692, 0.716) & 0.71 (0.697, 0.723)  & 0.004 (-0.004, 0.011)  \\\\\n",
       "\t GI             & phecode\\_522-1   & Inflammatory bowel disease                                                      & 0.535 (0.515, 0.554) & 0.538 (0.521, 0.56)  & 0.004 (-0.018, 0.022)  \\\\\n",
       "\t Cardio         & phecode\\_420     & Cardiac arrest                                                                  & 0.727 (0.711, 0.748) & 0.731 (0.709, 0.756) & 0.004 (-0.013, 0.021)  \\\\\n",
       "\t GI             & phecode\\_554-2   & Cyst and pseudocyst of pancreas                                                 & 0.606 (0.559, 0.649) & 0.604 (0.561, 0.651) & 0.004 (-0.036, 0.034)  \\\\\n",
       "\t Cardio         & phecode\\_404     & Ischemic heart disease                                                          & 0.703 (0.697, 0.708) & 0.707 (0.701, 0.713) & 0.005 (0.002, 0.007)   \\\\\n",
       "\t Neuro          & phecode\\_327     & Other degenerative diseases of nervous system                                   & 0.698 (0.674, 0.722) & 0.702 (0.673, 0.73)  & 0.005 (-0.012, 0.022)  \\\\\n",
       "\t GI             & phecode\\_545     & Nonspecific abnormal results of function study of liver                         & 0.609 (0.596, 0.626) & 0.614 (0.603, 0.625) & 0.005 (-0.008, 0.014)  \\\\\n",
       "\t Neuro          & phecode\\_330-3   & Convulsions                                                                     & 0.586 (0.562, 0.61)  & 0.588 (0.56, 0.617)  & 0.005 (-0.02, 0.027)   \\\\\n",
       "\t GI             & phecode\\_511     & Gastro-esophageal reflux disease                                                & 0.571 (0.566, 0.577) & 0.576 (0.571, 0.582) & 0.005 (0.001, 0.008)   \\\\\n",
       "\t Genitourinary  & phecode\\_596     & Other disorders of bladder                                                      & 0.644 (0.632, 0.657) & 0.648 (0.636, 0.66)  & 0.005 (0, 0.009)       \\\\\n",
       "\t Neuro          & phecode\\_324     & Extrapyramidal and movement disorders                                           & 0.655 (0.643, 0.67)  & 0.66 (0.649, 0.677)  & 0.005 (-0.002, 0.016)  \\\\\n",
       "\t GI             & phecode\\_522-11  & Crohn's disease                                                                 & 0.45 (0.422, 0.477)  & 0.454 (0.425, 0.49)  & 0.005 (-0.025, 0.033)  \\\\\n",
       "\t Cardio         & phecode\\_426     & Other heart disorders in diseases NEC                                           & 0.71 (0.695, 0.723)  & 0.713 (0.698, 0.729) & 0.005 (-0.007, 0.014)  \\\\\n",
       "\t GI             & phecode\\_514     & Gastrointestinal obstruction                                                    & 0.624 (0.61, 0.636)  & 0.628 (0.613, 0.64)  & 0.005 (-0.004, 0.014)  \\\\\n",
       "\t Signs/Symptoms & phecode\\_848     & Nonspecific abnormal findings of other body structures                          & 0.551 (0.516, 0.594) & 0.556 (0.523, 0.594) & 0.005 (-0.027, 0.031)  \\\\\n",
       "\t Derm           & phecode\\_678     & Other skin and connective tissue disorders                                      & 0.596 (0.58, 0.612)  & 0.601 (0.582, 0.617) & 0.005 (-0.002, 0.012)  \\\\\n",
       "\t Stat           & phecode\\_981     & Family history of malignant neoplasm                                            & 0.515 (0.503, 0.525) & 0.519 (0.508, 0.53)  & 0.005 (-0.002, 0.012)  \\\\\n",
       "\t Musc/Skel      & phecode\\_708-7   & Generalized osteoarthritis                                                      & 0.632 (0.621, 0.642) & 0.636 (0.625, 0.649) & 0.005 (-0.002, 0.014)  \\\\\n",
       "\t GI             & phecode\\_522     & Gastrointestinal inflammation                                                   & 0.577 (0.571, 0.583) & 0.583 (0.576, 0.589) & 0.005 (0.002, 0.009)   \\\\\n",
       "\t Musc/Skel      & phecode\\_708     & Osteoarthritis                                                                  & 0.637 (0.633, 0.642) & 0.643 (0.638, 0.647) & 0.005 (0.004, 0.007)   \\\\\n",
       "\t GI             & phecode\\_557-2   & Blood in stool                                                                  & 0.66 (0.639, 0.68)   & 0.664 (0.644, 0.687) & 0.006 (-0.008, 0.015)  \\\\\n",
       "\t Endo           & phecode\\_204     & Elevated blood glucose level                                                    & 0.639 (0.601, 0.662) & 0.643 (0.611, 0.669) & 0.006 (-0.016, 0.031)  \\\\\n",
       "\t Hearing        & phecode\\_394-1   & Meniere disease                                                                 & 0.592 (0.56, 0.624)  & 0.599 (0.562, 0.629) & 0.006 (-0.021, 0.031)  \\\\\n",
       "\t Neoplasms      & phecode\\_100     & Malignant neoplasm of the head and neck                                         & 0.613 (0.585, 0.644) & 0.619 (0.583, 0.646) & 0.006 (-0.012, 0.026)  \\\\\n",
       "\t Derm           & phecode\\_673     & Skin changes due to chronic exposure to nonionizing radiation                   & 0.679 (0.661, 0.695) & 0.685 (0.667, 0.702) & 0.006 (0.002, 0.01)    \\\\\n",
       "\t Genitourinary  & phecode\\_597-1   & Urethral stricture                                                              & 0.648 (0.628, 0.667) & 0.653 (0.635, 0.676) & 0.006 (-0.004, 0.012)  \\\\\n",
       "\t Cardio         & phecode\\_431-11  & Cerebral infarction {[}Ischemic stroke{]}                                           & 0.721 (0.708, 0.728) & 0.726 (0.715, 0.736) & 0.006 (-0.003, 0.014)  \\\\\n",
       "\t Derm           & phecode\\_673-1   & Actinic keratosis                                                               & 0.683 (0.669, 0.702) & 0.689 (0.674, 0.708) & 0.006 (0.001, 0.011)   \\\\\n",
       "\t Derm           & phecode\\_680     & Epidermal thickening                                                            & 0.58 (0.55, 0.605)   & 0.584 (0.553, 0.613) & 0.006 (-0.027, 0.026)  \\\\\n",
       "\t Musc/Skel      & phecode\\_703     & Chrystal arthropathies                                                          & 0.765 (0.755, 0.774) & 0.77 (0.76, 0.779)   & 0.006 (0.001, 0.011)   \\\\\n",
       "\t Musc/Skel      & phecode\\_721-1   & Synovitis and tenosynovitis                                                     & 0.554 (0.538, 0.573) & 0.561 (0.542, 0.573) & 0.006 (-0.01, 0.021)   \\\\\n",
       "\t Cardio         & phecode\\_404-1   & Myocardial infarction {[}Heart attack{]}                                            & 0.722 (0.715, 0.732) & 0.728 (0.721, 0.738) & 0.006 (0.001, 0.01)    \\\\\n",
       "\t Musc/Skel      & phecode\\_705     & Rheumatoid arthritis and other inflammatory polyarthropathies                   & 0.654 (0.644, 0.667) & 0.659 (0.646, 0.673) & 0.006 (0.001, 0.01)    \\\\\n",
       "\t GI             & phecode\\_522-9   & Gastritis                                                                       & 0.579 (0.571, 0.588) & 0.585 (0.578, 0.595) & 0.006 (0.001, 0.011)   \\\\\n",
       "\t ID             & phecode\\_015-2   & Clostridium difficile                                                           & 0.65 (0.607, 0.687)  & 0.655 (0.621, 0.699) & 0.006 (-0.025, 0.045)  \\\\\n",
       "\t Neuro          & phecode\\_334-2   & Facial nerve disorders and weakness                                             & 0.547 (0.514, 0.581) & 0.551 (0.52, 0.583)  & 0.006 (-0.027, 0.038)  \\\\\n",
       "\t Neoplasms      & phecode\\_116-2   & Secondary malignancy of respiratory organs                                      & 0.637 (0.621, 0.652) & 0.642 (0.63, 0.661)  & 0.006 (-0.004, 0.017)  \\\\\n",
       "\t Hearing        & phecode\\_396     & Hearing impairment                                                              & 0.678 (0.666, 0.69)  & 0.684 (0.672, 0.697) & 0.006 (0.002, 0.011)   \\\\\n",
       "\t Musc/Skel      & phecode\\_708-8   & Secondary osteoarthritis                                                        & 0.573 (0.544, 0.607) & 0.579 (0.556, 0.611) & 0.006 (-0.014, 0.03)   \\\\\n",
       "\t Resp           & phecode\\_468-8   & Bronchopneumonia                                                                & 0.699 (0.662, 0.734) & 0.705 (0.667, 0.739) & 0.006 (-0.015, 0.03)   \\\\\n",
       "\t Metab          & phecode\\_256-5   & Hypokalemia {[}Hypopotassemia{]}                                                    & 0.647 (0.633, 0.664) & 0.654 (0.64, 0.674)  & 0.006 (-0.004, 0.018)  \\\\\n",
       "\t Neuro          & phecode\\_334     & Disorders of other cranial nerves                                               & 0.558 (0.532, 0.586) & 0.564 (0.538, 0.587) & 0.007 (-0.018, 0.026)  \\\\\n",
       "\t Cardio         & phecode\\_444     & Venous insufficiency                                                            & 0.592 (0.581, 0.606) & 0.599 (0.588, 0.61)  & 0.007 (-0.003, 0.016)  \\\\\n",
       "\t Cardio         & phecode\\_439     & Hemorrhoids                                                                     & 0.505 (0.496, 0.514) & 0.512 (0.503, 0.521) & 0.007 (0.001, 0.014)   \\\\\n",
       "\t ID             & phecode\\_015     & Clostridium                                                                     & 0.64 (0.61, 0.675)   & 0.649 (0.614, 0.692) & 0.007 (-0.027, 0.052)  \\\\\n",
       "\t Genitourinary  & phecode\\_583     & Chronic kidney disease                                                          & 0.721 (0.713, 0.73)  & 0.728 (0.719, 0.737) & 0.007 (0.001, 0.012)   \\\\\n",
       "\t Musc/Skel      & phecode\\_703-11  & Gout                                                                            & 0.769 (0.76, 0.779)  & 0.776 (0.767, 0.786) & 0.007 (0.002, 0.012)   \\\\\n",
       "\t Cardio         & phecode\\_413-21  & Aortic stenosis                                                                 & 0.756 (0.745, 0.771) & 0.764 (0.749, 0.779) & 0.007 (-0.003, 0.016)  \\\\\n",
       "\t GI             & phecode\\_513     & Peptic ulcer                                                                    & 0.598 (0.589, 0.613) & 0.606 (0.594, 0.622) & 0.007 (-0.003, 0.017)  \\\\\n",
       "\t Cardio         & phecode\\_413-3   & Tricuspid valve disorders                                                       & 0.727 (0.714, 0.738) & 0.733 (0.72, 0.746)  & 0.007 (0, 0.015)       \\\\\n",
       "\t Resp           & phecode\\_484     & Pneumothorax and air leak                                                       & 0.639 (0.609, 0.669) & 0.648 (0.615, 0.681) & 0.007 (-0.023, 0.044)  \\\\\n",
       "\t Cardio         & phecode\\_444-1   & Varicose veins                                                                  & 0.584 (0.573, 0.596) & 0.591 (0.578, 0.602) & 0.007 (-0.001, 0.017)  \\\\\n",
       "\t Musc/Skel      & phecode\\_703-1   & Hyperuricemia                                                                   & 0.769 (0.761, 0.78)  & 0.777 (0.768, 0.787) & 0.007 (0.003, 0.013)   \\\\\n",
       "\t Cardio         & phecode\\_411     & Other diseases of pericardium                                                   & 0.654 (0.625, 0.677) & 0.661 (0.639, 0.684) & 0.007 (-0.009, 0.026)  \\\\\n",
       "\t Cardio         & phecode\\_446     & Hypotension                                                                     & 0.662 (0.652, 0.673) & 0.669 (0.658, 0.68)  & 0.008 (0, 0.014)       \\\\\n",
       "\t Neuro          & phecode\\_334-21  & Bell's palsy                                                                    & 0.553 (0.51, 0.579)  & 0.554 (0.534, 0.59)  & 0.008 (-0.03, 0.046)   \\\\\n",
       "\t Stat           & phecode\\_988     & Family history of cardiovascular disease                                        & 0.573 (0.564, 0.582) & 0.58 (0.569, 0.59)   & 0.008 (0.002, 0.014)   \\\\\n",
       "\t Musc/Skel      & phecode\\_726-2   & Pathologic fracture                                                             & 0.724 (0.698, 0.754) & 0.731 (0.7, 0.756)   & 0.008 (-0.006, 0.022)  \\\\\n",
       "\t Musc/Skel      & phecode\\_724-52  & Osteophyte*                                                                     & 0.559 (0.544, 0.58)  & 0.568 (0.551, 0.588) & 0.008 (-0.006, 0.022)  \\\\\n",
       "\t Cardio         & phecode\\_425     & Cardiomegaly                                                                    & 0.693 (0.682, 0.707) & 0.701 (0.691, 0.714) & 0.008 (-0.001, 0.017)  \\\\\n",
       "\t GI             & phecode\\_554-1   & Pancreatitis                                                                    & 0.581 (0.556, 0.608) & 0.591 (0.561, 0.612) & 0.008 (-0.016, 0.031)  \\\\\n",
       "\t GI             & phecode\\_528     & Nausea and vomiting                                                             & 0.601 (0.591, 0.609) & 0.609 (0.599, 0.616) & 0.008 (0.002, 0.013)   \\\\\n",
       "\t Blood          & phecode\\_177-4   & Lymphedema                                                                      & 0.66 (0.628, 0.692)  & 0.668 (0.637, 0.687) & 0.008 (-0.024, 0.029)  \\\\\n",
       "\t GI             & phecode\\_528-2   & Vomiting                                                                        & 0.6 (0.591, 0.609)   & 0.608 (0.6, 0.616)   & 0.008 (0.002, 0.013)   \\\\\n",
       "\t Musc/Skel      & phecode\\_709-22  & Hallux rigidus                                                                  & 0.589 (0.553, 0.618) & 0.594 (0.564, 0.632) & 0.008 (-0.011, 0.026)  \\\\\n",
       "\t GI             & phecode\\_522-8   & Duodenitis                                                                      & 0.603 (0.588, 0.62)  & 0.611 (0.597, 0.624) & 0.008 (-0.002, 0.019)  \\\\\n",
       "\t Metab          & phecode\\_230-21  & Abnormal weight loss                                                            & 0.628 (0.616, 0.64)  & 0.637 (0.625, 0.648) & 0.009 (0, 0.015)       \\\\\n",
       "\t Metab          & phecode\\_230     & Malnutrition and underweight                                                    & 0.627 (0.618, 0.637) & 0.636 (0.626, 0.646) & 0.009 (0.002, 0.014)   \\\\\n",
       "\t GI             & phecode\\_528-1   & Nausea                                                                          & 0.6 (0.59, 0.609)    & 0.609 (0.599, 0.618) & 0.009 (0.004, 0.016)   \\\\\n",
       "\t Cardio         & phecode\\_414-2   & Dilated cardiomyopathy*                                                         & 0.668 (0.624, 0.714) & 0.673 (0.634, 0.724) & 0.009 (-0.012, 0.025)  \\\\\n",
       "\t Resp           & phecode\\_463-2   & Allergic rhinitis                                                               & 0.444 (0.429, 0.469) & 0.455 (0.432, 0.473) & 0.009 (-0.011, 0.027)  \\\\\n",
       "\t GI             & phecode\\_527     & Abdominal pain                                                                  & 0.547 (0.541, 0.554) & 0.556 (0.548, 0.562) & 0.009 (0.005, 0.013)   \\\\\n",
       "\t Signs/Symptoms & phecode\\_841-4   & Allergy to analgesic agent                                                      & 0.602 (0.591, 0.616) & 0.609 (0.601, 0.625) & 0.009 (0.001, 0.015)   \\\\\n",
       "\t Signs/Symptoms & phecode\\_841-11  & Penicillin allergy                                                              & 0.577 (0.57, 0.585)  & 0.586 (0.579, 0.595) & 0.009 (0.005, 0.013)   \\\\\n",
       "\t Cardio         & phecode\\_417     & Abnormalities of heart beat                                                     & 0.595 (0.585, 0.605) & 0.605 (0.595, 0.613) & 0.009 (0.003, 0.015)   \\\\\n",
       "\t Musc/Skel      & phecode\\_711-1   & Derangement of meniscus                                                         & 0.522 (0.509, 0.531) & 0.53 (0.517, 0.542)  & 0.009 (-0.003, 0.019)  \\\\\n",
       "\t Cardio         & phecode\\_437     & Vascular insufficiency of intestine                                             & 0.669 (0.638, 0.699) & 0.681 (0.645, 0.712) & 0.009 (-0.018, 0.037)  \\\\\n",
       "\t Genitourinary  & phecode\\_586-2   & Cyst of kidney                                                                  & 0.66 (0.64, 0.679)   & 0.668 (0.65, 0.696)  & 0.009 (-0.001, 0.024)  \\\\\n",
       "\t Neuro          & phecode\\_329     & Symptoms and signs involving cognitive functions and awareness                  & 0.704 (0.695, 0.714) & 0.714 (0.702, 0.725) & 0.009 (0.002, 0.017)   \\\\\n",
       "\t ID             & phecode\\_061     & Influenza virus                                                                 & 0.614 (0.583, 0.643) & 0.624 (0.591, 0.659) & 0.009 (-0.014, 0.031)  \\\\\n",
       "\t Neoplasms      & phecode\\_108-4   & Malignant neoplasm of the kidney                                                & 0.669 (0.641, 0.693) & 0.68 (0.653, 0.708)  & 0.01 (-0.009, 0.032)   \\\\\n",
       "\t Musc/Skel      & phecode\\_712-1   & Loose body in joint                                                             & 0.507 (0.469, 0.534) & 0.511 (0.478, 0.553) & 0.01 (-0.022, 0.042)   \\\\\n",
       "\t Neoplasms      & phecode\\_103     & Malignant neoplasm of the skin                                                  & 0.662 (0.655, 0.671) & 0.671 (0.665, 0.681) & 0.01 (0.007, 0.013)    \\\\\n",
       "\t Metab          & phecode\\_230-2   & Abnormal loss of weight and underweight                                         & 0.627 (0.615, 0.641) & 0.637 (0.625, 0.65)  & 0.01 (0.003, 0.017)    \\\\\n",
       "\t Neoplasms      & phecode\\_101-2   & Malignant neoplasm of stomach                                                   & 0.676 (0.636, 0.709) & 0.686 (0.652, 0.716) & 0.01 (-0.009, 0.032)   \\\\\n",
       "\t Musc/Skel      & phecode\\_706     & Other inflammatory spondylopathies                                              & 0.61 (0.587, 0.629)  & 0.621 (0.6, 0.638)   & 0.01 (-0.005, 0.027)   \\\\\n",
       "\t Musc/Skel      & phecode\\_715-1   & Spondylosis                                                                     & 0.639 (0.629, 0.649) & 0.649 (0.64, 0.659)  & 0.01 (0.004, 0.015)    \\\\\n",
       "\t Cardio         & phecode\\_430-2   & Nontraumatic intracerebral hemorrhage                                           & 0.69 (0.664, 0.721)  & 0.701 (0.675, 0.734) & 0.01 (-0.008, 0.026)   \\\\\n",
       "\t Neuro          & phecode\\_336-5   & Mononeuritis of lower limb                                                      & 0.606 (0.579, 0.638) & 0.619 (0.586, 0.641) & 0.01 (-0.016, 0.03)    \\\\\n",
       "\t GI             & phecode\\_556-8   & Nonspecific abnormal findings in stool contents                                 & 0.591 (0.575, 0.608) & 0.6 (0.582, 0.618)   & 0.01 (-0.004, 0.023)   \\\\\n",
       "\t GI             & phecode\\_526-12  & Intestinal infection due to C. difficile                                        & 0.647 (0.613, 0.686) & 0.659 (0.621, 0.69)  & 0.01 (-0.015, 0.052)   \\\\\n",
       "\t GI             & phecode\\_512     & Dysphagia                                                                       & 0.57 (0.558, 0.581)  & 0.58 (0.569, 0.592)  & 0.01 (0.002, 0.02)     \\\\\n",
       "\t Cardio         & phecode\\_447     & Nonspecific low blood-pressure reading                                          & 0.63 (0.608, 0.658)  & 0.64 (0.614, 0.67)   & 0.01 (-0.005, 0.027)   \\\\\n",
       "\t Neuro          & phecode\\_354     & Dizziness and giddiness                                                         & 0.598 (0.585, 0.615) & 0.607 (0.595, 0.625) & 0.01 (0, 0.02)         \\\\\n",
       "\t Cardio         & phecode\\_424-1   & Left heart failure                                                              & 0.733 (0.714, 0.747) & 0.744 (0.73, 0.76)   & 0.01 (0.003, 0.022)    \\\\\n",
       "\t ID             & phecode\\_089     & Infections                                                                      & 0.612 (0.604, 0.618) & 0.622 (0.614, 0.629) & 0.011 (0.005, 0.017)   \\\\\n",
       "\t Signs/Symptoms & phecode\\_819     & General symptoms and other findings                                             & 0.689 (0.683, 0.696) & 0.701 (0.694, 0.707) & 0.011 (0.006, 0.016)   \\\\\n",
       "\t Musc/Skel      & phecode\\_724-5   & Exostosis                                                                       & 0.554 (0.533, 0.567) & 0.562 (0.546, 0.581) & 0.011 (-0.005, 0.024)  \\\\\n",
       "\t Eye            & phecode\\_363     & Disorders of lacrimal system                                                    & 0.667 (0.648, 0.689) & 0.678 (0.659, 0.699) & 0.011 (0.001, 0.019)   \\\\\n",
       "\t Musc/Skel      & phecode\\_721     & Synoviopathy and bursopathy                                                     & 0.556 (0.546, 0.568) & 0.567 (0.556, 0.578) & 0.011 (0.003, 0.018)   \\\\\n",
       "\t Cardio         & phecode\\_419     & Presence of cardiac device                                                      & 0.741 (0.726, 0.754) & 0.752 (0.739, 0.764) & 0.011 (0.004, 0.019)   \\\\\n",
       "\t GI             & phecode\\_513-2   & Gastric ulcer                                                                   & 0.588 (0.57, 0.602)  & 0.598 (0.585, 0.613) & 0.011 (-0.004, 0.024)  \\\\\n",
       "\t Derm           & phecode\\_668     & Dermatitis {[}eczema{]}                                                             & 0.552 (0.534, 0.57)  & 0.564 (0.547, 0.58)  & 0.011 (-0.001, 0.024)  \\\\\n",
       "\t Cardio         & phecode\\_440     & Embolism and thrombosis                                                         & 0.633 (0.622, 0.642) & 0.644 (0.635, 0.654) & 0.011 (0.004, 0.019)   \\\\\n",
       "\t Signs/Symptoms & phecode\\_815     & Symptoms and signs concerning food and fluid intake                             & 0.713 (0.688, 0.745) & 0.726 (0.689, 0.756) & 0.011 (-0.016, 0.033)  \\\\\n",
       "\t GI             & phecode\\_504     & Periodontal diseases                                                            & 0.494 (0.467, 0.525) & 0.503 (0.471, 0.548) & 0.011 (-0.024, 0.039)  \\\\\n",
       "\t Genitourinary  & phecode\\_581-31  & Hydronephrosis                                                                  & 0.618 (0.6, 0.637)   & 0.629 (0.611, 0.647) & 0.011 (-0.002, 0.02)   \\\\\n",
       "\t Cardio         & phecode\\_448-1   & Raynaud's syndrome                                                              & 0.608 (0.586, 0.63)  & 0.617 (0.602, 0.643) & 0.011 (-0.003, 0.026)  \\\\\n",
       "\t Neoplasms      & phecode\\_108-41  & Malignant neoplasm of kidney, except pelvis                                     & 0.671 (0.646, 0.701) & 0.681 (0.653, 0.713) & 0.011 (-0.007, 0.027)  \\\\\n",
       "\t Genitourinary  & phecode\\_594-3   & Urinary incontinence                                                            & 0.626 (0.612, 0.638) & 0.637 (0.621, 0.648) & 0.011 (0.002, 0.02)    \\\\\n",
       "\t ID             & phecode\\_089-1   & Bacterial infections                                                            & 0.625 (0.616, 0.635) & 0.636 (0.628, 0.644) & 0.011 (0.004, 0.017)   \\\\\n",
       "\t Genitourinary  & phecode\\_581-3   & Obstructive and reflux uropathy                                                 & 0.623 (0.604, 0.641) & 0.634 (0.614, 0.648) & 0.011 (-0.002, 0.022)  \\\\\n",
       "\t Resp           & phecode\\_483     & Pleural effusion                                                                & 0.68 (0.667, 0.69)   & 0.691 (0.682, 0.704) & 0.011 (0.004, 0.018)   \\\\\n",
       "\t Neuro          & phecode\\_353-1   & Hallucinations                                                                  & 0.631 (0.585, 0.669) & 0.642 (0.603, 0.676) & 0.011 (-0.027, 0.047)  \\\\\n",
       "\t Blood          & phecode\\_181     & Autoimmune disease                                                              & 0.575 (0.566, 0.587) & 0.586 (0.576, 0.597) & 0.012 (0.004, 0.02)    \\\\\n",
       "\t Resp           & phecode\\_487-1   & Epistaxis                                                                       & 0.643 (0.622, 0.667) & 0.655 (0.636, 0.677) & 0.012 (-0.002, 0.025)  \\\\\n",
       "\t GI             & phecode\\_523-4   & Diverticulitis                                                                  & 0.608 (0.567, 0.651) & 0.622 (0.577, 0.665) & 0.012 (-0.025, 0.049)  \\\\\n",
       "\t GI             & phecode\\_554-11  & Acute pancreatitis                                                              & 0.57 (0.545, 0.599)  & 0.584 (0.556, 0.61)  & 0.012 (-0.009, 0.032)  \\\\\n",
       "\t Metab          & phecode\\_239     & Hyperlipidemia                                                                  & 0.682 (0.678, 0.686) & 0.694 (0.691, 0.698) & 0.012 (0.009, 0.014)   \\\\\n",
       "\t Cardio         & phecode\\_401-1   & Essential hypertension                                                          & 0.663 (0.66, 0.667)  & 0.675 (0.672, 0.679) & 0.012 (0.01, 0.014)    \\\\\n",
       "\t GI             & phecode\\_558     & Abnormal findings on diagnostic imaging of the digestive tract                  & 0.578 (0.56, 0.599)  & 0.589 (0.572, 0.609) & 0.012 (-0.004, 0.026)  \\\\\n",
       "\t Metab          & phecode\\_239-11  & Pure hypercholesterolemia                                                       & 0.682 (0.678, 0.688) & 0.695 (0.69, 0.699)  & 0.012 (0.01, 0.015)    \\\\\n",
       "\t Metab          & phecode\\_239-1   & Hypercholesterolemia                                                            & 0.682 (0.677, 0.686) & 0.694 (0.69, 0.698)  & 0.012 (0.01, 0.014)    \\\\\n",
       "\t Musc/Skel      & phecode\\_715-3   & Spondylolisthesis                                                               & 0.667 (0.644, 0.687) & 0.678 (0.654, 0.701) & 0.012 (-0.004, 0.024)  \\\\\n",
       "\t Cardio         & phecode\\_401     & Hypertension                                                                    & 0.664 (0.659, 0.667) & 0.676 (0.672, 0.679) & 0.012 (0.01, 0.014)    \\\\\n",
       "\t Musc/Skel      & phecode\\_715     & Non-inflammatory spondylopathy                                                  & 0.639 (0.63, 0.646)  & 0.65 (0.642, 0.659)  & 0.012 (0.007, 0.017)   \\\\\n",
       "\t Metab          & phecode\\_256     & Disorders of fluid, electrolyte and acid-base balance                           & 0.673 (0.666, 0.682) & 0.686 (0.676, 0.694) & 0.012 (0.006, 0.018)   \\\\\n",
       "\t Neoplasms      & phecode\\_139-5   & Lipoma                                                                          & 0.539 (0.52, 0.56)   & 0.552 (0.535, 0.571) & 0.013 (0.003, 0.021)   \\\\\n",
       "\t GI             & phecode\\_516     & Other diseases of stomach and duodenum                                          & 0.571 (0.556, 0.588) & 0.586 (0.567, 0.601) & 0.013 (0.001, 0.026)   \\\\\n",
       "\t Stat           & phecode\\_983     & Family history of other endocrine and metabolic diseases                        & 0.506 (0.457, 0.545) & 0.515 (0.466, 0.552) & 0.013 (-0.039, 0.057)  \\\\\n",
       "\t Musc/Skel      & phecode\\_705-1   & Rheumatoid arthritis                                                            & 0.626 (0.612, 0.642) & 0.64 (0.625, 0.657)  & 0.013 (0.006, 0.02)    \\\\\n",
       "\t Death          & OMOP\\_4306655    & All-Cause Death                                                                 & 0.708 (0.701, 0.715) & 0.721 (0.715, 0.728) & 0.013 (0.009, 0.017)   \\\\\n",
       "\t Signs/Symptoms & phecode\\_812     & Edema                                                                           & 0.655 (0.64, 0.667)  & 0.666 (0.651, 0.681) & 0.013 (-0.002, 0.022)  \\\\\n",
       "\t Musc/Skel      & phecode\\_723-1   & Adhesive capsulitis of shoulder                                                 & 0.551 (0.522, 0.578) & 0.565 (0.535, 0.596) & 0.013 (-0.009, 0.031)  \\\\\n",
       "\t Resp           & phecode\\_463-21  & Seasonal allergic rhinitis                                                      & 0.447 (0.428, 0.465) & 0.46 (0.44, 0.476)   & 0.013 (-0.003, 0.033)  \\\\\n",
       "\t Eye            & phecode\\_360-4   & Blepharitis                                                                     & 0.629 (0.598, 0.666) & 0.641 (0.604, 0.681) & 0.013 (-0.015, 0.038)  \\\\\n",
       "\t Neuro          & phecode\\_356     & Speech disturbance                                                              & 0.647 (0.621, 0.667) & 0.658 (0.64, 0.682)  & 0.013 (-0.003, 0.028)  \\\\\n",
       "\t Cardio         & phecode\\_424     & Heart failure                                                                   & 0.744 (0.737, 0.754) & 0.759 (0.75, 0.769)  & 0.014 (0.008, 0.02)    \\\\\n",
       "\t Eye            & phecode\\_361     & Disorders of eyelid function                                                    & 0.681 (0.661, 0.698) & 0.694 (0.675, 0.713) & 0.014 (0.003, 0.023)   \\\\\n",
       "\t Resp           & phecode\\_465     & Pharyngitis                                                                     & 0.479 (0.445, 0.508) & 0.493 (0.461, 0.522) & 0.014 (-0.022, 0.052)  \\\\\n",
       "\t Genitourinary  & phecode\\_586     & Other disorders of the kidney and ureters                                       & 0.66 (0.646, 0.676)  & 0.675 (0.661, 0.691) & 0.014 (0.005, 0.025)   \\\\\n",
       "\t Eye            & phecode\\_374-3   & Retinal vascular changes and occlusions                                         & 0.683 (0.655, 0.7)   & 0.698 (0.67, 0.714)  & 0.014 (-0.002, 0.03)   \\\\\n",
       "\t Blood          & phecode\\_169-1   & Thrombocytopenia                                                                & 0.658 (0.642, 0.676) & 0.672 (0.648, 0.691) & 0.014 (-0.001, 0.024)  \\\\\n",
       "\t Neuro          & phecode\\_326     & Demyelinating diseases of the central nervous system                            & 0.593 (0.551, 0.625) & 0.608 (0.572, 0.643) & 0.014 (-0.001, 0.039)  \\\\\n",
       "\t Musc/Skel      & phecode\\_700-2   & Sicca syndrome {[}Sjogren syndrome{]}                                               & 0.749 (0.716, 0.791) & 0.766 (0.738, 0.803) & 0.015 (-0.008, 0.038)  \\\\\n",
       "\t Blood          & phecode\\_169     & Platelet defects                                                                & 0.654 (0.633, 0.673) & 0.669 (0.651, 0.685) & 0.015 (-0.001, 0.029)  \\\\\n",
       "\t Resp           & phecode\\_479-6   & Pulmonary collapse {[}Atelectasis{]}                                                & 0.644 (0.629, 0.658) & 0.658 (0.643, 0.674) & 0.015 (0.003, 0.026)   \\\\\n",
       "\t Cardio         & phecode\\_440-1   & Venous thromboembolism                                                          & 0.588 (0.575, 0.607) & 0.604 (0.588, 0.619) & 0.015 (0.003, 0.027)   \\\\\n",
       "\t Blood          & phecode\\_168     & Coagulation defects, purpura and other hemorrhagic conditions                   & 0.584 (0.553, 0.604) & 0.597 (0.57, 0.625)  & 0.015 (-0.006, 0.037)  \\\\\n",
       "\t GI             & phecode\\_515     & Heartburn and epigastric pain                                                   & 0.516 (0.49, 0.546)  & 0.53 (0.504, 0.563)  & 0.015 (-0.004, 0.042)  \\\\\n",
       "\t Mental         & phecode\\_283-8   & Other problems related to lifestyle                                             & 0.563 (0.549, 0.575) & 0.578 (0.564, 0.587) & 0.015 (0.007, 0.021)   \\\\\n",
       "\t Musc/Skel      & phecode\\_707     & Other arthropathies                                                             & 0.652 (0.648, 0.658) & 0.668 (0.662, 0.674) & 0.015 (0.011, 0.018)   \\\\\n",
       "\t Musc/Skel      & phecode\\_711     & Disorder of patella                                                             & 0.515 (0.505, 0.527) & 0.531 (0.521, 0.543) & 0.015 (0.004, 0.029)   \\\\\n",
       "\t Resp           & phecode\\_475     & Asthma                                                                          & 0.54 (0.533, 0.545)  & 0.555 (0.548, 0.561) & 0.015 (0.009, 0.022)   \\\\\n",
       "\t GI             & phecode\\_513-1   & Esophageal ulcer                                                                & 0.594 (0.576, 0.621) & 0.61 (0.588, 0.63)   & 0.016 (0.001, 0.028)   \\\\\n",
       "\t GI             & phecode\\_525     & Intestinal malabsorption                                                        & 0.533 (0.512, 0.561) & 0.549 (0.519, 0.573) & 0.016 (-0.008, 0.029)  \\\\\n",
       "\t Hearing        & phecode\\_395-1   & Labyrinthitis                                                                   & 0.535 (0.476, 0.578) & 0.551 (0.498, 0.61)  & 0.016 (-0.013, 0.061)  \\\\\n",
       "\t Derm           & phecode\\_682-11  & Sebaceous cyst {[}Epidermal cyst{]}                                                 & 0.503 (0.469, 0.535) & 0.515 (0.478, 0.548) & 0.016 (-0.021, 0.048)  \\\\\n",
       "\t Musc/Skel      & phecode\\_721-11  & Trigger finger                                                                  & 0.575 (0.553, 0.593) & 0.591 (0.568, 0.615) & 0.016 (-0.01, 0.032)   \\\\\n",
       "\t GI             & phecode\\_550-1   & Gallstones {[}Cholelithiasis{]}                                                     & 0.556 (0.546, 0.567) & 0.573 (0.561, 0.582) & 0.016 (0.006, 0.024)   \\\\\n",
       "\t Signs/Symptoms & phecode\\_841-3   & Allergy to narcotic agent                                                       & 0.606 (0.587, 0.622) & 0.622 (0.606, 0.639) & 0.016 (0.006, 0.024)   \\\\\n",
       "\t Mental         & phecode\\_288     & Anxiety disorders                                                               & 0.58 (0.572, 0.591)  & 0.597 (0.588, 0.606) & 0.016 (0.009, 0.022)   \\\\\n",
       "\t GI             & phecode\\_546     & Other disorders of liver                                                        & 0.619 (0.606, 0.638) & 0.637 (0.618, 0.656) & 0.016 (0.002, 0.032)   \\\\\n",
       "\t Signs/Symptoms & phecode\\_810     & Shock                                                                           & 0.726 (0.689, 0.759) & 0.739 (0.707, 0.769) & 0.017 (-0.014, 0.044)  \\\\\n",
       "\t Neuro          & phecode\\_351-3   & Paresthesia of skin*                                                            & 0.466 (0.44, 0.498)  & 0.484 (0.461, 0.512) & 0.017 (-0.01, 0.046)   \\\\\n",
       "\t Metab          & phecode\\_256-7   & Volume depletion                                                                & 0.67 (0.656, 0.682)  & 0.686 (0.676, 0.7)   & 0.017 (0.007, 0.027)   \\\\\n",
       "\t GI             & phecode\\_509     & Diseases of tongue                                                              & 0.508 (0.476, 0.532) & 0.524 (0.489, 0.56)  & 0.017 (-0.009, 0.041)  \\\\\n",
       "\t Eye            & phecode\\_361-1   & Entropion and trichiasis of eyelid                                              & 0.728 (0.689, 0.761) & 0.744 (0.714, 0.775) & 0.017 (-0.003, 0.035)  \\\\\n",
       "\t Neuro          & phecode\\_336-1   & Carpal tunnel syndrome                                                          & 0.572 (0.556, 0.587) & 0.589 (0.573, 0.6)   & 0.017 (0.005, 0.027)   \\\\\n",
       "\t Resp           & phecode\\_481     & Interstitial pulmonary diseases                                                 & 0.73 (0.712, 0.751)  & 0.747 (0.726, 0.771) & 0.017 (0.003, 0.029)   \\\\\n",
       "\t Genitourinary  & phecode\\_584     & Renal failure                                                                   & 0.702 (0.675, 0.724) & 0.719 (0.693, 0.743) & 0.017 (-0.002, 0.037)  \\\\\n",
       "\t Cardio         & phecode\\_440-13  & Phlebitis and thrombophlebitis                                                  & 0.589 (0.573, 0.606) & 0.608 (0.59, 0.622)  & 0.017 (0.01, 0.028)    \\\\\n",
       "\t Neuro          & phecode\\_341     & Cerebral palsy and other paralytic syndromes                                    & 0.662 (0.643, 0.687) & 0.679 (0.662, 0.698) & 0.017 (-0.001, 0.031)  \\\\\n",
       "\t Genitourinary  & phecode\\_594-32  & Stress incontinence                                                             & 0.691 (0.675, 0.706) & 0.707 (0.696, 0.721) & 0.018 (0.004, 0.031)   \\\\\n",
       "\t Neoplasms      & phecode\\_116-5   & Secondary malignancy of brain/spine                                             & 0.622 (0.6, 0.65)    & 0.641 (0.618, 0.663) & 0.018 (-0.007, 0.039)  \\\\\n",
       "\t Musc/Skel      & phecode\\_724     & Other symptoms and disorders of the soft tissue                                 & 0.567 (0.557, 0.578) & 0.586 (0.577, 0.597) & 0.018 (0.011, 0.026)   \\\\\n",
       "\t Neoplasms      & phecode\\_106-3   & Malignant neoplasm of the ovary                                                 & 0.598 (0.562, 0.632) & 0.615 (0.584, 0.646) & 0.018 (0, 0.04)        \\\\\n",
       "\t Signs/Symptoms & phecode\\_805     & Fever of unknown origin                                                         & 0.569 (0.555, 0.581) & 0.586 (0.57, 0.6)    & 0.018 (0.005, 0.028)   \\\\\n",
       "\t Cardio         & phecode\\_414     & Cardiomyopathy                                                                  & 0.672 (0.655, 0.692) & 0.69 (0.673, 0.712)  & 0.018 (0.003, 0.028)   \\\\\n",
       "\t Neuro          & phecode\\_329-9   & Delirium                                                                        & 0.752 (0.732, 0.765) & 0.768 (0.757, 0.784) & 0.018 (0.006, 0.032)   \\\\\n",
       "\t Cardio         & phecode\\_440-2   & Arterial embolism and thrombosis                                                & 0.704 (0.681, 0.728) & 0.722 (0.699, 0.744) & 0.018 (0.004, 0.033)   \\\\\n",
       "\t Blood          & phecode\\_160-2   & Megaloblastic anemia                                                            & 0.654 (0.624, 0.677) & 0.671 (0.643, 0.704) & 0.019 (-0.007, 0.041)  \\\\\n",
       "\t Musc/Skel      & phecode\\_716-3   & Spinal disc displacement (herniation)                                           & 0.551 (0.535, 0.567) & 0.57 (0.556, 0.589)  & 0.019 (0.007, 0.031)   \\\\\n",
       "\t Musc/Skel      & phecode\\_700     & Diffuse diseases of connective tissue                                           & 0.662 (0.635, 0.685) & 0.68 (0.653, 0.707)  & 0.019 (-0.003, 0.038)  \\\\\n",
       "\t Derm           & phecode\\_674     & Disorders of pigmentation                                                       & 0.503 (0.471, 0.531) & 0.519 (0.486, 0.556) & 0.019 (-0.016, 0.052)  \\\\\n",
       "\t GI             & phecode\\_526     & Intestinal infection                                                            & 0.591 (0.582, 0.599) & 0.609 (0.6, 0.618)   & 0.019 (0.011, 0.026)   \\\\\n",
       "\t Resp           & phecode\\_463     & Rhinitis and nasal congestion                                                   & 0.452 (0.437, 0.469) & 0.47 (0.457, 0.489)  & 0.019 (0.004, 0.035)   \\\\\n",
       "\t Resp           & phecode\\_468     & Pneumonia                                                                       & 0.674 (0.667, 0.681) & 0.693 (0.686, 0.701) & 0.019 (0.013, 0.024)   \\\\\n",
       "\t Resp           & phecode\\_487     & Hemorrhage from respiratory passages                                            & 0.623 (0.604, 0.64)  & 0.643 (0.626, 0.661) & 0.019 (0.007, 0.03)    \\\\\n",
       "\t Neuro          & phecode\\_335     & Nerve root and plexus disorders                                                 & 0.559 (0.54, 0.572)  & 0.577 (0.563, 0.592) & 0.019 (0.005, 0.033)   \\\\\n",
       "\t Musc/Skel      & phecode\\_715-4   & Spinal stenosis                                                                 & 0.648 (0.636, 0.661) & 0.669 (0.653, 0.682) & 0.019 (0.011, 0.03)    \\\\\n",
       "\t Genitourinary  & phecode\\_581     & Renal tubulo-interstitial diseases                                              & 0.577 (0.56, 0.598)  & 0.597 (0.584, 0.616) & 0.019 (0.007, 0.032)   \\\\\n",
       "\t Neuro          & phecode\\_336     & Mononeuropathies                                                                & 0.556 (0.546, 0.568) & 0.576 (0.566, 0.583) & 0.02 (0.009, 0.027)    \\\\\n",
       "\t GI             & phecode\\_550     & Disorders of the gallbladder                                                    & 0.555 (0.546, 0.568) & 0.575 (0.565, 0.586) & 0.02 (0.009, 0.029)    \\\\\n",
       "\t Musc/Skel      & phecode\\_728     & Chondropathies                                                                  & 0.492 (0.464, 0.517) & 0.511 (0.475, 0.541) & 0.02 (-0.004, 0.043)   \\\\\n",
       "\t Neuro          & phecode\\_348     & Other diseases of spinal cord                                                   & 0.619 (0.594, 0.641) & 0.637 (0.614, 0.668) & 0.02 (-0.001, 0.043)   \\\\\n",
       "\t Resp           & phecode\\_468-9   & Lobar pneumonia*                                                                & 0.679 (0.669, 0.689) & 0.699 (0.688, 0.709) & 0.02 (0.012, 0.028)    \\\\\n",
       "\t GI             & phecode\\_522-12  & Ulcerative colitis                                                              & 0.534 (0.503, 0.555) & 0.553 (0.526, 0.58)  & 0.02 (0, 0.042)        \\\\\n",
       "\t Cardio         & phecode\\_433     & Other cerebrovascular disease                                                   & 0.733 (0.721, 0.745) & 0.753 (0.742, 0.764) & 0.02 (0.012, 0.027)    \\\\\n",
       "\t Neuro          & phecode\\_350     & Other symptoms involving nervous system                                         & 0.697 (0.683, 0.708) & 0.718 (0.705, 0.729) & 0.02 (0.012, 0.029)    \\\\\n",
       "\t GI             & phecode\\_554     & Diseases of the pancreas                                                        & 0.593 (0.575, 0.612) & 0.612 (0.592, 0.633) & 0.02 (0.003, 0.034)    \\\\\n",
       "\t Musc/Skel      & phecode\\_718     & Back pain                                                                       & 0.583 (0.574, 0.593) & 0.603 (0.594, 0.612) & 0.021 (0.013, 0.028)   \\\\\n",
       "\t Neuro          & phecode\\_336-55  & Lesion of plantar nerve                                                         & 0.606 (0.579, 0.638) & 0.629 (0.599, 0.65)  & 0.021 (-0.008, 0.045)  \\\\\n",
       "\t Resp           & phecode\\_468-1   & Viral pneumonia                                                                 & 0.637 (0.607, 0.666) & 0.656 (0.626, 0.695) & 0.021 (-0.016, 0.067)  \\\\\n",
       "\t Eye            & phecode\\_361-4   & Blepharochalasis                                                                & 0.612 (0.567, 0.648) & 0.63 (0.595, 0.668)  & 0.021 (-0.008, 0.05)   \\\\\n",
       "\t Neoplasms      & phecode\\_149-3   & Benign neoplasm of the parathyroid gland                                        & 0.626 (0.592, 0.656) & 0.649 (0.607, 0.676) & 0.021 (-0.004, 0.047)  \\\\\n",
       "\t Neuro          & phecode\\_348-2   & Myelopathies                                                                    & 0.61 (0.58, 0.642)   & 0.629 (0.603, 0.66)  & 0.021 (-0.012, 0.052)  \\\\\n",
       "\t Genitourinary  & phecode\\_627-1   & Postmenopausal bleeding                                                         & 0.425 (0.406, 0.441) & 0.445 (0.426, 0.46)  & 0.021 (0.008, 0.036)   \\\\\n",
       "\t Resp           & phecode\\_479     & Pulmonary insufficiency and acute respiratory distress syndrome                 & 0.656 (0.643, 0.671) & 0.677 (0.663, 0.692) & 0.021 (0.011, 0.029)   \\\\\n",
       "\t Genitourinary  & phecode\\_582     & Acute kidney failure                                                            & 0.704 (0.695, 0.712) & 0.726 (0.718, 0.734) & 0.022 (0.015, 0.028)   \\\\\n",
       "\t ID             & phecode\\_003     & Escherichia coli                                                                & 0.628 (0.616, 0.644) & 0.651 (0.637, 0.663) & 0.022 (0.011, 0.036)   \\\\\n",
       "\t Musc/Skel      & phecode\\_713     & Symptoms related to joints                                                      & 0.578 (0.565, 0.592) & 0.6 (0.587, 0.61)    & 0.022 (0.013, 0.03)    \\\\\n",
       "\t Eye            & phecode\\_386-4   & Visual field defects                                                            & 0.646 (0.601, 0.689) & 0.668 (0.622, 0.718) & 0.022 (-0.023, 0.056)  \\\\\n",
       "\t Cardio         & phecode\\_402     & Elevated blood pressure reading without diagnosis of hypertension               & 0.577 (0.554, 0.602) & 0.599 (0.572, 0.628) & 0.022 (0.004, 0.043)   \\\\\n",
       "\t Genitourinary  & phecode\\_603-5   & Orchitis and epididymitis                                                       & 0.434 (0.381, 0.475) & 0.463 (0.423, 0.502) & 0.022 (-0.02, 0.088)   \\\\\n",
       "\t Neuro          & phecode\\_341-2   & Hemiplegia and hemiparesis                                                      & 0.673 (0.648, 0.697) & 0.695 (0.673, 0.719) & 0.022 (0.003, 0.039)   \\\\\n",
       "\t Metab          & phecode\\_247     & Disorders of mineral metabolism and mineral deficiencies                        & 0.603 (0.595, 0.611) & 0.626 (0.616, 0.635) & 0.022 (0.015, 0.028)   \\\\\n",
       "\t Blood          & phecode\\_164     & Anemia                                                                          & 0.605 (0.598, 0.611) & 0.627 (0.62, 0.634)  & 0.023 (0.015, 0.029)   \\\\\n",
       "\t Eye            & phecode\\_361-3   & Ptosis of eyelid                                                                & 0.657 (0.633, 0.681) & 0.68 (0.656, 0.701)  & 0.023 (0.004, 0.045)   \\\\\n",
       "\t Cardio         & phecode\\_448     & Peripheral vascular disease                                                     & 0.656 (0.64, 0.671)  & 0.679 (0.664, 0.693) & 0.023 (0.013, 0.035)   \\\\\n",
       "\t Resp           & phecode\\_463-1   & Chronic rhinitis                                                                & 0.541 (0.486, 0.581) & 0.56 (0.516, 0.609)  & 0.023 (-0.017, 0.064)  \\\\\n",
       "\t Neuro          & phecode\\_331     & Headache                                                                        & 0.567 (0.559, 0.58)  & 0.59 (0.582, 0.603)  & 0.023 (0.014, 0.032)   \\\\\n",
       "\t ID             & phecode\\_089-2   & Viral infections                                                                & 0.564 (0.553, 0.576) & 0.588 (0.575, 0.601) & 0.024 (0.01, 0.034)    \\\\\n",
       "\t Derm           & phecode\\_665-2   & Psoriatic arthropathy                                                           & 0.506 (0.443, 0.542) & 0.53 (0.485, 0.566)  & 0.024 (-0.019, 0.068)  \\\\\n",
       "\t Mental         & phecode\\_283     & Other behavioral problems                                                       & 0.549 (0.537, 0.56)  & 0.573 (0.564, 0.585) & 0.024 (0.014, 0.034)   \\\\\n",
       "\t Hearing        & phecode\\_391     & Disorders of the middle ear                                                     & 0.524 (0.499, 0.549) & 0.547 (0.524, 0.573) & 0.024 (-0.009, 0.051)  \\\\\n",
       "\t Resp           & phecode\\_491     & Pleurisy                                                                        & 0.687 (0.66, 0.721)  & 0.712 (0.69, 0.737)  & 0.024 (0.01, 0.037)    \\\\\n",
       "\t Signs/Symptoms & phecode\\_800     & Chest pain                                                                      & 0.528 (0.52, 0.536)  & 0.553 (0.546, 0.561) & 0.024 (0.017, 0.032)   \\\\\n",
       "\t Metab          & phecode\\_247-5   & Disorders of calcium metabolism                                                 & 0.64 (0.618, 0.663)  & 0.667 (0.642, 0.69)  & 0.024 (0.004, 0.044)   \\\\\n",
       "\t GI             & phecode\\_557-8   & Hemorrhage of rectum and anus                                                   & 0.472 (0.458, 0.484) & 0.496 (0.477, 0.51)  & 0.025 (0.007, 0.038)   \\\\\n",
       "\t Signs/Symptoms & phecode\\_801     & Cough                                                                           & 0.561 (0.542, 0.575) & 0.586 (0.567, 0.598) & 0.025 (0.007, 0.043)   \\\\\n",
       "\t Neuro          & phecode\\_350-5   & Repeated falls*                                                                 & 0.734 (0.725, 0.744) & 0.757 (0.748, 0.769) & 0.025 (0.016, 0.031)   \\\\\n",
       "\t Cardio         & phecode\\_433-1   & Occlusion and stenosis of cerebral arteries                                     & 0.722 (0.701, 0.746) & 0.748 (0.722, 0.77)  & 0.025 (0.008, 0.044)   \\\\\n",
       "\t Neuro          & phecode\\_331-8   & Headache NOS                                                                    & 0.558 (0.544, 0.57)  & 0.582 (0.568, 0.597) & 0.025 (0.015, 0.037)   \\\\\n",
       "\t Metab          & phecode\\_247-7   & Disorders of iron metabolism                                                    & 0.586 (0.576, 0.597) & 0.611 (0.601, 0.621) & 0.025 (0.016, 0.032)   \\\\\n",
       "\t Eye            & phecode\\_387-3   & Astigmatism                                                                     & 0.674 (0.661, 0.688) & 0.7 (0.685, 0.713)   & 0.025 (0.014, 0.036)   \\\\\n",
       "\t Musc/Skel      & phecode\\_716     & Intervertebral disc disorder                                                    & 0.551 (0.538, 0.565) & 0.577 (0.565, 0.588) & 0.026 (0.013, 0.036)   \\\\\n",
       "\t GI             & phecode\\_550-2   & Cholecystitis                                                                   & 0.559 (0.535, 0.585) & 0.586 (0.562, 0.614) & 0.026 (0.002, 0.056)   \\\\\n",
       "\t Cardio         & phecode\\_411-2   & Pericardial effusion (noninflammatory)*                                         & 0.652 (0.618, 0.677) & 0.674 (0.647, 0.704) & 0.026 (0.003, 0.039)   \\\\\n",
       "\t Signs/Symptoms & phecode\\_809     & Pain                                                                            & 0.579 (0.567, 0.59)  & 0.606 (0.593, 0.615) & 0.026 (0.016, 0.037)   \\\\\n",
       "\t Eye            & phecode\\_369-4   & Corneal degenerations                                                           & 0.73 (0.707, 0.751)  & 0.758 (0.737, 0.78)  & 0.026 (0.006, 0.046)   \\\\\n",
       "\t Derm           & phecode\\_667     & Erythematous conditions                                                         & 0.576 (0.525, 0.616) & 0.597 (0.553, 0.647) & 0.026 (-0.022, 0.069)  \\\\\n",
       "\t Signs/Symptoms & phecode\\_809-3   & Pain in limb                                                                    & 0.565 (0.55, 0.579)  & 0.59 (0.578, 0.607)  & 0.027 (0.015, 0.037)   \\\\\n",
       "\t Mental         & phecode\\_288-2   & Panic disorder {[}episodic paroxysmal anxiety{]}                                    & 0.561 (0.533, 0.59)  & 0.589 (0.559, 0.622) & 0.027 (-0.005, 0.069)  \\\\\n",
       "\t GI             & phecode\\_524     & Functional intestinal disorder                                                  & 0.579 (0.568, 0.589) & 0.606 (0.595, 0.619) & 0.027 (0.021, 0.034)   \\\\\n",
       "\t Resp           & phecode\\_488-1   & Dyspnea {[}Shortness of breath{]}                                                   & 0.606 (0.595, 0.618) & 0.633 (0.623, 0.643) & 0.027 (0.017, 0.037)   \\\\\n",
       "\t Derm           & phecode\\_679     & Skin symptoms                                                                   & 0.572 (0.556, 0.59)  & 0.598 (0.583, 0.617) & 0.027 (0.01, 0.047)    \\\\\n",
       "\t Derm           & phecode\\_660     & Infection of the skin                                                           & 0.577 (0.568, 0.588) & 0.604 (0.592, 0.615) & 0.027 (0.016, 0.037)   \\\\\n",
       "\t Resp           & phecode\\_462-2   & Chronic sinusitis                                                               & 0.531 (0.509, 0.551) & 0.558 (0.534, 0.585) & 0.027 (0.005, 0.053)   \\\\\n",
       "\t Blood          & phecode\\_160     & Nutritional anemias                                                             & 0.6 (0.589, 0.608)   & 0.628 (0.618, 0.636) & 0.028 (0.02, 0.035)    \\\\\n",
       "\t Blood          & phecode\\_164-1   & Microcytic anemia                                                               & 0.592 (0.582, 0.606) & 0.619 (0.612, 0.631) & 0.028 (0.018, 0.038)   \\\\\n",
       "\t Neuro          & phecode\\_347     & Other disorders of the brain and CNS                                            & 0.58 (0.535, 0.621)  & 0.607 (0.573, 0.639) & 0.028 (-0.004, 0.065)  \\\\\n",
       "\t Resp           & phecode\\_460     & Acute respiratory infection                                                     & 0.629 (0.619, 0.638) & 0.656 (0.647, 0.664) & 0.028 (0.019, 0.035)   \\\\\n",
       "\t Metab          & phecode\\_247-4   & Disorders of magnesium metabolism                                               & 0.661 (0.633, 0.689) & 0.687 (0.658, 0.712) & 0.028 (0.006, 0.042)   \\\\\n",
       "\t Cardio         & phecode\\_417-2   & Tachycardia                                                                     & 0.585 (0.566, 0.602) & 0.613 (0.593, 0.63)  & 0.028 (0.008, 0.038)   \\\\\n",
       "\t Derm           & phecode\\_660-6   & Cellulitis and abscess                                                          & 0.575 (0.563, 0.586) & 0.604 (0.592, 0.614) & 0.028 (0.02, 0.039)    \\\\\n",
       "\t Cardio         & phecode\\_401-3   & Hypertensive chronic kidney disease                                             & 0.703 (0.672, 0.745) & 0.731 (0.696, 0.759) & 0.028 (-0.005, 0.053)  \\\\\n",
       "\t Metab          & phecode\\_232-4   & Vitamin D deficiency                                                            & 0.6 (0.58, 0.621)    & 0.629 (0.612, 0.648) & 0.028 (0.013, 0.043)   \\\\\n",
       "\t Musc/Skel      & phecode\\_718-2   & Cervicalgia                                                                     & 0.604 (0.578, 0.633) & 0.634 (0.608, 0.662) & 0.028 (0.009, 0.053)   \\\\\n",
       "\t Blood          & phecode\\_164-2   & Macrocytic anemia                                                               & 0.649 (0.622, 0.674) & 0.679 (0.647, 0.706) & 0.028 (0.006, 0.052)   \\\\\n",
       "\t Blood          & phecode\\_160-1   & Iron deficiency anemia                                                          & 0.591 (0.581, 0.601) & 0.62 (0.609, 0.628)  & 0.029 (0.019, 0.038)   \\\\\n",
       "\t Metab          & phecode\\_247-72  & Iron deficiency                                                                 & 0.59 (0.58, 0.601)   & 0.619 (0.609, 0.628) & 0.029 (0.021, 0.038)   \\\\\n",
       "\t Derm           & phecode\\_665     & Psoriasis                                                                       & 0.581 (0.559, 0.6)   & 0.609 (0.588, 0.631) & 0.029 (0.009, 0.051)   \\\\\n",
       "\t Resp           & phecode\\_479-3   & Respiratory failure                                                             & 0.671 (0.649, 0.688) & 0.697 (0.68, 0.722)  & 0.029 (0.013, 0.044)   \\\\\n",
       "\t Musc/Skel      & phecode\\_718-1   & Radiculopathy                                                                   & 0.557 (0.533, 0.579) & 0.586 (0.561, 0.615) & 0.029 (0.005, 0.055)   \\\\\n",
       "\t Musc/Skel      & phecode\\_713-3   & Pain in joint                                                                   & 0.581 (0.569, 0.596) & 0.61 (0.597, 0.624)  & 0.029 (0.018, 0.036)   \\\\\n",
       "\t Hearing        & phecode\\_395     & Other diseases of inner ear                                                     & 0.526 (0.499, 0.574) & 0.556 (0.519, 0.598) & 0.029 (-0.008, 0.056)  \\\\\n",
       "\t GI             & phecode\\_555     & Ascites                                                                         & 0.637 (0.611, 0.657) & 0.665 (0.642, 0.692) & 0.029 (0.012, 0.049)   \\\\\n",
       "\t Eye            & phecode\\_377     & Hemorrhage of the eye                                                           & 0.588 (0.557, 0.629) & 0.616 (0.577, 0.672) & 0.029 (-0.038, 0.094)  \\\\\n",
       "\t Metab          & phecode\\_256-4   & Hyperkalemia {[}Hyperpotassemia{]}                                                  & 0.698 (0.68, 0.714)  & 0.725 (0.709, 0.747) & 0.029 (0.013, 0.046)   \\\\\n",
       "\t Stat           & phecode\\_979     & Transplated organ                                                               & 0.563 (0.531, 0.591) & 0.594 (0.556, 0.631) & 0.029 (-0.011, 0.077)  \\\\\n",
       "\t Neuro          & phecode\\_325-2   & Abnormality of gait and mobility                                                & 0.683 (0.671, 0.697) & 0.713 (0.703, 0.73)  & 0.03 (0.02, 0.041)     \\\\\n",
       "\t Resp           & phecode\\_486     & Other respiratory disorders                                                     & 0.651 (0.633, 0.665) & 0.681 (0.662, 0.698) & 0.03 (0.014, 0.042)    \\\\\n",
       "\t Signs/Symptoms & phecode\\_807     & Malaise and fatigue                                                             & 0.591 (0.571, 0.61)  & 0.622 (0.606, 0.641) & 0.03 (0.019, 0.043)    \\\\\n",
       "\t Neuro          & phecode\\_330     & Epilepsy, recurrent seizures, convulsions                                       & 0.572 (0.554, 0.589) & 0.602 (0.588, 0.617) & 0.03 (0.013, 0.047)    \\\\\n",
       "\t Mental         & phecode\\_284     & Suicide ideation and attempt or self harm                                       & 0.561 (0.53, 0.595)  & 0.594 (0.56, 0.635)  & 0.03 (-0.008, 0.068)   \\\\\n",
       "\t Resp           & phecode\\_488     & Abnormalities of breathing                                                      & 0.587 (0.576, 0.597) & 0.617 (0.607, 0.628) & 0.03 (0.021, 0.04)     \\\\\n",
       "\t Cardio         & phecode\\_448-9   & Peripheral vascular disease NOS {[}includes PAD{]}                                  & 0.755 (0.74, 0.771)  & 0.785 (0.767, 0.798) & 0.03 (0.014, 0.046)    \\\\\n",
       "\t Neoplasms      & phecode\\_138-2   & Melanocytic nevi*                                                               & 0.513 (0.489, 0.539) & 0.548 (0.526, 0.566) & 0.03 (0.013, 0.061)    \\\\\n",
       "\t Neuro          & phecode\\_325     & Symptoms and signs related to movement disorders                                & 0.673 (0.66, 0.687)  & 0.704 (0.692, 0.718) & 0.03 (0.022, 0.039)    \\\\\n",
       "\t GI             & phecode\\_535     & Intestinal or peritoneal adhesions                                              & 0.552 (0.534, 0.564) & 0.582 (0.565, 0.597) & 0.03 (0.018, 0.044)    \\\\\n",
       "\t Metab          & phecode\\_256-6   & Fluid overload                                                                  & 0.723 (0.699, 0.741) & 0.752 (0.731, 0.774) & 0.03 (0.011, 0.046)    \\\\\n",
       "\t ID             & phecode\\_096     & Contact or exposure to infectious agent                                         & 0.596 (0.497, 0.701) & 0.627 (0.507, 0.734) & 0.031 (-0.07, 0.137)   \\\\\n",
       "\t Resp           & phecode\\_468-2   & Bacterial pneumonia                                                             & 0.643 (0.617, 0.669) & 0.672 (0.647, 0.714) & 0.031 (0.011, 0.056)   \\\\\n",
       "\t Musc/Skel      & phecode\\_721-5   & Bursitis                                                                        & 0.499 (0.481, 0.52)  & 0.533 (0.51, 0.55)   & 0.031 (0.012, 0.058)   \\\\\n",
       "\t Derm           & phecode\\_679-1   & Rash and other nonspecific skin eruption                                        & 0.59 (0.564, 0.609)  & 0.621 (0.601, 0.64)  & 0.031 (0.014, 0.05)    \\\\\n",
       "\t GI             & phecode\\_525-1   & Celiac disease                                                                  & 0.522 (0.496, 0.549) & 0.552 (0.521, 0.576) & 0.031 (0.002, 0.053)   \\\\\n",
       "\t Genitourinary  & phecode\\_580     & Glomerular diseases                                                             & 0.659 (0.633, 0.689) & 0.69 (0.661, 0.719)  & 0.031 (0.011, 0.052)   \\\\\n",
       "\t Blood          & phecode\\_177-2   & Enlargement of lymph nodes {[}Lymphadenopathy{]}                                    & 0.58 (0.565, 0.597)  & 0.612 (0.593, 0.634) & 0.031 (0.014, 0.046)   \\\\\n",
       "\t Resp           & phecode\\_465-1   & Acute Pharyngitis                                                               & 0.467 (0.434, 0.504) & 0.5 (0.457, 0.534)   & 0.031 (-0.013, 0.061)  \\\\\n",
       "\t Metab          & phecode\\_232     & Vitamin deficiencies                                                            & 0.608 (0.595, 0.625) & 0.64 (0.627, 0.652)  & 0.032 (0.021, 0.043)   \\\\\n",
       "\t Musc/Skel      & phecode\\_707-8   & Polyarthritis                                                                   & 0.421 (0.389, 0.453) & 0.454 (0.423, 0.484) & 0.032 (0.014, 0.047)   \\\\\n",
       "\t GI             & phecode\\_508     & Diseases of lips                                                                & 0.49 (0.435, 0.53)   & 0.521 (0.465, 0.561) & 0.032 (-0.006, 0.072)  \\\\\n",
       "\t GI             & phecode\\_526-1   & Bacterial enteritis                                                             & 0.567 (0.539, 0.585) & 0.594 (0.574, 0.614) & 0.032 (0.013, 0.051)   \\\\\n",
       "\t Cardio         & phecode\\_443-1   & Stricture of artery {[}Arterial stenosis{]}                                         & 0.72 (0.688, 0.757)  & 0.752 (0.726, 0.787) & 0.032 (-0.002, 0.062)  \\\\\n",
       "\t GI             & phecode\\_526-2   & Viral enteritis                                                                 & 0.568 (0.544, 0.613) & 0.602 (0.571, 0.633) & 0.033 (-0.002, 0.071)  \\\\\n",
       "\t Derm           & phecode\\_686-1   & Pressure ulcer                                                                  & 0.718 (0.702, 0.734) & 0.749 (0.738, 0.765) & 0.033 (0.021, 0.045)   \\\\\n",
       "\t Mental         & phecode\\_299     & Mental disorder, not otherwise specified                                        & 0.631 (0.587, 0.665) & 0.663 (0.631, 0.695) & 0.033 (-0.002, 0.064)  \\\\\n",
       "\t Resp           & phecode\\_460-2   & Acute lower respiratory infection                                               & 0.645 (0.635, 0.655) & 0.678 (0.669, 0.687) & 0.033 (0.024, 0.04)    \\\\\n",
       "\t Musc/Skel      & phecode\\_723     & Enthesopathy/Enthesitis/Tendinopathy                                            & 0.506 (0.491, 0.517) & 0.539 (0.527, 0.55)  & 0.033 (0.021, 0.045)   \\\\\n",
       "\t Metab          & phecode\\_232-2   & Vitamin B group deficiency                                                      & 0.628 (0.607, 0.649) & 0.663 (0.649, 0.683) & 0.033 (0.02, 0.05)     \\\\\n",
       "\t Blood          & phecode\\_177     & Abnormality of the lymph nodes                                                  & 0.588 (0.576, 0.601) & 0.621 (0.608, 0.635) & 0.033 (0.021, 0.045)   \\\\\n",
       "\t GI             & phecode\\_520-13  & Umbilical hernia                                                                & 0.638 (0.617, 0.656) & 0.67 (0.656, 0.688)  & 0.034 (0.021, 0.045)   \\\\\n",
       "\t Musc/Skel      & phecode\\_702-3   & Enteropathic arthropathies                                                      & 0.497 (0.458, 0.532) & 0.532 (0.499, 0.562) & 0.034 (-0.006, 0.081)  \\\\\n",
       "\t ID             & phecode\\_004     & Streptococcus                                                                   & 0.593 (0.571, 0.615) & 0.627 (0.606, 0.649) & 0.034 (0.016, 0.056)   \\\\\n",
       "\t Cardio         & phecode\\_443     & Other specified disorders of arteries and arterioles                            & 0.698 (0.678, 0.73)  & 0.735 (0.709, 0.763) & 0.034 (0.009, 0.059)   \\\\\n",
       "\t Resp           & phecode\\_462     & Sinusitis                                                                       & 0.519 (0.498, 0.541) & 0.552 (0.528, 0.579) & 0.034 (0.008, 0.059)   \\\\\n",
       "\t GI             & phecode\\_524-1   & Irritable bowel syndrome                                                        & 0.567 (0.556, 0.579) & 0.602 (0.589, 0.613) & 0.035 (0.028, 0.043)   \\\\\n",
       "\t Mental         & phecode\\_284-29  & Intentional self-harm*                                                          & 0.554 (0.524, 0.598) & 0.593 (0.56, 0.625)  & 0.035 (-0.003, 0.075)  \\\\\n",
       "\t Derm           & phecode\\_686     & Chronic ulcer of skin                                                           & 0.706 (0.69, 0.72)   & 0.74 (0.726, 0.758)  & 0.035 (0.022, 0.044)   \\\\\n",
       "\t Metab          & phecode\\_256-1   & Hyperosmolality and/or hypernatremia                                            & 0.67 (0.632, 0.702)  & 0.708 (0.666, 0.744) & 0.035 (0.012, 0.071)   \\\\\n",
       "\t Derm           & phecode\\_682-1   & Cutaneous cyst                                                                  & 0.455 (0.43, 0.476)  & 0.49 (0.468, 0.507)  & 0.036 (0.015, 0.062)   \\\\\n",
       "\t Musc/Skel      & phecode\\_724-1   & Myalgia                                                                         & 0.61 (0.592, 0.632)  & 0.647 (0.627, 0.667) & 0.037 (0.025, 0.047)   \\\\\n",
       "\t Eye            & phecode\\_386     & Visual disturbances                                                             & 0.591 (0.573, 0.608) & 0.626 (0.609, 0.645) & 0.037 (0.02, 0.048)    \\\\\n",
       "\t Signs/Symptoms & phecode\\_835     & Cytology and pathology findings                                                 & 0.44 (0.406, 0.492)  & 0.474 (0.428, 0.521) & 0.037 (-0.006, 0.076)  \\\\\n",
       "\t ID             & phecode\\_002     & Staphylococcus                                                                  & 0.629 (0.617, 0.652) & 0.668 (0.652, 0.686) & 0.038 (0.021, 0.051)   \\\\\n",
       "\t GI             & phecode\\_507     & Lesions of mouth                                                                & 0.351 (0.331, 0.374) & 0.39 (0.367, 0.412)  & 0.038 (0.021, 0.054)   \\\\\n",
       "\t GI             & phecode\\_557-1   & Hematemesis                                                                     & 0.629 (0.605, 0.654) & 0.666 (0.642, 0.688) & 0.038 (0.014, 0.06)    \\\\\n",
       "\t Metab          & phecode\\_256-3   & Mixed disorder of acid-base balance                                             & 0.657 (0.636, 0.68)  & 0.694 (0.676, 0.714) & 0.038 (0.018, 0.055)   \\\\\n",
       "\t Neuro          & phecode\\_326-1   & Multiple sclerosis                                                              & 0.568 (0.528, 0.604) & 0.608 (0.566, 0.64)  & 0.039 (0.016, 0.069)   \\\\\n",
       "\t Genitourinary  & phecode\\_614-5   & Inflammatory disease of cervix, vagina, and vulva                               & 0.439 (0.397, 0.478) & 0.479 (0.431, 0.518) & 0.039 (0.009, 0.077)   \\\\\n",
       "\t GI             & phecode\\_537     & Abnormality of the peritoneum                                                   & 0.539 (0.511, 0.569) & 0.576 (0.546, 0.603) & 0.039 (-0.002, 0.064)  \\\\\n",
       "\t Neuro          & phecode\\_355     & Coma and other alteration of consciousness                                      & 0.597 (0.563, 0.625) & 0.634 (0.596, 0.666) & 0.039 (0.009, 0.073)   \\\\\n",
       "\t Neoplasms      & phecode\\_102     & Malignant neoplasm of the thoracic and respiratory organs                       & 0.674 (0.659, 0.686) & 0.713 (0.699, 0.725) & 0.039 (0.027, 0.049)   \\\\\n",
       "\t Metab          & phecode\\_247-3   & Disorder of phosphorus metabolism                                               & 0.631 (0.603, 0.653) & 0.67 (0.644, 0.701)  & 0.04 (0.014, 0.065)    \\\\\n",
       "\t Neuro          & phecode\\_344-1   & Hydrocephalus                                                                   & 0.631 (0.588, 0.666) & 0.667 (0.626, 0.709) & 0.04 (-0.006, 0.084)   \\\\\n",
       "\t Signs/Symptoms & phecode\\_800-2   & Precordial pain                                                                 & 0.509 (0.496, 0.522) & 0.549 (0.535, 0.564) & 0.04 (0.024, 0.056)    \\\\\n",
       "\t Metab          & phecode\\_244     & Disorders of lipoprotein metabolism and other lipidemias                        & 0.602 (0.573, 0.635) & 0.644 (0.606, 0.684) & 0.04 (0.015, 0.071)    \\\\\n",
       "\t Neoplasms      & phecode\\_104     & Malignant sarcoma-related cancers                                               & 0.52 (0.487, 0.55)   & 0.559 (0.524, 0.593) & 0.04 (0.009, 0.07)     \\\\\n",
       "\t Stat           & phecode\\_997     & Family history of other condition                                               & 0.697 (0.681, 0.716) & 0.737 (0.72, 0.759)  & 0.04 (0.026, 0.054)    \\\\\n",
       "\t GI             & phecode\\_502     & Other diseases of teeth and supporting structures                               & 0.489 (0.47, 0.508)  & 0.532 (0.511, 0.552) & 0.041 (0.021, 0.063)   \\\\\n",
       "\t Eye            & phecode\\_374-5   & Macular degeneration                                                            & 0.742 (0.73, 0.754)  & 0.785 (0.772, 0.793) & 0.041 (0.033, 0.05)    \\\\\n",
       "\t Resp           & phecode\\_472     & Diseases of vocal cords and larynx, not elsewhere classified                    & 0.582 (0.552, 0.608) & 0.62 (0.6, 0.656)    & 0.041 (0, 0.068)       \\\\\n",
       "\t Blood          & phecode\\_168-2   & Hyper-coagulability                                                             & 0.514 (0.477, 0.557) & 0.557 (0.52, 0.605)  & 0.042 (0.01, 0.083)    \\\\\n",
       "\t GI             & phecode\\_540     & Hepatitis                                                                       & 0.546 (0.513, 0.576) & 0.588 (0.552, 0.622) & 0.042 (0.011, 0.066)   \\\\\n",
       "\t Musc/Skel      & phecode\\_713-2   & Effusion of joint                                                               & 0.577 (0.551, 0.609) & 0.619 (0.594, 0.653) & 0.043 (0.015, 0.071)   \\\\\n",
       "\t Metab          & phecode\\_256-31  & Acidosis                                                                        & 0.655 (0.632, 0.675) & 0.696 (0.676, 0.716) & 0.043 (0.02, 0.064)    \\\\\n",
       "\t ID             & phecode\\_002-1   & Staphylococcus aureus                                                           & 0.617 (0.589, 0.642) & 0.66 (0.635, 0.687)  & 0.044 (0.022, 0.061)   \\\\\n",
       "\t Mental         & phecode\\_284-2   & Suicide and self-inflicted harm                                                 & 0.554 (0.525, 0.593) & 0.598 (0.565, 0.631) & 0.044 (0.001, 0.083)   \\\\\n",
       "\t Mental         & phecode\\_308     & Signs and symptoms involving emotional state                                    & 0.562 (0.53, 0.592)  & 0.605 (0.582, 0.63)  & 0.044 (0.01, 0.076)    \\\\\n",
       "\t ID             & phecode\\_052-3   & Varicella zoster virus                                                          & 0.545 (0.508, 0.587) & 0.591 (0.542, 0.636) & 0.044 (-0.003, 0.083)  \\\\\n",
       "\t Musc/Skel      & phecode\\_723-6   & Impingement syndrome of shoulder*                                               & 0.48 (0.466, 0.501)  & 0.523 (0.51, 0.542)  & 0.044 (0.028, 0.062)   \\\\\n",
       "\t Derm           & phecode\\_674-2   & Hypepigmentation                                                                & 0.492 (0.444, 0.545) & 0.535 (0.501, 0.58)  & 0.045 (-0.011, 0.1)    \\\\\n",
       "\t GI             & phecode\\_542-4   & Portal hypertension                                                             & 0.631 (0.597, 0.664) & 0.676 (0.623, 0.717) & 0.045 (0.005, 0.082)   \\\\\n",
       "\t Neuro          & phecode\\_344     & Disorders of the circulation of the cerebrospinal fluid                         & 0.553 (0.516, 0.587) & 0.597 (0.562, 0.633) & 0.045 (0.009, 0.083)   \\\\\n",
       "\t Genitourinary  & phecode\\_619-2   & Disorders of uterus, NEC                                                        & 0.412 (0.383, 0.43)  & 0.458 (0.428, 0.479) & 0.046 (0.024, 0.068)   \\\\\n",
       "\t Derm           & phecode\\_682-12  & Pilar and trichodermal cyst                                                     & 0.453 (0.434, 0.477) & 0.501 (0.478, 0.526) & 0.046 (0.022, 0.074)   \\\\\n",
       "\t Resp           & phecode\\_495     & Abnormal findings on diagnostic imaging of lung                                 & 0.63 (0.611, 0.649)  & 0.679 (0.658, 0.694) & 0.047 (0.033, 0.066)   \\\\\n",
       "\t Resp           & phecode\\_474     & Chronic obstructive pulmonary disease {[}COPD{]}                                    & 0.681 (0.673, 0.69)  & 0.728 (0.718, 0.736) & 0.047 (0.039, 0.054)   \\\\\n",
       "\t Eye            & phecode\\_367     & Inflammation of the eye                                                         & 0.592 (0.571, 0.617) & 0.639 (0.613, 0.663) & 0.048 (0.014, 0.067)   \\\\\n",
       "\t Resp           & phecode\\_487-3   & Hemoptysis                                                                      & 0.582 (0.554, 0.604) & 0.624 (0.6, 0.653)   & 0.048 (0.022, 0.068)   \\\\\n",
       "\t Eye            & phecode\\_375-1   & Glaucoma                                                                        & 0.708 (0.697, 0.72)  & 0.757 (0.746, 0.77)  & 0.048 (0.039, 0.058)   \\\\\n",
       "\t Neoplasms      & phecode\\_102-1   & Malignant neoplasm of the of bronchus and lung                                  & 0.676 (0.663, 0.692) & 0.724 (0.711, 0.738) & 0.049 (0.036, 0.06)    \\\\\n",
       "\t Neuro          & phecode\\_330-1   & Epilepsy                                                                        & 0.541 (0.522, 0.564) & 0.591 (0.57, 0.612)  & 0.049 (0.026, 0.069)   \\\\\n",
       "\t Musc/Skel      & phecode\\_718-5   & Sciatica                                                                        & 0.591 (0.568, 0.618) & 0.639 (0.616, 0.661) & 0.049 (0.029, 0.07)    \\\\\n",
       "\t GI             & phecode\\_542-3   & Hepatic failure                                                                 & 0.643 (0.611, 0.677) & 0.696 (0.66, 0.727)  & 0.049 (0.015, 0.079)   \\\\\n",
       "\t ID             & phecode\\_059     & Coronavirus                                                                     & 0.644 (0.599, 0.683) & 0.69 (0.651, 0.732)  & 0.05 (0.008, 0.086)    \\\\\n",
       "\t Neuro          & phecode\\_324-4   & Tremor                                                                          & 0.647 (0.616, 0.672) & 0.693 (0.669, 0.721) & 0.051 (0.028, 0.08)    \\\\\n",
       "\t Resp           & phecode\\_474-1   & Emphysema                                                                       & 0.695 (0.679, 0.714) & 0.748 (0.726, 0.762) & 0.051 (0.033, 0.072)   \\\\\n",
       "\t ID             & phecode\\_052-32  & Herpes zoster                                                                   & 0.554 (0.51, 0.596)  & 0.604 (0.566, 0.653) & 0.052 (0.004, 0.093)   \\\\\n",
       "\t Derm           & phecode\\_682     & Other follicular disorders                                                      & 0.456 (0.439, 0.473) & 0.507 (0.486, 0.523) & 0.052 (0.03, 0.071)    \\\\\n",
       "\t Metab          & phecode\\_248     & Disorders of plasma-protein metabolism, NEC                                     & 0.617 (0.582, 0.66)  & 0.67 (0.617, 0.716)  & 0.052 (0.012, 0.085)   \\\\\n",
       "\t Musc/Skel      & phecode\\_718-4   & Low back pain                                                                   & 0.533 (0.512, 0.548) & 0.585 (0.565, 0.597) & 0.053 (0.038, 0.071)   \\\\\n",
       "\t Eye            & phecode\\_375     & Abnormal intraocular pressure                                                   & 0.697 (0.688, 0.706) & 0.75 (0.739, 0.758)  & 0.053 (0.044, 0.063)   \\\\\n",
       "\t Mental         & phecode\\_280-1   & Alcohol use disorders                                                           & 0.622 (0.605, 0.635) & 0.675 (0.658, 0.688) & 0.053 (0.04, 0.064)    \\\\\n",
       "\t ID             & phecode\\_098     & Carrier or suspected carrier of infectious diseases                             & 0.559 (0.538, 0.583) & 0.61 (0.586, 0.637)  & 0.054 (0.029, 0.076)   \\\\\n",
       "\t Genitourinary  & phecode\\_613     & Other nonmalignant breast conditions                                            & 0.445 (0.4, 0.485)   & 0.5 (0.461, 0.532)   & 0.055 (0.014, 0.089)   \\\\\n",
       "\t Mental         & phecode\\_280     & Substance related disorders                                                     & 0.616 (0.603, 0.628) & 0.67 (0.652, 0.685)  & 0.055 (0.042, 0.068)   \\\\\n",
       "\t Derm           & phecode\\_664     & Papulosquamous disorders                                                        & 0.554 (0.514, 0.598) & 0.612 (0.553, 0.647) & 0.055 (0.011, 0.097)   \\\\\n",
       "\t Derm           & phecode\\_686-2   & Non-pressure chronic ulcer                                                      & 0.7 (0.676, 0.723)   & 0.753 (0.736, 0.777) & 0.056 (0.033, 0.076)   \\\\\n",
       "\t GI             & phecode\\_537-1   & Peritonitis                                                                     & 0.503 (0.476, 0.528) & 0.556 (0.529, 0.588) & 0.056 (0.022, 0.088)   \\\\\n",
       "\t Neoplasms      & phecode\\_138     & Benign neoplasm of the skin                                                     & 0.469 (0.452, 0.486) & 0.525 (0.51, 0.538)  & 0.057 (0.037, 0.071)   \\\\\n",
       "\t Genitourinary  & phecode\\_619-4   & Noninflammatory disorders of vagina                                             & 0.445 (0.397, 0.49)  & 0.501 (0.451, 0.54)  & 0.057 (0.01, 0.103)    \\\\\n",
       "\t Neuro          & phecode\\_337     & Polyneuropathies                                                                & 0.62 (0.602, 0.643)  & 0.679 (0.66, 0.697)  & 0.058 (0.04, 0.075)    \\\\\n",
       "\t Blood          & phecode\\_164-6   & Anemia secondary to chronic diseases and conditions                             & 0.631 (0.594, 0.675) & 0.687 (0.655, 0.724) & 0.058 (0.019, 0.09)    \\\\\n",
       "\t Mental         & phecode\\_286     & Mood {[}affective{]} disorders                                                      & 0.543 (0.532, 0.55)  & 0.6 (0.592, 0.608)   & 0.058 (0.051, 0.064)   \\\\\n",
       "\t ID             & phecode\\_056     & Human papillomavirus                                                            & 0.407 (0.368, 0.448) & 0.465 (0.418, 0.512) & 0.059 (0.025, 0.095)   \\\\\n",
       "\t Derm           & phecode\\_681     & Localized swelling, mass and lump of skin and subcutaneous tissue               & 0.503 (0.474, 0.53)  & 0.56 (0.535, 0.582)  & 0.059 (0.027, 0.086)   \\\\\n",
       "\t Genitourinary  & phecode\\_619-5   & Noninflammatory disorders of vulva and perineum                                 & 0.404 (0.36, 0.447)  & 0.458 (0.428, 0.496) & 0.059 (0.011, 0.109)   \\\\\n",
       "\t Mental         & phecode\\_286-2   & Major depressive disorder                                                       & 0.545 (0.538, 0.552) & 0.605 (0.597, 0.611) & 0.059 (0.052, 0.069)   \\\\\n",
       "\t Eye            & phecode\\_374     & Disorders of the retina                                                         & 0.678 (0.669, 0.686) & 0.737 (0.728, 0.747) & 0.06 (0.052, 0.069)    \\\\\n",
       "\t Genitourinary  & phecode\\_583-1   & End stage renal disease {[}CDK, stage 5{]}                                          & 0.7 (0.674, 0.728)   & 0.76 (0.74, 0.789)   & 0.06 (0.033, 0.081)    \\\\\n",
       "\t Neuro          & phecode\\_333     & Sleep disorders                                                                 & 0.556 (0.544, 0.567) & 0.616 (0.603, 0.63)  & 0.061 (0.047, 0.074)   \\\\\n",
       "\t Neuro          & phecode\\_336-2   & Lesion of median, ulnar, radial nerve                                           & 0.517 (0.49, 0.546)  & 0.578 (0.544, 0.604) & 0.061 (0.037, 0.088)   \\\\\n",
       "\t Eye            & phecode\\_371     & Cataract                                                                        & 0.739 (0.734, 0.744) & 0.801 (0.796, 0.804) & 0.062 (0.057, 0.065)   \\\\\n",
       "\t Neuro          & phecode\\_333-1   & Sleep apnea                                                                     & 0.561 (0.547, 0.579) & 0.624 (0.614, 0.641) & 0.063 (0.052, 0.076)   \\\\\n",
       "\t Mental         & phecode\\_280-11  & Alcohol abuse                                                                   & 0.632 (0.617, 0.654) & 0.697 (0.677, 0.715) & 0.064 (0.05, 0.083)    \\\\\n",
       "\t Eye            & phecode\\_376-2   & Vitreous opacities                                                              & 0.659 (0.629, 0.686) & 0.724 (0.708, 0.744) & 0.065 (0.036, 0.098)   \\\\\n",
       "\t Mental         & phecode\\_286-1   & Bipolar disorder                                                                & 0.504 (0.464, 0.543) & 0.568 (0.534, 0.61)  & 0.066 (0.028, 0.105)   \\\\\n",
       "\t Eye            & phecode\\_376     & Disorders of vitreous body                                                      & 0.659 (0.636, 0.683) & 0.724 (0.703, 0.745) & 0.066 (0.04, 0.091)    \\\\\n",
       "\t Eye            & phecode\\_371-3   & Nuclear cataract                                                                & 0.742 (0.737, 0.751) & 0.81 (0.804, 0.817)  & 0.067 (0.061, 0.073)   \\\\\n",
       "\t ID             & phecode\\_059-1   & COVID-19*                                                                       & 0.627 (0.583, 0.673) & 0.691 (0.659, 0.732) & 0.068 (0.017, 0.11)    \\\\\n",
       "\t Eye            & phecode\\_371-31  & Age-related nuclear cataract                                                    & 0.742 (0.735, 0.749) & 0.81 (0.805, 0.817)  & 0.068 (0.062, 0.075)   \\\\\n",
       "\t GI             & phecode\\_542-1   & Fibrosis and cirrhosis of liver                                                 & 0.638 (0.61, 0.667)  & 0.706 (0.675, 0.737) & 0.069 (0.04, 0.092)    \\\\\n",
       "\t Mental         & phecode\\_280-13  & Alcoholic liver disease                                                         & 0.68 (0.646, 0.711)  & 0.75 (0.717, 0.78)   & 0.07 (0.035, 0.102)    \\\\\n",
       "\t Eye            & phecode\\_369     & Noninflammatory disorders of the cornea                                         & 0.698 (0.676, 0.721) & 0.768 (0.751, 0.789) & 0.07 (0.054, 0.086)    \\\\\n",
       "\t Eye            & phecode\\_375-12  & Angle-Closure Glaucoma                                                          & 0.681 (0.638, 0.718) & 0.753 (0.714, 0.793) & 0.071 (0.031, 0.108)   \\\\\n",
       "\t ID             & phecode\\_052     & Herpesvirus                                                                     & 0.544 (0.511, 0.575) & 0.613 (0.583, 0.651) & 0.071 (0.033, 0.106)   \\\\\n",
       "\t Neuro          & phecode\\_355-2   & Alteration of consciousness                                                     & 0.587 (0.546, 0.625) & 0.66 (0.617, 0.697)  & 0.071 (0.023, 0.113)   \\\\\n",
       "\t Endo           & phecode\\_202     & Diabetes mellitus                                                               & 0.635 (0.627, 0.641) & 0.706 (0.7, 0.712)   & 0.072 (0.065, 0.078)   \\\\\n",
       "\t Neuro          & phecode\\_351     & Disturbances of skin sensation                                                  & 0.451 (0.432, 0.472) & 0.521 (0.5, 0.544)   & 0.072 (0.042, 0.099)   \\\\\n",
       "\t Mental         & phecode\\_281-1   & Substance abuse                                                                 & 0.62 (0.598, 0.641)  & 0.692 (0.673, 0.707) & 0.072 (0.055, 0.087)   \\\\\n",
       "\t Endo           & phecode\\_202-2   & Type 2 diabetes                                                                 & 0.636 (0.631, 0.643) & 0.71 (0.705, 0.715)  & 0.073 (0.068, 0.079)   \\\\\n",
       "\t Cardio         & phecode\\_418     & Abnormal results of cardiovascular function studies                             & 0.541 (0.506, 0.569) & 0.612 (0.58, 0.641)  & 0.074 (0.046, 0.109)   \\\\\n",
       "\t GI             & phecode\\_540-1   & Chronic hepatitis                                                               & 0.531 (0.499, 0.573) & 0.615 (0.579, 0.658) & 0.084 (0.047, 0.122)   \\\\\n",
       "\t Endo           & phecode\\_211     & Disorders of adrenal glands                                                     & 0.527 (0.491, 0.56)  & 0.611 (0.576, 0.661) & 0.085 (0.046, 0.138)   \\\\\n",
       "\t GI             & phecode\\_542     & Chronic liver disease and sequelae                                              & 0.565 (0.551, 0.58)  & 0.652 (0.642, 0.668) & 0.089 (0.068, 0.106)   \\\\\n",
       "\t Eye            & phecode\\_388     & Blindness and low vision                                                        & 0.617 (0.589, 0.652) & 0.709 (0.676, 0.751) & 0.092 (0.05, 0.128)    \\\\\n",
       "\t Metab          & phecode\\_236-1   & Obesity                                                                         & 0.523 (0.515, 0.529) & 0.615 (0.608, 0.622) & 0.093 (0.084, 0.103)   \\\\\n",
       "\t Metab          & phecode\\_236     & Overweight and obesity                                                          & 0.523 (0.516, 0.529) & 0.618 (0.611, 0.624) & 0.095 (0.086, 0.102)   \\\\\n",
       "\t Eye            & phecode\\_387     & Disorders of refraction and accommodation                                       & 0.677 (0.666, 0.69)  & 0.776 (0.765, 0.786) & 0.097 (0.084, 0.109)   \\\\\n",
       "\t Eye            & phecode\\_366     & Noninflammatory disorders of conjunctiva                                        & 0.549 (0.513, 0.589) & 0.649 (0.607, 0.705) & 0.098 (0.057, 0.136)   \\\\\n",
       "\t Eye            & phecode\\_360-2   & Chalazion                                                                       & 0.318 (0.287, 0.347) & 0.417 (0.382, 0.459) & 0.099 (0.074, 0.127)   \\\\\n",
       "\t Mental         & phecode\\_280-12  & Alcohol dependence                                                              & 0.607 (0.584, 0.633) & 0.709 (0.684, 0.729) & 0.101 (0.071, 0.127)   \\\\\n",
       "\t Eye            & phecode\\_375-11  & Open angle glaucoma                                                             & 0.711 (0.687, 0.732) & 0.814 (0.795, 0.833) & 0.103 (0.085, 0.121)   \\\\\n",
       "\t GI             & phecode\\_542-2   & Fatty liver disease (FLD)                                                       & 0.525 (0.506, 0.549) & 0.63 (0.611, 0.648)  & 0.105 (0.077, 0.13)    \\\\\n",
       "\t Mental         & phecode\\_287     & Psychotic disorder                                                              & 0.491 (0.446, 0.539) & 0.602 (0.559, 0.638) & 0.106 (0.059, 0.141)   \\\\\n",
       "\t Derm           & phecode\\_688     & Granulomatous disorder of the skin                                              & 0.431 (0.404, 0.464) & 0.54 (0.505, 0.566)  & 0.107 (0.067, 0.138)   \\\\\n",
       "\t GI             & phecode\\_501     & Dental caries                                                                   & 0.427 (0.41, 0.447)  & 0.536 (0.518, 0.552) & 0.108 (0.091, 0.128)   \\\\\n",
       "\t Derm           & phecode\\_688-1   & Sarcoidosis                                                                     & 0.447 (0.402, 0.474) & 0.563 (0.521, 0.613) & 0.119 (0.072, 0.169)   \\\\\n",
       "\t Mental         & phecode\\_281     & Substance abuse, dependence, and withdrawl                                      & 0.539 (0.531, 0.547) & 0.665 (0.657, 0.672) & 0.126 (0.116, 0.135)   \\\\\n",
       "\t Eye            & phecode\\_386-1   & Amblyopia                                                                       & 0.646 (0.618, 0.684) & 0.77 (0.731, 0.798)  & 0.126 (0.089, 0.155)   \\\\\n",
       "\t Endo           & phecode\\_205     & Hypoglycemia                                                                    & 0.669 (0.646, 0.696) & 0.797 (0.771, 0.815) & 0.128 (0.101, 0.155)   \\\\\n",
       "\t Mental         & phecode\\_282-1   & Current tobacco use and nicotine dependence                                     & 0.53 (0.521, 0.539)  & 0.66 (0.652, 0.667)  & 0.129 (0.119, 0.141)   \\\\\n",
       "\t Eye            & phecode\\_374-1   & Retinal detachments and breaks                                                  & 0.598 (0.574, 0.623) & 0.727 (0.708, 0.75)  & 0.129 (0.1, 0.154)     \\\\\n",
       "\t Mental         & phecode\\_282     & Nicotine dependence (current and history of)                                    & 0.53 (0.519, 0.537)  & 0.66 (0.653, 0.665)  & 0.129 (0.122, 0.14)    \\\\\n",
       "\t Mental         & phecode\\_283-4   & Patient's noncompliance with medical treatment and regimen                      & 0.53 (0.498, 0.569)  & 0.666 (0.635, 0.694) & 0.133 (0.097, 0.172)   \\\\\n",
       "\t Mental         & phecode\\_281-2   & Substance dependence                                                            & 0.528 (0.518, 0.535) & 0.666 (0.661, 0.673) & 0.138 (0.132, 0.146)   \\\\\n",
       "\t Endo           & phecode\\_202-1   & Type 1 diabetes                                                                 & 0.583 (0.563, 0.618) & 0.728 (0.709, 0.752) & 0.145 (0.12, 0.171)    \\\\\n",
       "\t Eye            & phecode\\_374-4   & Retinal disorders in diseases classified elsewhere                              & 0.685 (0.655, 0.704) & 0.836 (0.822, 0.853) & 0.153 (0.135, 0.179)   \\\\\n",
       "\t Musc/Skel      & phecode\\_716-2   & Degenerative disc disease                                                       & 0.325 (0.288, 0.373) & 0.488 (0.443, 0.535) & 0.156 (0.117, 0.201)   \\\\\n",
       "\t Neuro          & phecode\\_337-8   & Polyneuropathy in diseases classified elsewhere                                 & 0.629 (0.594, 0.67)  & 0.805 (0.779, 0.829) & 0.175 (0.139, 0.204)   \\\\\n",
       "\t Eye            & phecode\\_387-2   & Myopia                                                                          & 0.609 (0.59, 0.633)  & 0.869 (0.858, 0.884) & 0.259 (0.239, 0.281)   \\\\\n",
       "\t Blood          & phecode\\_165     & Hemoglobinopathies                                                              & 0.602 (0.551, 0.656) & 0.868 (0.84, 0.905)  & 0.265 (0.21, 0.324)    \\\\\n",
       "\\end{tabular}\n"
      ],
      "text/markdown": [
       "\n",
       "A data.table: 752 × 6\n",
       "\n",
       "| phecode_category &lt;chr&gt; | endpoint &lt;chr&gt; | phecode_string &lt;chr&gt; | Age+Sex &lt;chr&gt; | Age+Sex+Retina &lt;chr&gt; | delta &lt;chr&gt; |\n",
       "|---|---|---|---|---|---|\n",
       "| Blood          | phecode_168-1   | Hypo-coagulability                                                              | 0.655 (0.613, 0.691) | 0.486 (0.438, 0.547) | -0.166 (-0.212, -0.104) |\n",
       "| GI             | phecode_552-1   | Cholangitis                                                                     | 0.599 (0.575, 0.642) | 0.566 (0.539, 0.612) | -0.035 (-0.049, -0.013) |\n",
       "| Blood          | phecode_180     | Other disorders involving the immune mechanism                                  | 0.635 (0.612, 0.676) | 0.602 (0.574, 0.647) | -0.032 (-0.057, -0.008) |\n",
       "| Musc/Skel      | phecode_721-6   | Baker's cyst [popliteal cyst]                                                   | 0.627 (0.59, 0.665)  | 0.596 (0.561, 0.632) | -0.031 (-0.058, -0.012) |\n",
       "| GI             | phecode_520-15  | Incisional hernia                                                               | 0.585 (0.543, 0.618) | 0.552 (0.521, 0.583) | -0.031 (-0.067, 0.005)  |\n",
       "| Musc/Skel      | phecode_702     | Infective and reactive arthropathies                                            | 0.574 (0.542, 0.6)   | 0.544 (0.509, 0.573) | -0.03 (-0.054, 0.001)   |\n",
       "| Cardio         | phecode_430-1   | Nontraumatic subarachnoid hemorrhage                                            | 0.643 (0.596, 0.675) | 0.61 (0.569, 0.651)  | -0.03 (-0.055, 0)       |\n",
       "| Neuro          | phecode_329-1   | Memory loss                                                                     | 0.615 (0.583, 0.657) | 0.588 (0.544, 0.629) | -0.027 (-0.055, -0.005) |\n",
       "| GI             | phecode_532-4   | Volvulus                                                                        | 0.596 (0.554, 0.63)  | 0.573 (0.527, 0.6)   | -0.027 (-0.042, -0.005) |\n",
       "| Hearing        | phecode_397-1   | Tinnitus                                                                        | 0.591 (0.557, 0.624) | 0.564 (0.536, 0.595) | -0.026 (-0.055, 0)      |\n",
       "| Neuro          | phecode_324-3   | Dystonia                                                                        | 0.589 (0.557, 0.623) | 0.567 (0.521, 0.602) | -0.026 (-0.054, 0)      |\n",
       "| Genitourinary  | phecode_601-12  | Chronic prostatitis                                                             | 0.624 (0.584, 0.653) | 0.597 (0.558, 0.627) | -0.025 (-0.041, -0.006) |\n",
       "| Cardio         | phecode_423     | Abnormal cardiac sounds                                                         | 0.648 (0.621, 0.668) | 0.624 (0.596, 0.649) | -0.024 (-0.039, -0.009) |\n",
       "| Hearing        | phecode_397     | Other hearing abnormality                                                       | 0.579 (0.551, 0.618) | 0.558 (0.527, 0.593) | -0.024 (-0.046, 0.002)  |\n",
       "| Musc/Skel      | phecode_704     | Systemic vasculitis                                                             | 0.695 (0.658, 0.727) | 0.672 (0.636, 0.702) | -0.024 (-0.035, -0.008) |\n",
       "| GI             | phecode_506     | Diseases of salivary glands                                                     | 0.572 (0.533, 0.616) | 0.549 (0.498, 0.593) | -0.024 (-0.05, 0.014)   |\n",
       "| Endo           | phecode_200-22  | Uninodular goiter [single thyroid nodule]                                       | 0.642 (0.597, 0.674) | 0.619 (0.583, 0.653) | -0.023 (-0.047, 0.002)  |\n",
       "| Genitourinary  | phecode_625     | Pain and other symptoms associated with female genital organs                   | 0.647 (0.605, 0.677) | 0.623 (0.582, 0.66)  | -0.023 (-0.038, -0.007) |\n",
       "| GI             | phecode_504-32  | Chronic periodontitis                                                           | 0.554 (0.515, 0.604) | 0.534 (0.487, 0.569) | -0.023 (-0.057, 0.013)  |\n",
       "| Cardio         | phecode_423-1   | Cardiac murmurs                                                                 | 0.644 (0.621, 0.671) | 0.623 (0.594, 0.647) | -0.023 (-0.043, -0.007) |\n",
       "| Eye            | phecode_360     | Inflammation of eyelids                                                         | 0.492 (0.465, 0.519) | 0.471 (0.441, 0.493) | -0.022 (-0.04, 0.001)   |\n",
       "| GI             | phecode_530-3   | Rectal prolapse                                                                 | 0.694 (0.656, 0.727) | 0.669 (0.634, 0.705) | -0.022 (-0.041, -0.005) |\n",
       "| Resp           | phecode_494     | Voice disturbance                                                               | 0.621 (0.574, 0.659) | 0.601 (0.572, 0.638) | -0.021 (-0.047, 0.008)  |\n",
       "| GI             | phecode_522-7   | Ulceration of the lower GI tract                                                | 0.536 (0.513, 0.568) | 0.517 (0.485, 0.551) | -0.021 (-0.053, 0.007)  |\n",
       "| Neoplasms      | phecode_123     | Multiple myeloma and malignant plasma cell neoplasms                            | 0.69 (0.648, 0.721)  | 0.668 (0.624, 0.703) | -0.021 (-0.046, 0.002)  |\n",
       "| Blood          | phecode_180-3   | Paraproteinemias                                                                | 0.675 (0.637, 0.71)  | 0.655 (0.615, 0.692) | -0.02 (-0.043, 0.006)   |\n",
       "| Musc/Skel      | phecode_710-3   | Acquired deformities of the knee                                                | 0.599 (0.577, 0.63)  | 0.579 (0.548, 0.607) | -0.02 (-0.036, -0.006)  |\n",
       "| Neoplasms      | phecode_122-22  | Diffuse large B-cell lymphoma*                                                  | 0.656 (0.621, 0.698) | 0.636 (0.601, 0.667) | -0.02 (-0.041, 0.003)   |\n",
       "| Genitourinary  | phecode_610     | Benign mammary dysplasias                                                       | 0.416 (0.381, 0.461) | 0.401 (0.357, 0.438) | -0.02 (-0.038, 0.01)    |\n",
       "| Neoplasms      | phecode_139-61  | Hemangioma                                                                      | 0.55 (0.512, 0.578)  | 0.525 (0.488, 0.566) | -0.02 (-0.043, 0)       |\n",
       "| Eye            | phecode_363-7   | Stenosis and insufficiency of lacrimal passages                                 | 0.643 (0.608, 0.681) | 0.625 (0.582, 0.664) | -0.019 (-0.034, -0.007) |\n",
       "| Neoplasms      | phecode_139-6   | Hemangioma and lymphangioma                                                     | 0.55 (0.512, 0.581)  | 0.529 (0.496, 0.566) | -0.019 (-0.041, 0.008)  |\n",
       "| Neoplasms      | phecode_124     | Myeloproliferative disorder                                                     | 0.677 (0.646, 0.71)  | 0.656 (0.625, 0.687) | -0.018 (-0.037, -0.006) |\n",
       "| Cardio         | phecode_438-12  | Thoracic aneurysm                                                               | 0.659 (0.625, 0.688) | 0.643 (0.605, 0.676) | -0.018 (-0.052, 0.02)   |\n",
       "| Blood          | phecode_180-31  | Monoclonal gammopathy                                                           | 0.685 (0.641, 0.726) | 0.667 (0.628, 0.708) | -0.018 (-0.044, 0.014)  |\n",
       "| Neoplasms      | phecode_109-3   | Malignant neoplasm of brain                                                     | 0.604 (0.567, 0.636) | 0.581 (0.544, 0.616) | -0.018 (-0.051, 0.008)  |\n",
       "| Neoplasms      | phecode_123-1   | Multiple myeloma                                                                | 0.675 (0.633, 0.713) | 0.657 (0.61, 0.698)  | -0.017 (-0.041, 0.012)  |\n",
       "| Cardio         | phecode_413-22  | Aortic insufficiency                                                            | 0.69 (0.67, 0.712)   | 0.673 (0.654, 0.698) | -0.017 (-0.027, -0.003) |\n",
       "| Neuro          | phecode_328-7   | Vascular dementia                                                               | 0.805 (0.778, 0.828) | 0.788 (0.76, 0.816)  | -0.017 (-0.037, 0.002)  |\n",
       "| Genitourinary  | phecode_603     | Disorders and symptoms of testis                                                | 0.538 (0.51, 0.564)  | 0.521 (0.491, 0.547) | -0.017 (-0.039, 0.006)  |\n",
       "| Neuro          | phecode_349     | Disorder of nervous system                                                      | 0.577 (0.547, 0.623) | 0.568 (0.51, 0.611)  | -0.016 (-0.06, 0.019)   |\n",
       "| GI             | phecode_530-1   | Anal fissure                                                                    | 0.544 (0.509, 0.581) | 0.529 (0.493, 0.566) | -0.016 (-0.031, 0.002)  |\n",
       "| Neoplasms      | phecode_121-2   | Chronic leukemia                                                                | 0.724 (0.696, 0.751) | 0.709 (0.672, 0.738) | -0.016 (-0.031, -0.002) |\n",
       "| Neoplasms      | phecode_109     | Malignant neoplasm of the eye, brain and other parts of central nervous system  | 0.572 (0.54, 0.608)  | 0.556 (0.524, 0.588) | -0.016 (-0.038, 0.01)   |\n",
       "| Endo           | phecode_200-23  | Multinodular goiter                                                             | 0.689 (0.648, 0.719) | 0.673 (0.632, 0.71)  | -0.016 (-0.035, 0.003)  |\n",
       "| Derm           | phecode_679-4   | Pruritus                                                                        | 0.574 (0.53, 0.621)  | 0.563 (0.505, 0.602) | -0.016 (-0.05, 0.02)    |\n",
       "| GI             | phecode_529-2   | Abdominal distension and flatulence                                             | 0.529 (0.504, 0.553) | 0.514 (0.487, 0.537) | -0.015 (-0.033, 0.001)  |\n",
       "| Neoplasms      | phecode_148-2   | Benign neoplasm of meninges (Meningioma)                                        | 0.663 (0.629, 0.709) | 0.648 (0.612, 0.69)  | -0.015 (-0.038, 0.004)  |\n",
       "| Neoplasms      | phecode_121     | Leukemia                                                                        | 0.693 (0.665, 0.72)  | 0.68 (0.649, 0.701)  | -0.015 (-0.026, -0.003) |\n",
       "| Genitourinary  | phecode_601     | Inflammatory diseases of prostate                                               | 0.652 (0.627, 0.672) | 0.637 (0.609, 0.658) | -0.015 (-0.022, -0.006) |\n",
       "| Neoplasms      | phecode_106-2   | Malignant neoplasm of the uterus                                                | 0.581 (0.556, 0.613) | 0.567 (0.538, 0.6)   | -0.014 (-0.03, -0.001)  |\n",
       "| Resp           | phecode_466     | Tonsillitis and adenoiditis                                                     | 0.573 (0.533, 0.611) | 0.556 (0.519, 0.59)  | -0.014 (-0.033, 0.004)  |\n",
       "| Genitourinary  | phecode_601-1   | Prostatitis                                                                     | 0.65 (0.625, 0.671)  | 0.636 (0.61, 0.658)  | -0.014 (-0.021, -0.003) |\n",
       "| Genitourinary  | phecode_608     | Other disorders of male genital organs                                          | 0.526 (0.5, 0.554)   | 0.512 (0.486, 0.544) | -0.014 (-0.039, 0.01)   |\n",
       "| Stat           | phecode_990     | Family history of digestive disorders                                           | 0.582 (0.546, 0.612) | 0.568 (0.538, 0.601) | -0.014 (-0.039, 0.011)  |\n",
       "| Neoplasms      | phecode_106-21  | Malignant neoplasm of endometrium                                               | 0.587 (0.558, 0.611) | 0.574 (0.546, 0.594) | -0.013 (-0.027, 0.002)  |\n",
       "| Musc/Skel      | phecode_710     | Acquired deformities of limbs                                                   | 0.616 (0.596, 0.643) | 0.605 (0.581, 0.626) | -0.013 (-0.025, 0.001)  |\n",
       "| Genitourinary  | phecode_603-1   | Hydrocele                                                                       | 0.557 (0.527, 0.593) | 0.545 (0.513, 0.581) | -0.013 (-0.041, 0.019)  |\n",
       "| Neuro          | phecode_356-2   | Aphasia and dysphasia                                                           | 0.675 (0.638, 0.709) | 0.664 (0.621, 0.702) | -0.013 (-0.034, 0.019)  |\n",
       "| Neoplasms      | phecode_139-54  | Testicular limpoma                                                              | 0.567 (0.529, 0.611) | 0.554 (0.518, 0.599) | -0.012 (-0.017, -0.006) |\n",
       "| GI             | phecode_532-1   | Intestinal fistula                                                              | 0.596 (0.562, 0.623) | 0.582 (0.543, 0.612) | -0.012 (-0.037, 0.009)  |\n",
       "| Hearing        | phecode_390     | Disorders of external ear                                                       | 0.593 (0.554, 0.632) | 0.58 (0.546, 0.621)  | -0.012 (-0.028, 0.005)  |\n",
       "| Neoplasms      | phecode_120-1   | Myeloid                                                                         | 0.693 (0.673, 0.715) | 0.682 (0.66, 0.706)  | -0.012 (-0.021, -0.002) |\n",
       "| Hearing        | phecode_394-21  | Paroxysmal vertigo                                                              | 0.665 (0.625, 0.704) | 0.653 (0.617, 0.689) | -0.012 (-0.032, 0.01)   |\n",
       "| Neuro          | phecode_346     | Brain damage and brain death                                                    | 0.596 (0.551, 0.637) | 0.587 (0.536, 0.619) | -0.012 (-0.048, 0.024)  |\n",
       "| Genitourinary  | phecode_628     | Ovarian cyst                                                                    | 0.586 (0.56, 0.618)  | 0.575 (0.551, 0.606) | -0.011 (-0.021, 0.001)  |\n",
       "| ID             | phecode_009     | Pseudomonas                                                                     | 0.652 (0.625, 0.678) | 0.639 (0.614, 0.666) | -0.011 (-0.035, 0.007)  |\n",
       "| Blood          | phecode_172     | Other disorders of white blood cells                                            | 0.598 (0.55, 0.672)  | 0.591 (0.536, 0.649) | -0.011 (-0.044, 0.019)  |\n",
       "| Neoplasms      | phecode_135     | Benign neoplasm of the head and neck                                            | 0.593 (0.577, 0.615) | 0.582 (0.565, 0.606) | -0.011 (-0.019, -0.001) |\n",
       "| Neoplasms      | phecode_144-1   | Benign neoplasms of external female genital organs and cervix                   | 0.554 (0.515, 0.588) | 0.546 (0.511, 0.57)  | -0.011 (-0.032, 0.018)  |\n",
       "| Mental         | phecode_288-4   | Phobic disorders                                                                | 0.651 (0.621, 0.677) | 0.639 (0.611, 0.667) | -0.011 (-0.024, 0.006)  |\n",
       "| Neoplasms      | phecode_121-21  | Chronic lymphoid leukemia                                                       | 0.725 (0.695, 0.751) | 0.717 (0.68, 0.745)  | -0.01 (-0.027, 0.004)   |\n",
       "| GI             | phecode_500     | Disorders of tooth develoment                                                   | 0.59 (0.553, 0.628)  | 0.583 (0.551, 0.61)  | -0.01 (-0.026, 0.005)   |\n",
       "| ID             | phecode_011     | Klebsiella                                                                      | 0.669 (0.636, 0.7)   | 0.66 (0.628, 0.69)   | -0.01 (-0.041, 0.021)   |\n",
       "| GI             | phecode_503-5   | Periapical abscess                                                              | 0.454 (0.411, 0.487) | 0.445 (0.402, 0.49)  | -0.01 (-0.043, 0.033)   |\n",
       "| Musc/Skel      | phecode_712     | Other specific joint derangements                                               | 0.547 (0.523, 0.565) | 0.537 (0.518, 0.556) | -0.01 (-0.02, 0.004)    |\n",
       "| Musc/Skel      | phecode_719     | Disorders of muscle                                                             | 0.57 (0.539, 0.596)  | 0.56 (0.532, 0.581)  | -0.01 (-0.025, 0.009)   |\n",
       "| GI             | phecode_500-4   | Disturbances in tooth eruption                                                  | 0.588 (0.552, 0.631) | 0.577 (0.537, 0.621) | -0.01 (-0.027, 0.007)   |\n",
       "| Musc/Skel      | phecode_721-2   | Ganglion cyst                                                                   | 0.543 (0.515, 0.57)  | 0.533 (0.508, 0.558) | -0.01 (-0.028, 0.011)   |\n",
       "| Signs/Symptoms | phecode_841-13  | Allergy to sulfonamides                                                         | 0.687 (0.666, 0.716) | 0.678 (0.652, 0.703) | -0.01 (-0.02, 0.002)    |\n",
       "| Mental         | phecode_308-7   | Restlessness and agitation*                                                     | 0.654 (0.603, 0.696) | 0.641 (0.595, 0.683) | -0.009 (-0.038, 0.011)  |\n",
       "| Genitourinary  | phecode_602     | Other disorders of prostate                                                     | 0.656 (0.637, 0.682) | 0.647 (0.626, 0.673) | -0.009 (-0.024, 0.008)  |\n",
       "| Cardio         | phecode_416-5   | Premature depolarization [Premature beats]                                      | 0.667 (0.639, 0.691) | 0.659 (0.629, 0.679) | -0.009 (-0.018, 0)      |\n",
       "| GI             | phecode_556-3   | Abdominal or pelvic swelling, mass, or lump                                     | 0.601 (0.568, 0.636) | 0.593 (0.551, 0.628) | -0.009 (-0.035, 0.017)  |\n",
       "| Cardio         | phecode_416-52  | Ventricular premature depolarization*                                           | 0.654 (0.62, 0.681)  | 0.645 (0.613, 0.67)  | -0.009 (-0.019, 0.002)  |\n",
       "| Neoplasms      | phecode_149     | Benign neoplasm of the endocrine glands                                         | 0.593 (0.569, 0.616) | 0.583 (0.554, 0.607) | -0.009 (-0.03, 0.011)   |\n",
       "| Genitourinary  | phecode_614-1   | Pelvic peritoneal adhesions, female (postoperative) (postinfection)             | 0.545 (0.507, 0.587) | 0.536 (0.506, 0.569) | -0.009 (-0.031, 0.016)  |\n",
       "| Genitourinary  | phecode_596-3   | Diverticulum of bladder                                                         | 0.72 (0.691, 0.756)  | 0.714 (0.677, 0.745) | -0.009 (-0.015, -0.003) |\n",
       "| GI             | phecode_500-41  | Impacted teeth*                                                                 | 0.576 (0.548, 0.611) | 0.566 (0.531, 0.606) | -0.009 (-0.025, 0.011)  |\n",
       "| Endo           | phecode_208-21  | Primary hyperparathyroidism                                                     | 0.634 (0.608, 0.666) | 0.627 (0.597, 0.656) | -0.008 (-0.032, 0.016)  |\n",
       "| Eye            | phecode_381     | Strabismus                                                                      | 0.596 (0.57, 0.634)  | 0.586 (0.555, 0.618) | -0.008 (-0.037, 0.014)  |\n",
       "| GI             | phecode_520-14  | Ventral hernia                                                                  | 0.57 (0.547, 0.587)  | 0.561 (0.539, 0.581) | -0.008 (-0.025, 0.01)   |\n",
       "| Neoplasms      | phecode_144-3   | Benign neoplasms of the ovary                                                   | 0.49 (0.449, 0.529)  | 0.479 (0.449, 0.524) | -0.008 (-0.048, 0.03)   |\n",
       "| Genitourinary  | phecode_592-12  | Chronic cystitis                                                                | 0.55 (0.507, 0.589)  | 0.542 (0.509, 0.577) | -0.008 (-0.038, 0.02)   |\n",
       "| Genitourinary  | phecode_622-2   | Mucous polyp of cervix                                                          | 0.553 (0.521, 0.587) | 0.543 (0.516, 0.574) | -0.008 (-0.041, 0.021)  |\n",
       "| Genitourinary  | phecode_624     | Symptoms involving female genital tract                                         | 0.56 (0.534, 0.581)  | 0.551 (0.522, 0.578) | -0.008 (-0.026, 0.015)  |\n",
       "| Resp           | phecode_488-8   | Mouth breathing*                                                                | 0.57 (0.536, 0.611)  | 0.558 (0.523, 0.596) | -0.008 (-0.035, 0.021)  |\n",
       "| Cardio         | phecode_410     | Inflammation of the heart [Carditis]                                            | 0.656 (0.622, 0.685) | 0.647 (0.62, 0.678)  | -0.008 (-0.032, 0.017)  |\n",
       "| Musc/Skel      | phecode_708-12  | Primary osteoarthritis of knee, lower leg                                       | 0.633 (0.617, 0.649) | 0.626 (0.606, 0.642) | -0.007 (-0.014, 0.001)  |\n",
       "| GI             | phecode_514-3   | Ileus                                                                           | 0.694 (0.664, 0.731) | 0.682 (0.648, 0.723) | -0.007 (-0.03, 0.008)   |\n",
       "| Cardio         | phecode_416-12  | Ventricular tachycardia                                                         | 0.723 (0.689, 0.749) | 0.715 (0.688, 0.746) | -0.007 (-0.02, 0.007)   |\n",
       "| Neoplasms      | phecode_148     | Benign neoplasm of the eye, brain and other parts of central nervous system     | 0.634 (0.6, 0.661)   | 0.626 (0.598, 0.654) | -0.007 (-0.024, 0.014)  |\n",
       "| Cardio         | phecode_431-2   | Transient cerebral ischemic attacks                                             | 0.71 (0.693, 0.737)  | 0.703 (0.688, 0.728) | -0.007 (-0.017, 0.003)  |\n",
       "| Derm           | phecode_685-82  | Generalized hyperhidrosis                                                       | 0.527 (0.485, 0.574) | 0.52 (0.462, 0.565)  | -0.007 (-0.056, 0.029)  |\n",
       "| Genitourinary  | phecode_628-2   | Corpus luteum cyst or hematoma                                                  | 0.563 (0.536, 0.585) | 0.554 (0.525, 0.582) | -0.007 (-0.023, 0.007)  |\n",
       "| Genitourinary  | phecode_599     | Other symptoms/disorders or the urinary system                                  | 0.652 (0.636, 0.669) | 0.645 (0.63, 0.66)   | -0.007 (-0.013, -0.002) |\n",
       "| Cardio         | phecode_417-1   | Palpitations                                                                    | 0.583 (0.569, 0.599) | 0.575 (0.562, 0.591) | -0.007 (-0.014, -0.002) |\n",
       "| Cardio         | phecode_433-2   | Occlusion and stenosis of precerebral arteries                                  | 0.769 (0.748, 0.793) | 0.763 (0.741, 0.784) | -0.007 (-0.02, 0.01)    |\n",
       "| Endo           | phecode_209     | Disorders of the pituitary gland and its hypothalamic control                   | 0.613 (0.571, 0.646) | 0.604 (0.569, 0.644) | -0.007 (-0.036, 0.019)  |\n",
       "| Neoplasms      | phecode_120-21  | Mature B-cell                                                                   | 0.686 (0.666, 0.705) | 0.679 (0.663, 0.7)   | -0.007 (-0.017, 0.004)  |\n",
       "| Neoplasms      | phecode_122-2   | Non-Hodgkin lymphoma                                                            | 0.665 (0.64, 0.685)  | 0.659 (0.636, 0.678) | -0.006 (-0.017, 0.007)  |\n",
       "| Neoplasms      | phecode_120     | Hemo onc - by cell of origin                                                    | 0.668 (0.654, 0.683) | 0.662 (0.648, 0.679) | -0.006 (-0.012, -0.001) |\n",
       "| Neoplasms      | phecode_120-2   | Lymphoid                                                                        | 0.674 (0.66, 0.692)  | 0.669 (0.65, 0.685)  | -0.006 (-0.016, 0.003)  |\n",
       "| Endo           | phecode_200-3   | Thyrotoxicosis [hyperthyroidism]                                                | 0.63 (0.607, 0.653)  | 0.623 (0.599, 0.653) | -0.006 (-0.02, 0.006)   |\n",
       "| Cardio         | phecode_416-11  | Supraventricular tachycardia                                                    | 0.624 (0.602, 0.646) | 0.618 (0.595, 0.642) | -0.006 (-0.02, 0.006)   |\n",
       "| Neoplasms      | phecode_101-8   | Malignant neoplasm of the pancreas                                              | 0.678 (0.645, 0.703) | 0.673 (0.635, 0.697) | -0.006 (-0.028, 0.009)  |\n",
       "| Neoplasms      | phecode_144-13  | Benign neoplasms of the cervix                                                  | 0.565 (0.533, 0.602) | 0.557 (0.524, 0.595) | -0.005 (-0.028, 0.016)  |\n",
       "| Musc/Skel      | phecode_708-11  | Primary osteoarthritis of hip, pelvic region and thigh                          | 0.61 (0.59, 0.626)   | 0.603 (0.587, 0.622) | -0.005 (-0.014, 0.002)  |\n",
       "| Neuro          | phecode_324-1   | Parkinsonism                                                                    | 0.732 (0.709, 0.748) | 0.726 (0.705, 0.743) | -0.005 (-0.012, 0.003)  |\n",
       "| Hearing        | phecode_396-2   | Sensorineural hearing loss                                                      | 0.636 (0.613, 0.667) | 0.629 (0.608, 0.662) | -0.005 (-0.019, 0.009)  |\n",
       "| Neuro          | phecode_324-11  | Parkinson's disease (Primary)                                                   | 0.735 (0.721, 0.753) | 0.731 (0.714, 0.746) | -0.005 (-0.011, 0.001)  |\n",
       "| Musc/Skel      | phecode_714     | Deforming dorsopathies                                                          | 0.696 (0.671, 0.715) | 0.689 (0.67, 0.714)  | -0.005 (-0.015, 0.005)  |\n",
       "| Cardio         | phecode_433-21  | Carotid artery stenosis                                                         | 0.767 (0.749, 0.794) | 0.761 (0.742, 0.792) | -0.005 (-0.022, 0.008)  |\n",
       "| Genitourinary  | phecode_622-1   | Polyp of corpus uteri                                                           | 0.523 (0.508, 0.537) | 0.52 (0.501, 0.533)  | -0.005 (-0.016, 0.006)  |\n",
       "| Genitourinary  | phecode_618-11  | Cystocele                                                                       | 0.585 (0.565, 0.602) | 0.579 (0.562, 0.596) | -0.005 (-0.011, 0.003)  |\n",
       "| ID             | phecode_095     | Sequela of infection                                                            | 0.536 (0.502, 0.574) | 0.529 (0.499, 0.566) | -0.005 (-0.026, 0.021)  |\n",
       "| Genitourinary  | phecode_622     | Polyp of female genital organs                                                  | 0.534 (0.517, 0.553) | 0.53 (0.515, 0.547)  | -0.005 (-0.017, 0.009)  |\n",
       "| Resp           | phecode_471-2   | Deviated nasal septum                                                           | 0.617 (0.591, 0.649) | 0.613 (0.584, 0.646) | -0.005 (-0.01, 0.002)   |\n",
       "| Resp           | phecode_460-1   | Acute upper respiratory infection                                               | 0.523 (0.5, 0.544)   | 0.518 (0.494, 0.535) | -0.004 (-0.025, 0.012)  |\n",
       "| Blood          | phecode_170-1   | Neutropenia                                                                     | 0.623 (0.605, 0.638) | 0.619 (0.599, 0.633) | -0.004 (-0.015, 0.007)  |\n",
       "| Resp           | phecode_473     | Other diseases of upper respiratory tract                                       | 0.531 (0.499, 0.578) | 0.529 (0.484, 0.573) | -0.004 (-0.037, 0.02)   |\n",
       "| Derm           | phecode_685-8   | Hyperhidrosis                                                                   | 0.524 (0.487, 0.572) | 0.524 (0.46, 0.573)  | -0.004 (-0.044, 0.032)  |\n",
       "| Neoplasms      | phecode_106     | Gynecological malignant neoplasms                                               | 0.58 (0.564, 0.602)  | 0.574 (0.56, 0.601)  | -0.004 (-0.014, 0.004)  |\n",
       "| Genitourinary  | phecode_594-4   | Frequency of urination and polyuria                                             | 0.631 (0.611, 0.655) | 0.626 (0.605, 0.652) | -0.004 (-0.009, 0.002)  |\n",
       "| Neuro          | phecode_328-1   | Alzheimer's disease                                                             | 0.812 (0.793, 0.829) | 0.808 (0.788, 0.826) | -0.004 (-0.009, 0)      |\n",
       "| GI             | phecode_503     | Diseases of pulp and periapical tissues                                         | 0.435 (0.404, 0.465) | 0.432 (0.402, 0.47)  | -0.004 (-0.036, 0.029)  |\n",
       "| Derm           | phecode_676-2   | Scar conditions and fibrosis of skin                                            | 0.533 (0.503, 0.556) | 0.526 (0.497, 0.552) | -0.004 (-0.026, 0.023)  |\n",
       "| Cardio         | phecode_416-7   | Sinoatrial node dysfunction                                                     | 0.736 (0.704, 0.771) | 0.73 (0.703, 0.765)  | -0.004 (-0.016, 0.007)  |\n",
       "| Blood          | phecode_170     | Decreased white blood cell count                                                | 0.624 (0.606, 0.641) | 0.62 (0.597, 0.636)  | -0.004 (-0.018, 0.006)  |\n",
       "| Blood          | phecode_162     | Aplastic anemia                                                                 | 0.664 (0.634, 0.7)   | 0.66 (0.629, 0.699)  | -0.004 (-0.033, 0.024)  |\n",
       "| Cardio         | phecode_416-43  | Right bundle branch block                                                       | 0.706 (0.694, 0.724) | 0.702 (0.687, 0.721) | -0.004 (-0.009, 0.001)  |\n",
       "| Signs/Symptoms | phecode_814     | Jaundice (not of newborn)                                                       | 0.599 (0.562, 0.627) | 0.595 (0.554, 0.623) | -0.004 (-0.03, 0.028)   |\n",
       "| GI             | phecode_510-8   | Barrett's esophagus                                                             | 0.657 (0.643, 0.666) | 0.653 (0.64, 0.662)  | -0.004 (-0.008, 0)      |\n",
       "| Neoplasms      | phecode_108-5   | Malignant neoplasm of the bladder                                               | 0.743 (0.721, 0.764) | 0.739 (0.718, 0.764) | -0.004 (-0.009, 0.004)  |\n",
       "| Cardio         | phecode_416-71  | Sick sinus syndrome*                                                            | 0.73 (0.697, 0.765)  | 0.726 (0.7, 0.762)   | -0.004 (-0.015, 0.01)   |\n",
       "| Resp           | phecode_471     | Other disorders of nose and nasal sinuses                                       | 0.573 (0.555, 0.592) | 0.57 (0.551, 0.589)  | -0.003 (-0.013, 0.005)  |\n",
       "| GI             | phecode_518     | Appendicitis                                                                    | 0.55 (0.529, 0.578)  | 0.546 (0.526, 0.571) | -0.003 (-0.02, 0.017)   |\n",
       "| Genitourinary  | phecode_596-1   | Bladder neck obstruction                                                        | 0.793 (0.772, 0.822) | 0.791 (0.769, 0.818) | -0.003 (-0.011, 0.004)  |\n",
       "| Genitourinary  | phecode_614     | Inflammatory diseases of female pelvic organs                                   | 0.537 (0.513, 0.562) | 0.535 (0.5, 0.561)   | -0.003 (-0.021, 0.009)  |\n",
       "| GI             | phecode_504-3   | Periodontitis                                                                   | 0.542 (0.501, 0.587) | 0.537 (0.499, 0.576) | -0.003 (-0.037, 0.025)  |\n",
       "| Neoplasms      | phecode_139-53  | Lipoma of other skin subcutaneous tissue                                        | 0.516 (0.493, 0.549) | 0.513 (0.484, 0.536) | -0.003 (-0.017, 0.012)  |\n",
       "| Cardio         | phecode_413-6   | Heart valve replaced                                                            | 0.726 (0.706, 0.75)  | 0.723 (0.702, 0.744) | -0.003 (-0.012, 0.006)  |\n",
       "| Eye            | phecode_362     | Other disorders of the eyelids                                                  | 0.582 (0.555, 0.605) | 0.579 (0.551, 0.603) | -0.003 (-0.015, 0.008)  |\n",
       "| Neoplasms      | phecode_136-2   | Benign neoplasm of stomach                                                      | 0.629 (0.617, 0.641) | 0.626 (0.614, 0.637) | -0.003 (-0.006, 0)      |\n",
       "| ID             | phecode_089-3   | Fungal infections                                                               | 0.649 (0.635, 0.663) | 0.647 (0.626, 0.665) | -0.003 (-0.015, 0.012)  |\n",
       "| Genitourinary  | phecode_626-14  | Irregular menstrual bleeding                                                    | 0.863 (0.851, 0.874) | 0.86 (0.846, 0.873)  | -0.003 (-0.011, 0.005)  |\n",
       "| Neoplasms      | phecode_101-6   | Malignant neoplasm of the liver and intrahepatic bile ducts                     | 0.729 (0.698, 0.762) | 0.727 (0.682, 0.764) | -0.003 (-0.028, 0.019)  |\n",
       "| Genitourinary  | phecode_619-3   | Noninflammatory disorders of cervix                                             | 0.5 (0.465, 0.527)   | 0.496 (0.46, 0.533)  | -0.003 (-0.024, 0.018)  |\n",
       "| Genitourinary  | phecode_627     | Menopausal and postmenopausal disorders                                         | 0.655 (0.643, 0.666) | 0.652 (0.639, 0.664) | -0.003 (-0.006, 0.001)  |\n",
       "| Neoplasms      | phecode_122     | Lymphoma                                                                        | 0.663 (0.642, 0.68)  | 0.659 (0.638, 0.678) | -0.003 (-0.012, 0.007)  |\n",
       "| Neoplasms      | phecode_101-1   | Malignant neoplasm of the esophagus                                             | 0.725 (0.701, 0.754) | 0.723 (0.699, 0.753) | -0.003 (-0.018, 0.012)  |\n",
       "| Cardio         | phecode_417-3   | Bradycardia*                                                                    | 0.687 (0.675, 0.703) | 0.684 (0.674, 0.703) | -0.003 (-0.007, 0.004)  |\n",
       "| Eye            | phecode_386-2   | Diplopia                                                                        | 0.578 (0.535, 0.618) | 0.578 (0.536, 0.611) | -0.003 (-0.026, 0.027)  |\n",
       "| Neoplasms      | phecode_116-3   | Secondary malignant neoplasm of digestive systems                               | 0.635 (0.611, 0.655) | 0.632 (0.606, 0.654) | -0.003 (-0.016, 0.011)  |\n",
       "| Cardio         | phecode_440-3   | Pulmonary embolism                                                              | 0.634 (0.617, 0.649) | 0.633 (0.617, 0.648) | -0.002 (-0.01, 0.009)   |\n",
       "| Genitourinary  | phecode_592-1   | Cystitis                                                                        | 0.618 (0.597, 0.641) | 0.615 (0.595, 0.637) | -0.002 (-0.015, 0.014)  |\n",
       "| Endo           | phecode_208     | Disorders of parathyroid gland                                                  | 0.642 (0.614, 0.668) | 0.64 (0.612, 0.666)  | -0.002 (-0.021, 0.015)  |\n",
       "| Musc/Skel      | phecode_705-3   | Polymyalgia rheumatica                                                          | 0.738 (0.72, 0.751)  | 0.735 (0.716, 0.751) | -0.002 (-0.008, 0.003)  |\n",
       "| ID             | phecode_070     | Candidiasis                                                                     | 0.645 (0.628, 0.665) | 0.643 (0.624, 0.66)  | -0.002 (-0.013, 0.011)  |\n",
       "| GI             | phecode_513-3   | Duodenal ulcer                                                                  | 0.623 (0.601, 0.65)  | 0.623 (0.601, 0.644) | -0.002 (-0.015, 0.012)  |\n",
       "| Cong           | phecode_773     | Congenital malformation of kidney                                               | 0.592 (0.532, 0.631) | 0.588 (0.538, 0.631) | -0.002 (-0.033, 0.023)  |\n",
       "| Genitourinary  | phecode_618-12  | Rectocele                                                                       | 0.566 (0.542, 0.587) | 0.564 (0.542, 0.583) | -0.002 (-0.01, 0.011)   |\n",
       "| Genitourinary  | phecode_618-1   | Prolapse of vaginal walls                                                       | 0.58 (0.568, 0.595)  | 0.578 (0.566, 0.594) | -0.002 (-0.009, 0.003)  |\n",
       "| Neoplasms      | phecode_105     | Malignant neoplasm of the breast                                                | 0.765 (0.759, 0.773) | 0.764 (0.758, 0.771) | -0.002 (-0.003, -0.001) |\n",
       "| Derm           | phecode_676     | Hypertrophic conditions of skin                                                 | 0.505 (0.486, 0.531) | 0.505 (0.483, 0.524) | -0.002 (-0.021, 0.019)  |\n",
       "| Genitourinary  | phecode_594-1   | Retention of urine                                                              | 0.734 (0.726, 0.743) | 0.732 (0.724, 0.741) | -0.002 (-0.004, 0)      |\n",
       "| Neuro          | phecode_328-9   | Dementia NOS                                                                    | 0.783 (0.768, 0.805) | 0.78 (0.764, 0.798)  | -0.002 (-0.01, 0.005)   |\n",
       "| Cardio         | phecode_416-42  | Left bundle branch block                                                        | 0.729 (0.71, 0.746)  | 0.726 (0.709, 0.743) | -0.002 (-0.009, 0.004)  |\n",
       "| Genitourinary  | phecode_615     | Endometriosis                                                                   | 0.703 (0.673, 0.741) | 0.7 (0.676, 0.736)   | -0.002 (-0.012, 0.01)   |\n",
       "| Genitourinary  | phecode_592     | Cystitis and urethritis                                                         | 0.622 (0.599, 0.646) | 0.619 (0.598, 0.642) | -0.002 (-0.012, 0.008)  |\n",
       "| Genitourinary  | phecode_626-1   | Irregular menstrual cycle/bleeding                                              | 0.847 (0.836, 0.861) | 0.847 (0.835, 0.858) | -0.002 (-0.008, 0.004)  |\n",
       "| Cardio         | phecode_438-1   | Aortic aneurysm and ectasia                                                     | 0.793 (0.777, 0.813) | 0.792 (0.776, 0.814) | -0.002 (-0.01, 0.006)   |\n",
       "| Neoplasms      | phecode_101-4   | Malignant neoplasm of the colon and rectum                                      | 0.683 (0.672, 0.696) | 0.682 (0.669, 0.695) | -0.002 (-0.007, 0.003)  |\n",
       "| Endo           | phecode_208-2   | Hyperparathyroidism                                                             | 0.637 (0.613, 0.667) | 0.636 (0.604, 0.665) | -0.002 (-0.016, 0.014)  |\n",
       "| GI             | phecode_532     | Other disorders of the intestines                                               | 0.559 (0.541, 0.573) | 0.557 (0.539, 0.571) | -0.001 (-0.015, 0.01)   |\n",
       "| Genitourinary  | phecode_618     | Genital prolapse                                                                | 0.588 (0.575, 0.603) | 0.586 (0.575, 0.599) | -0.001 (-0.006, 0.003)  |\n",
       "| Neuro          | phecode_328     | Dementias and cerebral degeneration                                             | 0.788 (0.779, 0.803) | 0.787 (0.777, 0.801) | -0.001 (-0.009, 0.004)  |\n",
       "| Neoplasms      | phecode_101-41  | Malignant neoplasm of the colon                                                 | 0.685 (0.671, 0.7)   | 0.682 (0.669, 0.7)   | -0.001 (-0.006, 0.005)  |\n",
       "| Signs/Symptoms | phecode_840     | Allergy                                                                         | 0.563 (0.549, 0.576) | 0.562 (0.552, 0.573) | -0.001 (-0.007, 0.004)  |\n",
       "| Signs/Symptoms | phecode_808     | Syncope and collapse                                                            | 0.637 (0.626, 0.648) | 0.636 (0.624, 0.646) | -0.001 (-0.005, 0.004)  |\n",
       "| Mental         | phecode_290     | Reaction to severe stress, and adjustment disorders                             | 0.632 (0.595, 0.675) | 0.635 (0.597, 0.674) | -0.001 (-0.034, 0.044)  |\n",
       "| Genitourinary  | phecode_593     | Hematuria                                                                       | 0.646 (0.633, 0.658) | 0.646 (0.633, 0.658) | -0.001 (-0.004, 0.002)  |\n",
       "| Genitourinary  | phecode_594     | Abnormality of urination                                                        | 0.661 (0.655, 0.67)  | 0.661 (0.654, 0.668) | -0.001 (-0.004, 0.002)  |\n",
       "| GI             | phecode_517     | Gastrointestinal angiodysplasia                                                 | 0.703 (0.672, 0.73)  | 0.703 (0.665, 0.729) | -0.001 (-0.024, 0.021)  |\n",
       "| Musc/Skel      | phecode_709-21  | Hallux valgus (Bunion)                                                          | 0.695 (0.684, 0.704) | 0.693 (0.682, 0.704) | -0.001 (-0.006, 0.003)  |\n",
       "| Blood          | phecode_174-2   | Splenomegaly                                                                    | 0.648 (0.606, 0.696) | 0.645 (0.593, 0.686) | -0.001 (-0.06, 0.053)   |\n",
       "| Hearing        | phecode_394-2   | Vertigo                                                                         | 0.625 (0.597, 0.658) | 0.624 (0.589, 0.66)  | -0.001 (-0.031, 0.023)  |\n",
       "| Blood          | phecode_174     | Diseases of spleen                                                              | 0.605 (0.577, 0.641) | 0.602 (0.574, 0.636) | -0.001 (-0.033, 0.032)  |\n",
       "| Cardio         | phecode_416-1   | Paroxysmal tachycardia                                                          | 0.642 (0.63, 0.659)  | 0.641 (0.627, 0.658) | -0.001 (-0.012, 0.01)   |\n",
       "| Metab          | phecode_256-2   | Hyposmolality and/or hyponatremia                                               | 0.693 (0.678, 0.705) | 0.692 (0.677, 0.704) | -0.001 (-0.009, 0.006)  |\n",
       "| Cardio         | phecode_404-11  | Acute myocardial infarction                                                     | 0.703 (0.694, 0.715) | 0.702 (0.693, 0.714) | -0.001 (-0.006, 0.005)  |\n",
       "| Neoplasms      | phecode_132     | Sequelae of cancer                                                              | 0.739 (0.727, 0.752) | 0.737 (0.725, 0.751) | -0.001 (-0.005, 0.003)  |\n",
       "| Neoplasms      | phecode_107     | Malignant neoplasm of male genitalia                                            | 0.686 (0.676, 0.698) | 0.685 (0.674, 0.697) | -0.001 (-0.003, 0.001)  |\n",
       "| Cardio         | phecode_406-1   | Pulmonary hypertension                                                          | 0.74 (0.717, 0.76)   | 0.739 (0.713, 0.765) | -0.001 (-0.016, 0.016)  |\n",
       "| Neoplasms      | phecode_107-2   | Malignant neoplasm of the prostate                                              | 0.691 (0.681, 0.7)   | 0.69 (0.68, 0.698)   | -0.001 (-0.002, 0.001)  |\n",
       "| Genitourinary  | phecode_627-4   | Menorrhagia/Excessive and frequent menstruation                                 | 0.875 (0.869, 0.882) | 0.875 (0.867, 0.881) | -0.001 (-0.003, 0.002)  |\n",
       "| Cardio         | phecode_416-21  | Atrial fibrillation                                                             | 0.699 (0.69, 0.712)  | 0.699 (0.689, 0.712) | -0.001 (-0.006, 0.005)  |\n",
       "| Musc/Skel      | phecode_708-1   | Primary osteoarthritis                                                          | 0.606 (0.593, 0.617) | 0.605 (0.594, 0.615) | -0.001 (-0.005, 0.004)  |\n",
       "| Cardio         | phecode_416-41  | Atrioventricular block                                                          | 0.76 (0.748, 0.773)  | 0.759 (0.746, 0.771) | 0 (-0.005, 0.002)       |\n",
       "| GI             | phecode_510     | Diseases of esophagus                                                           | 0.599 (0.592, 0.606) | 0.599 (0.591, 0.606) | 0 (-0.004, 0.005)       |\n",
       "| Genitourinary  | phecode_600     | Benign prostatic hyperplasia                                                    | 0.693 (0.685, 0.7)   | 0.693 (0.685, 0.7)   | 0 (-0.002, 0.001)       |\n",
       "| Neoplasms      | phecode_101-42  | Malignant neoplasm of the rectum                                                | 0.683 (0.647, 0.712) | 0.68 (0.652, 0.709)  | 0 (-0.01, 0.008)        |\n",
       "| GI             | phecode_520-11  | Inguinal hernia                                                                 | 0.799 (0.791, 0.804) | 0.799 (0.791, 0.804) | 0 (0, 0)                |\n",
       "| GI             | phecode_520-1   | Hernia of the abdominal wall                                                    | 0.724 (0.717, 0.732) | 0.724 (0.717, 0.732) | 0 (-0.001, 0.001)       |\n",
       "| Neoplasms      | phecode_135-5   | Benign neoplasm of the paranasal sinus and nasal cavity                         | 0.62 (0.588, 0.649)  | 0.62 (0.596, 0.645)  | 0 (-0.01, 0.012)        |\n",
       "| GI             | phecode_552-2   | Obstruction of bile duct                                                        | 0.648 (0.618, 0.673) | 0.647 (0.611, 0.676) | 0 (-0.019, 0.019)       |\n",
       "| Resp           | phecode_471-5   | Nasal polyps                                                                    | 0.617 (0.591, 0.653) | 0.618 (0.595, 0.644) | 0 (-0.014, 0.014)       |\n",
       "| Cardio         | phecode_416-211 | Paroxysmal atrial fibrillation*                                                 | 0.697 (0.683, 0.709) | 0.697 (0.682, 0.71)  | 0 (-0.007, 0.006)       |\n",
       "| Neoplasms      | phecode_116-4   | Secondary malignant neoplasm of liver                                           | 0.665 (0.65, 0.679)  | 0.664 (0.65, 0.681)  | 0 (-0.007, 0.007)       |\n",
       "| Cardio         | phecode_413-11  | Mitral valve insufficiency                                                      | 0.696 (0.682, 0.713) | 0.696 (0.677, 0.713) | 0 (-0.007, 0.008)       |\n",
       "| Neoplasms      | phecode_101     | Malignant neoplasm of the digestive organs                                      | 0.675 (0.665, 0.684) | 0.676 (0.666, 0.682) | 0 (-0.004, 0.004)       |\n",
       "| Genitourinary  | phecode_626     | Disorders of menstruation and other abnormal bleeding from female genital tract | 0.798 (0.78, 0.815)  | 0.8 (0.779, 0.815)   | 0 (-0.005, 0.005)       |\n",
       "| Cardio         | phecode_444-11  | Varicose veins of lower extremities                                             | 0.579 (0.565, 0.593) | 0.578 (0.565, 0.593) | 0 (-0.008, 0.01)        |\n",
       "| Genitourinary  | phecode_604     | Disorders of penis                                                              | 0.568 (0.541, 0.588) | 0.566 (0.54, 0.593)  | 0 (-0.021, 0.021)       |\n",
       "| GI             | phecode_529-3   | Fecal incontinence                                                              | 0.638 (0.611, 0.656) | 0.637 (0.62, 0.657)  | 0.001 (-0.015, 0.015)   |\n",
       "| Cardio         | phecode_400     | Rheumatic fever and chronic rheumatic heart diseases                            | 0.72 (0.709, 0.731)  | 0.721 (0.707, 0.734) | 0.001 (-0.005, 0.008)   |\n",
       "| GI             | phecode_552     | Other diseases of biliary tract                                                 | 0.616 (0.591, 0.642) | 0.615 (0.594, 0.636) | 0.001 (-0.015, 0.011)   |\n",
       "| Neoplasms      | phecode_136-42  | Benign neoplasm of rectum and anus                                              | 0.59 (0.579, 0.599)  | 0.591 (0.578, 0.6)   | 0.001 (-0.004, 0.005)   |\n",
       "| Hearing        | phecode_391-1   | Otitis media                                                                    | 0.541 (0.493, 0.577) | 0.541 (0.512, 0.572) | 0.001 (-0.032, 0.045)   |\n",
       "| Derm           | phecode_668-4   | Dermatitis due to substances taken internally                                   | 0.509 (0.461, 0.556) | 0.511 (0.459, 0.551) | 0.001 (-0.054, 0.053)   |\n",
       "| Cardio         | phecode_446-2   | Orthostatic hypotension                                                         | 0.707 (0.688, 0.721) | 0.708 (0.691, 0.722) | 0.001 (-0.009, 0.013)   |\n",
       "| Cardio         | phecode_413-32  | Tricuspid value insufficiency*                                                  | 0.703 (0.682, 0.735) | 0.707 (0.682, 0.741) | 0.001 (-0.014, 0.027)   |\n",
       "| Cardio         | phecode_416-212 | Persistent atrial fibrillation*                                                 | 0.679 (0.652, 0.707) | 0.68 (0.655, 0.72)   | 0.001 (-0.02, 0.022)    |\n",
       "| Cardio         | phecode_438-11  | Abdominal aortic aneurysm                                                       | 0.845 (0.826, 0.858) | 0.845 (0.829, 0.862) | 0.001 (-0.01, 0.012)    |\n",
       "| Neoplasms      | phecode_116     | Secondary malignant neoplasm                                                    | 0.656 (0.649, 0.666) | 0.657 (0.648, 0.667) | 0.001 (-0.004, 0.006)   |\n",
       "| GI             | phecode_514-2   | Intestinal obstruction                                                          | 0.606 (0.58, 0.625)  | 0.607 (0.585, 0.626) | 0.001 (-0.012, 0.015)   |\n",
       "| GI             | phecode_520     | Hernia                                                                          | 0.624 (0.619, 0.63)  | 0.625 (0.62, 0.631)  | 0.001 (-0.001, 0.003)   |\n",
       "| Cardio         | phecode_416-4   | Heart block                                                                     | 0.73 (0.722, 0.74)   | 0.732 (0.722, 0.74)  | 0.001 (-0.002, 0.004)   |\n",
       "| Resp           | phecode_480     | Pulmonary edema                                                                 | 0.673 (0.642, 0.707) | 0.672 (0.638, 0.712) | 0.001 (-0.022, 0.028)   |\n",
       "| Musc/Skel      | phecode_709-24  | Hammer toe                                                                      | 0.706 (0.682, 0.722) | 0.707 (0.684, 0.724) | 0.001 (-0.005, 0.008)   |\n",
       "| Neoplasms      | phecode_144-2   | Benign neoplasms of the uterus                                                  | 0.61 (0.597, 0.621)  | 0.611 (0.598, 0.624) | 0.001 (-0.005, 0.006)   |\n",
       "| Genitourinary  | phecode_580-3   | Nephrotic syndrome                                                              | 0.539 (0.495, 0.58)  | 0.54 (0.5, 0.581)    | 0.001 (-0.033, 0.03)    |\n",
       "| Cardio         | phecode_400-2   | Chronic rheumatic heart diseases                                                | 0.721 (0.711, 0.733) | 0.723 (0.71, 0.734)  | 0.001 (-0.007, 0.007)   |\n",
       "| Neoplasms      | phecode_130     | Cancer (solid tumor, excluding BCC)                                             | 0.644 (0.64, 0.648)  | 0.645 (0.642, 0.649) | 0.001 (0, 0.003)        |\n",
       "| Neoplasms      | phecode_103-1   | Melanomas of skin                                                               | 0.592 (0.574, 0.613) | 0.593 (0.574, 0.616) | 0.001 (-0.012, 0.013)   |\n",
       "| Derm           | phecode_670     | Seborrheic keratosis                                                            | 0.615 (0.591, 0.637) | 0.617 (0.594, 0.638) | 0.001 (-0.007, 0.011)   |\n",
       "| Neoplasms      | phecode_136     | Benign neoplasm of the digestive organs                                         | 0.587 (0.581, 0.594) | 0.588 (0.582, 0.595) | 0.001 (-0.001, 0.003)   |\n",
       "| Cardio         | phecode_403     | Angina pectoris                                                                 | 0.682 (0.676, 0.69)  | 0.684 (0.676, 0.692) | 0.001 (-0.003, 0.007)   |\n",
       "| Metab          | phecode_230-3   | Anorexia                                                                        | 0.644 (0.616, 0.677) | 0.649 (0.615, 0.678) | 0.001 (-0.018, 0.028)   |\n",
       "| Genitourinary  | phecode_619     | Noninflammatory female genital disorders                                        | 0.496 (0.48, 0.512)  | 0.499 (0.48, 0.513)  | 0.001 (-0.008, 0.013)   |\n",
       "| GI             | phecode_510-2   | Esophagitis                                                                     | 0.585 (0.578, 0.595) | 0.586 (0.579, 0.595) | 0.001 (-0.004, 0.007)   |\n",
       "| Genitourinary  | phecode_594-2   | Dysuria                                                                         | 0.588 (0.55, 0.619)  | 0.592 (0.558, 0.621) | 0.001 (-0.024, 0.028)   |\n",
       "| Endo           | phecode_200-13  | Postprocedural hypothyroidism                                                   | 0.663 (0.638, 0.683) | 0.663 (0.639, 0.69)  | 0.001 (-0.009, 0.013)   |\n",
       "| Neoplasms      | phecode_112     | Malignant neoplasm of other and ill-defined sites                               | 0.656 (0.649, 0.663) | 0.657 (0.65, 0.665)  | 0.001 (-0.001, 0.003)   |\n",
       "| Endo           | phecode_200-2   | Goiter                                                                          | 0.661 (0.638, 0.679) | 0.661 (0.642, 0.681) | 0.002 (-0.01, 0.01)     |\n",
       "| Neoplasms      | phecode_144     | Gynecological benign neoplasms                                                  | 0.6 (0.588, 0.611)   | 0.601 (0.588, 0.611) | 0.002 (-0.005, 0.007)   |\n",
       "| Musc/Skel      | phecode_722     | Fasciopathy                                                                     | 0.675 (0.657, 0.689) | 0.676 (0.656, 0.69)  | 0.002 (-0.003, 0.007)   |\n",
       "| Musc/Skel      | phecode_722-4   | Palmar fascial fibromatosis [Dupuytren]                                         | 0.717 (0.704, 0.736) | 0.719 (0.704, 0.735) | 0.002 (-0.003, 0.006)   |\n",
       "| GI             | phecode_523     | Diverticular disease [Bowel diverticulosis]                                     | 0.629 (0.624, 0.634) | 0.631 (0.626, 0.635) | 0.002 (0, 0.004)        |\n",
       "| Musc/Skel      | phecode_709     | Acquired deformities of fingers and toes                                        | 0.671 (0.66, 0.682)  | 0.672 (0.663, 0.683) | 0.002 (-0.002, 0.006)   |\n",
       "| GI             | phecode_557     | Gastrointestinal hemorrhage                                                     | 0.551 (0.541, 0.561) | 0.552 (0.542, 0.56)  | 0.002 (-0.006, 0.008)   |\n",
       "| GI             | phecode_530     | Disease of anus and rectum                                                      | 0.565 (0.55, 0.58)   | 0.567 (0.552, 0.58)  | 0.002 (-0.008, 0.011)   |\n",
       "| Resp           | phecode_478     | Aspiration pneumonia                                                            | 0.736 (0.713, 0.756) | 0.736 (0.711, 0.754) | 0.002 (-0.016, 0.017)   |\n",
       "| GI             | phecode_523-2   | Diverticula of colon                                                            | 0.629 (0.623, 0.634) | 0.631 (0.626, 0.636) | 0.002 (0, 0.003)        |\n",
       "| Neoplasms      | phecode_116-1   | Secondary malignancy of lymph nodes                                             | 0.614 (0.603, 0.628) | 0.615 (0.604, 0.626) | 0.002 (-0.008, 0.009)   |\n",
       "| GI             | phecode_529     | Symptoms involving digestive system                                             | 0.592 (0.586, 0.598) | 0.594 (0.589, 0.599) | 0.002 (-0.002, 0.005)   |\n",
       "| Hearing        | phecode_394     | Disorders of vestibular function                                                | 0.632 (0.608, 0.66)  | 0.635 (0.609, 0.662) | 0.002 (-0.014, 0.017)   |\n",
       "| Neoplasms      | phecode_139     | Benign sarcoma-related cancers                                                  | 0.541 (0.521, 0.553) | 0.542 (0.523, 0.555) | 0.002 (-0.006, 0.009)   |\n",
       "| Endo           | phecode_200     | Disorders of thyroid gland                                                      | 0.669 (0.66, 0.677)  | 0.67 (0.663, 0.68)   | 0.002 (0, 0.004)        |\n",
       "| Musc/Skel      | phecode_709-2   | Acquired deformities of toe                                                     | 0.674 (0.663, 0.685) | 0.676 (0.668, 0.686) | 0.002 (-0.002, 0.006)   |\n",
       "| Genitourinary  | phecode_618-2   | Uterine/Uterovaginal prolapse                                                   | 0.585 (0.569, 0.606) | 0.588 (0.571, 0.607) | 0.002 (-0.01, 0.015)    |\n",
       "| Cardio         | phecode_413-2   | Aortic valve disorders                                                          | 0.744 (0.733, 0.756) | 0.746 (0.734, 0.758) | 0.002 (-0.005, 0.007)   |\n",
       "| Resp           | phecode_469     | Bronchitis                                                                      | 0.607 (0.583, 0.633) | 0.609 (0.589, 0.637) | 0.002 (-0.015, 0.022)   |\n",
       "| Musc/Skel      | phecode_714-3   | Scoliosis                                                                       | 0.718 (0.696, 0.739) | 0.72 (0.698, 0.743)  | 0.002 (-0.009, 0.011)   |\n",
       "| GI             | phecode_514-1   | Esophageal obstruction (Stricture and stenosis of esophagus)                    | 0.628 (0.611, 0.645) | 0.628 (0.612, 0.649) | 0.002 (-0.01, 0.011)    |\n",
       "| Cardio         | phecode_431     | Stroke and transient cerebral ischemic attacks                                  | 0.703 (0.691, 0.711) | 0.705 (0.695, 0.715) | 0.002 (-0.004, 0.01)    |\n",
       "| Genitourinary  | phecode_597     | Other disorders of urethra and urinary tract                                    | 0.624 (0.599, 0.64)  | 0.627 (0.603, 0.644) | 0.002 (-0.005, 0.011)   |\n",
       "| Metab          | phecode_232-27  | Vitamin B12 deficiency                                                          | 0.606 (0.577, 0.64)  | 0.61 (0.571, 0.638)  | 0.003 (-0.035, 0.04)    |\n",
       "| Endo           | phecode_200-1   | Hypothyroidism                                                                  | 0.672 (0.663, 0.678) | 0.674 (0.665, 0.682) | 0.003 (0.001, 0.005)    |\n",
       "| Neoplasms      | phecode_136-4   | Benign neoplasm of colon, rectum, anus and anal canal                           | 0.588 (0.582, 0.593) | 0.59 (0.584, 0.596)  | 0.003 (0, 0.005)        |\n",
       "| GI             | phecode_556     | Other symptoms involving the digestive system and abdomen                       | 0.599 (0.582, 0.614) | 0.602 (0.583, 0.618) | 0.003 (-0.009, 0.012)   |\n",
       "| Musc/Skel      | phecode_727     | Other disorders of bone                                                         | 0.645 (0.629, 0.659) | 0.647 (0.632, 0.661) | 0.003 (-0.003, 0.01)    |\n",
       "| Derm           | phecode_685     | Disorders of sweat glands                                                       | 0.558 (0.51, 0.588)  | 0.553 (0.514, 0.597) | 0.003 (-0.033, 0.039)   |\n",
       "| Endo           | phecode_200-14  | Hypothyroidism, not specified as secondary                                      | 0.671 (0.664, 0.68)  | 0.674 (0.667, 0.682) | 0.003 (0, 0.005)        |\n",
       "| Neoplasms      | phecode_136-41  | Benign neoplasm of the colon                                                    | 0.602 (0.597, 0.609) | 0.605 (0.599, 0.611) | 0.003 (0.001, 0.006)    |\n",
       "| Cardio         | phecode_436     | Atherosclerosis [ASCVD]                                                         | 0.714 (0.705, 0.72)  | 0.716 (0.709, 0.723) | 0.003 (-0.001, 0.005)   |\n",
       "| GI             | phecode_520-2   | Diaphragmatic hernia [Hiatal hernia]                                            | 0.608 (0.602, 0.613) | 0.61 (0.604, 0.617)  | 0.003 (0, 0.006)        |\n",
       "| Neuro          | phecode_353     | Symptoms and signs involving general sensations and perceptions                 | 0.623 (0.595, 0.659) | 0.627 (0.593, 0.655) | 0.003 (-0.033, 0.031)   |\n",
       "| Genitourinary  | phecode_585     | Kidney stone disease                                                            | 0.643 (0.63, 0.656)  | 0.646 (0.631, 0.658) | 0.003 (-0.004, 0.011)   |\n",
       "| Genitourinary  | phecode_591     | Urinary tract infection                                                         | 0.662 (0.654, 0.672) | 0.666 (0.657, 0.676) | 0.003 (-0.002, 0.01)    |\n",
       "| ID             | phecode_092     | Bacteremia, Sepsis, and SIRS                                                    | 0.674 (0.663, 0.682) | 0.677 (0.667, 0.686) | 0.003 (-0.002, 0.009)   |\n",
       "| Cardio         | phecode_406     | Chronic pulmonary heart disease                                                 | 0.735 (0.712, 0.758) | 0.74 (0.716, 0.765)  | 0.003 (-0.017, 0.022)   |\n",
       "| Neoplasms      | phecode_108     | Malignant neoplasm of the urinary tract                                         | 0.719 (0.706, 0.735) | 0.723 (0.71, 0.737)  | 0.003 (-0.001, 0.009)   |\n",
       "| Neoplasms      | phecode_144-21  | Leiomyoma of uterus                                                             | 0.67 (0.654, 0.685)  | 0.674 (0.658, 0.69)  | 0.003 (-0.003, 0.01)    |\n",
       "| Signs/Symptoms | phecode_840-8   | Allergies related to other diseases/symptoms                                    | 0.456 (0.438, 0.474) | 0.459 (0.44, 0.478)  | 0.003 (-0.009, 0.018)   |\n",
       "| Resp           | phecode_476     | Bronchiectasis                                                                  | 0.7 (0.685, 0.718)   | 0.705 (0.688, 0.721) | 0.003 (-0.005, 0.012)   |\n",
       "| Cardio         | phecode_416     | Cardiac arrhythmia and conduction disorders                                     | 0.719 (0.713, 0.725) | 0.723 (0.717, 0.728) | 0.003 (0.002, 0.005)    |\n",
       "| Signs/Symptoms | phecode_829     | Nonspecific findings on examination of blood                                    | 0.701 (0.694, 0.709) | 0.705 (0.698, 0.713) | 0.003 (0.001, 0.006)    |\n",
       "| Cardio         | phecode_413-1   | Mitral valve disorders                                                          | 0.708 (0.697, 0.718) | 0.712 (0.699, 0.723) | 0.003 (-0.003, 0.009)   |\n",
       "| Musc/Skel      | phecode_723-2   | Rotator cuff tear or rupture                                                    | 0.573 (0.558, 0.592) | 0.576 (0.564, 0.596) | 0.003 (-0.007, 0.012)   |\n",
       "| Neuro          | phecode_331-6   | Migraine                                                                        | 0.596 (0.582, 0.614) | 0.599 (0.585, 0.622) | 0.003 (-0.005, 0.012)   |\n",
       "| Signs/Symptoms | phecode_841-1   | Allergy to other anti-infective agents                                          | 0.592 (0.587, 0.599) | 0.595 (0.59, 0.601)  | 0.003 (0.001, 0.006)    |\n",
       "| Cardio         | phecode_410-2   | Endocarditis                                                                    | 0.675 (0.638, 0.712) | 0.677 (0.645, 0.717) | 0.004 (-0.017, 0.024)   |\n",
       "| Signs/Symptoms | phecode_841     | Drug and medical agent allergy                                                  | 0.588 (0.583, 0.595) | 0.592 (0.586, 0.598) | 0.004 (0.001, 0.007)    |\n",
       "| Neoplasms      | phecode_103-3   | Carcinoma in situ of skin                                                       | 0.732 (0.699, 0.755) | 0.733 (0.704, 0.76)  | 0.004 (-0.005, 0.013)   |\n",
       "| Musc/Skel      | phecode_726     | Osteoporosis and low bone density                                               | 0.756 (0.745, 0.766) | 0.76 (0.75, 0.769)   | 0.004 (0.001, 0.005)    |\n",
       "| Cardio         | phecode_404-2   | Coronary atherosclerosis [Atherosclerotic heart disease]                        | 0.712 (0.704, 0.718) | 0.715 (0.708, 0.722) | 0.004 (0.001, 0.007)    |\n",
       "| Cardio         | phecode_416-2   | Atrial fibrillation and flutter                                                 | 0.739 (0.734, 0.746) | 0.743 (0.737, 0.749) | 0.004 (0.001, 0.006)    |\n",
       "| Musc/Skel      | phecode_726-1   | Osteoporosis                                                                    | 0.762 (0.755, 0.771) | 0.766 (0.758, 0.774) | 0.004 (0.002, 0.006)    |\n",
       "| Genitourinary  | phecode_627-3   | Postmenopausal atrophic vaginitis                                               | 0.497 (0.467, 0.525) | 0.5 (0.472, 0.53)    | 0.004 (-0.023, 0.025)   |\n",
       "| Cardio         | phecode_438     | Aneurysm or ectasia                                                             | 0.71 (0.693, 0.726)  | 0.714 (0.696, 0.734) | 0.004 (-0.004, 0.012)   |\n",
       "| Cardio         | phecode_413     | Heart valve disorders                                                           | 0.719 (0.71, 0.729)  | 0.723 (0.714, 0.734) | 0.004 (-0.002, 0.008)   |\n",
       "| Signs/Symptoms | phecode_841-12  | Allergy to antibiotic agent (excluding penicillin)                              | 0.636 (0.626, 0.648) | 0.64 (0.629, 0.651)  | 0.004 (-0.003, 0.009)   |\n",
       "| Neoplasms      | phecode_116-6   | Secondary malignancy of bone                                                    | 0.687 (0.672, 0.7)   | 0.69 (0.677, 0.703)  | 0.004 (-0.003, 0.01)    |\n",
       "| ID             | phecode_092-2   | Sepsis                                                                          | 0.671 (0.66, 0.682)  | 0.675 (0.664, 0.684) | 0.004 (-0.005, 0.011)   |\n",
       "| Cardio         | phecode_431-12  | Hemorrhagic stroke                                                              | 0.658 (0.633, 0.686) | 0.662 (0.638, 0.682) | 0.004 (-0.013, 0.018)   |\n",
       "| Cardio         | phecode_430     | Nontraumatic Intracranial hemorrhage                                            | 0.659 (0.643, 0.685) | 0.664 (0.642, 0.688) | 0.004 (-0.006, 0.018)   |\n",
       "| GI             | phecode_529-5   | Constipation                                                                    | 0.632 (0.624, 0.639) | 0.635 (0.629, 0.642) | 0.004 (-0.001, 0.009)   |\n",
       "| Cardio         | phecode_431-1   | Stroke                                                                          | 0.706 (0.692, 0.716) | 0.71 (0.697, 0.723)  | 0.004 (-0.004, 0.011)   |\n",
       "| GI             | phecode_522-1   | Inflammatory bowel disease                                                      | 0.535 (0.515, 0.554) | 0.538 (0.521, 0.56)  | 0.004 (-0.018, 0.022)   |\n",
       "| Cardio         | phecode_420     | Cardiac arrest                                                                  | 0.727 (0.711, 0.748) | 0.731 (0.709, 0.756) | 0.004 (-0.013, 0.021)   |\n",
       "| GI             | phecode_554-2   | Cyst and pseudocyst of pancreas                                                 | 0.606 (0.559, 0.649) | 0.604 (0.561, 0.651) | 0.004 (-0.036, 0.034)   |\n",
       "| Cardio         | phecode_404     | Ischemic heart disease                                                          | 0.703 (0.697, 0.708) | 0.707 (0.701, 0.713) | 0.005 (0.002, 0.007)    |\n",
       "| Neuro          | phecode_327     | Other degenerative diseases of nervous system                                   | 0.698 (0.674, 0.722) | 0.702 (0.673, 0.73)  | 0.005 (-0.012, 0.022)   |\n",
       "| GI             | phecode_545     | Nonspecific abnormal results of function study of liver                         | 0.609 (0.596, 0.626) | 0.614 (0.603, 0.625) | 0.005 (-0.008, 0.014)   |\n",
       "| Neuro          | phecode_330-3   | Convulsions                                                                     | 0.586 (0.562, 0.61)  | 0.588 (0.56, 0.617)  | 0.005 (-0.02, 0.027)    |\n",
       "| GI             | phecode_511     | Gastro-esophageal reflux disease                                                | 0.571 (0.566, 0.577) | 0.576 (0.571, 0.582) | 0.005 (0.001, 0.008)    |\n",
       "| Genitourinary  | phecode_596     | Other disorders of bladder                                                      | 0.644 (0.632, 0.657) | 0.648 (0.636, 0.66)  | 0.005 (0, 0.009)        |\n",
       "| Neuro          | phecode_324     | Extrapyramidal and movement disorders                                           | 0.655 (0.643, 0.67)  | 0.66 (0.649, 0.677)  | 0.005 (-0.002, 0.016)   |\n",
       "| GI             | phecode_522-11  | Crohn's disease                                                                 | 0.45 (0.422, 0.477)  | 0.454 (0.425, 0.49)  | 0.005 (-0.025, 0.033)   |\n",
       "| Cardio         | phecode_426     | Other heart disorders in diseases NEC                                           | 0.71 (0.695, 0.723)  | 0.713 (0.698, 0.729) | 0.005 (-0.007, 0.014)   |\n",
       "| GI             | phecode_514     | Gastrointestinal obstruction                                                    | 0.624 (0.61, 0.636)  | 0.628 (0.613, 0.64)  | 0.005 (-0.004, 0.014)   |\n",
       "| Signs/Symptoms | phecode_848     | Nonspecific abnormal findings of other body structures                          | 0.551 (0.516, 0.594) | 0.556 (0.523, 0.594) | 0.005 (-0.027, 0.031)   |\n",
       "| Derm           | phecode_678     | Other skin and connective tissue disorders                                      | 0.596 (0.58, 0.612)  | 0.601 (0.582, 0.617) | 0.005 (-0.002, 0.012)   |\n",
       "| Stat           | phecode_981     | Family history of malignant neoplasm                                            | 0.515 (0.503, 0.525) | 0.519 (0.508, 0.53)  | 0.005 (-0.002, 0.012)   |\n",
       "| Musc/Skel      | phecode_708-7   | Generalized osteoarthritis                                                      | 0.632 (0.621, 0.642) | 0.636 (0.625, 0.649) | 0.005 (-0.002, 0.014)   |\n",
       "| GI             | phecode_522     | Gastrointestinal inflammation                                                   | 0.577 (0.571, 0.583) | 0.583 (0.576, 0.589) | 0.005 (0.002, 0.009)    |\n",
       "| Musc/Skel      | phecode_708     | Osteoarthritis                                                                  | 0.637 (0.633, 0.642) | 0.643 (0.638, 0.647) | 0.005 (0.004, 0.007)    |\n",
       "| GI             | phecode_557-2   | Blood in stool                                                                  | 0.66 (0.639, 0.68)   | 0.664 (0.644, 0.687) | 0.006 (-0.008, 0.015)   |\n",
       "| Endo           | phecode_204     | Elevated blood glucose level                                                    | 0.639 (0.601, 0.662) | 0.643 (0.611, 0.669) | 0.006 (-0.016, 0.031)   |\n",
       "| Hearing        | phecode_394-1   | Meniere disease                                                                 | 0.592 (0.56, 0.624)  | 0.599 (0.562, 0.629) | 0.006 (-0.021, 0.031)   |\n",
       "| Neoplasms      | phecode_100     | Malignant neoplasm of the head and neck                                         | 0.613 (0.585, 0.644) | 0.619 (0.583, 0.646) | 0.006 (-0.012, 0.026)   |\n",
       "| Derm           | phecode_673     | Skin changes due to chronic exposure to nonionizing radiation                   | 0.679 (0.661, 0.695) | 0.685 (0.667, 0.702) | 0.006 (0.002, 0.01)     |\n",
       "| Genitourinary  | phecode_597-1   | Urethral stricture                                                              | 0.648 (0.628, 0.667) | 0.653 (0.635, 0.676) | 0.006 (-0.004, 0.012)   |\n",
       "| Cardio         | phecode_431-11  | Cerebral infarction [Ischemic stroke]                                           | 0.721 (0.708, 0.728) | 0.726 (0.715, 0.736) | 0.006 (-0.003, 0.014)   |\n",
       "| Derm           | phecode_673-1   | Actinic keratosis                                                               | 0.683 (0.669, 0.702) | 0.689 (0.674, 0.708) | 0.006 (0.001, 0.011)    |\n",
       "| Derm           | phecode_680     | Epidermal thickening                                                            | 0.58 (0.55, 0.605)   | 0.584 (0.553, 0.613) | 0.006 (-0.027, 0.026)   |\n",
       "| Musc/Skel      | phecode_703     | Chrystal arthropathies                                                          | 0.765 (0.755, 0.774) | 0.77 (0.76, 0.779)   | 0.006 (0.001, 0.011)    |\n",
       "| Musc/Skel      | phecode_721-1   | Synovitis and tenosynovitis                                                     | 0.554 (0.538, 0.573) | 0.561 (0.542, 0.573) | 0.006 (-0.01, 0.021)    |\n",
       "| Cardio         | phecode_404-1   | Myocardial infarction [Heart attack]                                            | 0.722 (0.715, 0.732) | 0.728 (0.721, 0.738) | 0.006 (0.001, 0.01)     |\n",
       "| Musc/Skel      | phecode_705     | Rheumatoid arthritis and other inflammatory polyarthropathies                   | 0.654 (0.644, 0.667) | 0.659 (0.646, 0.673) | 0.006 (0.001, 0.01)     |\n",
       "| GI             | phecode_522-9   | Gastritis                                                                       | 0.579 (0.571, 0.588) | 0.585 (0.578, 0.595) | 0.006 (0.001, 0.011)    |\n",
       "| ID             | phecode_015-2   | Clostridium difficile                                                           | 0.65 (0.607, 0.687)  | 0.655 (0.621, 0.699) | 0.006 (-0.025, 0.045)   |\n",
       "| Neuro          | phecode_334-2   | Facial nerve disorders and weakness                                             | 0.547 (0.514, 0.581) | 0.551 (0.52, 0.583)  | 0.006 (-0.027, 0.038)   |\n",
       "| Neoplasms      | phecode_116-2   | Secondary malignancy of respiratory organs                                      | 0.637 (0.621, 0.652) | 0.642 (0.63, 0.661)  | 0.006 (-0.004, 0.017)   |\n",
       "| Hearing        | phecode_396     | Hearing impairment                                                              | 0.678 (0.666, 0.69)  | 0.684 (0.672, 0.697) | 0.006 (0.002, 0.011)    |\n",
       "| Musc/Skel      | phecode_708-8   | Secondary osteoarthritis                                                        | 0.573 (0.544, 0.607) | 0.579 (0.556, 0.611) | 0.006 (-0.014, 0.03)    |\n",
       "| Resp           | phecode_468-8   | Bronchopneumonia                                                                | 0.699 (0.662, 0.734) | 0.705 (0.667, 0.739) | 0.006 (-0.015, 0.03)    |\n",
       "| Metab          | phecode_256-5   | Hypokalemia [Hypopotassemia]                                                    | 0.647 (0.633, 0.664) | 0.654 (0.64, 0.674)  | 0.006 (-0.004, 0.018)   |\n",
       "| Neuro          | phecode_334     | Disorders of other cranial nerves                                               | 0.558 (0.532, 0.586) | 0.564 (0.538, 0.587) | 0.007 (-0.018, 0.026)   |\n",
       "| Cardio         | phecode_444     | Venous insufficiency                                                            | 0.592 (0.581, 0.606) | 0.599 (0.588, 0.61)  | 0.007 (-0.003, 0.016)   |\n",
       "| Cardio         | phecode_439     | Hemorrhoids                                                                     | 0.505 (0.496, 0.514) | 0.512 (0.503, 0.521) | 0.007 (0.001, 0.014)    |\n",
       "| ID             | phecode_015     | Clostridium                                                                     | 0.64 (0.61, 0.675)   | 0.649 (0.614, 0.692) | 0.007 (-0.027, 0.052)   |\n",
       "| Genitourinary  | phecode_583     | Chronic kidney disease                                                          | 0.721 (0.713, 0.73)  | 0.728 (0.719, 0.737) | 0.007 (0.001, 0.012)    |\n",
       "| Musc/Skel      | phecode_703-11  | Gout                                                                            | 0.769 (0.76, 0.779)  | 0.776 (0.767, 0.786) | 0.007 (0.002, 0.012)    |\n",
       "| Cardio         | phecode_413-21  | Aortic stenosis                                                                 | 0.756 (0.745, 0.771) | 0.764 (0.749, 0.779) | 0.007 (-0.003, 0.016)   |\n",
       "| GI             | phecode_513     | Peptic ulcer                                                                    | 0.598 (0.589, 0.613) | 0.606 (0.594, 0.622) | 0.007 (-0.003, 0.017)   |\n",
       "| Cardio         | phecode_413-3   | Tricuspid valve disorders                                                       | 0.727 (0.714, 0.738) | 0.733 (0.72, 0.746)  | 0.007 (0, 0.015)        |\n",
       "| Resp           | phecode_484     | Pneumothorax and air leak                                                       | 0.639 (0.609, 0.669) | 0.648 (0.615, 0.681) | 0.007 (-0.023, 0.044)   |\n",
       "| Cardio         | phecode_444-1   | Varicose veins                                                                  | 0.584 (0.573, 0.596) | 0.591 (0.578, 0.602) | 0.007 (-0.001, 0.017)   |\n",
       "| Musc/Skel      | phecode_703-1   | Hyperuricemia                                                                   | 0.769 (0.761, 0.78)  | 0.777 (0.768, 0.787) | 0.007 (0.003, 0.013)    |\n",
       "| Cardio         | phecode_411     | Other diseases of pericardium                                                   | 0.654 (0.625, 0.677) | 0.661 (0.639, 0.684) | 0.007 (-0.009, 0.026)   |\n",
       "| Cardio         | phecode_446     | Hypotension                                                                     | 0.662 (0.652, 0.673) | 0.669 (0.658, 0.68)  | 0.008 (0, 0.014)        |\n",
       "| Neuro          | phecode_334-21  | Bell's palsy                                                                    | 0.553 (0.51, 0.579)  | 0.554 (0.534, 0.59)  | 0.008 (-0.03, 0.046)    |\n",
       "| Stat           | phecode_988     | Family history of cardiovascular disease                                        | 0.573 (0.564, 0.582) | 0.58 (0.569, 0.59)   | 0.008 (0.002, 0.014)    |\n",
       "| Musc/Skel      | phecode_726-2   | Pathologic fracture                                                             | 0.724 (0.698, 0.754) | 0.731 (0.7, 0.756)   | 0.008 (-0.006, 0.022)   |\n",
       "| Musc/Skel      | phecode_724-52  | Osteophyte*                                                                     | 0.559 (0.544, 0.58)  | 0.568 (0.551, 0.588) | 0.008 (-0.006, 0.022)   |\n",
       "| Cardio         | phecode_425     | Cardiomegaly                                                                    | 0.693 (0.682, 0.707) | 0.701 (0.691, 0.714) | 0.008 (-0.001, 0.017)   |\n",
       "| GI             | phecode_554-1   | Pancreatitis                                                                    | 0.581 (0.556, 0.608) | 0.591 (0.561, 0.612) | 0.008 (-0.016, 0.031)   |\n",
       "| GI             | phecode_528     | Nausea and vomiting                                                             | 0.601 (0.591, 0.609) | 0.609 (0.599, 0.616) | 0.008 (0.002, 0.013)    |\n",
       "| Blood          | phecode_177-4   | Lymphedema                                                                      | 0.66 (0.628, 0.692)  | 0.668 (0.637, 0.687) | 0.008 (-0.024, 0.029)   |\n",
       "| GI             | phecode_528-2   | Vomiting                                                                        | 0.6 (0.591, 0.609)   | 0.608 (0.6, 0.616)   | 0.008 (0.002, 0.013)    |\n",
       "| Musc/Skel      | phecode_709-22  | Hallux rigidus                                                                  | 0.589 (0.553, 0.618) | 0.594 (0.564, 0.632) | 0.008 (-0.011, 0.026)   |\n",
       "| GI             | phecode_522-8   | Duodenitis                                                                      | 0.603 (0.588, 0.62)  | 0.611 (0.597, 0.624) | 0.008 (-0.002, 0.019)   |\n",
       "| Metab          | phecode_230-21  | Abnormal weight loss                                                            | 0.628 (0.616, 0.64)  | 0.637 (0.625, 0.648) | 0.009 (0, 0.015)        |\n",
       "| Metab          | phecode_230     | Malnutrition and underweight                                                    | 0.627 (0.618, 0.637) | 0.636 (0.626, 0.646) | 0.009 (0.002, 0.014)    |\n",
       "| GI             | phecode_528-1   | Nausea                                                                          | 0.6 (0.59, 0.609)    | 0.609 (0.599, 0.618) | 0.009 (0.004, 0.016)    |\n",
       "| Cardio         | phecode_414-2   | Dilated cardiomyopathy*                                                         | 0.668 (0.624, 0.714) | 0.673 (0.634, 0.724) | 0.009 (-0.012, 0.025)   |\n",
       "| Resp           | phecode_463-2   | Allergic rhinitis                                                               | 0.444 (0.429, 0.469) | 0.455 (0.432, 0.473) | 0.009 (-0.011, 0.027)   |\n",
       "| GI             | phecode_527     | Abdominal pain                                                                  | 0.547 (0.541, 0.554) | 0.556 (0.548, 0.562) | 0.009 (0.005, 0.013)    |\n",
       "| Signs/Symptoms | phecode_841-4   | Allergy to analgesic agent                                                      | 0.602 (0.591, 0.616) | 0.609 (0.601, 0.625) | 0.009 (0.001, 0.015)    |\n",
       "| Signs/Symptoms | phecode_841-11  | Penicillin allergy                                                              | 0.577 (0.57, 0.585)  | 0.586 (0.579, 0.595) | 0.009 (0.005, 0.013)    |\n",
       "| Cardio         | phecode_417     | Abnormalities of heart beat                                                     | 0.595 (0.585, 0.605) | 0.605 (0.595, 0.613) | 0.009 (0.003, 0.015)    |\n",
       "| Musc/Skel      | phecode_711-1   | Derangement of meniscus                                                         | 0.522 (0.509, 0.531) | 0.53 (0.517, 0.542)  | 0.009 (-0.003, 0.019)   |\n",
       "| Cardio         | phecode_437     | Vascular insufficiency of intestine                                             | 0.669 (0.638, 0.699) | 0.681 (0.645, 0.712) | 0.009 (-0.018, 0.037)   |\n",
       "| Genitourinary  | phecode_586-2   | Cyst of kidney                                                                  | 0.66 (0.64, 0.679)   | 0.668 (0.65, 0.696)  | 0.009 (-0.001, 0.024)   |\n",
       "| Neuro          | phecode_329     | Symptoms and signs involving cognitive functions and awareness                  | 0.704 (0.695, 0.714) | 0.714 (0.702, 0.725) | 0.009 (0.002, 0.017)    |\n",
       "| ID             | phecode_061     | Influenza virus                                                                 | 0.614 (0.583, 0.643) | 0.624 (0.591, 0.659) | 0.009 (-0.014, 0.031)   |\n",
       "| Neoplasms      | phecode_108-4   | Malignant neoplasm of the kidney                                                | 0.669 (0.641, 0.693) | 0.68 (0.653, 0.708)  | 0.01 (-0.009, 0.032)    |\n",
       "| Musc/Skel      | phecode_712-1   | Loose body in joint                                                             | 0.507 (0.469, 0.534) | 0.511 (0.478, 0.553) | 0.01 (-0.022, 0.042)    |\n",
       "| Neoplasms      | phecode_103     | Malignant neoplasm of the skin                                                  | 0.662 (0.655, 0.671) | 0.671 (0.665, 0.681) | 0.01 (0.007, 0.013)     |\n",
       "| Metab          | phecode_230-2   | Abnormal loss of weight and underweight                                         | 0.627 (0.615, 0.641) | 0.637 (0.625, 0.65)  | 0.01 (0.003, 0.017)     |\n",
       "| Neoplasms      | phecode_101-2   | Malignant neoplasm of stomach                                                   | 0.676 (0.636, 0.709) | 0.686 (0.652, 0.716) | 0.01 (-0.009, 0.032)    |\n",
       "| Musc/Skel      | phecode_706     | Other inflammatory spondylopathies                                              | 0.61 (0.587, 0.629)  | 0.621 (0.6, 0.638)   | 0.01 (-0.005, 0.027)    |\n",
       "| Musc/Skel      | phecode_715-1   | Spondylosis                                                                     | 0.639 (0.629, 0.649) | 0.649 (0.64, 0.659)  | 0.01 (0.004, 0.015)     |\n",
       "| Cardio         | phecode_430-2   | Nontraumatic intracerebral hemorrhage                                           | 0.69 (0.664, 0.721)  | 0.701 (0.675, 0.734) | 0.01 (-0.008, 0.026)    |\n",
       "| Neuro          | phecode_336-5   | Mononeuritis of lower limb                                                      | 0.606 (0.579, 0.638) | 0.619 (0.586, 0.641) | 0.01 (-0.016, 0.03)     |\n",
       "| GI             | phecode_556-8   | Nonspecific abnormal findings in stool contents                                 | 0.591 (0.575, 0.608) | 0.6 (0.582, 0.618)   | 0.01 (-0.004, 0.023)    |\n",
       "| GI             | phecode_526-12  | Intestinal infection due to C. difficile                                        | 0.647 (0.613, 0.686) | 0.659 (0.621, 0.69)  | 0.01 (-0.015, 0.052)    |\n",
       "| GI             | phecode_512     | Dysphagia                                                                       | 0.57 (0.558, 0.581)  | 0.58 (0.569, 0.592)  | 0.01 (0.002, 0.02)      |\n",
       "| Cardio         | phecode_447     | Nonspecific low blood-pressure reading                                          | 0.63 (0.608, 0.658)  | 0.64 (0.614, 0.67)   | 0.01 (-0.005, 0.027)    |\n",
       "| Neuro          | phecode_354     | Dizziness and giddiness                                                         | 0.598 (0.585, 0.615) | 0.607 (0.595, 0.625) | 0.01 (0, 0.02)          |\n",
       "| Cardio         | phecode_424-1   | Left heart failure                                                              | 0.733 (0.714, 0.747) | 0.744 (0.73, 0.76)   | 0.01 (0.003, 0.022)     |\n",
       "| ID             | phecode_089     | Infections                                                                      | 0.612 (0.604, 0.618) | 0.622 (0.614, 0.629) | 0.011 (0.005, 0.017)    |\n",
       "| Signs/Symptoms | phecode_819     | General symptoms and other findings                                             | 0.689 (0.683, 0.696) | 0.701 (0.694, 0.707) | 0.011 (0.006, 0.016)    |\n",
       "| Musc/Skel      | phecode_724-5   | Exostosis                                                                       | 0.554 (0.533, 0.567) | 0.562 (0.546, 0.581) | 0.011 (-0.005, 0.024)   |\n",
       "| Eye            | phecode_363     | Disorders of lacrimal system                                                    | 0.667 (0.648, 0.689) | 0.678 (0.659, 0.699) | 0.011 (0.001, 0.019)    |\n",
       "| Musc/Skel      | phecode_721     | Synoviopathy and bursopathy                                                     | 0.556 (0.546, 0.568) | 0.567 (0.556, 0.578) | 0.011 (0.003, 0.018)    |\n",
       "| Cardio         | phecode_419     | Presence of cardiac device                                                      | 0.741 (0.726, 0.754) | 0.752 (0.739, 0.764) | 0.011 (0.004, 0.019)    |\n",
       "| GI             | phecode_513-2   | Gastric ulcer                                                                   | 0.588 (0.57, 0.602)  | 0.598 (0.585, 0.613) | 0.011 (-0.004, 0.024)   |\n",
       "| Derm           | phecode_668     | Dermatitis [eczema]                                                             | 0.552 (0.534, 0.57)  | 0.564 (0.547, 0.58)  | 0.011 (-0.001, 0.024)   |\n",
       "| Cardio         | phecode_440     | Embolism and thrombosis                                                         | 0.633 (0.622, 0.642) | 0.644 (0.635, 0.654) | 0.011 (0.004, 0.019)    |\n",
       "| Signs/Symptoms | phecode_815     | Symptoms and signs concerning food and fluid intake                             | 0.713 (0.688, 0.745) | 0.726 (0.689, 0.756) | 0.011 (-0.016, 0.033)   |\n",
       "| GI             | phecode_504     | Periodontal diseases                                                            | 0.494 (0.467, 0.525) | 0.503 (0.471, 0.548) | 0.011 (-0.024, 0.039)   |\n",
       "| Genitourinary  | phecode_581-31  | Hydronephrosis                                                                  | 0.618 (0.6, 0.637)   | 0.629 (0.611, 0.647) | 0.011 (-0.002, 0.02)    |\n",
       "| Cardio         | phecode_448-1   | Raynaud's syndrome                                                              | 0.608 (0.586, 0.63)  | 0.617 (0.602, 0.643) | 0.011 (-0.003, 0.026)   |\n",
       "| Neoplasms      | phecode_108-41  | Malignant neoplasm of kidney, except pelvis                                     | 0.671 (0.646, 0.701) | 0.681 (0.653, 0.713) | 0.011 (-0.007, 0.027)   |\n",
       "| Genitourinary  | phecode_594-3   | Urinary incontinence                                                            | 0.626 (0.612, 0.638) | 0.637 (0.621, 0.648) | 0.011 (0.002, 0.02)     |\n",
       "| ID             | phecode_089-1   | Bacterial infections                                                            | 0.625 (0.616, 0.635) | 0.636 (0.628, 0.644) | 0.011 (0.004, 0.017)    |\n",
       "| Genitourinary  | phecode_581-3   | Obstructive and reflux uropathy                                                 | 0.623 (0.604, 0.641) | 0.634 (0.614, 0.648) | 0.011 (-0.002, 0.022)   |\n",
       "| Resp           | phecode_483     | Pleural effusion                                                                | 0.68 (0.667, 0.69)   | 0.691 (0.682, 0.704) | 0.011 (0.004, 0.018)    |\n",
       "| Neuro          | phecode_353-1   | Hallucinations                                                                  | 0.631 (0.585, 0.669) | 0.642 (0.603, 0.676) | 0.011 (-0.027, 0.047)   |\n",
       "| Blood          | phecode_181     | Autoimmune disease                                                              | 0.575 (0.566, 0.587) | 0.586 (0.576, 0.597) | 0.012 (0.004, 0.02)     |\n",
       "| Resp           | phecode_487-1   | Epistaxis                                                                       | 0.643 (0.622, 0.667) | 0.655 (0.636, 0.677) | 0.012 (-0.002, 0.025)   |\n",
       "| GI             | phecode_523-4   | Diverticulitis                                                                  | 0.608 (0.567, 0.651) | 0.622 (0.577, 0.665) | 0.012 (-0.025, 0.049)   |\n",
       "| GI             | phecode_554-11  | Acute pancreatitis                                                              | 0.57 (0.545, 0.599)  | 0.584 (0.556, 0.61)  | 0.012 (-0.009, 0.032)   |\n",
       "| Metab          | phecode_239     | Hyperlipidemia                                                                  | 0.682 (0.678, 0.686) | 0.694 (0.691, 0.698) | 0.012 (0.009, 0.014)    |\n",
       "| Cardio         | phecode_401-1   | Essential hypertension                                                          | 0.663 (0.66, 0.667)  | 0.675 (0.672, 0.679) | 0.012 (0.01, 0.014)     |\n",
       "| GI             | phecode_558     | Abnormal findings on diagnostic imaging of the digestive tract                  | 0.578 (0.56, 0.599)  | 0.589 (0.572, 0.609) | 0.012 (-0.004, 0.026)   |\n",
       "| Metab          | phecode_239-11  | Pure hypercholesterolemia                                                       | 0.682 (0.678, 0.688) | 0.695 (0.69, 0.699)  | 0.012 (0.01, 0.015)     |\n",
       "| Metab          | phecode_239-1   | Hypercholesterolemia                                                            | 0.682 (0.677, 0.686) | 0.694 (0.69, 0.698)  | 0.012 (0.01, 0.014)     |\n",
       "| Musc/Skel      | phecode_715-3   | Spondylolisthesis                                                               | 0.667 (0.644, 0.687) | 0.678 (0.654, 0.701) | 0.012 (-0.004, 0.024)   |\n",
       "| Cardio         | phecode_401     | Hypertension                                                                    | 0.664 (0.659, 0.667) | 0.676 (0.672, 0.679) | 0.012 (0.01, 0.014)     |\n",
       "| Musc/Skel      | phecode_715     | Non-inflammatory spondylopathy                                                  | 0.639 (0.63, 0.646)  | 0.65 (0.642, 0.659)  | 0.012 (0.007, 0.017)    |\n",
       "| Metab          | phecode_256     | Disorders of fluid, electrolyte and acid-base balance                           | 0.673 (0.666, 0.682) | 0.686 (0.676, 0.694) | 0.012 (0.006, 0.018)    |\n",
       "| Neoplasms      | phecode_139-5   | Lipoma                                                                          | 0.539 (0.52, 0.56)   | 0.552 (0.535, 0.571) | 0.013 (0.003, 0.021)    |\n",
       "| GI             | phecode_516     | Other diseases of stomach and duodenum                                          | 0.571 (0.556, 0.588) | 0.586 (0.567, 0.601) | 0.013 (0.001, 0.026)    |\n",
       "| Stat           | phecode_983     | Family history of other endocrine and metabolic diseases                        | 0.506 (0.457, 0.545) | 0.515 (0.466, 0.552) | 0.013 (-0.039, 0.057)   |\n",
       "| Musc/Skel      | phecode_705-1   | Rheumatoid arthritis                                                            | 0.626 (0.612, 0.642) | 0.64 (0.625, 0.657)  | 0.013 (0.006, 0.02)     |\n",
       "| Death          | OMOP_4306655    | All-Cause Death                                                                 | 0.708 (0.701, 0.715) | 0.721 (0.715, 0.728) | 0.013 (0.009, 0.017)    |\n",
       "| Signs/Symptoms | phecode_812     | Edema                                                                           | 0.655 (0.64, 0.667)  | 0.666 (0.651, 0.681) | 0.013 (-0.002, 0.022)   |\n",
       "| Musc/Skel      | phecode_723-1   | Adhesive capsulitis of shoulder                                                 | 0.551 (0.522, 0.578) | 0.565 (0.535, 0.596) | 0.013 (-0.009, 0.031)   |\n",
       "| Resp           | phecode_463-21  | Seasonal allergic rhinitis                                                      | 0.447 (0.428, 0.465) | 0.46 (0.44, 0.476)   | 0.013 (-0.003, 0.033)   |\n",
       "| Eye            | phecode_360-4   | Blepharitis                                                                     | 0.629 (0.598, 0.666) | 0.641 (0.604, 0.681) | 0.013 (-0.015, 0.038)   |\n",
       "| Neuro          | phecode_356     | Speech disturbance                                                              | 0.647 (0.621, 0.667) | 0.658 (0.64, 0.682)  | 0.013 (-0.003, 0.028)   |\n",
       "| Cardio         | phecode_424     | Heart failure                                                                   | 0.744 (0.737, 0.754) | 0.759 (0.75, 0.769)  | 0.014 (0.008, 0.02)     |\n",
       "| Eye            | phecode_361     | Disorders of eyelid function                                                    | 0.681 (0.661, 0.698) | 0.694 (0.675, 0.713) | 0.014 (0.003, 0.023)    |\n",
       "| Resp           | phecode_465     | Pharyngitis                                                                     | 0.479 (0.445, 0.508) | 0.493 (0.461, 0.522) | 0.014 (-0.022, 0.052)   |\n",
       "| Genitourinary  | phecode_586     | Other disorders of the kidney and ureters                                       | 0.66 (0.646, 0.676)  | 0.675 (0.661, 0.691) | 0.014 (0.005, 0.025)    |\n",
       "| Eye            | phecode_374-3   | Retinal vascular changes and occlusions                                         | 0.683 (0.655, 0.7)   | 0.698 (0.67, 0.714)  | 0.014 (-0.002, 0.03)    |\n",
       "| Blood          | phecode_169-1   | Thrombocytopenia                                                                | 0.658 (0.642, 0.676) | 0.672 (0.648, 0.691) | 0.014 (-0.001, 0.024)   |\n",
       "| Neuro          | phecode_326     | Demyelinating diseases of the central nervous system                            | 0.593 (0.551, 0.625) | 0.608 (0.572, 0.643) | 0.014 (-0.001, 0.039)   |\n",
       "| Musc/Skel      | phecode_700-2   | Sicca syndrome [Sjogren syndrome]                                               | 0.749 (0.716, 0.791) | 0.766 (0.738, 0.803) | 0.015 (-0.008, 0.038)   |\n",
       "| Blood          | phecode_169     | Platelet defects                                                                | 0.654 (0.633, 0.673) | 0.669 (0.651, 0.685) | 0.015 (-0.001, 0.029)   |\n",
       "| Resp           | phecode_479-6   | Pulmonary collapse [Atelectasis]                                                | 0.644 (0.629, 0.658) | 0.658 (0.643, 0.674) | 0.015 (0.003, 0.026)    |\n",
       "| Cardio         | phecode_440-1   | Venous thromboembolism                                                          | 0.588 (0.575, 0.607) | 0.604 (0.588, 0.619) | 0.015 (0.003, 0.027)    |\n",
       "| Blood          | phecode_168     | Coagulation defects, purpura and other hemorrhagic conditions                   | 0.584 (0.553, 0.604) | 0.597 (0.57, 0.625)  | 0.015 (-0.006, 0.037)   |\n",
       "| GI             | phecode_515     | Heartburn and epigastric pain                                                   | 0.516 (0.49, 0.546)  | 0.53 (0.504, 0.563)  | 0.015 (-0.004, 0.042)   |\n",
       "| Mental         | phecode_283-8   | Other problems related to lifestyle                                             | 0.563 (0.549, 0.575) | 0.578 (0.564, 0.587) | 0.015 (0.007, 0.021)    |\n",
       "| Musc/Skel      | phecode_707     | Other arthropathies                                                             | 0.652 (0.648, 0.658) | 0.668 (0.662, 0.674) | 0.015 (0.011, 0.018)    |\n",
       "| Musc/Skel      | phecode_711     | Disorder of patella                                                             | 0.515 (0.505, 0.527) | 0.531 (0.521, 0.543) | 0.015 (0.004, 0.029)    |\n",
       "| Resp           | phecode_475     | Asthma                                                                          | 0.54 (0.533, 0.545)  | 0.555 (0.548, 0.561) | 0.015 (0.009, 0.022)    |\n",
       "| GI             | phecode_513-1   | Esophageal ulcer                                                                | 0.594 (0.576, 0.621) | 0.61 (0.588, 0.63)   | 0.016 (0.001, 0.028)    |\n",
       "| GI             | phecode_525     | Intestinal malabsorption                                                        | 0.533 (0.512, 0.561) | 0.549 (0.519, 0.573) | 0.016 (-0.008, 0.029)   |\n",
       "| Hearing        | phecode_395-1   | Labyrinthitis                                                                   | 0.535 (0.476, 0.578) | 0.551 (0.498, 0.61)  | 0.016 (-0.013, 0.061)   |\n",
       "| Derm           | phecode_682-11  | Sebaceous cyst [Epidermal cyst]                                                 | 0.503 (0.469, 0.535) | 0.515 (0.478, 0.548) | 0.016 (-0.021, 0.048)   |\n",
       "| Musc/Skel      | phecode_721-11  | Trigger finger                                                                  | 0.575 (0.553, 0.593) | 0.591 (0.568, 0.615) | 0.016 (-0.01, 0.032)    |\n",
       "| GI             | phecode_550-1   | Gallstones [Cholelithiasis]                                                     | 0.556 (0.546, 0.567) | 0.573 (0.561, 0.582) | 0.016 (0.006, 0.024)    |\n",
       "| Signs/Symptoms | phecode_841-3   | Allergy to narcotic agent                                                       | 0.606 (0.587, 0.622) | 0.622 (0.606, 0.639) | 0.016 (0.006, 0.024)    |\n",
       "| Mental         | phecode_288     | Anxiety disorders                                                               | 0.58 (0.572, 0.591)  | 0.597 (0.588, 0.606) | 0.016 (0.009, 0.022)    |\n",
       "| GI             | phecode_546     | Other disorders of liver                                                        | 0.619 (0.606, 0.638) | 0.637 (0.618, 0.656) | 0.016 (0.002, 0.032)    |\n",
       "| Signs/Symptoms | phecode_810     | Shock                                                                           | 0.726 (0.689, 0.759) | 0.739 (0.707, 0.769) | 0.017 (-0.014, 0.044)   |\n",
       "| Neuro          | phecode_351-3   | Paresthesia of skin*                                                            | 0.466 (0.44, 0.498)  | 0.484 (0.461, 0.512) | 0.017 (-0.01, 0.046)    |\n",
       "| Metab          | phecode_256-7   | Volume depletion                                                                | 0.67 (0.656, 0.682)  | 0.686 (0.676, 0.7)   | 0.017 (0.007, 0.027)    |\n",
       "| GI             | phecode_509     | Diseases of tongue                                                              | 0.508 (0.476, 0.532) | 0.524 (0.489, 0.56)  | 0.017 (-0.009, 0.041)   |\n",
       "| Eye            | phecode_361-1   | Entropion and trichiasis of eyelid                                              | 0.728 (0.689, 0.761) | 0.744 (0.714, 0.775) | 0.017 (-0.003, 0.035)   |\n",
       "| Neuro          | phecode_336-1   | Carpal tunnel syndrome                                                          | 0.572 (0.556, 0.587) | 0.589 (0.573, 0.6)   | 0.017 (0.005, 0.027)    |\n",
       "| Resp           | phecode_481     | Interstitial pulmonary diseases                                                 | 0.73 (0.712, 0.751)  | 0.747 (0.726, 0.771) | 0.017 (0.003, 0.029)    |\n",
       "| Genitourinary  | phecode_584     | Renal failure                                                                   | 0.702 (0.675, 0.724) | 0.719 (0.693, 0.743) | 0.017 (-0.002, 0.037)   |\n",
       "| Cardio         | phecode_440-13  | Phlebitis and thrombophlebitis                                                  | 0.589 (0.573, 0.606) | 0.608 (0.59, 0.622)  | 0.017 (0.01, 0.028)     |\n",
       "| Neuro          | phecode_341     | Cerebral palsy and other paralytic syndromes                                    | 0.662 (0.643, 0.687) | 0.679 (0.662, 0.698) | 0.017 (-0.001, 0.031)   |\n",
       "| Genitourinary  | phecode_594-32  | Stress incontinence                                                             | 0.691 (0.675, 0.706) | 0.707 (0.696, 0.721) | 0.018 (0.004, 0.031)    |\n",
       "| Neoplasms      | phecode_116-5   | Secondary malignancy of brain/spine                                             | 0.622 (0.6, 0.65)    | 0.641 (0.618, 0.663) | 0.018 (-0.007, 0.039)   |\n",
       "| Musc/Skel      | phecode_724     | Other symptoms and disorders of the soft tissue                                 | 0.567 (0.557, 0.578) | 0.586 (0.577, 0.597) | 0.018 (0.011, 0.026)    |\n",
       "| Neoplasms      | phecode_106-3   | Malignant neoplasm of the ovary                                                 | 0.598 (0.562, 0.632) | 0.615 (0.584, 0.646) | 0.018 (0, 0.04)         |\n",
       "| Signs/Symptoms | phecode_805     | Fever of unknown origin                                                         | 0.569 (0.555, 0.581) | 0.586 (0.57, 0.6)    | 0.018 (0.005, 0.028)    |\n",
       "| Cardio         | phecode_414     | Cardiomyopathy                                                                  | 0.672 (0.655, 0.692) | 0.69 (0.673, 0.712)  | 0.018 (0.003, 0.028)    |\n",
       "| Neuro          | phecode_329-9   | Delirium                                                                        | 0.752 (0.732, 0.765) | 0.768 (0.757, 0.784) | 0.018 (0.006, 0.032)    |\n",
       "| Cardio         | phecode_440-2   | Arterial embolism and thrombosis                                                | 0.704 (0.681, 0.728) | 0.722 (0.699, 0.744) | 0.018 (0.004, 0.033)    |\n",
       "| Blood          | phecode_160-2   | Megaloblastic anemia                                                            | 0.654 (0.624, 0.677) | 0.671 (0.643, 0.704) | 0.019 (-0.007, 0.041)   |\n",
       "| Musc/Skel      | phecode_716-3   | Spinal disc displacement (herniation)                                           | 0.551 (0.535, 0.567) | 0.57 (0.556, 0.589)  | 0.019 (0.007, 0.031)    |\n",
       "| Musc/Skel      | phecode_700     | Diffuse diseases of connective tissue                                           | 0.662 (0.635, 0.685) | 0.68 (0.653, 0.707)  | 0.019 (-0.003, 0.038)   |\n",
       "| Derm           | phecode_674     | Disorders of pigmentation                                                       | 0.503 (0.471, 0.531) | 0.519 (0.486, 0.556) | 0.019 (-0.016, 0.052)   |\n",
       "| GI             | phecode_526     | Intestinal infection                                                            | 0.591 (0.582, 0.599) | 0.609 (0.6, 0.618)   | 0.019 (0.011, 0.026)    |\n",
       "| Resp           | phecode_463     | Rhinitis and nasal congestion                                                   | 0.452 (0.437, 0.469) | 0.47 (0.457, 0.489)  | 0.019 (0.004, 0.035)    |\n",
       "| Resp           | phecode_468     | Pneumonia                                                                       | 0.674 (0.667, 0.681) | 0.693 (0.686, 0.701) | 0.019 (0.013, 0.024)    |\n",
       "| Resp           | phecode_487     | Hemorrhage from respiratory passages                                            | 0.623 (0.604, 0.64)  | 0.643 (0.626, 0.661) | 0.019 (0.007, 0.03)     |\n",
       "| Neuro          | phecode_335     | Nerve root and plexus disorders                                                 | 0.559 (0.54, 0.572)  | 0.577 (0.563, 0.592) | 0.019 (0.005, 0.033)    |\n",
       "| Musc/Skel      | phecode_715-4   | Spinal stenosis                                                                 | 0.648 (0.636, 0.661) | 0.669 (0.653, 0.682) | 0.019 (0.011, 0.03)     |\n",
       "| Genitourinary  | phecode_581     | Renal tubulo-interstitial diseases                                              | 0.577 (0.56, 0.598)  | 0.597 (0.584, 0.616) | 0.019 (0.007, 0.032)    |\n",
       "| Neuro          | phecode_336     | Mononeuropathies                                                                | 0.556 (0.546, 0.568) | 0.576 (0.566, 0.583) | 0.02 (0.009, 0.027)     |\n",
       "| GI             | phecode_550     | Disorders of the gallbladder                                                    | 0.555 (0.546, 0.568) | 0.575 (0.565, 0.586) | 0.02 (0.009, 0.029)     |\n",
       "| Musc/Skel      | phecode_728     | Chondropathies                                                                  | 0.492 (0.464, 0.517) | 0.511 (0.475, 0.541) | 0.02 (-0.004, 0.043)    |\n",
       "| Neuro          | phecode_348     | Other diseases of spinal cord                                                   | 0.619 (0.594, 0.641) | 0.637 (0.614, 0.668) | 0.02 (-0.001, 0.043)    |\n",
       "| Resp           | phecode_468-9   | Lobar pneumonia*                                                                | 0.679 (0.669, 0.689) | 0.699 (0.688, 0.709) | 0.02 (0.012, 0.028)     |\n",
       "| GI             | phecode_522-12  | Ulcerative colitis                                                              | 0.534 (0.503, 0.555) | 0.553 (0.526, 0.58)  | 0.02 (0, 0.042)         |\n",
       "| Cardio         | phecode_433     | Other cerebrovascular disease                                                   | 0.733 (0.721, 0.745) | 0.753 (0.742, 0.764) | 0.02 (0.012, 0.027)     |\n",
       "| Neuro          | phecode_350     | Other symptoms involving nervous system                                         | 0.697 (0.683, 0.708) | 0.718 (0.705, 0.729) | 0.02 (0.012, 0.029)     |\n",
       "| GI             | phecode_554     | Diseases of the pancreas                                                        | 0.593 (0.575, 0.612) | 0.612 (0.592, 0.633) | 0.02 (0.003, 0.034)     |\n",
       "| Musc/Skel      | phecode_718     | Back pain                                                                       | 0.583 (0.574, 0.593) | 0.603 (0.594, 0.612) | 0.021 (0.013, 0.028)    |\n",
       "| Neuro          | phecode_336-55  | Lesion of plantar nerve                                                         | 0.606 (0.579, 0.638) | 0.629 (0.599, 0.65)  | 0.021 (-0.008, 0.045)   |\n",
       "| Resp           | phecode_468-1   | Viral pneumonia                                                                 | 0.637 (0.607, 0.666) | 0.656 (0.626, 0.695) | 0.021 (-0.016, 0.067)   |\n",
       "| Eye            | phecode_361-4   | Blepharochalasis                                                                | 0.612 (0.567, 0.648) | 0.63 (0.595, 0.668)  | 0.021 (-0.008, 0.05)    |\n",
       "| Neoplasms      | phecode_149-3   | Benign neoplasm of the parathyroid gland                                        | 0.626 (0.592, 0.656) | 0.649 (0.607, 0.676) | 0.021 (-0.004, 0.047)   |\n",
       "| Neuro          | phecode_348-2   | Myelopathies                                                                    | 0.61 (0.58, 0.642)   | 0.629 (0.603, 0.66)  | 0.021 (-0.012, 0.052)   |\n",
       "| Genitourinary  | phecode_627-1   | Postmenopausal bleeding                                                         | 0.425 (0.406, 0.441) | 0.445 (0.426, 0.46)  | 0.021 (0.008, 0.036)    |\n",
       "| Resp           | phecode_479     | Pulmonary insufficiency and acute respiratory distress syndrome                 | 0.656 (0.643, 0.671) | 0.677 (0.663, 0.692) | 0.021 (0.011, 0.029)    |\n",
       "| Genitourinary  | phecode_582     | Acute kidney failure                                                            | 0.704 (0.695, 0.712) | 0.726 (0.718, 0.734) | 0.022 (0.015, 0.028)    |\n",
       "| ID             | phecode_003     | Escherichia coli                                                                | 0.628 (0.616, 0.644) | 0.651 (0.637, 0.663) | 0.022 (0.011, 0.036)    |\n",
       "| Musc/Skel      | phecode_713     | Symptoms related to joints                                                      | 0.578 (0.565, 0.592) | 0.6 (0.587, 0.61)    | 0.022 (0.013, 0.03)     |\n",
       "| Eye            | phecode_386-4   | Visual field defects                                                            | 0.646 (0.601, 0.689) | 0.668 (0.622, 0.718) | 0.022 (-0.023, 0.056)   |\n",
       "| Cardio         | phecode_402     | Elevated blood pressure reading without diagnosis of hypertension               | 0.577 (0.554, 0.602) | 0.599 (0.572, 0.628) | 0.022 (0.004, 0.043)    |\n",
       "| Genitourinary  | phecode_603-5   | Orchitis and epididymitis                                                       | 0.434 (0.381, 0.475) | 0.463 (0.423, 0.502) | 0.022 (-0.02, 0.088)    |\n",
       "| Neuro          | phecode_341-2   | Hemiplegia and hemiparesis                                                      | 0.673 (0.648, 0.697) | 0.695 (0.673, 0.719) | 0.022 (0.003, 0.039)    |\n",
       "| Metab          | phecode_247     | Disorders of mineral metabolism and mineral deficiencies                        | 0.603 (0.595, 0.611) | 0.626 (0.616, 0.635) | 0.022 (0.015, 0.028)    |\n",
       "| Blood          | phecode_164     | Anemia                                                                          | 0.605 (0.598, 0.611) | 0.627 (0.62, 0.634)  | 0.023 (0.015, 0.029)    |\n",
       "| Eye            | phecode_361-3   | Ptosis of eyelid                                                                | 0.657 (0.633, 0.681) | 0.68 (0.656, 0.701)  | 0.023 (0.004, 0.045)    |\n",
       "| Cardio         | phecode_448     | Peripheral vascular disease                                                     | 0.656 (0.64, 0.671)  | 0.679 (0.664, 0.693) | 0.023 (0.013, 0.035)    |\n",
       "| Resp           | phecode_463-1   | Chronic rhinitis                                                                | 0.541 (0.486, 0.581) | 0.56 (0.516, 0.609)  | 0.023 (-0.017, 0.064)   |\n",
       "| Neuro          | phecode_331     | Headache                                                                        | 0.567 (0.559, 0.58)  | 0.59 (0.582, 0.603)  | 0.023 (0.014, 0.032)    |\n",
       "| ID             | phecode_089-2   | Viral infections                                                                | 0.564 (0.553, 0.576) | 0.588 (0.575, 0.601) | 0.024 (0.01, 0.034)     |\n",
       "| Derm           | phecode_665-2   | Psoriatic arthropathy                                                           | 0.506 (0.443, 0.542) | 0.53 (0.485, 0.566)  | 0.024 (-0.019, 0.068)   |\n",
       "| Mental         | phecode_283     | Other behavioral problems                                                       | 0.549 (0.537, 0.56)  | 0.573 (0.564, 0.585) | 0.024 (0.014, 0.034)    |\n",
       "| Hearing        | phecode_391     | Disorders of the middle ear                                                     | 0.524 (0.499, 0.549) | 0.547 (0.524, 0.573) | 0.024 (-0.009, 0.051)   |\n",
       "| Resp           | phecode_491     | Pleurisy                                                                        | 0.687 (0.66, 0.721)  | 0.712 (0.69, 0.737)  | 0.024 (0.01, 0.037)     |\n",
       "| Signs/Symptoms | phecode_800     | Chest pain                                                                      | 0.528 (0.52, 0.536)  | 0.553 (0.546, 0.561) | 0.024 (0.017, 0.032)    |\n",
       "| Metab          | phecode_247-5   | Disorders of calcium metabolism                                                 | 0.64 (0.618, 0.663)  | 0.667 (0.642, 0.69)  | 0.024 (0.004, 0.044)    |\n",
       "| GI             | phecode_557-8   | Hemorrhage of rectum and anus                                                   | 0.472 (0.458, 0.484) | 0.496 (0.477, 0.51)  | 0.025 (0.007, 0.038)    |\n",
       "| Signs/Symptoms | phecode_801     | Cough                                                                           | 0.561 (0.542, 0.575) | 0.586 (0.567, 0.598) | 0.025 (0.007, 0.043)    |\n",
       "| Neuro          | phecode_350-5   | Repeated falls*                                                                 | 0.734 (0.725, 0.744) | 0.757 (0.748, 0.769) | 0.025 (0.016, 0.031)    |\n",
       "| Cardio         | phecode_433-1   | Occlusion and stenosis of cerebral arteries                                     | 0.722 (0.701, 0.746) | 0.748 (0.722, 0.77)  | 0.025 (0.008, 0.044)    |\n",
       "| Neuro          | phecode_331-8   | Headache NOS                                                                    | 0.558 (0.544, 0.57)  | 0.582 (0.568, 0.597) | 0.025 (0.015, 0.037)    |\n",
       "| Metab          | phecode_247-7   | Disorders of iron metabolism                                                    | 0.586 (0.576, 0.597) | 0.611 (0.601, 0.621) | 0.025 (0.016, 0.032)    |\n",
       "| Eye            | phecode_387-3   | Astigmatism                                                                     | 0.674 (0.661, 0.688) | 0.7 (0.685, 0.713)   | 0.025 (0.014, 0.036)    |\n",
       "| Musc/Skel      | phecode_716     | Intervertebral disc disorder                                                    | 0.551 (0.538, 0.565) | 0.577 (0.565, 0.588) | 0.026 (0.013, 0.036)    |\n",
       "| GI             | phecode_550-2   | Cholecystitis                                                                   | 0.559 (0.535, 0.585) | 0.586 (0.562, 0.614) | 0.026 (0.002, 0.056)    |\n",
       "| Cardio         | phecode_411-2   | Pericardial effusion (noninflammatory)*                                         | 0.652 (0.618, 0.677) | 0.674 (0.647, 0.704) | 0.026 (0.003, 0.039)    |\n",
       "| Signs/Symptoms | phecode_809     | Pain                                                                            | 0.579 (0.567, 0.59)  | 0.606 (0.593, 0.615) | 0.026 (0.016, 0.037)    |\n",
       "| Eye            | phecode_369-4   | Corneal degenerations                                                           | 0.73 (0.707, 0.751)  | 0.758 (0.737, 0.78)  | 0.026 (0.006, 0.046)    |\n",
       "| Derm           | phecode_667     | Erythematous conditions                                                         | 0.576 (0.525, 0.616) | 0.597 (0.553, 0.647) | 0.026 (-0.022, 0.069)   |\n",
       "| Signs/Symptoms | phecode_809-3   | Pain in limb                                                                    | 0.565 (0.55, 0.579)  | 0.59 (0.578, 0.607)  | 0.027 (0.015, 0.037)    |\n",
       "| Mental         | phecode_288-2   | Panic disorder [episodic paroxysmal anxiety]                                    | 0.561 (0.533, 0.59)  | 0.589 (0.559, 0.622) | 0.027 (-0.005, 0.069)   |\n",
       "| GI             | phecode_524     | Functional intestinal disorder                                                  | 0.579 (0.568, 0.589) | 0.606 (0.595, 0.619) | 0.027 (0.021, 0.034)    |\n",
       "| Resp           | phecode_488-1   | Dyspnea [Shortness of breath]                                                   | 0.606 (0.595, 0.618) | 0.633 (0.623, 0.643) | 0.027 (0.017, 0.037)    |\n",
       "| Derm           | phecode_679     | Skin symptoms                                                                   | 0.572 (0.556, 0.59)  | 0.598 (0.583, 0.617) | 0.027 (0.01, 0.047)     |\n",
       "| Derm           | phecode_660     | Infection of the skin                                                           | 0.577 (0.568, 0.588) | 0.604 (0.592, 0.615) | 0.027 (0.016, 0.037)    |\n",
       "| Resp           | phecode_462-2   | Chronic sinusitis                                                               | 0.531 (0.509, 0.551) | 0.558 (0.534, 0.585) | 0.027 (0.005, 0.053)    |\n",
       "| Blood          | phecode_160     | Nutritional anemias                                                             | 0.6 (0.589, 0.608)   | 0.628 (0.618, 0.636) | 0.028 (0.02, 0.035)     |\n",
       "| Blood          | phecode_164-1   | Microcytic anemia                                                               | 0.592 (0.582, 0.606) | 0.619 (0.612, 0.631) | 0.028 (0.018, 0.038)    |\n",
       "| Neuro          | phecode_347     | Other disorders of the brain and CNS                                            | 0.58 (0.535, 0.621)  | 0.607 (0.573, 0.639) | 0.028 (-0.004, 0.065)   |\n",
       "| Resp           | phecode_460     | Acute respiratory infection                                                     | 0.629 (0.619, 0.638) | 0.656 (0.647, 0.664) | 0.028 (0.019, 0.035)    |\n",
       "| Metab          | phecode_247-4   | Disorders of magnesium metabolism                                               | 0.661 (0.633, 0.689) | 0.687 (0.658, 0.712) | 0.028 (0.006, 0.042)    |\n",
       "| Cardio         | phecode_417-2   | Tachycardia                                                                     | 0.585 (0.566, 0.602) | 0.613 (0.593, 0.63)  | 0.028 (0.008, 0.038)    |\n",
       "| Derm           | phecode_660-6   | Cellulitis and abscess                                                          | 0.575 (0.563, 0.586) | 0.604 (0.592, 0.614) | 0.028 (0.02, 0.039)     |\n",
       "| Cardio         | phecode_401-3   | Hypertensive chronic kidney disease                                             | 0.703 (0.672, 0.745) | 0.731 (0.696, 0.759) | 0.028 (-0.005, 0.053)   |\n",
       "| Metab          | phecode_232-4   | Vitamin D deficiency                                                            | 0.6 (0.58, 0.621)    | 0.629 (0.612, 0.648) | 0.028 (0.013, 0.043)    |\n",
       "| Musc/Skel      | phecode_718-2   | Cervicalgia                                                                     | 0.604 (0.578, 0.633) | 0.634 (0.608, 0.662) | 0.028 (0.009, 0.053)    |\n",
       "| Blood          | phecode_164-2   | Macrocytic anemia                                                               | 0.649 (0.622, 0.674) | 0.679 (0.647, 0.706) | 0.028 (0.006, 0.052)    |\n",
       "| Blood          | phecode_160-1   | Iron deficiency anemia                                                          | 0.591 (0.581, 0.601) | 0.62 (0.609, 0.628)  | 0.029 (0.019, 0.038)    |\n",
       "| Metab          | phecode_247-72  | Iron deficiency                                                                 | 0.59 (0.58, 0.601)   | 0.619 (0.609, 0.628) | 0.029 (0.021, 0.038)    |\n",
       "| Derm           | phecode_665     | Psoriasis                                                                       | 0.581 (0.559, 0.6)   | 0.609 (0.588, 0.631) | 0.029 (0.009, 0.051)    |\n",
       "| Resp           | phecode_479-3   | Respiratory failure                                                             | 0.671 (0.649, 0.688) | 0.697 (0.68, 0.722)  | 0.029 (0.013, 0.044)    |\n",
       "| Musc/Skel      | phecode_718-1   | Radiculopathy                                                                   | 0.557 (0.533, 0.579) | 0.586 (0.561, 0.615) | 0.029 (0.005, 0.055)    |\n",
       "| Musc/Skel      | phecode_713-3   | Pain in joint                                                                   | 0.581 (0.569, 0.596) | 0.61 (0.597, 0.624)  | 0.029 (0.018, 0.036)    |\n",
       "| Hearing        | phecode_395     | Other diseases of inner ear                                                     | 0.526 (0.499, 0.574) | 0.556 (0.519, 0.598) | 0.029 (-0.008, 0.056)   |\n",
       "| GI             | phecode_555     | Ascites                                                                         | 0.637 (0.611, 0.657) | 0.665 (0.642, 0.692) | 0.029 (0.012, 0.049)    |\n",
       "| Eye            | phecode_377     | Hemorrhage of the eye                                                           | 0.588 (0.557, 0.629) | 0.616 (0.577, 0.672) | 0.029 (-0.038, 0.094)   |\n",
       "| Metab          | phecode_256-4   | Hyperkalemia [Hyperpotassemia]                                                  | 0.698 (0.68, 0.714)  | 0.725 (0.709, 0.747) | 0.029 (0.013, 0.046)    |\n",
       "| Stat           | phecode_979     | Transplated organ                                                               | 0.563 (0.531, 0.591) | 0.594 (0.556, 0.631) | 0.029 (-0.011, 0.077)   |\n",
       "| Neuro          | phecode_325-2   | Abnormality of gait and mobility                                                | 0.683 (0.671, 0.697) | 0.713 (0.703, 0.73)  | 0.03 (0.02, 0.041)      |\n",
       "| Resp           | phecode_486     | Other respiratory disorders                                                     | 0.651 (0.633, 0.665) | 0.681 (0.662, 0.698) | 0.03 (0.014, 0.042)     |\n",
       "| Signs/Symptoms | phecode_807     | Malaise and fatigue                                                             | 0.591 (0.571, 0.61)  | 0.622 (0.606, 0.641) | 0.03 (0.019, 0.043)     |\n",
       "| Neuro          | phecode_330     | Epilepsy, recurrent seizures, convulsions                                       | 0.572 (0.554, 0.589) | 0.602 (0.588, 0.617) | 0.03 (0.013, 0.047)     |\n",
       "| Mental         | phecode_284     | Suicide ideation and attempt or self harm                                       | 0.561 (0.53, 0.595)  | 0.594 (0.56, 0.635)  | 0.03 (-0.008, 0.068)    |\n",
       "| Resp           | phecode_488     | Abnormalities of breathing                                                      | 0.587 (0.576, 0.597) | 0.617 (0.607, 0.628) | 0.03 (0.021, 0.04)      |\n",
       "| Cardio         | phecode_448-9   | Peripheral vascular disease NOS [includes PAD]                                  | 0.755 (0.74, 0.771)  | 0.785 (0.767, 0.798) | 0.03 (0.014, 0.046)     |\n",
       "| Neoplasms      | phecode_138-2   | Melanocytic nevi*                                                               | 0.513 (0.489, 0.539) | 0.548 (0.526, 0.566) | 0.03 (0.013, 0.061)     |\n",
       "| Neuro          | phecode_325     | Symptoms and signs related to movement disorders                                | 0.673 (0.66, 0.687)  | 0.704 (0.692, 0.718) | 0.03 (0.022, 0.039)     |\n",
       "| GI             | phecode_535     | Intestinal or peritoneal adhesions                                              | 0.552 (0.534, 0.564) | 0.582 (0.565, 0.597) | 0.03 (0.018, 0.044)     |\n",
       "| Metab          | phecode_256-6   | Fluid overload                                                                  | 0.723 (0.699, 0.741) | 0.752 (0.731, 0.774) | 0.03 (0.011, 0.046)     |\n",
       "| ID             | phecode_096     | Contact or exposure to infectious agent                                         | 0.596 (0.497, 0.701) | 0.627 (0.507, 0.734) | 0.031 (-0.07, 0.137)    |\n",
       "| Resp           | phecode_468-2   | Bacterial pneumonia                                                             | 0.643 (0.617, 0.669) | 0.672 (0.647, 0.714) | 0.031 (0.011, 0.056)    |\n",
       "| Musc/Skel      | phecode_721-5   | Bursitis                                                                        | 0.499 (0.481, 0.52)  | 0.533 (0.51, 0.55)   | 0.031 (0.012, 0.058)    |\n",
       "| Derm           | phecode_679-1   | Rash and other nonspecific skin eruption                                        | 0.59 (0.564, 0.609)  | 0.621 (0.601, 0.64)  | 0.031 (0.014, 0.05)     |\n",
       "| GI             | phecode_525-1   | Celiac disease                                                                  | 0.522 (0.496, 0.549) | 0.552 (0.521, 0.576) | 0.031 (0.002, 0.053)    |\n",
       "| Genitourinary  | phecode_580     | Glomerular diseases                                                             | 0.659 (0.633, 0.689) | 0.69 (0.661, 0.719)  | 0.031 (0.011, 0.052)    |\n",
       "| Blood          | phecode_177-2   | Enlargement of lymph nodes [Lymphadenopathy]                                    | 0.58 (0.565, 0.597)  | 0.612 (0.593, 0.634) | 0.031 (0.014, 0.046)    |\n",
       "| Resp           | phecode_465-1   | Acute Pharyngitis                                                               | 0.467 (0.434, 0.504) | 0.5 (0.457, 0.534)   | 0.031 (-0.013, 0.061)   |\n",
       "| Metab          | phecode_232     | Vitamin deficiencies                                                            | 0.608 (0.595, 0.625) | 0.64 (0.627, 0.652)  | 0.032 (0.021, 0.043)    |\n",
       "| Musc/Skel      | phecode_707-8   | Polyarthritis                                                                   | 0.421 (0.389, 0.453) | 0.454 (0.423, 0.484) | 0.032 (0.014, 0.047)    |\n",
       "| GI             | phecode_508     | Diseases of lips                                                                | 0.49 (0.435, 0.53)   | 0.521 (0.465, 0.561) | 0.032 (-0.006, 0.072)   |\n",
       "| GI             | phecode_526-1   | Bacterial enteritis                                                             | 0.567 (0.539, 0.585) | 0.594 (0.574, 0.614) | 0.032 (0.013, 0.051)    |\n",
       "| Cardio         | phecode_443-1   | Stricture of artery [Arterial stenosis]                                         | 0.72 (0.688, 0.757)  | 0.752 (0.726, 0.787) | 0.032 (-0.002, 0.062)   |\n",
       "| GI             | phecode_526-2   | Viral enteritis                                                                 | 0.568 (0.544, 0.613) | 0.602 (0.571, 0.633) | 0.033 (-0.002, 0.071)   |\n",
       "| Derm           | phecode_686-1   | Pressure ulcer                                                                  | 0.718 (0.702, 0.734) | 0.749 (0.738, 0.765) | 0.033 (0.021, 0.045)    |\n",
       "| Mental         | phecode_299     | Mental disorder, not otherwise specified                                        | 0.631 (0.587, 0.665) | 0.663 (0.631, 0.695) | 0.033 (-0.002, 0.064)   |\n",
       "| Resp           | phecode_460-2   | Acute lower respiratory infection                                               | 0.645 (0.635, 0.655) | 0.678 (0.669, 0.687) | 0.033 (0.024, 0.04)     |\n",
       "| Musc/Skel      | phecode_723     | Enthesopathy/Enthesitis/Tendinopathy                                            | 0.506 (0.491, 0.517) | 0.539 (0.527, 0.55)  | 0.033 (0.021, 0.045)    |\n",
       "| Metab          | phecode_232-2   | Vitamin B group deficiency                                                      | 0.628 (0.607, 0.649) | 0.663 (0.649, 0.683) | 0.033 (0.02, 0.05)      |\n",
       "| Blood          | phecode_177     | Abnormality of the lymph nodes                                                  | 0.588 (0.576, 0.601) | 0.621 (0.608, 0.635) | 0.033 (0.021, 0.045)    |\n",
       "| GI             | phecode_520-13  | Umbilical hernia                                                                | 0.638 (0.617, 0.656) | 0.67 (0.656, 0.688)  | 0.034 (0.021, 0.045)    |\n",
       "| Musc/Skel      | phecode_702-3   | Enteropathic arthropathies                                                      | 0.497 (0.458, 0.532) | 0.532 (0.499, 0.562) | 0.034 (-0.006, 0.081)   |\n",
       "| ID             | phecode_004     | Streptococcus                                                                   | 0.593 (0.571, 0.615) | 0.627 (0.606, 0.649) | 0.034 (0.016, 0.056)    |\n",
       "| Cardio         | phecode_443     | Other specified disorders of arteries and arterioles                            | 0.698 (0.678, 0.73)  | 0.735 (0.709, 0.763) | 0.034 (0.009, 0.059)    |\n",
       "| Resp           | phecode_462     | Sinusitis                                                                       | 0.519 (0.498, 0.541) | 0.552 (0.528, 0.579) | 0.034 (0.008, 0.059)    |\n",
       "| GI             | phecode_524-1   | Irritable bowel syndrome                                                        | 0.567 (0.556, 0.579) | 0.602 (0.589, 0.613) | 0.035 (0.028, 0.043)    |\n",
       "| Mental         | phecode_284-29  | Intentional self-harm*                                                          | 0.554 (0.524, 0.598) | 0.593 (0.56, 0.625)  | 0.035 (-0.003, 0.075)   |\n",
       "| Derm           | phecode_686     | Chronic ulcer of skin                                                           | 0.706 (0.69, 0.72)   | 0.74 (0.726, 0.758)  | 0.035 (0.022, 0.044)    |\n",
       "| Metab          | phecode_256-1   | Hyperosmolality and/or hypernatremia                                            | 0.67 (0.632, 0.702)  | 0.708 (0.666, 0.744) | 0.035 (0.012, 0.071)    |\n",
       "| Derm           | phecode_682-1   | Cutaneous cyst                                                                  | 0.455 (0.43, 0.476)  | 0.49 (0.468, 0.507)  | 0.036 (0.015, 0.062)    |\n",
       "| Musc/Skel      | phecode_724-1   | Myalgia                                                                         | 0.61 (0.592, 0.632)  | 0.647 (0.627, 0.667) | 0.037 (0.025, 0.047)    |\n",
       "| Eye            | phecode_386     | Visual disturbances                                                             | 0.591 (0.573, 0.608) | 0.626 (0.609, 0.645) | 0.037 (0.02, 0.048)     |\n",
       "| Signs/Symptoms | phecode_835     | Cytology and pathology findings                                                 | 0.44 (0.406, 0.492)  | 0.474 (0.428, 0.521) | 0.037 (-0.006, 0.076)   |\n",
       "| ID             | phecode_002     | Staphylococcus                                                                  | 0.629 (0.617, 0.652) | 0.668 (0.652, 0.686) | 0.038 (0.021, 0.051)    |\n",
       "| GI             | phecode_507     | Lesions of mouth                                                                | 0.351 (0.331, 0.374) | 0.39 (0.367, 0.412)  | 0.038 (0.021, 0.054)    |\n",
       "| GI             | phecode_557-1   | Hematemesis                                                                     | 0.629 (0.605, 0.654) | 0.666 (0.642, 0.688) | 0.038 (0.014, 0.06)     |\n",
       "| Metab          | phecode_256-3   | Mixed disorder of acid-base balance                                             | 0.657 (0.636, 0.68)  | 0.694 (0.676, 0.714) | 0.038 (0.018, 0.055)    |\n",
       "| Neuro          | phecode_326-1   | Multiple sclerosis                                                              | 0.568 (0.528, 0.604) | 0.608 (0.566, 0.64)  | 0.039 (0.016, 0.069)    |\n",
       "| Genitourinary  | phecode_614-5   | Inflammatory disease of cervix, vagina, and vulva                               | 0.439 (0.397, 0.478) | 0.479 (0.431, 0.518) | 0.039 (0.009, 0.077)    |\n",
       "| GI             | phecode_537     | Abnormality of the peritoneum                                                   | 0.539 (0.511, 0.569) | 0.576 (0.546, 0.603) | 0.039 (-0.002, 0.064)   |\n",
       "| Neuro          | phecode_355     | Coma and other alteration of consciousness                                      | 0.597 (0.563, 0.625) | 0.634 (0.596, 0.666) | 0.039 (0.009, 0.073)    |\n",
       "| Neoplasms      | phecode_102     | Malignant neoplasm of the thoracic and respiratory organs                       | 0.674 (0.659, 0.686) | 0.713 (0.699, 0.725) | 0.039 (0.027, 0.049)    |\n",
       "| Metab          | phecode_247-3   | Disorder of phosphorus metabolism                                               | 0.631 (0.603, 0.653) | 0.67 (0.644, 0.701)  | 0.04 (0.014, 0.065)     |\n",
       "| Neuro          | phecode_344-1   | Hydrocephalus                                                                   | 0.631 (0.588, 0.666) | 0.667 (0.626, 0.709) | 0.04 (-0.006, 0.084)    |\n",
       "| Signs/Symptoms | phecode_800-2   | Precordial pain                                                                 | 0.509 (0.496, 0.522) | 0.549 (0.535, 0.564) | 0.04 (0.024, 0.056)     |\n",
       "| Metab          | phecode_244     | Disorders of lipoprotein metabolism and other lipidemias                        | 0.602 (0.573, 0.635) | 0.644 (0.606, 0.684) | 0.04 (0.015, 0.071)     |\n",
       "| Neoplasms      | phecode_104     | Malignant sarcoma-related cancers                                               | 0.52 (0.487, 0.55)   | 0.559 (0.524, 0.593) | 0.04 (0.009, 0.07)      |\n",
       "| Stat           | phecode_997     | Family history of other condition                                               | 0.697 (0.681, 0.716) | 0.737 (0.72, 0.759)  | 0.04 (0.026, 0.054)     |\n",
       "| GI             | phecode_502     | Other diseases of teeth and supporting structures                               | 0.489 (0.47, 0.508)  | 0.532 (0.511, 0.552) | 0.041 (0.021, 0.063)    |\n",
       "| Eye            | phecode_374-5   | Macular degeneration                                                            | 0.742 (0.73, 0.754)  | 0.785 (0.772, 0.793) | 0.041 (0.033, 0.05)     |\n",
       "| Resp           | phecode_472     | Diseases of vocal cords and larynx, not elsewhere classified                    | 0.582 (0.552, 0.608) | 0.62 (0.6, 0.656)    | 0.041 (0, 0.068)        |\n",
       "| Blood          | phecode_168-2   | Hyper-coagulability                                                             | 0.514 (0.477, 0.557) | 0.557 (0.52, 0.605)  | 0.042 (0.01, 0.083)     |\n",
       "| GI             | phecode_540     | Hepatitis                                                                       | 0.546 (0.513, 0.576) | 0.588 (0.552, 0.622) | 0.042 (0.011, 0.066)    |\n",
       "| Musc/Skel      | phecode_713-2   | Effusion of joint                                                               | 0.577 (0.551, 0.609) | 0.619 (0.594, 0.653) | 0.043 (0.015, 0.071)    |\n",
       "| Metab          | phecode_256-31  | Acidosis                                                                        | 0.655 (0.632, 0.675) | 0.696 (0.676, 0.716) | 0.043 (0.02, 0.064)     |\n",
       "| ID             | phecode_002-1   | Staphylococcus aureus                                                           | 0.617 (0.589, 0.642) | 0.66 (0.635, 0.687)  | 0.044 (0.022, 0.061)    |\n",
       "| Mental         | phecode_284-2   | Suicide and self-inflicted harm                                                 | 0.554 (0.525, 0.593) | 0.598 (0.565, 0.631) | 0.044 (0.001, 0.083)    |\n",
       "| Mental         | phecode_308     | Signs and symptoms involving emotional state                                    | 0.562 (0.53, 0.592)  | 0.605 (0.582, 0.63)  | 0.044 (0.01, 0.076)     |\n",
       "| ID             | phecode_052-3   | Varicella zoster virus                                                          | 0.545 (0.508, 0.587) | 0.591 (0.542, 0.636) | 0.044 (-0.003, 0.083)   |\n",
       "| Musc/Skel      | phecode_723-6   | Impingement syndrome of shoulder*                                               | 0.48 (0.466, 0.501)  | 0.523 (0.51, 0.542)  | 0.044 (0.028, 0.062)    |\n",
       "| Derm           | phecode_674-2   | Hypepigmentation                                                                | 0.492 (0.444, 0.545) | 0.535 (0.501, 0.58)  | 0.045 (-0.011, 0.1)     |\n",
       "| GI             | phecode_542-4   | Portal hypertension                                                             | 0.631 (0.597, 0.664) | 0.676 (0.623, 0.717) | 0.045 (0.005, 0.082)    |\n",
       "| Neuro          | phecode_344     | Disorders of the circulation of the cerebrospinal fluid                         | 0.553 (0.516, 0.587) | 0.597 (0.562, 0.633) | 0.045 (0.009, 0.083)    |\n",
       "| Genitourinary  | phecode_619-2   | Disorders of uterus, NEC                                                        | 0.412 (0.383, 0.43)  | 0.458 (0.428, 0.479) | 0.046 (0.024, 0.068)    |\n",
       "| Derm           | phecode_682-12  | Pilar and trichodermal cyst                                                     | 0.453 (0.434, 0.477) | 0.501 (0.478, 0.526) | 0.046 (0.022, 0.074)    |\n",
       "| Resp           | phecode_495     | Abnormal findings on diagnostic imaging of lung                                 | 0.63 (0.611, 0.649)  | 0.679 (0.658, 0.694) | 0.047 (0.033, 0.066)    |\n",
       "| Resp           | phecode_474     | Chronic obstructive pulmonary disease [COPD]                                    | 0.681 (0.673, 0.69)  | 0.728 (0.718, 0.736) | 0.047 (0.039, 0.054)    |\n",
       "| Eye            | phecode_367     | Inflammation of the eye                                                         | 0.592 (0.571, 0.617) | 0.639 (0.613, 0.663) | 0.048 (0.014, 0.067)    |\n",
       "| Resp           | phecode_487-3   | Hemoptysis                                                                      | 0.582 (0.554, 0.604) | 0.624 (0.6, 0.653)   | 0.048 (0.022, 0.068)    |\n",
       "| Eye            | phecode_375-1   | Glaucoma                                                                        | 0.708 (0.697, 0.72)  | 0.757 (0.746, 0.77)  | 0.048 (0.039, 0.058)    |\n",
       "| Neoplasms      | phecode_102-1   | Malignant neoplasm of the of bronchus and lung                                  | 0.676 (0.663, 0.692) | 0.724 (0.711, 0.738) | 0.049 (0.036, 0.06)     |\n",
       "| Neuro          | phecode_330-1   | Epilepsy                                                                        | 0.541 (0.522, 0.564) | 0.591 (0.57, 0.612)  | 0.049 (0.026, 0.069)    |\n",
       "| Musc/Skel      | phecode_718-5   | Sciatica                                                                        | 0.591 (0.568, 0.618) | 0.639 (0.616, 0.661) | 0.049 (0.029, 0.07)     |\n",
       "| GI             | phecode_542-3   | Hepatic failure                                                                 | 0.643 (0.611, 0.677) | 0.696 (0.66, 0.727)  | 0.049 (0.015, 0.079)    |\n",
       "| ID             | phecode_059     | Coronavirus                                                                     | 0.644 (0.599, 0.683) | 0.69 (0.651, 0.732)  | 0.05 (0.008, 0.086)     |\n",
       "| Neuro          | phecode_324-4   | Tremor                                                                          | 0.647 (0.616, 0.672) | 0.693 (0.669, 0.721) | 0.051 (0.028, 0.08)     |\n",
       "| Resp           | phecode_474-1   | Emphysema                                                                       | 0.695 (0.679, 0.714) | 0.748 (0.726, 0.762) | 0.051 (0.033, 0.072)    |\n",
       "| ID             | phecode_052-32  | Herpes zoster                                                                   | 0.554 (0.51, 0.596)  | 0.604 (0.566, 0.653) | 0.052 (0.004, 0.093)    |\n",
       "| Derm           | phecode_682     | Other follicular disorders                                                      | 0.456 (0.439, 0.473) | 0.507 (0.486, 0.523) | 0.052 (0.03, 0.071)     |\n",
       "| Metab          | phecode_248     | Disorders of plasma-protein metabolism, NEC                                     | 0.617 (0.582, 0.66)  | 0.67 (0.617, 0.716)  | 0.052 (0.012, 0.085)    |\n",
       "| Musc/Skel      | phecode_718-4   | Low back pain                                                                   | 0.533 (0.512, 0.548) | 0.585 (0.565, 0.597) | 0.053 (0.038, 0.071)    |\n",
       "| Eye            | phecode_375     | Abnormal intraocular pressure                                                   | 0.697 (0.688, 0.706) | 0.75 (0.739, 0.758)  | 0.053 (0.044, 0.063)    |\n",
       "| Mental         | phecode_280-1   | Alcohol use disorders                                                           | 0.622 (0.605, 0.635) | 0.675 (0.658, 0.688) | 0.053 (0.04, 0.064)     |\n",
       "| ID             | phecode_098     | Carrier or suspected carrier of infectious diseases                             | 0.559 (0.538, 0.583) | 0.61 (0.586, 0.637)  | 0.054 (0.029, 0.076)    |\n",
       "| Genitourinary  | phecode_613     | Other nonmalignant breast conditions                                            | 0.445 (0.4, 0.485)   | 0.5 (0.461, 0.532)   | 0.055 (0.014, 0.089)    |\n",
       "| Mental         | phecode_280     | Substance related disorders                                                     | 0.616 (0.603, 0.628) | 0.67 (0.652, 0.685)  | 0.055 (0.042, 0.068)    |\n",
       "| Derm           | phecode_664     | Papulosquamous disorders                                                        | 0.554 (0.514, 0.598) | 0.612 (0.553, 0.647) | 0.055 (0.011, 0.097)    |\n",
       "| Derm           | phecode_686-2   | Non-pressure chronic ulcer                                                      | 0.7 (0.676, 0.723)   | 0.753 (0.736, 0.777) | 0.056 (0.033, 0.076)    |\n",
       "| GI             | phecode_537-1   | Peritonitis                                                                     | 0.503 (0.476, 0.528) | 0.556 (0.529, 0.588) | 0.056 (0.022, 0.088)    |\n",
       "| Neoplasms      | phecode_138     | Benign neoplasm of the skin                                                     | 0.469 (0.452, 0.486) | 0.525 (0.51, 0.538)  | 0.057 (0.037, 0.071)    |\n",
       "| Genitourinary  | phecode_619-4   | Noninflammatory disorders of vagina                                             | 0.445 (0.397, 0.49)  | 0.501 (0.451, 0.54)  | 0.057 (0.01, 0.103)     |\n",
       "| Neuro          | phecode_337     | Polyneuropathies                                                                | 0.62 (0.602, 0.643)  | 0.679 (0.66, 0.697)  | 0.058 (0.04, 0.075)     |\n",
       "| Blood          | phecode_164-6   | Anemia secondary to chronic diseases and conditions                             | 0.631 (0.594, 0.675) | 0.687 (0.655, 0.724) | 0.058 (0.019, 0.09)     |\n",
       "| Mental         | phecode_286     | Mood [affective] disorders                                                      | 0.543 (0.532, 0.55)  | 0.6 (0.592, 0.608)   | 0.058 (0.051, 0.064)    |\n",
       "| ID             | phecode_056     | Human papillomavirus                                                            | 0.407 (0.368, 0.448) | 0.465 (0.418, 0.512) | 0.059 (0.025, 0.095)    |\n",
       "| Derm           | phecode_681     | Localized swelling, mass and lump of skin and subcutaneous tissue               | 0.503 (0.474, 0.53)  | 0.56 (0.535, 0.582)  | 0.059 (0.027, 0.086)    |\n",
       "| Genitourinary  | phecode_619-5   | Noninflammatory disorders of vulva and perineum                                 | 0.404 (0.36, 0.447)  | 0.458 (0.428, 0.496) | 0.059 (0.011, 0.109)    |\n",
       "| Mental         | phecode_286-2   | Major depressive disorder                                                       | 0.545 (0.538, 0.552) | 0.605 (0.597, 0.611) | 0.059 (0.052, 0.069)    |\n",
       "| Eye            | phecode_374     | Disorders of the retina                                                         | 0.678 (0.669, 0.686) | 0.737 (0.728, 0.747) | 0.06 (0.052, 0.069)     |\n",
       "| Genitourinary  | phecode_583-1   | End stage renal disease [CDK, stage 5]                                          | 0.7 (0.674, 0.728)   | 0.76 (0.74, 0.789)   | 0.06 (0.033, 0.081)     |\n",
       "| Neuro          | phecode_333     | Sleep disorders                                                                 | 0.556 (0.544, 0.567) | 0.616 (0.603, 0.63)  | 0.061 (0.047, 0.074)    |\n",
       "| Neuro          | phecode_336-2   | Lesion of median, ulnar, radial nerve                                           | 0.517 (0.49, 0.546)  | 0.578 (0.544, 0.604) | 0.061 (0.037, 0.088)    |\n",
       "| Eye            | phecode_371     | Cataract                                                                        | 0.739 (0.734, 0.744) | 0.801 (0.796, 0.804) | 0.062 (0.057, 0.065)    |\n",
       "| Neuro          | phecode_333-1   | Sleep apnea                                                                     | 0.561 (0.547, 0.579) | 0.624 (0.614, 0.641) | 0.063 (0.052, 0.076)    |\n",
       "| Mental         | phecode_280-11  | Alcohol abuse                                                                   | 0.632 (0.617, 0.654) | 0.697 (0.677, 0.715) | 0.064 (0.05, 0.083)     |\n",
       "| Eye            | phecode_376-2   | Vitreous opacities                                                              | 0.659 (0.629, 0.686) | 0.724 (0.708, 0.744) | 0.065 (0.036, 0.098)    |\n",
       "| Mental         | phecode_286-1   | Bipolar disorder                                                                | 0.504 (0.464, 0.543) | 0.568 (0.534, 0.61)  | 0.066 (0.028, 0.105)    |\n",
       "| Eye            | phecode_376     | Disorders of vitreous body                                                      | 0.659 (0.636, 0.683) | 0.724 (0.703, 0.745) | 0.066 (0.04, 0.091)     |\n",
       "| Eye            | phecode_371-3   | Nuclear cataract                                                                | 0.742 (0.737, 0.751) | 0.81 (0.804, 0.817)  | 0.067 (0.061, 0.073)    |\n",
       "| ID             | phecode_059-1   | COVID-19*                                                                       | 0.627 (0.583, 0.673) | 0.691 (0.659, 0.732) | 0.068 (0.017, 0.11)     |\n",
       "| Eye            | phecode_371-31  | Age-related nuclear cataract                                                    | 0.742 (0.735, 0.749) | 0.81 (0.805, 0.817)  | 0.068 (0.062, 0.075)    |\n",
       "| GI             | phecode_542-1   | Fibrosis and cirrhosis of liver                                                 | 0.638 (0.61, 0.667)  | 0.706 (0.675, 0.737) | 0.069 (0.04, 0.092)     |\n",
       "| Mental         | phecode_280-13  | Alcoholic liver disease                                                         | 0.68 (0.646, 0.711)  | 0.75 (0.717, 0.78)   | 0.07 (0.035, 0.102)     |\n",
       "| Eye            | phecode_369     | Noninflammatory disorders of the cornea                                         | 0.698 (0.676, 0.721) | 0.768 (0.751, 0.789) | 0.07 (0.054, 0.086)     |\n",
       "| Eye            | phecode_375-12  | Angle-Closure Glaucoma                                                          | 0.681 (0.638, 0.718) | 0.753 (0.714, 0.793) | 0.071 (0.031, 0.108)    |\n",
       "| ID             | phecode_052     | Herpesvirus                                                                     | 0.544 (0.511, 0.575) | 0.613 (0.583, 0.651) | 0.071 (0.033, 0.106)    |\n",
       "| Neuro          | phecode_355-2   | Alteration of consciousness                                                     | 0.587 (0.546, 0.625) | 0.66 (0.617, 0.697)  | 0.071 (0.023, 0.113)    |\n",
       "| Endo           | phecode_202     | Diabetes mellitus                                                               | 0.635 (0.627, 0.641) | 0.706 (0.7, 0.712)   | 0.072 (0.065, 0.078)    |\n",
       "| Neuro          | phecode_351     | Disturbances of skin sensation                                                  | 0.451 (0.432, 0.472) | 0.521 (0.5, 0.544)   | 0.072 (0.042, 0.099)    |\n",
       "| Mental         | phecode_281-1   | Substance abuse                                                                 | 0.62 (0.598, 0.641)  | 0.692 (0.673, 0.707) | 0.072 (0.055, 0.087)    |\n",
       "| Endo           | phecode_202-2   | Type 2 diabetes                                                                 | 0.636 (0.631, 0.643) | 0.71 (0.705, 0.715)  | 0.073 (0.068, 0.079)    |\n",
       "| Cardio         | phecode_418     | Abnormal results of cardiovascular function studies                             | 0.541 (0.506, 0.569) | 0.612 (0.58, 0.641)  | 0.074 (0.046, 0.109)    |\n",
       "| GI             | phecode_540-1   | Chronic hepatitis                                                               | 0.531 (0.499, 0.573) | 0.615 (0.579, 0.658) | 0.084 (0.047, 0.122)    |\n",
       "| Endo           | phecode_211     | Disorders of adrenal glands                                                     | 0.527 (0.491, 0.56)  | 0.611 (0.576, 0.661) | 0.085 (0.046, 0.138)    |\n",
       "| GI             | phecode_542     | Chronic liver disease and sequelae                                              | 0.565 (0.551, 0.58)  | 0.652 (0.642, 0.668) | 0.089 (0.068, 0.106)    |\n",
       "| Eye            | phecode_388     | Blindness and low vision                                                        | 0.617 (0.589, 0.652) | 0.709 (0.676, 0.751) | 0.092 (0.05, 0.128)     |\n",
       "| Metab          | phecode_236-1   | Obesity                                                                         | 0.523 (0.515, 0.529) | 0.615 (0.608, 0.622) | 0.093 (0.084, 0.103)    |\n",
       "| Metab          | phecode_236     | Overweight and obesity                                                          | 0.523 (0.516, 0.529) | 0.618 (0.611, 0.624) | 0.095 (0.086, 0.102)    |\n",
       "| Eye            | phecode_387     | Disorders of refraction and accommodation                                       | 0.677 (0.666, 0.69)  | 0.776 (0.765, 0.786) | 0.097 (0.084, 0.109)    |\n",
       "| Eye            | phecode_366     | Noninflammatory disorders of conjunctiva                                        | 0.549 (0.513, 0.589) | 0.649 (0.607, 0.705) | 0.098 (0.057, 0.136)    |\n",
       "| Eye            | phecode_360-2   | Chalazion                                                                       | 0.318 (0.287, 0.347) | 0.417 (0.382, 0.459) | 0.099 (0.074, 0.127)    |\n",
       "| Mental         | phecode_280-12  | Alcohol dependence                                                              | 0.607 (0.584, 0.633) | 0.709 (0.684, 0.729) | 0.101 (0.071, 0.127)    |\n",
       "| Eye            | phecode_375-11  | Open angle glaucoma                                                             | 0.711 (0.687, 0.732) | 0.814 (0.795, 0.833) | 0.103 (0.085, 0.121)    |\n",
       "| GI             | phecode_542-2   | Fatty liver disease (FLD)                                                       | 0.525 (0.506, 0.549) | 0.63 (0.611, 0.648)  | 0.105 (0.077, 0.13)     |\n",
       "| Mental         | phecode_287     | Psychotic disorder                                                              | 0.491 (0.446, 0.539) | 0.602 (0.559, 0.638) | 0.106 (0.059, 0.141)    |\n",
       "| Derm           | phecode_688     | Granulomatous disorder of the skin                                              | 0.431 (0.404, 0.464) | 0.54 (0.505, 0.566)  | 0.107 (0.067, 0.138)    |\n",
       "| GI             | phecode_501     | Dental caries                                                                   | 0.427 (0.41, 0.447)  | 0.536 (0.518, 0.552) | 0.108 (0.091, 0.128)    |\n",
       "| Derm           | phecode_688-1   | Sarcoidosis                                                                     | 0.447 (0.402, 0.474) | 0.563 (0.521, 0.613) | 0.119 (0.072, 0.169)    |\n",
       "| Mental         | phecode_281     | Substance abuse, dependence, and withdrawl                                      | 0.539 (0.531, 0.547) | 0.665 (0.657, 0.672) | 0.126 (0.116, 0.135)    |\n",
       "| Eye            | phecode_386-1   | Amblyopia                                                                       | 0.646 (0.618, 0.684) | 0.77 (0.731, 0.798)  | 0.126 (0.089, 0.155)    |\n",
       "| Endo           | phecode_205     | Hypoglycemia                                                                    | 0.669 (0.646, 0.696) | 0.797 (0.771, 0.815) | 0.128 (0.101, 0.155)    |\n",
       "| Mental         | phecode_282-1   | Current tobacco use and nicotine dependence                                     | 0.53 (0.521, 0.539)  | 0.66 (0.652, 0.667)  | 0.129 (0.119, 0.141)    |\n",
       "| Eye            | phecode_374-1   | Retinal detachments and breaks                                                  | 0.598 (0.574, 0.623) | 0.727 (0.708, 0.75)  | 0.129 (0.1, 0.154)      |\n",
       "| Mental         | phecode_282     | Nicotine dependence (current and history of)                                    | 0.53 (0.519, 0.537)  | 0.66 (0.653, 0.665)  | 0.129 (0.122, 0.14)     |\n",
       "| Mental         | phecode_283-4   | Patient's noncompliance with medical treatment and regimen                      | 0.53 (0.498, 0.569)  | 0.666 (0.635, 0.694) | 0.133 (0.097, 0.172)    |\n",
       "| Mental         | phecode_281-2   | Substance dependence                                                            | 0.528 (0.518, 0.535) | 0.666 (0.661, 0.673) | 0.138 (0.132, 0.146)    |\n",
       "| Endo           | phecode_202-1   | Type 1 diabetes                                                                 | 0.583 (0.563, 0.618) | 0.728 (0.709, 0.752) | 0.145 (0.12, 0.171)     |\n",
       "| Eye            | phecode_374-4   | Retinal disorders in diseases classified elsewhere                              | 0.685 (0.655, 0.704) | 0.836 (0.822, 0.853) | 0.153 (0.135, 0.179)    |\n",
       "| Musc/Skel      | phecode_716-2   | Degenerative disc disease                                                       | 0.325 (0.288, 0.373) | 0.488 (0.443, 0.535) | 0.156 (0.117, 0.201)    |\n",
       "| Neuro          | phecode_337-8   | Polyneuropathy in diseases classified elsewhere                                 | 0.629 (0.594, 0.67)  | 0.805 (0.779, 0.829) | 0.175 (0.139, 0.204)    |\n",
       "| Eye            | phecode_387-2   | Myopia                                                                          | 0.609 (0.59, 0.633)  | 0.869 (0.858, 0.884) | 0.259 (0.239, 0.281)    |\n",
       "| Blood          | phecode_165     | Hemoglobinopathies                                                              | 0.602 (0.551, 0.656) | 0.868 (0.84, 0.905)  | 0.265 (0.21, 0.324)     |\n",
       "\n"
      ],
      "text/plain": [
       "    phecode_category endpoint       \n",
       "1   Blood            phecode_168-1  \n",
       "2   GI               phecode_552-1  \n",
       "3   Blood            phecode_180    \n",
       "4   Musc/Skel        phecode_721-6  \n",
       "5   GI               phecode_520-15 \n",
       "6   Musc/Skel        phecode_702    \n",
       "7   Cardio           phecode_430-1  \n",
       "8   Neuro            phecode_329-1  \n",
       "9   GI               phecode_532-4  \n",
       "10  Hearing          phecode_397-1  \n",
       "11  Neuro            phecode_324-3  \n",
       "12  Genitourinary    phecode_601-12 \n",
       "13  Cardio           phecode_423    \n",
       "14  Hearing          phecode_397    \n",
       "15  Musc/Skel        phecode_704    \n",
       "16  GI               phecode_506    \n",
       "17  Endo             phecode_200-22 \n",
       "18  Genitourinary    phecode_625    \n",
       "19  GI               phecode_504-32 \n",
       "20  Cardio           phecode_423-1  \n",
       "21  Eye              phecode_360    \n",
       "22  GI               phecode_530-3  \n",
       "23  Resp             phecode_494    \n",
       "24  GI               phecode_522-7  \n",
       "25  Neoplasms        phecode_123    \n",
       "26  Blood            phecode_180-3  \n",
       "27  Musc/Skel        phecode_710-3  \n",
       "28  Neoplasms        phecode_122-22 \n",
       "29  Genitourinary    phecode_610    \n",
       "30  Neoplasms        phecode_139-61 \n",
       "31  Eye              phecode_363-7  \n",
       "32  Neoplasms        phecode_139-6  \n",
       "33  Neoplasms        phecode_124    \n",
       "34  Cardio           phecode_438-12 \n",
       "35  Blood            phecode_180-31 \n",
       "36  Neoplasms        phecode_109-3  \n",
       "37  Neoplasms        phecode_123-1  \n",
       "38  Cardio           phecode_413-22 \n",
       "39  Neuro            phecode_328-7  \n",
       "40  Genitourinary    phecode_603    \n",
       "41  Neuro            phecode_349    \n",
       "42  GI               phecode_530-1  \n",
       "43  Neoplasms        phecode_121-2  \n",
       "44  Neoplasms        phecode_109    \n",
       "45  Endo             phecode_200-23 \n",
       "46  Derm             phecode_679-4  \n",
       "47  GI               phecode_529-2  \n",
       "48  Neoplasms        phecode_148-2  \n",
       "49  Neoplasms        phecode_121    \n",
       "50  Genitourinary    phecode_601    \n",
       "51  Neoplasms        phecode_106-2  \n",
       "52  Resp             phecode_466    \n",
       "53  Genitourinary    phecode_601-1  \n",
       "54  Genitourinary    phecode_608    \n",
       "55  Stat             phecode_990    \n",
       "56  Neoplasms        phecode_106-21 \n",
       "57  Musc/Skel        phecode_710    \n",
       "58  Genitourinary    phecode_603-1  \n",
       "59  Neuro            phecode_356-2  \n",
       "60  Neoplasms        phecode_139-54 \n",
       "61  GI               phecode_532-1  \n",
       "62  Hearing          phecode_390    \n",
       "63  Neoplasms        phecode_120-1  \n",
       "64  Hearing          phecode_394-21 \n",
       "65  Neuro            phecode_346    \n",
       "66  Genitourinary    phecode_628    \n",
       "67  ID               phecode_009    \n",
       "68  Blood            phecode_172    \n",
       "69  Neoplasms        phecode_135    \n",
       "70  Neoplasms        phecode_144-1  \n",
       "71  Mental           phecode_288-4  \n",
       "72  Neoplasms        phecode_121-21 \n",
       "73  GI               phecode_500    \n",
       "74  ID               phecode_011    \n",
       "75  GI               phecode_503-5  \n",
       "76  Musc/Skel        phecode_712    \n",
       "77  Musc/Skel        phecode_719    \n",
       "78  GI               phecode_500-4  \n",
       "79  Musc/Skel        phecode_721-2  \n",
       "80  Signs/Symptoms   phecode_841-13 \n",
       "81  Mental           phecode_308-7  \n",
       "82  Genitourinary    phecode_602    \n",
       "83  Cardio           phecode_416-5  \n",
       "84  GI               phecode_556-3  \n",
       "85  Cardio           phecode_416-52 \n",
       "86  Neoplasms        phecode_149    \n",
       "87  Genitourinary    phecode_614-1  \n",
       "88  Genitourinary    phecode_596-3  \n",
       "89  GI               phecode_500-41 \n",
       "90  Endo             phecode_208-21 \n",
       "91  Eye              phecode_381    \n",
       "92  GI               phecode_520-14 \n",
       "93  Neoplasms        phecode_144-3  \n",
       "94  Genitourinary    phecode_592-12 \n",
       "95  Genitourinary    phecode_622-2  \n",
       "96  Genitourinary    phecode_624    \n",
       "97  Resp             phecode_488-8  \n",
       "98  Cardio           phecode_410    \n",
       "99  Musc/Skel        phecode_708-12 \n",
       "100 GI               phecode_514-3  \n",
       "101 Cardio           phecode_416-12 \n",
       "102 Neoplasms        phecode_148    \n",
       "103 Cardio           phecode_431-2  \n",
       "104 Derm             phecode_685-82 \n",
       "105 Genitourinary    phecode_628-2  \n",
       "106 Genitourinary    phecode_599    \n",
       "107 Cardio           phecode_417-1  \n",
       "108 Cardio           phecode_433-2  \n",
       "109 Endo             phecode_209    \n",
       "110 Neoplasms        phecode_120-21 \n",
       "111 Neoplasms        phecode_122-2  \n",
       "112 Neoplasms        phecode_120    \n",
       "113 Neoplasms        phecode_120-2  \n",
       "114 Endo             phecode_200-3  \n",
       "115 Cardio           phecode_416-11 \n",
       "116 Neoplasms        phecode_101-8  \n",
       "117 Neoplasms        phecode_144-13 \n",
       "118 Musc/Skel        phecode_708-11 \n",
       "119 Neuro            phecode_324-1  \n",
       "120 Hearing          phecode_396-2  \n",
       "121 Neuro            phecode_324-11 \n",
       "122 Musc/Skel        phecode_714    \n",
       "123 Cardio           phecode_433-21 \n",
       "124 Genitourinary    phecode_622-1  \n",
       "125 Genitourinary    phecode_618-11 \n",
       "126 ID               phecode_095    \n",
       "127 Genitourinary    phecode_622    \n",
       "128 Resp             phecode_471-2  \n",
       "129 Resp             phecode_460-1  \n",
       "130 Blood            phecode_170-1  \n",
       "131 Resp             phecode_473    \n",
       "132 Derm             phecode_685-8  \n",
       "133 Neoplasms        phecode_106    \n",
       "134 Genitourinary    phecode_594-4  \n",
       "135 Neuro            phecode_328-1  \n",
       "136 GI               phecode_503    \n",
       "137 Derm             phecode_676-2  \n",
       "138 Cardio           phecode_416-7  \n",
       "139 Blood            phecode_170    \n",
       "140 Blood            phecode_162    \n",
       "141 Cardio           phecode_416-43 \n",
       "142 Signs/Symptoms   phecode_814    \n",
       "143 GI               phecode_510-8  \n",
       "144 Neoplasms        phecode_108-5  \n",
       "145 Cardio           phecode_416-71 \n",
       "146 Resp             phecode_471    \n",
       "147 GI               phecode_518    \n",
       "148 Genitourinary    phecode_596-1  \n",
       "149 Genitourinary    phecode_614    \n",
       "150 GI               phecode_504-3  \n",
       "151 Neoplasms        phecode_139-53 \n",
       "152 Cardio           phecode_413-6  \n",
       "153 Eye              phecode_362    \n",
       "154 Neoplasms        phecode_136-2  \n",
       "155 ID               phecode_089-3  \n",
       "156 Genitourinary    phecode_626-14 \n",
       "157 Neoplasms        phecode_101-6  \n",
       "158 Genitourinary    phecode_619-3  \n",
       "159 Genitourinary    phecode_627    \n",
       "160 Neoplasms        phecode_122    \n",
       "161 Neoplasms        phecode_101-1  \n",
       "162 Cardio           phecode_417-3  \n",
       "163 Eye              phecode_386-2  \n",
       "164 Neoplasms        phecode_116-3  \n",
       "165 Cardio           phecode_440-3  \n",
       "166 Genitourinary    phecode_592-1  \n",
       "167 Endo             phecode_208    \n",
       "168 Musc/Skel        phecode_705-3  \n",
       "169 ID               phecode_070    \n",
       "170 GI               phecode_513-3  \n",
       "171 Cong             phecode_773    \n",
       "172 Genitourinary    phecode_618-12 \n",
       "173 Genitourinary    phecode_618-1  \n",
       "174 Neoplasms        phecode_105    \n",
       "175 Derm             phecode_676    \n",
       "176 Genitourinary    phecode_594-1  \n",
       "177 Neuro            phecode_328-9  \n",
       "178 Cardio           phecode_416-42 \n",
       "179 Genitourinary    phecode_615    \n",
       "180 Genitourinary    phecode_592    \n",
       "181 Genitourinary    phecode_626-1  \n",
       "182 Cardio           phecode_438-1  \n",
       "183 Neoplasms        phecode_101-4  \n",
       "184 Endo             phecode_208-2  \n",
       "185 GI               phecode_532    \n",
       "186 Genitourinary    phecode_618    \n",
       "187 Neuro            phecode_328    \n",
       "188 Neoplasms        phecode_101-41 \n",
       "189 Signs/Symptoms   phecode_840    \n",
       "190 Signs/Symptoms   phecode_808    \n",
       "191 Mental           phecode_290    \n",
       "192 Genitourinary    phecode_593    \n",
       "193 Genitourinary    phecode_594    \n",
       "194 GI               phecode_517    \n",
       "195 Musc/Skel        phecode_709-21 \n",
       "196 Blood            phecode_174-2  \n",
       "197 Hearing          phecode_394-2  \n",
       "198 Blood            phecode_174    \n",
       "199 Cardio           phecode_416-1  \n",
       "200 Metab            phecode_256-2  \n",
       "201 Cardio           phecode_404-11 \n",
       "202 Neoplasms        phecode_132    \n",
       "203 Neoplasms        phecode_107    \n",
       "204 Cardio           phecode_406-1  \n",
       "205 Neoplasms        phecode_107-2  \n",
       "206 Genitourinary    phecode_627-4  \n",
       "207 Cardio           phecode_416-21 \n",
       "208 Musc/Skel        phecode_708-1  \n",
       "209 Cardio           phecode_416-41 \n",
       "210 GI               phecode_510    \n",
       "211 Genitourinary    phecode_600    \n",
       "212 Neoplasms        phecode_101-42 \n",
       "213 GI               phecode_520-11 \n",
       "214 GI               phecode_520-1  \n",
       "215 Neoplasms        phecode_135-5  \n",
       "216 GI               phecode_552-2  \n",
       "217 Resp             phecode_471-5  \n",
       "218 Cardio           phecode_416-211\n",
       "219 Neoplasms        phecode_116-4  \n",
       "220 Cardio           phecode_413-11 \n",
       "221 Neoplasms        phecode_101    \n",
       "222 Genitourinary    phecode_626    \n",
       "223 Cardio           phecode_444-11 \n",
       "224 Genitourinary    phecode_604    \n",
       "225 GI               phecode_529-3  \n",
       "226 Cardio           phecode_400    \n",
       "227 GI               phecode_552    \n",
       "228 Neoplasms        phecode_136-42 \n",
       "229 Hearing          phecode_391-1  \n",
       "230 Derm             phecode_668-4  \n",
       "231 Cardio           phecode_446-2  \n",
       "232 Cardio           phecode_413-32 \n",
       "233 Cardio           phecode_416-212\n",
       "234 Cardio           phecode_438-11 \n",
       "235 Neoplasms        phecode_116    \n",
       "236 GI               phecode_514-2  \n",
       "237 GI               phecode_520    \n",
       "238 Cardio           phecode_416-4  \n",
       "239 Resp             phecode_480    \n",
       "240 Musc/Skel        phecode_709-24 \n",
       "241 Neoplasms        phecode_144-2  \n",
       "242 Genitourinary    phecode_580-3  \n",
       "243 Cardio           phecode_400-2  \n",
       "244 Neoplasms        phecode_130    \n",
       "245 Neoplasms        phecode_103-1  \n",
       "246 Derm             phecode_670    \n",
       "247 Neoplasms        phecode_136    \n",
       "248 Cardio           phecode_403    \n",
       "249 Metab            phecode_230-3  \n",
       "250 Genitourinary    phecode_619    \n",
       "251 GI               phecode_510-2  \n",
       "252 Genitourinary    phecode_594-2  \n",
       "253 Endo             phecode_200-13 \n",
       "254 Neoplasms        phecode_112    \n",
       "255 Endo             phecode_200-2  \n",
       "256 Neoplasms        phecode_144    \n",
       "257 Musc/Skel        phecode_722    \n",
       "258 Musc/Skel        phecode_722-4  \n",
       "259 GI               phecode_523    \n",
       "260 Musc/Skel        phecode_709    \n",
       "261 GI               phecode_557    \n",
       "262 GI               phecode_530    \n",
       "263 Resp             phecode_478    \n",
       "264 GI               phecode_523-2  \n",
       "265 Neoplasms        phecode_116-1  \n",
       "266 GI               phecode_529    \n",
       "267 Hearing          phecode_394    \n",
       "268 Neoplasms        phecode_139    \n",
       "269 Endo             phecode_200    \n",
       "270 Musc/Skel        phecode_709-2  \n",
       "271 Genitourinary    phecode_618-2  \n",
       "272 Cardio           phecode_413-2  \n",
       "273 Resp             phecode_469    \n",
       "274 Musc/Skel        phecode_714-3  \n",
       "275 GI               phecode_514-1  \n",
       "276 Cardio           phecode_431    \n",
       "277 Genitourinary    phecode_597    \n",
       "278 Metab            phecode_232-27 \n",
       "279 Endo             phecode_200-1  \n",
       "280 Neoplasms        phecode_136-4  \n",
       "281 GI               phecode_556    \n",
       "282 Musc/Skel        phecode_727    \n",
       "283 Derm             phecode_685    \n",
       "284 Endo             phecode_200-14 \n",
       "285 Neoplasms        phecode_136-41 \n",
       "286 Cardio           phecode_436    \n",
       "287 GI               phecode_520-2  \n",
       "288 Neuro            phecode_353    \n",
       "289 Genitourinary    phecode_585    \n",
       "290 Genitourinary    phecode_591    \n",
       "291 ID               phecode_092    \n",
       "292 Cardio           phecode_406    \n",
       "293 Neoplasms        phecode_108    \n",
       "294 Neoplasms        phecode_144-21 \n",
       "295 Signs/Symptoms   phecode_840-8  \n",
       "296 Resp             phecode_476    \n",
       "297 Cardio           phecode_416    \n",
       "298 Signs/Symptoms   phecode_829    \n",
       "299 Cardio           phecode_413-1  \n",
       "300 Musc/Skel        phecode_723-2  \n",
       "301 Neuro            phecode_331-6  \n",
       "302 Signs/Symptoms   phecode_841-1  \n",
       "303 Cardio           phecode_410-2  \n",
       "304 Signs/Symptoms   phecode_841    \n",
       "305 Neoplasms        phecode_103-3  \n",
       "306 Musc/Skel        phecode_726    \n",
       "307 Cardio           phecode_404-2  \n",
       "308 Cardio           phecode_416-2  \n",
       "309 Musc/Skel        phecode_726-1  \n",
       "310 Genitourinary    phecode_627-3  \n",
       "311 Cardio           phecode_438    \n",
       "312 Cardio           phecode_413    \n",
       "313 Signs/Symptoms   phecode_841-12 \n",
       "314 Neoplasms        phecode_116-6  \n",
       "315 ID               phecode_092-2  \n",
       "316 Cardio           phecode_431-12 \n",
       "317 Cardio           phecode_430    \n",
       "318 GI               phecode_529-5  \n",
       "319 Cardio           phecode_431-1  \n",
       "320 GI               phecode_522-1  \n",
       "321 Cardio           phecode_420    \n",
       "322 GI               phecode_554-2  \n",
       "323 Cardio           phecode_404    \n",
       "324 Neuro            phecode_327    \n",
       "325 GI               phecode_545    \n",
       "326 Neuro            phecode_330-3  \n",
       "327 GI               phecode_511    \n",
       "328 Genitourinary    phecode_596    \n",
       "329 Neuro            phecode_324    \n",
       "330 GI               phecode_522-11 \n",
       "331 Cardio           phecode_426    \n",
       "332 GI               phecode_514    \n",
       "333 Signs/Symptoms   phecode_848    \n",
       "334 Derm             phecode_678    \n",
       "335 Stat             phecode_981    \n",
       "336 Musc/Skel        phecode_708-7  \n",
       "337 GI               phecode_522    \n",
       "338 Musc/Skel        phecode_708    \n",
       "339 GI               phecode_557-2  \n",
       "340 Endo             phecode_204    \n",
       "341 Hearing          phecode_394-1  \n",
       "342 Neoplasms        phecode_100    \n",
       "343 Derm             phecode_673    \n",
       "344 Genitourinary    phecode_597-1  \n",
       "345 Cardio           phecode_431-11 \n",
       "346 Derm             phecode_673-1  \n",
       "347 Derm             phecode_680    \n",
       "348 Musc/Skel        phecode_703    \n",
       "349 Musc/Skel        phecode_721-1  \n",
       "350 Cardio           phecode_404-1  \n",
       "351 Musc/Skel        phecode_705    \n",
       "352 GI               phecode_522-9  \n",
       "353 ID               phecode_015-2  \n",
       "354 Neuro            phecode_334-2  \n",
       "355 Neoplasms        phecode_116-2  \n",
       "356 Hearing          phecode_396    \n",
       "357 Musc/Skel        phecode_708-8  \n",
       "358 Resp             phecode_468-8  \n",
       "359 Metab            phecode_256-5  \n",
       "360 Neuro            phecode_334    \n",
       "361 Cardio           phecode_444    \n",
       "362 Cardio           phecode_439    \n",
       "363 ID               phecode_015    \n",
       "364 Genitourinary    phecode_583    \n",
       "365 Musc/Skel        phecode_703-11 \n",
       "366 Cardio           phecode_413-21 \n",
       "367 GI               phecode_513    \n",
       "368 Cardio           phecode_413-3  \n",
       "369 Resp             phecode_484    \n",
       "370 Cardio           phecode_444-1  \n",
       "371 Musc/Skel        phecode_703-1  \n",
       "372 Cardio           phecode_411    \n",
       "373 Cardio           phecode_446    \n",
       "374 Neuro            phecode_334-21 \n",
       "375 Stat             phecode_988    \n",
       "376 Musc/Skel        phecode_726-2  \n",
       "377 Musc/Skel        phecode_724-52 \n",
       "378 Cardio           phecode_425    \n",
       "379 GI               phecode_554-1  \n",
       "380 GI               phecode_528    \n",
       "381 Blood            phecode_177-4  \n",
       "382 GI               phecode_528-2  \n",
       "383 Musc/Skel        phecode_709-22 \n",
       "384 GI               phecode_522-8  \n",
       "385 Metab            phecode_230-21 \n",
       "386 Metab            phecode_230    \n",
       "387 GI               phecode_528-1  \n",
       "388 Cardio           phecode_414-2  \n",
       "389 Resp             phecode_463-2  \n",
       "390 GI               phecode_527    \n",
       "391 Signs/Symptoms   phecode_841-4  \n",
       "392 Signs/Symptoms   phecode_841-11 \n",
       "393 Cardio           phecode_417    \n",
       "394 Musc/Skel        phecode_711-1  \n",
       "395 Cardio           phecode_437    \n",
       "396 Genitourinary    phecode_586-2  \n",
       "397 Neuro            phecode_329    \n",
       "398 ID               phecode_061    \n",
       "399 Neoplasms        phecode_108-4  \n",
       "400 Musc/Skel        phecode_712-1  \n",
       "401 Neoplasms        phecode_103    \n",
       "402 Metab            phecode_230-2  \n",
       "403 Neoplasms        phecode_101-2  \n",
       "404 Musc/Skel        phecode_706    \n",
       "405 Musc/Skel        phecode_715-1  \n",
       "406 Cardio           phecode_430-2  \n",
       "407 Neuro            phecode_336-5  \n",
       "408 GI               phecode_556-8  \n",
       "409 GI               phecode_526-12 \n",
       "410 GI               phecode_512    \n",
       "411 Cardio           phecode_447    \n",
       "412 Neuro            phecode_354    \n",
       "413 Cardio           phecode_424-1  \n",
       "414 ID               phecode_089    \n",
       "415 Signs/Symptoms   phecode_819    \n",
       "416 Musc/Skel        phecode_724-5  \n",
       "417 Eye              phecode_363    \n",
       "418 Musc/Skel        phecode_721    \n",
       "419 Cardio           phecode_419    \n",
       "420 GI               phecode_513-2  \n",
       "421 Derm             phecode_668    \n",
       "422 Cardio           phecode_440    \n",
       "423 Signs/Symptoms   phecode_815    \n",
       "424 GI               phecode_504    \n",
       "425 Genitourinary    phecode_581-31 \n",
       "426 Cardio           phecode_448-1  \n",
       "427 Neoplasms        phecode_108-41 \n",
       "428 Genitourinary    phecode_594-3  \n",
       "429 ID               phecode_089-1  \n",
       "430 Genitourinary    phecode_581-3  \n",
       "431 Resp             phecode_483    \n",
       "432 Neuro            phecode_353-1  \n",
       "433 Blood            phecode_181    \n",
       "434 Resp             phecode_487-1  \n",
       "435 GI               phecode_523-4  \n",
       "436 GI               phecode_554-11 \n",
       "437 Metab            phecode_239    \n",
       "438 Cardio           phecode_401-1  \n",
       "439 GI               phecode_558    \n",
       "440 Metab            phecode_239-11 \n",
       "441 Metab            phecode_239-1  \n",
       "442 Musc/Skel        phecode_715-3  \n",
       "443 Cardio           phecode_401    \n",
       "444 Musc/Skel        phecode_715    \n",
       "445 Metab            phecode_256    \n",
       "446 Neoplasms        phecode_139-5  \n",
       "447 GI               phecode_516    \n",
       "448 Stat             phecode_983    \n",
       "449 Musc/Skel        phecode_705-1  \n",
       "450 Death            OMOP_4306655   \n",
       "451 Signs/Symptoms   phecode_812    \n",
       "452 Musc/Skel        phecode_723-1  \n",
       "453 Resp             phecode_463-21 \n",
       "454 Eye              phecode_360-4  \n",
       "455 Neuro            phecode_356    \n",
       "456 Cardio           phecode_424    \n",
       "457 Eye              phecode_361    \n",
       "458 Resp             phecode_465    \n",
       "459 Genitourinary    phecode_586    \n",
       "460 Eye              phecode_374-3  \n",
       "461 Blood            phecode_169-1  \n",
       "462 Neuro            phecode_326    \n",
       "463 Musc/Skel        phecode_700-2  \n",
       "464 Blood            phecode_169    \n",
       "465 Resp             phecode_479-6  \n",
       "466 Cardio           phecode_440-1  \n",
       "467 Blood            phecode_168    \n",
       "468 GI               phecode_515    \n",
       "469 Mental           phecode_283-8  \n",
       "470 Musc/Skel        phecode_707    \n",
       "471 Musc/Skel        phecode_711    \n",
       "472 Resp             phecode_475    \n",
       "473 GI               phecode_513-1  \n",
       "474 GI               phecode_525    \n",
       "475 Hearing          phecode_395-1  \n",
       "476 Derm             phecode_682-11 \n",
       "477 Musc/Skel        phecode_721-11 \n",
       "478 GI               phecode_550-1  \n",
       "479 Signs/Symptoms   phecode_841-3  \n",
       "480 Mental           phecode_288    \n",
       "481 GI               phecode_546    \n",
       "482 Signs/Symptoms   phecode_810    \n",
       "483 Neuro            phecode_351-3  \n",
       "484 Metab            phecode_256-7  \n",
       "485 GI               phecode_509    \n",
       "486 Eye              phecode_361-1  \n",
       "487 Neuro            phecode_336-1  \n",
       "488 Resp             phecode_481    \n",
       "489 Genitourinary    phecode_584    \n",
       "490 Cardio           phecode_440-13 \n",
       "491 Neuro            phecode_341    \n",
       "492 Genitourinary    phecode_594-32 \n",
       "493 Neoplasms        phecode_116-5  \n",
       "494 Musc/Skel        phecode_724    \n",
       "495 Neoplasms        phecode_106-3  \n",
       "496 Signs/Symptoms   phecode_805    \n",
       "497 Cardio           phecode_414    \n",
       "498 Neuro            phecode_329-9  \n",
       "499 Cardio           phecode_440-2  \n",
       "500 Blood            phecode_160-2  \n",
       "501 Musc/Skel        phecode_716-3  \n",
       "502 Musc/Skel        phecode_700    \n",
       "503 Derm             phecode_674    \n",
       "504 GI               phecode_526    \n",
       "505 Resp             phecode_463    \n",
       "506 Resp             phecode_468    \n",
       "507 Resp             phecode_487    \n",
       "508 Neuro            phecode_335    \n",
       "509 Musc/Skel        phecode_715-4  \n",
       "510 Genitourinary    phecode_581    \n",
       "511 Neuro            phecode_336    \n",
       "512 GI               phecode_550    \n",
       "513 Musc/Skel        phecode_728    \n",
       "514 Neuro            phecode_348    \n",
       "515 Resp             phecode_468-9  \n",
       "516 GI               phecode_522-12 \n",
       "517 Cardio           phecode_433    \n",
       "518 Neuro            phecode_350    \n",
       "519 GI               phecode_554    \n",
       "520 Musc/Skel        phecode_718    \n",
       "521 Neuro            phecode_336-55 \n",
       "522 Resp             phecode_468-1  \n",
       "523 Eye              phecode_361-4  \n",
       "524 Neoplasms        phecode_149-3  \n",
       "525 Neuro            phecode_348-2  \n",
       "526 Genitourinary    phecode_627-1  \n",
       "527 Resp             phecode_479    \n",
       "528 Genitourinary    phecode_582    \n",
       "529 ID               phecode_003    \n",
       "530 Musc/Skel        phecode_713    \n",
       "531 Eye              phecode_386-4  \n",
       "532 Cardio           phecode_402    \n",
       "533 Genitourinary    phecode_603-5  \n",
       "534 Neuro            phecode_341-2  \n",
       "535 Metab            phecode_247    \n",
       "536 Blood            phecode_164    \n",
       "537 Eye              phecode_361-3  \n",
       "538 Cardio           phecode_448    \n",
       "539 Resp             phecode_463-1  \n",
       "540 Neuro            phecode_331    \n",
       "541 ID               phecode_089-2  \n",
       "542 Derm             phecode_665-2  \n",
       "543 Mental           phecode_283    \n",
       "544 Hearing          phecode_391    \n",
       "545 Resp             phecode_491    \n",
       "546 Signs/Symptoms   phecode_800    \n",
       "547 Metab            phecode_247-5  \n",
       "548 GI               phecode_557-8  \n",
       "549 Signs/Symptoms   phecode_801    \n",
       "550 Neuro            phecode_350-5  \n",
       "551 Cardio           phecode_433-1  \n",
       "552 Neuro            phecode_331-8  \n",
       "553 Metab            phecode_247-7  \n",
       "554 Eye              phecode_387-3  \n",
       "555 Musc/Skel        phecode_716    \n",
       "556 GI               phecode_550-2  \n",
       "557 Cardio           phecode_411-2  \n",
       "558 Signs/Symptoms   phecode_809    \n",
       "559 Eye              phecode_369-4  \n",
       "560 Derm             phecode_667    \n",
       "561 Signs/Symptoms   phecode_809-3  \n",
       "562 Mental           phecode_288-2  \n",
       "563 GI               phecode_524    \n",
       "564 Resp             phecode_488-1  \n",
       "565 Derm             phecode_679    \n",
       "566 Derm             phecode_660    \n",
       "567 Resp             phecode_462-2  \n",
       "568 Blood            phecode_160    \n",
       "569 Blood            phecode_164-1  \n",
       "570 Neuro            phecode_347    \n",
       "571 Resp             phecode_460    \n",
       "572 Metab            phecode_247-4  \n",
       "573 Cardio           phecode_417-2  \n",
       "574 Derm             phecode_660-6  \n",
       "575 Cardio           phecode_401-3  \n",
       "576 Metab            phecode_232-4  \n",
       "577 Musc/Skel        phecode_718-2  \n",
       "578 Blood            phecode_164-2  \n",
       "579 Blood            phecode_160-1  \n",
       "580 Metab            phecode_247-72 \n",
       "581 Derm             phecode_665    \n",
       "582 Resp             phecode_479-3  \n",
       "583 Musc/Skel        phecode_718-1  \n",
       "584 Musc/Skel        phecode_713-3  \n",
       "585 Hearing          phecode_395    \n",
       "586 GI               phecode_555    \n",
       "587 Eye              phecode_377    \n",
       "588 Metab            phecode_256-4  \n",
       "589 Stat             phecode_979    \n",
       "590 Neuro            phecode_325-2  \n",
       "591 Resp             phecode_486    \n",
       "592 Signs/Symptoms   phecode_807    \n",
       "593 Neuro            phecode_330    \n",
       "594 Mental           phecode_284    \n",
       "595 Resp             phecode_488    \n",
       "596 Cardio           phecode_448-9  \n",
       "597 Neoplasms        phecode_138-2  \n",
       "598 Neuro            phecode_325    \n",
       "599 GI               phecode_535    \n",
       "600 Metab            phecode_256-6  \n",
       "601 ID               phecode_096    \n",
       "602 Resp             phecode_468-2  \n",
       "603 Musc/Skel        phecode_721-5  \n",
       "604 Derm             phecode_679-1  \n",
       "605 GI               phecode_525-1  \n",
       "606 Genitourinary    phecode_580    \n",
       "607 Blood            phecode_177-2  \n",
       "608 Resp             phecode_465-1  \n",
       "609 Metab            phecode_232    \n",
       "610 Musc/Skel        phecode_707-8  \n",
       "611 GI               phecode_508    \n",
       "612 GI               phecode_526-1  \n",
       "613 Cardio           phecode_443-1  \n",
       "614 GI               phecode_526-2  \n",
       "615 Derm             phecode_686-1  \n",
       "616 Mental           phecode_299    \n",
       "617 Resp             phecode_460-2  \n",
       "618 Musc/Skel        phecode_723    \n",
       "619 Metab            phecode_232-2  \n",
       "620 Blood            phecode_177    \n",
       "621 GI               phecode_520-13 \n",
       "622 Musc/Skel        phecode_702-3  \n",
       "623 ID               phecode_004    \n",
       "624 Cardio           phecode_443    \n",
       "625 Resp             phecode_462    \n",
       "626 GI               phecode_524-1  \n",
       "627 Mental           phecode_284-29 \n",
       "628 Derm             phecode_686    \n",
       "629 Metab            phecode_256-1  \n",
       "630 Derm             phecode_682-1  \n",
       "631 Musc/Skel        phecode_724-1  \n",
       "632 Eye              phecode_386    \n",
       "633 Signs/Symptoms   phecode_835    \n",
       "634 ID               phecode_002    \n",
       "635 GI               phecode_507    \n",
       "636 GI               phecode_557-1  \n",
       "637 Metab            phecode_256-3  \n",
       "638 Neuro            phecode_326-1  \n",
       "639 Genitourinary    phecode_614-5  \n",
       "640 GI               phecode_537    \n",
       "641 Neuro            phecode_355    \n",
       "642 Neoplasms        phecode_102    \n",
       "643 Metab            phecode_247-3  \n",
       "644 Neuro            phecode_344-1  \n",
       "645 Signs/Symptoms   phecode_800-2  \n",
       "646 Metab            phecode_244    \n",
       "647 Neoplasms        phecode_104    \n",
       "648 Stat             phecode_997    \n",
       "649 GI               phecode_502    \n",
       "650 Eye              phecode_374-5  \n",
       "651 Resp             phecode_472    \n",
       "652 Blood            phecode_168-2  \n",
       "653 GI               phecode_540    \n",
       "654 Musc/Skel        phecode_713-2  \n",
       "655 Metab            phecode_256-31 \n",
       "656 ID               phecode_002-1  \n",
       "657 Mental           phecode_284-2  \n",
       "658 Mental           phecode_308    \n",
       "659 ID               phecode_052-3  \n",
       "660 Musc/Skel        phecode_723-6  \n",
       "661 Derm             phecode_674-2  \n",
       "662 GI               phecode_542-4  \n",
       "663 Neuro            phecode_344    \n",
       "664 Genitourinary    phecode_619-2  \n",
       "665 Derm             phecode_682-12 \n",
       "666 Resp             phecode_495    \n",
       "667 Resp             phecode_474    \n",
       "668 Eye              phecode_367    \n",
       "669 Resp             phecode_487-3  \n",
       "670 Eye              phecode_375-1  \n",
       "671 Neoplasms        phecode_102-1  \n",
       "672 Neuro            phecode_330-1  \n",
       "673 Musc/Skel        phecode_718-5  \n",
       "674 GI               phecode_542-3  \n",
       "675 ID               phecode_059    \n",
       "676 Neuro            phecode_324-4  \n",
       "677 Resp             phecode_474-1  \n",
       "678 ID               phecode_052-32 \n",
       "679 Derm             phecode_682    \n",
       "680 Metab            phecode_248    \n",
       "681 Musc/Skel        phecode_718-4  \n",
       "682 Eye              phecode_375    \n",
       "683 Mental           phecode_280-1  \n",
       "684 ID               phecode_098    \n",
       "685 Genitourinary    phecode_613    \n",
       "686 Mental           phecode_280    \n",
       "687 Derm             phecode_664    \n",
       "688 Derm             phecode_686-2  \n",
       "689 GI               phecode_537-1  \n",
       "690 Neoplasms        phecode_138    \n",
       "691 Genitourinary    phecode_619-4  \n",
       "692 Neuro            phecode_337    \n",
       "693 Blood            phecode_164-6  \n",
       "694 Mental           phecode_286    \n",
       "695 ID               phecode_056    \n",
       "696 Derm             phecode_681    \n",
       "697 Genitourinary    phecode_619-5  \n",
       "698 Mental           phecode_286-2  \n",
       "699 Eye              phecode_374    \n",
       "700 Genitourinary    phecode_583-1  \n",
       "701 Neuro            phecode_333    \n",
       "702 Neuro            phecode_336-2  \n",
       "703 Eye              phecode_371    \n",
       "704 Neuro            phecode_333-1  \n",
       "705 Mental           phecode_280-11 \n",
       "706 Eye              phecode_376-2  \n",
       "707 Mental           phecode_286-1  \n",
       "708 Eye              phecode_376    \n",
       "709 Eye              phecode_371-3  \n",
       "710 ID               phecode_059-1  \n",
       "711 Eye              phecode_371-31 \n",
       "712 GI               phecode_542-1  \n",
       "713 Mental           phecode_280-13 \n",
       "714 Eye              phecode_369    \n",
       "715 Eye              phecode_375-12 \n",
       "716 ID               phecode_052    \n",
       "717 Neuro            phecode_355-2  \n",
       "718 Endo             phecode_202    \n",
       "719 Neuro            phecode_351    \n",
       "720 Mental           phecode_281-1  \n",
       "721 Endo             phecode_202-2  \n",
       "722 Cardio           phecode_418    \n",
       "723 GI               phecode_540-1  \n",
       "724 Endo             phecode_211    \n",
       "725 GI               phecode_542    \n",
       "726 Eye              phecode_388    \n",
       "727 Metab            phecode_236-1  \n",
       "728 Metab            phecode_236    \n",
       "729 Eye              phecode_387    \n",
       "730 Eye              phecode_366    \n",
       "731 Eye              phecode_360-2  \n",
       "732 Mental           phecode_280-12 \n",
       "733 Eye              phecode_375-11 \n",
       "734 GI               phecode_542-2  \n",
       "735 Mental           phecode_287    \n",
       "736 Derm             phecode_688    \n",
       "737 GI               phecode_501    \n",
       "738 Derm             phecode_688-1  \n",
       "739 Mental           phecode_281    \n",
       "740 Eye              phecode_386-1  \n",
       "741 Endo             phecode_205    \n",
       "742 Mental           phecode_282-1  \n",
       "743 Eye              phecode_374-1  \n",
       "744 Mental           phecode_282    \n",
       "745 Mental           phecode_283-4  \n",
       "746 Mental           phecode_281-2  \n",
       "747 Endo             phecode_202-1  \n",
       "748 Eye              phecode_374-4  \n",
       "749 Musc/Skel        phecode_716-2  \n",
       "750 Neuro            phecode_337-8  \n",
       "751 Eye              phecode_387-2  \n",
       "752 Blood            phecode_165    \n",
       "    phecode_string                                                                 \n",
       "1   Hypo-coagulability                                                             \n",
       "2   Cholangitis                                                                    \n",
       "3   Other disorders involving the immune mechanism                                 \n",
       "4   Baker's cyst [popliteal cyst]                                                  \n",
       "5   Incisional hernia                                                              \n",
       "6   Infective and reactive arthropathies                                           \n",
       "7   Nontraumatic subarachnoid hemorrhage                                           \n",
       "8   Memory loss                                                                    \n",
       "9   Volvulus                                                                       \n",
       "10  Tinnitus                                                                       \n",
       "11  Dystonia                                                                       \n",
       "12  Chronic prostatitis                                                            \n",
       "13  Abnormal cardiac sounds                                                        \n",
       "14  Other hearing abnormality                                                      \n",
       "15  Systemic vasculitis                                                            \n",
       "16  Diseases of salivary glands                                                    \n",
       "17  Uninodular goiter [single thyroid nodule]                                      \n",
       "18  Pain and other symptoms associated with female genital organs                  \n",
       "19  Chronic periodontitis                                                          \n",
       "20  Cardiac murmurs                                                                \n",
       "21  Inflammation of eyelids                                                        \n",
       "22  Rectal prolapse                                                                \n",
       "23  Voice disturbance                                                              \n",
       "24  Ulceration of the lower GI tract                                               \n",
       "25  Multiple myeloma and malignant plasma cell neoplasms                           \n",
       "26  Paraproteinemias                                                               \n",
       "27  Acquired deformities of the knee                                               \n",
       "28  Diffuse large B-cell lymphoma*                                                 \n",
       "29  Benign mammary dysplasias                                                      \n",
       "30  Hemangioma                                                                     \n",
       "31  Stenosis and insufficiency of lacrimal passages                                \n",
       "32  Hemangioma and lymphangioma                                                    \n",
       "33  Myeloproliferative disorder                                                    \n",
       "34  Thoracic aneurysm                                                              \n",
       "35  Monoclonal gammopathy                                                          \n",
       "36  Malignant neoplasm of brain                                                    \n",
       "37  Multiple myeloma                                                               \n",
       "38  Aortic insufficiency                                                           \n",
       "39  Vascular dementia                                                              \n",
       "40  Disorders and symptoms of testis                                               \n",
       "41  Disorder of nervous system                                                     \n",
       "42  Anal fissure                                                                   \n",
       "43  Chronic leukemia                                                               \n",
       "44  Malignant neoplasm of the eye, brain and other parts of central nervous system \n",
       "45  Multinodular goiter                                                            \n",
       "46  Pruritus                                                                       \n",
       "47  Abdominal distension and flatulence                                            \n",
       "48  Benign neoplasm of meninges (Meningioma)                                       \n",
       "49  Leukemia                                                                       \n",
       "50  Inflammatory diseases of prostate                                              \n",
       "51  Malignant neoplasm of the uterus                                               \n",
       "52  Tonsillitis and adenoiditis                                                    \n",
       "53  Prostatitis                                                                    \n",
       "54  Other disorders of male genital organs                                         \n",
       "55  Family history of digestive disorders                                          \n",
       "56  Malignant neoplasm of endometrium                                              \n",
       "57  Acquired deformities of limbs                                                  \n",
       "58  Hydrocele                                                                      \n",
       "59  Aphasia and dysphasia                                                          \n",
       "60  Testicular limpoma                                                             \n",
       "61  Intestinal fistula                                                             \n",
       "62  Disorders of external ear                                                      \n",
       "63  Myeloid                                                                        \n",
       "64  Paroxysmal vertigo                                                             \n",
       "65  Brain damage and brain death                                                   \n",
       "66  Ovarian cyst                                                                   \n",
       "67  Pseudomonas                                                                    \n",
       "68  Other disorders of white blood cells                                           \n",
       "69  Benign neoplasm of the head and neck                                           \n",
       "70  Benign neoplasms of external female genital organs and cervix                  \n",
       "71  Phobic disorders                                                               \n",
       "72  Chronic lymphoid leukemia                                                      \n",
       "73  Disorders of tooth develoment                                                  \n",
       "74  Klebsiella                                                                     \n",
       "75  Periapical abscess                                                             \n",
       "76  Other specific joint derangements                                              \n",
       "77  Disorders of muscle                                                            \n",
       "78  Disturbances in tooth eruption                                                 \n",
       "79  Ganglion cyst                                                                  \n",
       "80  Allergy to sulfonamides                                                        \n",
       "81  Restlessness and agitation*                                                    \n",
       "82  Other disorders of prostate                                                    \n",
       "83  Premature depolarization [Premature beats]                                     \n",
       "84  Abdominal or pelvic swelling, mass, or lump                                    \n",
       "85  Ventricular premature depolarization*                                          \n",
       "86  Benign neoplasm of the endocrine glands                                        \n",
       "87  Pelvic peritoneal adhesions, female (postoperative) (postinfection)            \n",
       "88  Diverticulum of bladder                                                        \n",
       "89  Impacted teeth*                                                                \n",
       "90  Primary hyperparathyroidism                                                    \n",
       "91  Strabismus                                                                     \n",
       "92  Ventral hernia                                                                 \n",
       "93  Benign neoplasms of the ovary                                                  \n",
       "94  Chronic cystitis                                                               \n",
       "95  Mucous polyp of cervix                                                         \n",
       "96  Symptoms involving female genital tract                                        \n",
       "97  Mouth breathing*                                                               \n",
       "98  Inflammation of the heart [Carditis]                                           \n",
       "99  Primary osteoarthritis of knee, lower leg                                      \n",
       "100 Ileus                                                                          \n",
       "101 Ventricular tachycardia                                                        \n",
       "102 Benign neoplasm of the eye, brain and other parts of central nervous system    \n",
       "103 Transient cerebral ischemic attacks                                            \n",
       "104 Generalized hyperhidrosis                                                      \n",
       "105 Corpus luteum cyst or hematoma                                                 \n",
       "106 Other symptoms/disorders or the urinary system                                 \n",
       "107 Palpitations                                                                   \n",
       "108 Occlusion and stenosis of precerebral arteries                                 \n",
       "109 Disorders of the pituitary gland and its hypothalamic control                  \n",
       "110 Mature B-cell                                                                  \n",
       "111 Non-Hodgkin lymphoma                                                           \n",
       "112 Hemo onc - by cell of origin                                                   \n",
       "113 Lymphoid                                                                       \n",
       "114 Thyrotoxicosis [hyperthyroidism]                                               \n",
       "115 Supraventricular tachycardia                                                   \n",
       "116 Malignant neoplasm of the pancreas                                             \n",
       "117 Benign neoplasms of the cervix                                                 \n",
       "118 Primary osteoarthritis of hip, pelvic region and thigh                         \n",
       "119 Parkinsonism                                                                   \n",
       "120 Sensorineural hearing loss                                                     \n",
       "121 Parkinson's disease (Primary)                                                  \n",
       "122 Deforming dorsopathies                                                         \n",
       "123 Carotid artery stenosis                                                        \n",
       "124 Polyp of corpus uteri                                                          \n",
       "125 Cystocele                                                                      \n",
       "126 Sequela of infection                                                           \n",
       "127 Polyp of female genital organs                                                 \n",
       "128 Deviated nasal septum                                                          \n",
       "129 Acute upper respiratory infection                                              \n",
       "130 Neutropenia                                                                    \n",
       "131 Other diseases of upper respiratory tract                                      \n",
       "132 Hyperhidrosis                                                                  \n",
       "133 Gynecological malignant neoplasms                                              \n",
       "134 Frequency of urination and polyuria                                            \n",
       "135 Alzheimer's disease                                                            \n",
       "136 Diseases of pulp and periapical tissues                                        \n",
       "137 Scar conditions and fibrosis of skin                                           \n",
       "138 Sinoatrial node dysfunction                                                    \n",
       "139 Decreased white blood cell count                                               \n",
       "140 Aplastic anemia                                                                \n",
       "141 Right bundle branch block                                                      \n",
       "142 Jaundice (not of newborn)                                                      \n",
       "143 Barrett's esophagus                                                            \n",
       "144 Malignant neoplasm of the bladder                                              \n",
       "145 Sick sinus syndrome*                                                           \n",
       "146 Other disorders of nose and nasal sinuses                                      \n",
       "147 Appendicitis                                                                   \n",
       "148 Bladder neck obstruction                                                       \n",
       "149 Inflammatory diseases of female pelvic organs                                  \n",
       "150 Periodontitis                                                                  \n",
       "151 Lipoma of other skin subcutaneous tissue                                       \n",
       "152 Heart valve replaced                                                           \n",
       "153 Other disorders of the eyelids                                                 \n",
       "154 Benign neoplasm of stomach                                                     \n",
       "155 Fungal infections                                                              \n",
       "156 Irregular menstrual bleeding                                                   \n",
       "157 Malignant neoplasm of the liver and intrahepatic bile ducts                    \n",
       "158 Noninflammatory disorders of cervix                                            \n",
       "159 Menopausal and postmenopausal disorders                                        \n",
       "160 Lymphoma                                                                       \n",
       "161 Malignant neoplasm of the esophagus                                            \n",
       "162 Bradycardia*                                                                   \n",
       "163 Diplopia                                                                       \n",
       "164 Secondary malignant neoplasm of digestive systems                              \n",
       "165 Pulmonary embolism                                                             \n",
       "166 Cystitis                                                                       \n",
       "167 Disorders of parathyroid gland                                                 \n",
       "168 Polymyalgia rheumatica                                                         \n",
       "169 Candidiasis                                                                    \n",
       "170 Duodenal ulcer                                                                 \n",
       "171 Congenital malformation of kidney                                              \n",
       "172 Rectocele                                                                      \n",
       "173 Prolapse of vaginal walls                                                      \n",
       "174 Malignant neoplasm of the breast                                               \n",
       "175 Hypertrophic conditions of skin                                                \n",
       "176 Retention of urine                                                             \n",
       "177 Dementia NOS                                                                   \n",
       "178 Left bundle branch block                                                       \n",
       "179 Endometriosis                                                                  \n",
       "180 Cystitis and urethritis                                                        \n",
       "181 Irregular menstrual cycle/bleeding                                             \n",
       "182 Aortic aneurysm and ectasia                                                    \n",
       "183 Malignant neoplasm of the colon and rectum                                     \n",
       "184 Hyperparathyroidism                                                            \n",
       "185 Other disorders of the intestines                                              \n",
       "186 Genital prolapse                                                               \n",
       "187 Dementias and cerebral degeneration                                            \n",
       "188 Malignant neoplasm of the colon                                                \n",
       "189 Allergy                                                                        \n",
       "190 Syncope and collapse                                                           \n",
       "191 Reaction to severe stress, and adjustment disorders                            \n",
       "192 Hematuria                                                                      \n",
       "193 Abnormality of urination                                                       \n",
       "194 Gastrointestinal angiodysplasia                                                \n",
       "195 Hallux valgus (Bunion)                                                         \n",
       "196 Splenomegaly                                                                   \n",
       "197 Vertigo                                                                        \n",
       "198 Diseases of spleen                                                             \n",
       "199 Paroxysmal tachycardia                                                         \n",
       "200 Hyposmolality and/or hyponatremia                                              \n",
       "201 Acute myocardial infarction                                                    \n",
       "202 Sequelae of cancer                                                             \n",
       "203 Malignant neoplasm of male genitalia                                           \n",
       "204 Pulmonary hypertension                                                         \n",
       "205 Malignant neoplasm of the prostate                                             \n",
       "206 Menorrhagia/Excessive and frequent menstruation                                \n",
       "207 Atrial fibrillation                                                            \n",
       "208 Primary osteoarthritis                                                         \n",
       "209 Atrioventricular block                                                         \n",
       "210 Diseases of esophagus                                                          \n",
       "211 Benign prostatic hyperplasia                                                   \n",
       "212 Malignant neoplasm of the rectum                                               \n",
       "213 Inguinal hernia                                                                \n",
       "214 Hernia of the abdominal wall                                                   \n",
       "215 Benign neoplasm of the paranasal sinus and nasal cavity                        \n",
       "216 Obstruction of bile duct                                                       \n",
       "217 Nasal polyps                                                                   \n",
       "218 Paroxysmal atrial fibrillation*                                                \n",
       "219 Secondary malignant neoplasm of liver                                          \n",
       "220 Mitral valve insufficiency                                                     \n",
       "221 Malignant neoplasm of the digestive organs                                     \n",
       "222 Disorders of menstruation and other abnormal bleeding from female genital tract\n",
       "223 Varicose veins of lower extremities                                            \n",
       "224 Disorders of penis                                                             \n",
       "225 Fecal incontinence                                                             \n",
       "226 Rheumatic fever and chronic rheumatic heart diseases                           \n",
       "227 Other diseases of biliary tract                                                \n",
       "228 Benign neoplasm of rectum and anus                                             \n",
       "229 Otitis media                                                                   \n",
       "230 Dermatitis due to substances taken internally                                  \n",
       "231 Orthostatic hypotension                                                        \n",
       "232 Tricuspid value insufficiency*                                                 \n",
       "233 Persistent atrial fibrillation*                                                \n",
       "234 Abdominal aortic aneurysm                                                      \n",
       "235 Secondary malignant neoplasm                                                   \n",
       "236 Intestinal obstruction                                                         \n",
       "237 Hernia                                                                         \n",
       "238 Heart block                                                                    \n",
       "239 Pulmonary edema                                                                \n",
       "240 Hammer toe                                                                     \n",
       "241 Benign neoplasms of the uterus                                                 \n",
       "242 Nephrotic syndrome                                                             \n",
       "243 Chronic rheumatic heart diseases                                               \n",
       "244 Cancer (solid tumor, excluding BCC)                                            \n",
       "245 Melanomas of skin                                                              \n",
       "246 Seborrheic keratosis                                                           \n",
       "247 Benign neoplasm of the digestive organs                                        \n",
       "248 Angina pectoris                                                                \n",
       "249 Anorexia                                                                       \n",
       "250 Noninflammatory female genital disorders                                       \n",
       "251 Esophagitis                                                                    \n",
       "252 Dysuria                                                                        \n",
       "253 Postprocedural hypothyroidism                                                  \n",
       "254 Malignant neoplasm of other and ill-defined sites                              \n",
       "255 Goiter                                                                         \n",
       "256 Gynecological benign neoplasms                                                 \n",
       "257 Fasciopathy                                                                    \n",
       "258 Palmar fascial fibromatosis [Dupuytren]                                        \n",
       "259 Diverticular disease [Bowel diverticulosis]                                    \n",
       "260 Acquired deformities of fingers and toes                                       \n",
       "261 Gastrointestinal hemorrhage                                                    \n",
       "262 Disease of anus and rectum                                                     \n",
       "263 Aspiration pneumonia                                                           \n",
       "264 Diverticula of colon                                                           \n",
       "265 Secondary malignancy of lymph nodes                                            \n",
       "266 Symptoms involving digestive system                                            \n",
       "267 Disorders of vestibular function                                               \n",
       "268 Benign sarcoma-related cancers                                                 \n",
       "269 Disorders of thyroid gland                                                     \n",
       "270 Acquired deformities of toe                                                    \n",
       "271 Uterine/Uterovaginal prolapse                                                  \n",
       "272 Aortic valve disorders                                                         \n",
       "273 Bronchitis                                                                     \n",
       "274 Scoliosis                                                                      \n",
       "275 Esophageal obstruction (Stricture and stenosis of esophagus)                   \n",
       "276 Stroke and transient cerebral ischemic attacks                                 \n",
       "277 Other disorders of urethra and urinary tract                                   \n",
       "278 Vitamin B12 deficiency                                                         \n",
       "279 Hypothyroidism                                                                 \n",
       "280 Benign neoplasm of colon, rectum, anus and anal canal                          \n",
       "281 Other symptoms involving the digestive system and abdomen                      \n",
       "282 Other disorders of bone                                                        \n",
       "283 Disorders of sweat glands                                                      \n",
       "284 Hypothyroidism, not specified as secondary                                     \n",
       "285 Benign neoplasm of the colon                                                   \n",
       "286 Atherosclerosis [ASCVD]                                                        \n",
       "287 Diaphragmatic hernia [Hiatal hernia]                                           \n",
       "288 Symptoms and signs involving general sensations and perceptions                \n",
       "289 Kidney stone disease                                                           \n",
       "290 Urinary tract infection                                                        \n",
       "291 Bacteremia, Sepsis, and SIRS                                                   \n",
       "292 Chronic pulmonary heart disease                                                \n",
       "293 Malignant neoplasm of the urinary tract                                        \n",
       "294 Leiomyoma of uterus                                                            \n",
       "295 Allergies related to other diseases/symptoms                                   \n",
       "296 Bronchiectasis                                                                 \n",
       "297 Cardiac arrhythmia and conduction disorders                                    \n",
       "298 Nonspecific findings on examination of blood                                   \n",
       "299 Mitral valve disorders                                                         \n",
       "300 Rotator cuff tear or rupture                                                   \n",
       "301 Migraine                                                                       \n",
       "302 Allergy to other anti-infective agents                                         \n",
       "303 Endocarditis                                                                   \n",
       "304 Drug and medical agent allergy                                                 \n",
       "305 Carcinoma in situ of skin                                                      \n",
       "306 Osteoporosis and low bone density                                              \n",
       "307 Coronary atherosclerosis [Atherosclerotic heart disease]                       \n",
       "308 Atrial fibrillation and flutter                                                \n",
       "309 Osteoporosis                                                                   \n",
       "310 Postmenopausal atrophic vaginitis                                              \n",
       "311 Aneurysm or ectasia                                                            \n",
       "312 Heart valve disorders                                                          \n",
       "313 Allergy to antibiotic agent (excluding penicillin)                             \n",
       "314 Secondary malignancy of bone                                                   \n",
       "315 Sepsis                                                                         \n",
       "316 Hemorrhagic stroke                                                             \n",
       "317 Nontraumatic Intracranial hemorrhage                                           \n",
       "318 Constipation                                                                   \n",
       "319 Stroke                                                                         \n",
       "320 Inflammatory bowel disease                                                     \n",
       "321 Cardiac arrest                                                                 \n",
       "322 Cyst and pseudocyst of pancreas                                                \n",
       "323 Ischemic heart disease                                                         \n",
       "324 Other degenerative diseases of nervous system                                  \n",
       "325 Nonspecific abnormal results of function study of liver                        \n",
       "326 Convulsions                                                                    \n",
       "327 Gastro-esophageal reflux disease                                               \n",
       "328 Other disorders of bladder                                                     \n",
       "329 Extrapyramidal and movement disorders                                          \n",
       "330 Crohn's disease                                                                \n",
       "331 Other heart disorders in diseases NEC                                          \n",
       "332 Gastrointestinal obstruction                                                   \n",
       "333 Nonspecific abnormal findings of other body structures                         \n",
       "334 Other skin and connective tissue disorders                                     \n",
       "335 Family history of malignant neoplasm                                           \n",
       "336 Generalized osteoarthritis                                                     \n",
       "337 Gastrointestinal inflammation                                                  \n",
       "338 Osteoarthritis                                                                 \n",
       "339 Blood in stool                                                                 \n",
       "340 Elevated blood glucose level                                                   \n",
       "341 Meniere disease                                                                \n",
       "342 Malignant neoplasm of the head and neck                                        \n",
       "343 Skin changes due to chronic exposure to nonionizing radiation                  \n",
       "344 Urethral stricture                                                             \n",
       "345 Cerebral infarction [Ischemic stroke]                                          \n",
       "346 Actinic keratosis                                                              \n",
       "347 Epidermal thickening                                                           \n",
       "348 Chrystal arthropathies                                                         \n",
       "349 Synovitis and tenosynovitis                                                    \n",
       "350 Myocardial infarction [Heart attack]                                           \n",
       "351 Rheumatoid arthritis and other inflammatory polyarthropathies                  \n",
       "352 Gastritis                                                                      \n",
       "353 Clostridium difficile                                                          \n",
       "354 Facial nerve disorders and weakness                                            \n",
       "355 Secondary malignancy of respiratory organs                                     \n",
       "356 Hearing impairment                                                             \n",
       "357 Secondary osteoarthritis                                                       \n",
       "358 Bronchopneumonia                                                               \n",
       "359 Hypokalemia [Hypopotassemia]                                                   \n",
       "360 Disorders of other cranial nerves                                              \n",
       "361 Venous insufficiency                                                           \n",
       "362 Hemorrhoids                                                                    \n",
       "363 Clostridium                                                                    \n",
       "364 Chronic kidney disease                                                         \n",
       "365 Gout                                                                           \n",
       "366 Aortic stenosis                                                                \n",
       "367 Peptic ulcer                                                                   \n",
       "368 Tricuspid valve disorders                                                      \n",
       "369 Pneumothorax and air leak                                                      \n",
       "370 Varicose veins                                                                 \n",
       "371 Hyperuricemia                                                                  \n",
       "372 Other diseases of pericardium                                                  \n",
       "373 Hypotension                                                                    \n",
       "374 Bell's palsy                                                                   \n",
       "375 Family history of cardiovascular disease                                       \n",
       "376 Pathologic fracture                                                            \n",
       "377 Osteophyte*                                                                    \n",
       "378 Cardiomegaly                                                                   \n",
       "379 Pancreatitis                                                                   \n",
       "380 Nausea and vomiting                                                            \n",
       "381 Lymphedema                                                                     \n",
       "382 Vomiting                                                                       \n",
       "383 Hallux rigidus                                                                 \n",
       "384 Duodenitis                                                                     \n",
       "385 Abnormal weight loss                                                           \n",
       "386 Malnutrition and underweight                                                   \n",
       "387 Nausea                                                                         \n",
       "388 Dilated cardiomyopathy*                                                        \n",
       "389 Allergic rhinitis                                                              \n",
       "390 Abdominal pain                                                                 \n",
       "391 Allergy to analgesic agent                                                     \n",
       "392 Penicillin allergy                                                             \n",
       "393 Abnormalities of heart beat                                                    \n",
       "394 Derangement of meniscus                                                        \n",
       "395 Vascular insufficiency of intestine                                            \n",
       "396 Cyst of kidney                                                                 \n",
       "397 Symptoms and signs involving cognitive functions and awareness                 \n",
       "398 Influenza virus                                                                \n",
       "399 Malignant neoplasm of the kidney                                               \n",
       "400 Loose body in joint                                                            \n",
       "401 Malignant neoplasm of the skin                                                 \n",
       "402 Abnormal loss of weight and underweight                                        \n",
       "403 Malignant neoplasm of stomach                                                  \n",
       "404 Other inflammatory spondylopathies                                             \n",
       "405 Spondylosis                                                                    \n",
       "406 Nontraumatic intracerebral hemorrhage                                          \n",
       "407 Mononeuritis of lower limb                                                     \n",
       "408 Nonspecific abnormal findings in stool contents                                \n",
       "409 Intestinal infection due to C. difficile                                       \n",
       "410 Dysphagia                                                                      \n",
       "411 Nonspecific low blood-pressure reading                                         \n",
       "412 Dizziness and giddiness                                                        \n",
       "413 Left heart failure                                                             \n",
       "414 Infections                                                                     \n",
       "415 General symptoms and other findings                                            \n",
       "416 Exostosis                                                                      \n",
       "417 Disorders of lacrimal system                                                   \n",
       "418 Synoviopathy and bursopathy                                                    \n",
       "419 Presence of cardiac device                                                     \n",
       "420 Gastric ulcer                                                                  \n",
       "421 Dermatitis [eczema]                                                            \n",
       "422 Embolism and thrombosis                                                        \n",
       "423 Symptoms and signs concerning food and fluid intake                            \n",
       "424 Periodontal diseases                                                           \n",
       "425 Hydronephrosis                                                                 \n",
       "426 Raynaud's syndrome                                                             \n",
       "427 Malignant neoplasm of kidney, except pelvis                                    \n",
       "428 Urinary incontinence                                                           \n",
       "429 Bacterial infections                                                           \n",
       "430 Obstructive and reflux uropathy                                                \n",
       "431 Pleural effusion                                                               \n",
       "432 Hallucinations                                                                 \n",
       "433 Autoimmune disease                                                             \n",
       "434 Epistaxis                                                                      \n",
       "435 Diverticulitis                                                                 \n",
       "436 Acute pancreatitis                                                             \n",
       "437 Hyperlipidemia                                                                 \n",
       "438 Essential hypertension                                                         \n",
       "439 Abnormal findings on diagnostic imaging of the digestive tract                 \n",
       "440 Pure hypercholesterolemia                                                      \n",
       "441 Hypercholesterolemia                                                           \n",
       "442 Spondylolisthesis                                                              \n",
       "443 Hypertension                                                                   \n",
       "444 Non-inflammatory spondylopathy                                                 \n",
       "445 Disorders of fluid, electrolyte and acid-base balance                          \n",
       "446 Lipoma                                                                         \n",
       "447 Other diseases of stomach and duodenum                                         \n",
       "448 Family history of other endocrine and metabolic diseases                       \n",
       "449 Rheumatoid arthritis                                                           \n",
       "450 All-Cause Death                                                                \n",
       "451 Edema                                                                          \n",
       "452 Adhesive capsulitis of shoulder                                                \n",
       "453 Seasonal allergic rhinitis                                                     \n",
       "454 Blepharitis                                                                    \n",
       "455 Speech disturbance                                                             \n",
       "456 Heart failure                                                                  \n",
       "457 Disorders of eyelid function                                                   \n",
       "458 Pharyngitis                                                                    \n",
       "459 Other disorders of the kidney and ureters                                      \n",
       "460 Retinal vascular changes and occlusions                                        \n",
       "461 Thrombocytopenia                                                               \n",
       "462 Demyelinating diseases of the central nervous system                           \n",
       "463 Sicca syndrome [Sjogren syndrome]                                              \n",
       "464 Platelet defects                                                               \n",
       "465 Pulmonary collapse [Atelectasis]                                               \n",
       "466 Venous thromboembolism                                                         \n",
       "467 Coagulation defects, purpura and other hemorrhagic conditions                  \n",
       "468 Heartburn and epigastric pain                                                  \n",
       "469 Other problems related to lifestyle                                            \n",
       "470 Other arthropathies                                                            \n",
       "471 Disorder of patella                                                            \n",
       "472 Asthma                                                                         \n",
       "473 Esophageal ulcer                                                               \n",
       "474 Intestinal malabsorption                                                       \n",
       "475 Labyrinthitis                                                                  \n",
       "476 Sebaceous cyst [Epidermal cyst]                                                \n",
       "477 Trigger finger                                                                 \n",
       "478 Gallstones [Cholelithiasis]                                                    \n",
       "479 Allergy to narcotic agent                                                      \n",
       "480 Anxiety disorders                                                              \n",
       "481 Other disorders of liver                                                       \n",
       "482 Shock                                                                          \n",
       "483 Paresthesia of skin*                                                           \n",
       "484 Volume depletion                                                               \n",
       "485 Diseases of tongue                                                             \n",
       "486 Entropion and trichiasis of eyelid                                             \n",
       "487 Carpal tunnel syndrome                                                         \n",
       "488 Interstitial pulmonary diseases                                                \n",
       "489 Renal failure                                                                  \n",
       "490 Phlebitis and thrombophlebitis                                                 \n",
       "491 Cerebral palsy and other paralytic syndromes                                   \n",
       "492 Stress incontinence                                                            \n",
       "493 Secondary malignancy of brain/spine                                            \n",
       "494 Other symptoms and disorders of the soft tissue                                \n",
       "495 Malignant neoplasm of the ovary                                                \n",
       "496 Fever of unknown origin                                                        \n",
       "497 Cardiomyopathy                                                                 \n",
       "498 Delirium                                                                       \n",
       "499 Arterial embolism and thrombosis                                               \n",
       "500 Megaloblastic anemia                                                           \n",
       "501 Spinal disc displacement (herniation)                                          \n",
       "502 Diffuse diseases of connective tissue                                          \n",
       "503 Disorders of pigmentation                                                      \n",
       "504 Intestinal infection                                                           \n",
       "505 Rhinitis and nasal congestion                                                  \n",
       "506 Pneumonia                                                                      \n",
       "507 Hemorrhage from respiratory passages                                           \n",
       "508 Nerve root and plexus disorders                                                \n",
       "509 Spinal stenosis                                                                \n",
       "510 Renal tubulo-interstitial diseases                                             \n",
       "511 Mononeuropathies                                                               \n",
       "512 Disorders of the gallbladder                                                   \n",
       "513 Chondropathies                                                                 \n",
       "514 Other diseases of spinal cord                                                  \n",
       "515 Lobar pneumonia*                                                               \n",
       "516 Ulcerative colitis                                                             \n",
       "517 Other cerebrovascular disease                                                  \n",
       "518 Other symptoms involving nervous system                                        \n",
       "519 Diseases of the pancreas                                                       \n",
       "520 Back pain                                                                      \n",
       "521 Lesion of plantar nerve                                                        \n",
       "522 Viral pneumonia                                                                \n",
       "523 Blepharochalasis                                                               \n",
       "524 Benign neoplasm of the parathyroid gland                                       \n",
       "525 Myelopathies                                                                   \n",
       "526 Postmenopausal bleeding                                                        \n",
       "527 Pulmonary insufficiency and acute respiratory distress syndrome                \n",
       "528 Acute kidney failure                                                           \n",
       "529 Escherichia coli                                                               \n",
       "530 Symptoms related to joints                                                     \n",
       "531 Visual field defects                                                           \n",
       "532 Elevated blood pressure reading without diagnosis of hypertension              \n",
       "533 Orchitis and epididymitis                                                      \n",
       "534 Hemiplegia and hemiparesis                                                     \n",
       "535 Disorders of mineral metabolism and mineral deficiencies                       \n",
       "536 Anemia                                                                         \n",
       "537 Ptosis of eyelid                                                               \n",
       "538 Peripheral vascular disease                                                    \n",
       "539 Chronic rhinitis                                                               \n",
       "540 Headache                                                                       \n",
       "541 Viral infections                                                               \n",
       "542 Psoriatic arthropathy                                                          \n",
       "543 Other behavioral problems                                                      \n",
       "544 Disorders of the middle ear                                                    \n",
       "545 Pleurisy                                                                       \n",
       "546 Chest pain                                                                     \n",
       "547 Disorders of calcium metabolism                                                \n",
       "548 Hemorrhage of rectum and anus                                                  \n",
       "549 Cough                                                                          \n",
       "550 Repeated falls*                                                                \n",
       "551 Occlusion and stenosis of cerebral arteries                                    \n",
       "552 Headache NOS                                                                   \n",
       "553 Disorders of iron metabolism                                                   \n",
       "554 Astigmatism                                                                    \n",
       "555 Intervertebral disc disorder                                                   \n",
       "556 Cholecystitis                                                                  \n",
       "557 Pericardial effusion (noninflammatory)*                                        \n",
       "558 Pain                                                                           \n",
       "559 Corneal degenerations                                                          \n",
       "560 Erythematous conditions                                                        \n",
       "561 Pain in limb                                                                   \n",
       "562 Panic disorder [episodic paroxysmal anxiety]                                   \n",
       "563 Functional intestinal disorder                                                 \n",
       "564 Dyspnea [Shortness of breath]                                                  \n",
       "565 Skin symptoms                                                                  \n",
       "566 Infection of the skin                                                          \n",
       "567 Chronic sinusitis                                                              \n",
       "568 Nutritional anemias                                                            \n",
       "569 Microcytic anemia                                                              \n",
       "570 Other disorders of the brain and CNS                                           \n",
       "571 Acute respiratory infection                                                    \n",
       "572 Disorders of magnesium metabolism                                              \n",
       "573 Tachycardia                                                                    \n",
       "574 Cellulitis and abscess                                                         \n",
       "575 Hypertensive chronic kidney disease                                            \n",
       "576 Vitamin D deficiency                                                           \n",
       "577 Cervicalgia                                                                    \n",
       "578 Macrocytic anemia                                                              \n",
       "579 Iron deficiency anemia                                                         \n",
       "580 Iron deficiency                                                                \n",
       "581 Psoriasis                                                                      \n",
       "582 Respiratory failure                                                            \n",
       "583 Radiculopathy                                                                  \n",
       "584 Pain in joint                                                                  \n",
       "585 Other diseases of inner ear                                                    \n",
       "586 Ascites                                                                        \n",
       "587 Hemorrhage of the eye                                                          \n",
       "588 Hyperkalemia [Hyperpotassemia]                                                 \n",
       "589 Transplated organ                                                              \n",
       "590 Abnormality of gait and mobility                                               \n",
       "591 Other respiratory disorders                                                    \n",
       "592 Malaise and fatigue                                                            \n",
       "593 Epilepsy, recurrent seizures, convulsions                                      \n",
       "594 Suicide ideation and attempt or self harm                                      \n",
       "595 Abnormalities of breathing                                                     \n",
       "596 Peripheral vascular disease NOS [includes PAD]                                 \n",
       "597 Melanocytic nevi*                                                              \n",
       "598 Symptoms and signs related to movement disorders                               \n",
       "599 Intestinal or peritoneal adhesions                                             \n",
       "600 Fluid overload                                                                 \n",
       "601 Contact or exposure to infectious agent                                        \n",
       "602 Bacterial pneumonia                                                            \n",
       "603 Bursitis                                                                       \n",
       "604 Rash and other nonspecific skin eruption                                       \n",
       "605 Celiac disease                                                                 \n",
       "606 Glomerular diseases                                                            \n",
       "607 Enlargement of lymph nodes [Lymphadenopathy]                                   \n",
       "608 Acute Pharyngitis                                                              \n",
       "609 Vitamin deficiencies                                                           \n",
       "610 Polyarthritis                                                                  \n",
       "611 Diseases of lips                                                               \n",
       "612 Bacterial enteritis                                                            \n",
       "613 Stricture of artery [Arterial stenosis]                                        \n",
       "614 Viral enteritis                                                                \n",
       "615 Pressure ulcer                                                                 \n",
       "616 Mental disorder, not otherwise specified                                       \n",
       "617 Acute lower respiratory infection                                              \n",
       "618 Enthesopathy/Enthesitis/Tendinopathy                                           \n",
       "619 Vitamin B group deficiency                                                     \n",
       "620 Abnormality of the lymph nodes                                                 \n",
       "621 Umbilical hernia                                                               \n",
       "622 Enteropathic arthropathies                                                     \n",
       "623 Streptococcus                                                                  \n",
       "624 Other specified disorders of arteries and arterioles                           \n",
       "625 Sinusitis                                                                      \n",
       "626 Irritable bowel syndrome                                                       \n",
       "627 Intentional self-harm*                                                         \n",
       "628 Chronic ulcer of skin                                                          \n",
       "629 Hyperosmolality and/or hypernatremia                                           \n",
       "630 Cutaneous cyst                                                                 \n",
       "631 Myalgia                                                                        \n",
       "632 Visual disturbances                                                            \n",
       "633 Cytology and pathology findings                                                \n",
       "634 Staphylococcus                                                                 \n",
       "635 Lesions of mouth                                                               \n",
       "636 Hematemesis                                                                    \n",
       "637 Mixed disorder of acid-base balance                                            \n",
       "638 Multiple sclerosis                                                             \n",
       "639 Inflammatory disease of cervix, vagina, and vulva                              \n",
       "640 Abnormality of the peritoneum                                                  \n",
       "641 Coma and other alteration of consciousness                                     \n",
       "642 Malignant neoplasm of the thoracic and respiratory organs                      \n",
       "643 Disorder of phosphorus metabolism                                              \n",
       "644 Hydrocephalus                                                                  \n",
       "645 Precordial pain                                                                \n",
       "646 Disorders of lipoprotein metabolism and other lipidemias                       \n",
       "647 Malignant sarcoma-related cancers                                              \n",
       "648 Family history of other condition                                              \n",
       "649 Other diseases of teeth and supporting structures                              \n",
       "650 Macular degeneration                                                           \n",
       "651 Diseases of vocal cords and larynx, not elsewhere classified                   \n",
       "652 Hyper-coagulability                                                            \n",
       "653 Hepatitis                                                                      \n",
       "654 Effusion of joint                                                              \n",
       "655 Acidosis                                                                       \n",
       "656 Staphylococcus aureus                                                          \n",
       "657 Suicide and self-inflicted harm                                                \n",
       "658 Signs and symptoms involving emotional state                                   \n",
       "659 Varicella zoster virus                                                         \n",
       "660 Impingement syndrome of shoulder*                                              \n",
       "661 Hypepigmentation                                                               \n",
       "662 Portal hypertension                                                            \n",
       "663 Disorders of the circulation of the cerebrospinal fluid                        \n",
       "664 Disorders of uterus, NEC                                                       \n",
       "665 Pilar and trichodermal cyst                                                    \n",
       "666 Abnormal findings on diagnostic imaging of lung                                \n",
       "667 Chronic obstructive pulmonary disease [COPD]                                   \n",
       "668 Inflammation of the eye                                                        \n",
       "669 Hemoptysis                                                                     \n",
       "670 Glaucoma                                                                       \n",
       "671 Malignant neoplasm of the of bronchus and lung                                 \n",
       "672 Epilepsy                                                                       \n",
       "673 Sciatica                                                                       \n",
       "674 Hepatic failure                                                                \n",
       "675 Coronavirus                                                                    \n",
       "676 Tremor                                                                         \n",
       "677 Emphysema                                                                      \n",
       "678 Herpes zoster                                                                  \n",
       "679 Other follicular disorders                                                     \n",
       "680 Disorders of plasma-protein metabolism, NEC                                    \n",
       "681 Low back pain                                                                  \n",
       "682 Abnormal intraocular pressure                                                  \n",
       "683 Alcohol use disorders                                                          \n",
       "684 Carrier or suspected carrier of infectious diseases                            \n",
       "685 Other nonmalignant breast conditions                                           \n",
       "686 Substance related disorders                                                    \n",
       "687 Papulosquamous disorders                                                       \n",
       "688 Non-pressure chronic ulcer                                                     \n",
       "689 Peritonitis                                                                    \n",
       "690 Benign neoplasm of the skin                                                    \n",
       "691 Noninflammatory disorders of vagina                                            \n",
       "692 Polyneuropathies                                                               \n",
       "693 Anemia secondary to chronic diseases and conditions                            \n",
       "694 Mood [affective] disorders                                                     \n",
       "695 Human papillomavirus                                                           \n",
       "696 Localized swelling, mass and lump of skin and subcutaneous tissue              \n",
       "697 Noninflammatory disorders of vulva and perineum                                \n",
       "698 Major depressive disorder                                                      \n",
       "699 Disorders of the retina                                                        \n",
       "700 End stage renal disease [CDK, stage 5]                                         \n",
       "701 Sleep disorders                                                                \n",
       "702 Lesion of median, ulnar, radial nerve                                          \n",
       "703 Cataract                                                                       \n",
       "704 Sleep apnea                                                                    \n",
       "705 Alcohol abuse                                                                  \n",
       "706 Vitreous opacities                                                             \n",
       "707 Bipolar disorder                                                               \n",
       "708 Disorders of vitreous body                                                     \n",
       "709 Nuclear cataract                                                               \n",
       "710 COVID-19*                                                                      \n",
       "711 Age-related nuclear cataract                                                   \n",
       "712 Fibrosis and cirrhosis of liver                                                \n",
       "713 Alcoholic liver disease                                                        \n",
       "714 Noninflammatory disorders of the cornea                                        \n",
       "715 Angle-Closure Glaucoma                                                         \n",
       "716 Herpesvirus                                                                    \n",
       "717 Alteration of consciousness                                                    \n",
       "718 Diabetes mellitus                                                              \n",
       "719 Disturbances of skin sensation                                                 \n",
       "720 Substance abuse                                                                \n",
       "721 Type 2 diabetes                                                                \n",
       "722 Abnormal results of cardiovascular function studies                            \n",
       "723 Chronic hepatitis                                                              \n",
       "724 Disorders of adrenal glands                                                    \n",
       "725 Chronic liver disease and sequelae                                             \n",
       "726 Blindness and low vision                                                       \n",
       "727 Obesity                                                                        \n",
       "728 Overweight and obesity                                                         \n",
       "729 Disorders of refraction and accommodation                                      \n",
       "730 Noninflammatory disorders of conjunctiva                                       \n",
       "731 Chalazion                                                                      \n",
       "732 Alcohol dependence                                                             \n",
       "733 Open angle glaucoma                                                            \n",
       "734 Fatty liver disease (FLD)                                                      \n",
       "735 Psychotic disorder                                                             \n",
       "736 Granulomatous disorder of the skin                                             \n",
       "737 Dental caries                                                                  \n",
       "738 Sarcoidosis                                                                    \n",
       "739 Substance abuse, dependence, and withdrawl                                     \n",
       "740 Amblyopia                                                                      \n",
       "741 Hypoglycemia                                                                   \n",
       "742 Current tobacco use and nicotine dependence                                    \n",
       "743 Retinal detachments and breaks                                                 \n",
       "744 Nicotine dependence (current and history of)                                   \n",
       "745 Patient's noncompliance with medical treatment and regimen                     \n",
       "746 Substance dependence                                                           \n",
       "747 Type 1 diabetes                                                                \n",
       "748 Retinal disorders in diseases classified elsewhere                             \n",
       "749 Degenerative disc disease                                                      \n",
       "750 Polyneuropathy in diseases classified elsewhere                                \n",
       "751 Myopia                                                                         \n",
       "752 Hemoglobinopathies                                                             \n",
       "    Age+Sex              Age+Sex+Retina       delta                  \n",
       "1   0.655 (0.613, 0.691) 0.486 (0.438, 0.547) -0.166 (-0.212, -0.104)\n",
       "2   0.599 (0.575, 0.642) 0.566 (0.539, 0.612) -0.035 (-0.049, -0.013)\n",
       "3   0.635 (0.612, 0.676) 0.602 (0.574, 0.647) -0.032 (-0.057, -0.008)\n",
       "4   0.627 (0.59, 0.665)  0.596 (0.561, 0.632) -0.031 (-0.058, -0.012)\n",
       "5   0.585 (0.543, 0.618) 0.552 (0.521, 0.583) -0.031 (-0.067, 0.005) \n",
       "6   0.574 (0.542, 0.6)   0.544 (0.509, 0.573) -0.03 (-0.054, 0.001)  \n",
       "7   0.643 (0.596, 0.675) 0.61 (0.569, 0.651)  -0.03 (-0.055, 0)      \n",
       "8   0.615 (0.583, 0.657) 0.588 (0.544, 0.629) -0.027 (-0.055, -0.005)\n",
       "9   0.596 (0.554, 0.63)  0.573 (0.527, 0.6)   -0.027 (-0.042, -0.005)\n",
       "10  0.591 (0.557, 0.624) 0.564 (0.536, 0.595) -0.026 (-0.055, 0)     \n",
       "11  0.589 (0.557, 0.623) 0.567 (0.521, 0.602) -0.026 (-0.054, 0)     \n",
       "12  0.624 (0.584, 0.653) 0.597 (0.558, 0.627) -0.025 (-0.041, -0.006)\n",
       "13  0.648 (0.621, 0.668) 0.624 (0.596, 0.649) -0.024 (-0.039, -0.009)\n",
       "14  0.579 (0.551, 0.618) 0.558 (0.527, 0.593) -0.024 (-0.046, 0.002) \n",
       "15  0.695 (0.658, 0.727) 0.672 (0.636, 0.702) -0.024 (-0.035, -0.008)\n",
       "16  0.572 (0.533, 0.616) 0.549 (0.498, 0.593) -0.024 (-0.05, 0.014)  \n",
       "17  0.642 (0.597, 0.674) 0.619 (0.583, 0.653) -0.023 (-0.047, 0.002) \n",
       "18  0.647 (0.605, 0.677) 0.623 (0.582, 0.66)  -0.023 (-0.038, -0.007)\n",
       "19  0.554 (0.515, 0.604) 0.534 (0.487, 0.569) -0.023 (-0.057, 0.013) \n",
       "20  0.644 (0.621, 0.671) 0.623 (0.594, 0.647) -0.023 (-0.043, -0.007)\n",
       "21  0.492 (0.465, 0.519) 0.471 (0.441, 0.493) -0.022 (-0.04, 0.001)  \n",
       "22  0.694 (0.656, 0.727) 0.669 (0.634, 0.705) -0.022 (-0.041, -0.005)\n",
       "23  0.621 (0.574, 0.659) 0.601 (0.572, 0.638) -0.021 (-0.047, 0.008) \n",
       "24  0.536 (0.513, 0.568) 0.517 (0.485, 0.551) -0.021 (-0.053, 0.007) \n",
       "25  0.69 (0.648, 0.721)  0.668 (0.624, 0.703) -0.021 (-0.046, 0.002) \n",
       "26  0.675 (0.637, 0.71)  0.655 (0.615, 0.692) -0.02 (-0.043, 0.006)  \n",
       "27  0.599 (0.577, 0.63)  0.579 (0.548, 0.607) -0.02 (-0.036, -0.006) \n",
       "28  0.656 (0.621, 0.698) 0.636 (0.601, 0.667) -0.02 (-0.041, 0.003)  \n",
       "29  0.416 (0.381, 0.461) 0.401 (0.357, 0.438) -0.02 (-0.038, 0.01)   \n",
       "30  0.55 (0.512, 0.578)  0.525 (0.488, 0.566) -0.02 (-0.043, 0)      \n",
       "31  0.643 (0.608, 0.681) 0.625 (0.582, 0.664) -0.019 (-0.034, -0.007)\n",
       "32  0.55 (0.512, 0.581)  0.529 (0.496, 0.566) -0.019 (-0.041, 0.008) \n",
       "33  0.677 (0.646, 0.71)  0.656 (0.625, 0.687) -0.018 (-0.037, -0.006)\n",
       "34  0.659 (0.625, 0.688) 0.643 (0.605, 0.676) -0.018 (-0.052, 0.02)  \n",
       "35  0.685 (0.641, 0.726) 0.667 (0.628, 0.708) -0.018 (-0.044, 0.014) \n",
       "36  0.604 (0.567, 0.636) 0.581 (0.544, 0.616) -0.018 (-0.051, 0.008) \n",
       "37  0.675 (0.633, 0.713) 0.657 (0.61, 0.698)  -0.017 (-0.041, 0.012) \n",
       "38  0.69 (0.67, 0.712)   0.673 (0.654, 0.698) -0.017 (-0.027, -0.003)\n",
       "39  0.805 (0.778, 0.828) 0.788 (0.76, 0.816)  -0.017 (-0.037, 0.002) \n",
       "40  0.538 (0.51, 0.564)  0.521 (0.491, 0.547) -0.017 (-0.039, 0.006) \n",
       "41  0.577 (0.547, 0.623) 0.568 (0.51, 0.611)  -0.016 (-0.06, 0.019)  \n",
       "42  0.544 (0.509, 0.581) 0.529 (0.493, 0.566) -0.016 (-0.031, 0.002) \n",
       "43  0.724 (0.696, 0.751) 0.709 (0.672, 0.738) -0.016 (-0.031, -0.002)\n",
       "44  0.572 (0.54, 0.608)  0.556 (0.524, 0.588) -0.016 (-0.038, 0.01)  \n",
       "45  0.689 (0.648, 0.719) 0.673 (0.632, 0.71)  -0.016 (-0.035, 0.003) \n",
       "46  0.574 (0.53, 0.621)  0.563 (0.505, 0.602) -0.016 (-0.05, 0.02)   \n",
       "47  0.529 (0.504, 0.553) 0.514 (0.487, 0.537) -0.015 (-0.033, 0.001) \n",
       "48  0.663 (0.629, 0.709) 0.648 (0.612, 0.69)  -0.015 (-0.038, 0.004) \n",
       "49  0.693 (0.665, 0.72)  0.68 (0.649, 0.701)  -0.015 (-0.026, -0.003)\n",
       "50  0.652 (0.627, 0.672) 0.637 (0.609, 0.658) -0.015 (-0.022, -0.006)\n",
       "51  0.581 (0.556, 0.613) 0.567 (0.538, 0.6)   -0.014 (-0.03, -0.001) \n",
       "52  0.573 (0.533, 0.611) 0.556 (0.519, 0.59)  -0.014 (-0.033, 0.004) \n",
       "53  0.65 (0.625, 0.671)  0.636 (0.61, 0.658)  -0.014 (-0.021, -0.003)\n",
       "54  0.526 (0.5, 0.554)   0.512 (0.486, 0.544) -0.014 (-0.039, 0.01)  \n",
       "55  0.582 (0.546, 0.612) 0.568 (0.538, 0.601) -0.014 (-0.039, 0.011) \n",
       "56  0.587 (0.558, 0.611) 0.574 (0.546, 0.594) -0.013 (-0.027, 0.002) \n",
       "57  0.616 (0.596, 0.643) 0.605 (0.581, 0.626) -0.013 (-0.025, 0.001) \n",
       "58  0.557 (0.527, 0.593) 0.545 (0.513, 0.581) -0.013 (-0.041, 0.019) \n",
       "59  0.675 (0.638, 0.709) 0.664 (0.621, 0.702) -0.013 (-0.034, 0.019) \n",
       "60  0.567 (0.529, 0.611) 0.554 (0.518, 0.599) -0.012 (-0.017, -0.006)\n",
       "61  0.596 (0.562, 0.623) 0.582 (0.543, 0.612) -0.012 (-0.037, 0.009) \n",
       "62  0.593 (0.554, 0.632) 0.58 (0.546, 0.621)  -0.012 (-0.028, 0.005) \n",
       "63  0.693 (0.673, 0.715) 0.682 (0.66, 0.706)  -0.012 (-0.021, -0.002)\n",
       "64  0.665 (0.625, 0.704) 0.653 (0.617, 0.689) -0.012 (-0.032, 0.01)  \n",
       "65  0.596 (0.551, 0.637) 0.587 (0.536, 0.619) -0.012 (-0.048, 0.024) \n",
       "66  0.586 (0.56, 0.618)  0.575 (0.551, 0.606) -0.011 (-0.021, 0.001) \n",
       "67  0.652 (0.625, 0.678) 0.639 (0.614, 0.666) -0.011 (-0.035, 0.007) \n",
       "68  0.598 (0.55, 0.672)  0.591 (0.536, 0.649) -0.011 (-0.044, 0.019) \n",
       "69  0.593 (0.577, 0.615) 0.582 (0.565, 0.606) -0.011 (-0.019, -0.001)\n",
       "70  0.554 (0.515, 0.588) 0.546 (0.511, 0.57)  -0.011 (-0.032, 0.018) \n",
       "71  0.651 (0.621, 0.677) 0.639 (0.611, 0.667) -0.011 (-0.024, 0.006) \n",
       "72  0.725 (0.695, 0.751) 0.717 (0.68, 0.745)  -0.01 (-0.027, 0.004)  \n",
       "73  0.59 (0.553, 0.628)  0.583 (0.551, 0.61)  -0.01 (-0.026, 0.005)  \n",
       "74  0.669 (0.636, 0.7)   0.66 (0.628, 0.69)   -0.01 (-0.041, 0.021)  \n",
       "75  0.454 (0.411, 0.487) 0.445 (0.402, 0.49)  -0.01 (-0.043, 0.033)  \n",
       "76  0.547 (0.523, 0.565) 0.537 (0.518, 0.556) -0.01 (-0.02, 0.004)   \n",
       "77  0.57 (0.539, 0.596)  0.56 (0.532, 0.581)  -0.01 (-0.025, 0.009)  \n",
       "78  0.588 (0.552, 0.631) 0.577 (0.537, 0.621) -0.01 (-0.027, 0.007)  \n",
       "79  0.543 (0.515, 0.57)  0.533 (0.508, 0.558) -0.01 (-0.028, 0.011)  \n",
       "80  0.687 (0.666, 0.716) 0.678 (0.652, 0.703) -0.01 (-0.02, 0.002)   \n",
       "81  0.654 (0.603, 0.696) 0.641 (0.595, 0.683) -0.009 (-0.038, 0.011) \n",
       "82  0.656 (0.637, 0.682) 0.647 (0.626, 0.673) -0.009 (-0.024, 0.008) \n",
       "83  0.667 (0.639, 0.691) 0.659 (0.629, 0.679) -0.009 (-0.018, 0)     \n",
       "84  0.601 (0.568, 0.636) 0.593 (0.551, 0.628) -0.009 (-0.035, 0.017) \n",
       "85  0.654 (0.62, 0.681)  0.645 (0.613, 0.67)  -0.009 (-0.019, 0.002) \n",
       "86  0.593 (0.569, 0.616) 0.583 (0.554, 0.607) -0.009 (-0.03, 0.011)  \n",
       "87  0.545 (0.507, 0.587) 0.536 (0.506, 0.569) -0.009 (-0.031, 0.016) \n",
       "88  0.72 (0.691, 0.756)  0.714 (0.677, 0.745) -0.009 (-0.015, -0.003)\n",
       "89  0.576 (0.548, 0.611) 0.566 (0.531, 0.606) -0.009 (-0.025, 0.011) \n",
       "90  0.634 (0.608, 0.666) 0.627 (0.597, 0.656) -0.008 (-0.032, 0.016) \n",
       "91  0.596 (0.57, 0.634)  0.586 (0.555, 0.618) -0.008 (-0.037, 0.014) \n",
       "92  0.57 (0.547, 0.587)  0.561 (0.539, 0.581) -0.008 (-0.025, 0.01)  \n",
       "93  0.49 (0.449, 0.529)  0.479 (0.449, 0.524) -0.008 (-0.048, 0.03)  \n",
       "94  0.55 (0.507, 0.589)  0.542 (0.509, 0.577) -0.008 (-0.038, 0.02)  \n",
       "95  0.553 (0.521, 0.587) 0.543 (0.516, 0.574) -0.008 (-0.041, 0.021) \n",
       "96  0.56 (0.534, 0.581)  0.551 (0.522, 0.578) -0.008 (-0.026, 0.015) \n",
       "97  0.57 (0.536, 0.611)  0.558 (0.523, 0.596) -0.008 (-0.035, 0.021) \n",
       "98  0.656 (0.622, 0.685) 0.647 (0.62, 0.678)  -0.008 (-0.032, 0.017) \n",
       "99  0.633 (0.617, 0.649) 0.626 (0.606, 0.642) -0.007 (-0.014, 0.001) \n",
       "100 0.694 (0.664, 0.731) 0.682 (0.648, 0.723) -0.007 (-0.03, 0.008)  \n",
       "101 0.723 (0.689, 0.749) 0.715 (0.688, 0.746) -0.007 (-0.02, 0.007)  \n",
       "102 0.634 (0.6, 0.661)   0.626 (0.598, 0.654) -0.007 (-0.024, 0.014) \n",
       "103 0.71 (0.693, 0.737)  0.703 (0.688, 0.728) -0.007 (-0.017, 0.003) \n",
       "104 0.527 (0.485, 0.574) 0.52 (0.462, 0.565)  -0.007 (-0.056, 0.029) \n",
       "105 0.563 (0.536, 0.585) 0.554 (0.525, 0.582) -0.007 (-0.023, 0.007) \n",
       "106 0.652 (0.636, 0.669) 0.645 (0.63, 0.66)   -0.007 (-0.013, -0.002)\n",
       "107 0.583 (0.569, 0.599) 0.575 (0.562, 0.591) -0.007 (-0.014, -0.002)\n",
       "108 0.769 (0.748, 0.793) 0.763 (0.741, 0.784) -0.007 (-0.02, 0.01)   \n",
       "109 0.613 (0.571, 0.646) 0.604 (0.569, 0.644) -0.007 (-0.036, 0.019) \n",
       "110 0.686 (0.666, 0.705) 0.679 (0.663, 0.7)   -0.007 (-0.017, 0.004) \n",
       "111 0.665 (0.64, 0.685)  0.659 (0.636, 0.678) -0.006 (-0.017, 0.007) \n",
       "112 0.668 (0.654, 0.683) 0.662 (0.648, 0.679) -0.006 (-0.012, -0.001)\n",
       "113 0.674 (0.66, 0.692)  0.669 (0.65, 0.685)  -0.006 (-0.016, 0.003) \n",
       "114 0.63 (0.607, 0.653)  0.623 (0.599, 0.653) -0.006 (-0.02, 0.006)  \n",
       "115 0.624 (0.602, 0.646) 0.618 (0.595, 0.642) -0.006 (-0.02, 0.006)  \n",
       "116 0.678 (0.645, 0.703) 0.673 (0.635, 0.697) -0.006 (-0.028, 0.009) \n",
       "117 0.565 (0.533, 0.602) 0.557 (0.524, 0.595) -0.005 (-0.028, 0.016) \n",
       "118 0.61 (0.59, 0.626)   0.603 (0.587, 0.622) -0.005 (-0.014, 0.002) \n",
       "119 0.732 (0.709, 0.748) 0.726 (0.705, 0.743) -0.005 (-0.012, 0.003) \n",
       "120 0.636 (0.613, 0.667) 0.629 (0.608, 0.662) -0.005 (-0.019, 0.009) \n",
       "121 0.735 (0.721, 0.753) 0.731 (0.714, 0.746) -0.005 (-0.011, 0.001) \n",
       "122 0.696 (0.671, 0.715) 0.689 (0.67, 0.714)  -0.005 (-0.015, 0.005) \n",
       "123 0.767 (0.749, 0.794) 0.761 (0.742, 0.792) -0.005 (-0.022, 0.008) \n",
       "124 0.523 (0.508, 0.537) 0.52 (0.501, 0.533)  -0.005 (-0.016, 0.006) \n",
       "125 0.585 (0.565, 0.602) 0.579 (0.562, 0.596) -0.005 (-0.011, 0.003) \n",
       "126 0.536 (0.502, 0.574) 0.529 (0.499, 0.566) -0.005 (-0.026, 0.021) \n",
       "127 0.534 (0.517, 0.553) 0.53 (0.515, 0.547)  -0.005 (-0.017, 0.009) \n",
       "128 0.617 (0.591, 0.649) 0.613 (0.584, 0.646) -0.005 (-0.01, 0.002)  \n",
       "129 0.523 (0.5, 0.544)   0.518 (0.494, 0.535) -0.004 (-0.025, 0.012) \n",
       "130 0.623 (0.605, 0.638) 0.619 (0.599, 0.633) -0.004 (-0.015, 0.007) \n",
       "131 0.531 (0.499, 0.578) 0.529 (0.484, 0.573) -0.004 (-0.037, 0.02)  \n",
       "132 0.524 (0.487, 0.572) 0.524 (0.46, 0.573)  -0.004 (-0.044, 0.032) \n",
       "133 0.58 (0.564, 0.602)  0.574 (0.56, 0.601)  -0.004 (-0.014, 0.004) \n",
       "134 0.631 (0.611, 0.655) 0.626 (0.605, 0.652) -0.004 (-0.009, 0.002) \n",
       "135 0.812 (0.793, 0.829) 0.808 (0.788, 0.826) -0.004 (-0.009, 0)     \n",
       "136 0.435 (0.404, 0.465) 0.432 (0.402, 0.47)  -0.004 (-0.036, 0.029) \n",
       "137 0.533 (0.503, 0.556) 0.526 (0.497, 0.552) -0.004 (-0.026, 0.023) \n",
       "138 0.736 (0.704, 0.771) 0.73 (0.703, 0.765)  -0.004 (-0.016, 0.007) \n",
       "139 0.624 (0.606, 0.641) 0.62 (0.597, 0.636)  -0.004 (-0.018, 0.006) \n",
       "140 0.664 (0.634, 0.7)   0.66 (0.629, 0.699)  -0.004 (-0.033, 0.024) \n",
       "141 0.706 (0.694, 0.724) 0.702 (0.687, 0.721) -0.004 (-0.009, 0.001) \n",
       "142 0.599 (0.562, 0.627) 0.595 (0.554, 0.623) -0.004 (-0.03, 0.028)  \n",
       "143 0.657 (0.643, 0.666) 0.653 (0.64, 0.662)  -0.004 (-0.008, 0)     \n",
       "144 0.743 (0.721, 0.764) 0.739 (0.718, 0.764) -0.004 (-0.009, 0.004) \n",
       "145 0.73 (0.697, 0.765)  0.726 (0.7, 0.762)   -0.004 (-0.015, 0.01)  \n",
       "146 0.573 (0.555, 0.592) 0.57 (0.551, 0.589)  -0.003 (-0.013, 0.005) \n",
       "147 0.55 (0.529, 0.578)  0.546 (0.526, 0.571) -0.003 (-0.02, 0.017)  \n",
       "148 0.793 (0.772, 0.822) 0.791 (0.769, 0.818) -0.003 (-0.011, 0.004) \n",
       "149 0.537 (0.513, 0.562) 0.535 (0.5, 0.561)   -0.003 (-0.021, 0.009) \n",
       "150 0.542 (0.501, 0.587) 0.537 (0.499, 0.576) -0.003 (-0.037, 0.025) \n",
       "151 0.516 (0.493, 0.549) 0.513 (0.484, 0.536) -0.003 (-0.017, 0.012) \n",
       "152 0.726 (0.706, 0.75)  0.723 (0.702, 0.744) -0.003 (-0.012, 0.006) \n",
       "153 0.582 (0.555, 0.605) 0.579 (0.551, 0.603) -0.003 (-0.015, 0.008) \n",
       "154 0.629 (0.617, 0.641) 0.626 (0.614, 0.637) -0.003 (-0.006, 0)     \n",
       "155 0.649 (0.635, 0.663) 0.647 (0.626, 0.665) -0.003 (-0.015, 0.012) \n",
       "156 0.863 (0.851, 0.874) 0.86 (0.846, 0.873)  -0.003 (-0.011, 0.005) \n",
       "157 0.729 (0.698, 0.762) 0.727 (0.682, 0.764) -0.003 (-0.028, 0.019) \n",
       "158 0.5 (0.465, 0.527)   0.496 (0.46, 0.533)  -0.003 (-0.024, 0.018) \n",
       "159 0.655 (0.643, 0.666) 0.652 (0.639, 0.664) -0.003 (-0.006, 0.001) \n",
       "160 0.663 (0.642, 0.68)  0.659 (0.638, 0.678) -0.003 (-0.012, 0.007) \n",
       "161 0.725 (0.701, 0.754) 0.723 (0.699, 0.753) -0.003 (-0.018, 0.012) \n",
       "162 0.687 (0.675, 0.703) 0.684 (0.674, 0.703) -0.003 (-0.007, 0.004) \n",
       "163 0.578 (0.535, 0.618) 0.578 (0.536, 0.611) -0.003 (-0.026, 0.027) \n",
       "164 0.635 (0.611, 0.655) 0.632 (0.606, 0.654) -0.003 (-0.016, 0.011) \n",
       "165 0.634 (0.617, 0.649) 0.633 (0.617, 0.648) -0.002 (-0.01, 0.009)  \n",
       "166 0.618 (0.597, 0.641) 0.615 (0.595, 0.637) -0.002 (-0.015, 0.014) \n",
       "167 0.642 (0.614, 0.668) 0.64 (0.612, 0.666)  -0.002 (-0.021, 0.015) \n",
       "168 0.738 (0.72, 0.751)  0.735 (0.716, 0.751) -0.002 (-0.008, 0.003) \n",
       "169 0.645 (0.628, 0.665) 0.643 (0.624, 0.66)  -0.002 (-0.013, 0.011) \n",
       "170 0.623 (0.601, 0.65)  0.623 (0.601, 0.644) -0.002 (-0.015, 0.012) \n",
       "171 0.592 (0.532, 0.631) 0.588 (0.538, 0.631) -0.002 (-0.033, 0.023) \n",
       "172 0.566 (0.542, 0.587) 0.564 (0.542, 0.583) -0.002 (-0.01, 0.011)  \n",
       "173 0.58 (0.568, 0.595)  0.578 (0.566, 0.594) -0.002 (-0.009, 0.003) \n",
       "174 0.765 (0.759, 0.773) 0.764 (0.758, 0.771) -0.002 (-0.003, -0.001)\n",
       "175 0.505 (0.486, 0.531) 0.505 (0.483, 0.524) -0.002 (-0.021, 0.019) \n",
       "176 0.734 (0.726, 0.743) 0.732 (0.724, 0.741) -0.002 (-0.004, 0)     \n",
       "177 0.783 (0.768, 0.805) 0.78 (0.764, 0.798)  -0.002 (-0.01, 0.005)  \n",
       "178 0.729 (0.71, 0.746)  0.726 (0.709, 0.743) -0.002 (-0.009, 0.004) \n",
       "179 0.703 (0.673, 0.741) 0.7 (0.676, 0.736)   -0.002 (-0.012, 0.01)  \n",
       "180 0.622 (0.599, 0.646) 0.619 (0.598, 0.642) -0.002 (-0.012, 0.008) \n",
       "181 0.847 (0.836, 0.861) 0.847 (0.835, 0.858) -0.002 (-0.008, 0.004) \n",
       "182 0.793 (0.777, 0.813) 0.792 (0.776, 0.814) -0.002 (-0.01, 0.006)  \n",
       "183 0.683 (0.672, 0.696) 0.682 (0.669, 0.695) -0.002 (-0.007, 0.003) \n",
       "184 0.637 (0.613, 0.667) 0.636 (0.604, 0.665) -0.002 (-0.016, 0.014) \n",
       "185 0.559 (0.541, 0.573) 0.557 (0.539, 0.571) -0.001 (-0.015, 0.01)  \n",
       "186 0.588 (0.575, 0.603) 0.586 (0.575, 0.599) -0.001 (-0.006, 0.003) \n",
       "187 0.788 (0.779, 0.803) 0.787 (0.777, 0.801) -0.001 (-0.009, 0.004) \n",
       "188 0.685 (0.671, 0.7)   0.682 (0.669, 0.7)   -0.001 (-0.006, 0.005) \n",
       "189 0.563 (0.549, 0.576) 0.562 (0.552, 0.573) -0.001 (-0.007, 0.004) \n",
       "190 0.637 (0.626, 0.648) 0.636 (0.624, 0.646) -0.001 (-0.005, 0.004) \n",
       "191 0.632 (0.595, 0.675) 0.635 (0.597, 0.674) -0.001 (-0.034, 0.044) \n",
       "192 0.646 (0.633, 0.658) 0.646 (0.633, 0.658) -0.001 (-0.004, 0.002) \n",
       "193 0.661 (0.655, 0.67)  0.661 (0.654, 0.668) -0.001 (-0.004, 0.002) \n",
       "194 0.703 (0.672, 0.73)  0.703 (0.665, 0.729) -0.001 (-0.024, 0.021) \n",
       "195 0.695 (0.684, 0.704) 0.693 (0.682, 0.704) -0.001 (-0.006, 0.003) \n",
       "196 0.648 (0.606, 0.696) 0.645 (0.593, 0.686) -0.001 (-0.06, 0.053)  \n",
       "197 0.625 (0.597, 0.658) 0.624 (0.589, 0.66)  -0.001 (-0.031, 0.023) \n",
       "198 0.605 (0.577, 0.641) 0.602 (0.574, 0.636) -0.001 (-0.033, 0.032) \n",
       "199 0.642 (0.63, 0.659)  0.641 (0.627, 0.658) -0.001 (-0.012, 0.01)  \n",
       "200 0.693 (0.678, 0.705) 0.692 (0.677, 0.704) -0.001 (-0.009, 0.006) \n",
       "201 0.703 (0.694, 0.715) 0.702 (0.693, 0.714) -0.001 (-0.006, 0.005) \n",
       "202 0.739 (0.727, 0.752) 0.737 (0.725, 0.751) -0.001 (-0.005, 0.003) \n",
       "203 0.686 (0.676, 0.698) 0.685 (0.674, 0.697) -0.001 (-0.003, 0.001) \n",
       "204 0.74 (0.717, 0.76)   0.739 (0.713, 0.765) -0.001 (-0.016, 0.016) \n",
       "205 0.691 (0.681, 0.7)   0.69 (0.68, 0.698)   -0.001 (-0.002, 0.001) \n",
       "206 0.875 (0.869, 0.882) 0.875 (0.867, 0.881) -0.001 (-0.003, 0.002) \n",
       "207 0.699 (0.69, 0.712)  0.699 (0.689, 0.712) -0.001 (-0.006, 0.005) \n",
       "208 0.606 (0.593, 0.617) 0.605 (0.594, 0.615) -0.001 (-0.005, 0.004) \n",
       "209 0.76 (0.748, 0.773)  0.759 (0.746, 0.771) 0 (-0.005, 0.002)      \n",
       "210 0.599 (0.592, 0.606) 0.599 (0.591, 0.606) 0 (-0.004, 0.005)      \n",
       "211 0.693 (0.685, 0.7)   0.693 (0.685, 0.7)   0 (-0.002, 0.001)      \n",
       "212 0.683 (0.647, 0.712) 0.68 (0.652, 0.709)  0 (-0.01, 0.008)       \n",
       "213 0.799 (0.791, 0.804) 0.799 (0.791, 0.804) 0 (0, 0)               \n",
       "214 0.724 (0.717, 0.732) 0.724 (0.717, 0.732) 0 (-0.001, 0.001)      \n",
       "215 0.62 (0.588, 0.649)  0.62 (0.596, 0.645)  0 (-0.01, 0.012)       \n",
       "216 0.648 (0.618, 0.673) 0.647 (0.611, 0.676) 0 (-0.019, 0.019)      \n",
       "217 0.617 (0.591, 0.653) 0.618 (0.595, 0.644) 0 (-0.014, 0.014)      \n",
       "218 0.697 (0.683, 0.709) 0.697 (0.682, 0.71)  0 (-0.007, 0.006)      \n",
       "219 0.665 (0.65, 0.679)  0.664 (0.65, 0.681)  0 (-0.007, 0.007)      \n",
       "220 0.696 (0.682, 0.713) 0.696 (0.677, 0.713) 0 (-0.007, 0.008)      \n",
       "221 0.675 (0.665, 0.684) 0.676 (0.666, 0.682) 0 (-0.004, 0.004)      \n",
       "222 0.798 (0.78, 0.815)  0.8 (0.779, 0.815)   0 (-0.005, 0.005)      \n",
       "223 0.579 (0.565, 0.593) 0.578 (0.565, 0.593) 0 (-0.008, 0.01)       \n",
       "224 0.568 (0.541, 0.588) 0.566 (0.54, 0.593)  0 (-0.021, 0.021)      \n",
       "225 0.638 (0.611, 0.656) 0.637 (0.62, 0.657)  0.001 (-0.015, 0.015)  \n",
       "226 0.72 (0.709, 0.731)  0.721 (0.707, 0.734) 0.001 (-0.005, 0.008)  \n",
       "227 0.616 (0.591, 0.642) 0.615 (0.594, 0.636) 0.001 (-0.015, 0.011)  \n",
       "228 0.59 (0.579, 0.599)  0.591 (0.578, 0.6)   0.001 (-0.004, 0.005)  \n",
       "229 0.541 (0.493, 0.577) 0.541 (0.512, 0.572) 0.001 (-0.032, 0.045)  \n",
       "230 0.509 (0.461, 0.556) 0.511 (0.459, 0.551) 0.001 (-0.054, 0.053)  \n",
       "231 0.707 (0.688, 0.721) 0.708 (0.691, 0.722) 0.001 (-0.009, 0.013)  \n",
       "232 0.703 (0.682, 0.735) 0.707 (0.682, 0.741) 0.001 (-0.014, 0.027)  \n",
       "233 0.679 (0.652, 0.707) 0.68 (0.655, 0.72)   0.001 (-0.02, 0.022)   \n",
       "234 0.845 (0.826, 0.858) 0.845 (0.829, 0.862) 0.001 (-0.01, 0.012)   \n",
       "235 0.656 (0.649, 0.666) 0.657 (0.648, 0.667) 0.001 (-0.004, 0.006)  \n",
       "236 0.606 (0.58, 0.625)  0.607 (0.585, 0.626) 0.001 (-0.012, 0.015)  \n",
       "237 0.624 (0.619, 0.63)  0.625 (0.62, 0.631)  0.001 (-0.001, 0.003)  \n",
       "238 0.73 (0.722, 0.74)   0.732 (0.722, 0.74)  0.001 (-0.002, 0.004)  \n",
       "239 0.673 (0.642, 0.707) 0.672 (0.638, 0.712) 0.001 (-0.022, 0.028)  \n",
       "240 0.706 (0.682, 0.722) 0.707 (0.684, 0.724) 0.001 (-0.005, 0.008)  \n",
       "241 0.61 (0.597, 0.621)  0.611 (0.598, 0.624) 0.001 (-0.005, 0.006)  \n",
       "242 0.539 (0.495, 0.58)  0.54 (0.5, 0.581)    0.001 (-0.033, 0.03)   \n",
       "243 0.721 (0.711, 0.733) 0.723 (0.71, 0.734)  0.001 (-0.007, 0.007)  \n",
       "244 0.644 (0.64, 0.648)  0.645 (0.642, 0.649) 0.001 (0, 0.003)       \n",
       "245 0.592 (0.574, 0.613) 0.593 (0.574, 0.616) 0.001 (-0.012, 0.013)  \n",
       "246 0.615 (0.591, 0.637) 0.617 (0.594, 0.638) 0.001 (-0.007, 0.011)  \n",
       "247 0.587 (0.581, 0.594) 0.588 (0.582, 0.595) 0.001 (-0.001, 0.003)  \n",
       "248 0.682 (0.676, 0.69)  0.684 (0.676, 0.692) 0.001 (-0.003, 0.007)  \n",
       "249 0.644 (0.616, 0.677) 0.649 (0.615, 0.678) 0.001 (-0.018, 0.028)  \n",
       "250 0.496 (0.48, 0.512)  0.499 (0.48, 0.513)  0.001 (-0.008, 0.013)  \n",
       "251 0.585 (0.578, 0.595) 0.586 (0.579, 0.595) 0.001 (-0.004, 0.007)  \n",
       "252 0.588 (0.55, 0.619)  0.592 (0.558, 0.621) 0.001 (-0.024, 0.028)  \n",
       "253 0.663 (0.638, 0.683) 0.663 (0.639, 0.69)  0.001 (-0.009, 0.013)  \n",
       "254 0.656 (0.649, 0.663) 0.657 (0.65, 0.665)  0.001 (-0.001, 0.003)  \n",
       "255 0.661 (0.638, 0.679) 0.661 (0.642, 0.681) 0.002 (-0.01, 0.01)    \n",
       "256 0.6 (0.588, 0.611)   0.601 (0.588, 0.611) 0.002 (-0.005, 0.007)  \n",
       "257 0.675 (0.657, 0.689) 0.676 (0.656, 0.69)  0.002 (-0.003, 0.007)  \n",
       "258 0.717 (0.704, 0.736) 0.719 (0.704, 0.735) 0.002 (-0.003, 0.006)  \n",
       "259 0.629 (0.624, 0.634) 0.631 (0.626, 0.635) 0.002 (0, 0.004)       \n",
       "260 0.671 (0.66, 0.682)  0.672 (0.663, 0.683) 0.002 (-0.002, 0.006)  \n",
       "261 0.551 (0.541, 0.561) 0.552 (0.542, 0.56)  0.002 (-0.006, 0.008)  \n",
       "262 0.565 (0.55, 0.58)   0.567 (0.552, 0.58)  0.002 (-0.008, 0.011)  \n",
       "263 0.736 (0.713, 0.756) 0.736 (0.711, 0.754) 0.002 (-0.016, 0.017)  \n",
       "264 0.629 (0.623, 0.634) 0.631 (0.626, 0.636) 0.002 (0, 0.003)       \n",
       "265 0.614 (0.603, 0.628) 0.615 (0.604, 0.626) 0.002 (-0.008, 0.009)  \n",
       "266 0.592 (0.586, 0.598) 0.594 (0.589, 0.599) 0.002 (-0.002, 0.005)  \n",
       "267 0.632 (0.608, 0.66)  0.635 (0.609, 0.662) 0.002 (-0.014, 0.017)  \n",
       "268 0.541 (0.521, 0.553) 0.542 (0.523, 0.555) 0.002 (-0.006, 0.009)  \n",
       "269 0.669 (0.66, 0.677)  0.67 (0.663, 0.68)   0.002 (0, 0.004)       \n",
       "270 0.674 (0.663, 0.685) 0.676 (0.668, 0.686) 0.002 (-0.002, 0.006)  \n",
       "271 0.585 (0.569, 0.606) 0.588 (0.571, 0.607) 0.002 (-0.01, 0.015)   \n",
       "272 0.744 (0.733, 0.756) 0.746 (0.734, 0.758) 0.002 (-0.005, 0.007)  \n",
       "273 0.607 (0.583, 0.633) 0.609 (0.589, 0.637) 0.002 (-0.015, 0.022)  \n",
       "274 0.718 (0.696, 0.739) 0.72 (0.698, 0.743)  0.002 (-0.009, 0.011)  \n",
       "275 0.628 (0.611, 0.645) 0.628 (0.612, 0.649) 0.002 (-0.01, 0.011)   \n",
       "276 0.703 (0.691, 0.711) 0.705 (0.695, 0.715) 0.002 (-0.004, 0.01)   \n",
       "277 0.624 (0.599, 0.64)  0.627 (0.603, 0.644) 0.002 (-0.005, 0.011)  \n",
       "278 0.606 (0.577, 0.64)  0.61 (0.571, 0.638)  0.003 (-0.035, 0.04)   \n",
       "279 0.672 (0.663, 0.678) 0.674 (0.665, 0.682) 0.003 (0.001, 0.005)   \n",
       "280 0.588 (0.582, 0.593) 0.59 (0.584, 0.596)  0.003 (0, 0.005)       \n",
       "281 0.599 (0.582, 0.614) 0.602 (0.583, 0.618) 0.003 (-0.009, 0.012)  \n",
       "282 0.645 (0.629, 0.659) 0.647 (0.632, 0.661) 0.003 (-0.003, 0.01)   \n",
       "283 0.558 (0.51, 0.588)  0.553 (0.514, 0.597) 0.003 (-0.033, 0.039)  \n",
       "284 0.671 (0.664, 0.68)  0.674 (0.667, 0.682) 0.003 (0, 0.005)       \n",
       "285 0.602 (0.597, 0.609) 0.605 (0.599, 0.611) 0.003 (0.001, 0.006)   \n",
       "286 0.714 (0.705, 0.72)  0.716 (0.709, 0.723) 0.003 (-0.001, 0.005)  \n",
       "287 0.608 (0.602, 0.613) 0.61 (0.604, 0.617)  0.003 (0, 0.006)       \n",
       "288 0.623 (0.595, 0.659) 0.627 (0.593, 0.655) 0.003 (-0.033, 0.031)  \n",
       "289 0.643 (0.63, 0.656)  0.646 (0.631, 0.658) 0.003 (-0.004, 0.011)  \n",
       "290 0.662 (0.654, 0.672) 0.666 (0.657, 0.676) 0.003 (-0.002, 0.01)   \n",
       "291 0.674 (0.663, 0.682) 0.677 (0.667, 0.686) 0.003 (-0.002, 0.009)  \n",
       "292 0.735 (0.712, 0.758) 0.74 (0.716, 0.765)  0.003 (-0.017, 0.022)  \n",
       "293 0.719 (0.706, 0.735) 0.723 (0.71, 0.737)  0.003 (-0.001, 0.009)  \n",
       "294 0.67 (0.654, 0.685)  0.674 (0.658, 0.69)  0.003 (-0.003, 0.01)   \n",
       "295 0.456 (0.438, 0.474) 0.459 (0.44, 0.478)  0.003 (-0.009, 0.018)  \n",
       "296 0.7 (0.685, 0.718)   0.705 (0.688, 0.721) 0.003 (-0.005, 0.012)  \n",
       "297 0.719 (0.713, 0.725) 0.723 (0.717, 0.728) 0.003 (0.002, 0.005)   \n",
       "298 0.701 (0.694, 0.709) 0.705 (0.698, 0.713) 0.003 (0.001, 0.006)   \n",
       "299 0.708 (0.697, 0.718) 0.712 (0.699, 0.723) 0.003 (-0.003, 0.009)  \n",
       "300 0.573 (0.558, 0.592) 0.576 (0.564, 0.596) 0.003 (-0.007, 0.012)  \n",
       "301 0.596 (0.582, 0.614) 0.599 (0.585, 0.622) 0.003 (-0.005, 0.012)  \n",
       "302 0.592 (0.587, 0.599) 0.595 (0.59, 0.601)  0.003 (0.001, 0.006)   \n",
       "303 0.675 (0.638, 0.712) 0.677 (0.645, 0.717) 0.004 (-0.017, 0.024)  \n",
       "304 0.588 (0.583, 0.595) 0.592 (0.586, 0.598) 0.004 (0.001, 0.007)   \n",
       "305 0.732 (0.699, 0.755) 0.733 (0.704, 0.76)  0.004 (-0.005, 0.013)  \n",
       "306 0.756 (0.745, 0.766) 0.76 (0.75, 0.769)   0.004 (0.001, 0.005)   \n",
       "307 0.712 (0.704, 0.718) 0.715 (0.708, 0.722) 0.004 (0.001, 0.007)   \n",
       "308 0.739 (0.734, 0.746) 0.743 (0.737, 0.749) 0.004 (0.001, 0.006)   \n",
       "309 0.762 (0.755, 0.771) 0.766 (0.758, 0.774) 0.004 (0.002, 0.006)   \n",
       "310 0.497 (0.467, 0.525) 0.5 (0.472, 0.53)    0.004 (-0.023, 0.025)  \n",
       "311 0.71 (0.693, 0.726)  0.714 (0.696, 0.734) 0.004 (-0.004, 0.012)  \n",
       "312 0.719 (0.71, 0.729)  0.723 (0.714, 0.734) 0.004 (-0.002, 0.008)  \n",
       "313 0.636 (0.626, 0.648) 0.64 (0.629, 0.651)  0.004 (-0.003, 0.009)  \n",
       "314 0.687 (0.672, 0.7)   0.69 (0.677, 0.703)  0.004 (-0.003, 0.01)   \n",
       "315 0.671 (0.66, 0.682)  0.675 (0.664, 0.684) 0.004 (-0.005, 0.011)  \n",
       "316 0.658 (0.633, 0.686) 0.662 (0.638, 0.682) 0.004 (-0.013, 0.018)  \n",
       "317 0.659 (0.643, 0.685) 0.664 (0.642, 0.688) 0.004 (-0.006, 0.018)  \n",
       "318 0.632 (0.624, 0.639) 0.635 (0.629, 0.642) 0.004 (-0.001, 0.009)  \n",
       "319 0.706 (0.692, 0.716) 0.71 (0.697, 0.723)  0.004 (-0.004, 0.011)  \n",
       "320 0.535 (0.515, 0.554) 0.538 (0.521, 0.56)  0.004 (-0.018, 0.022)  \n",
       "321 0.727 (0.711, 0.748) 0.731 (0.709, 0.756) 0.004 (-0.013, 0.021)  \n",
       "322 0.606 (0.559, 0.649) 0.604 (0.561, 0.651) 0.004 (-0.036, 0.034)  \n",
       "323 0.703 (0.697, 0.708) 0.707 (0.701, 0.713) 0.005 (0.002, 0.007)   \n",
       "324 0.698 (0.674, 0.722) 0.702 (0.673, 0.73)  0.005 (-0.012, 0.022)  \n",
       "325 0.609 (0.596, 0.626) 0.614 (0.603, 0.625) 0.005 (-0.008, 0.014)  \n",
       "326 0.586 (0.562, 0.61)  0.588 (0.56, 0.617)  0.005 (-0.02, 0.027)   \n",
       "327 0.571 (0.566, 0.577) 0.576 (0.571, 0.582) 0.005 (0.001, 0.008)   \n",
       "328 0.644 (0.632, 0.657) 0.648 (0.636, 0.66)  0.005 (0, 0.009)       \n",
       "329 0.655 (0.643, 0.67)  0.66 (0.649, 0.677)  0.005 (-0.002, 0.016)  \n",
       "330 0.45 (0.422, 0.477)  0.454 (0.425, 0.49)  0.005 (-0.025, 0.033)  \n",
       "331 0.71 (0.695, 0.723)  0.713 (0.698, 0.729) 0.005 (-0.007, 0.014)  \n",
       "332 0.624 (0.61, 0.636)  0.628 (0.613, 0.64)  0.005 (-0.004, 0.014)  \n",
       "333 0.551 (0.516, 0.594) 0.556 (0.523, 0.594) 0.005 (-0.027, 0.031)  \n",
       "334 0.596 (0.58, 0.612)  0.601 (0.582, 0.617) 0.005 (-0.002, 0.012)  \n",
       "335 0.515 (0.503, 0.525) 0.519 (0.508, 0.53)  0.005 (-0.002, 0.012)  \n",
       "336 0.632 (0.621, 0.642) 0.636 (0.625, 0.649) 0.005 (-0.002, 0.014)  \n",
       "337 0.577 (0.571, 0.583) 0.583 (0.576, 0.589) 0.005 (0.002, 0.009)   \n",
       "338 0.637 (0.633, 0.642) 0.643 (0.638, 0.647) 0.005 (0.004, 0.007)   \n",
       "339 0.66 (0.639, 0.68)   0.664 (0.644, 0.687) 0.006 (-0.008, 0.015)  \n",
       "340 0.639 (0.601, 0.662) 0.643 (0.611, 0.669) 0.006 (-0.016, 0.031)  \n",
       "341 0.592 (0.56, 0.624)  0.599 (0.562, 0.629) 0.006 (-0.021, 0.031)  \n",
       "342 0.613 (0.585, 0.644) 0.619 (0.583, 0.646) 0.006 (-0.012, 0.026)  \n",
       "343 0.679 (0.661, 0.695) 0.685 (0.667, 0.702) 0.006 (0.002, 0.01)    \n",
       "344 0.648 (0.628, 0.667) 0.653 (0.635, 0.676) 0.006 (-0.004, 0.012)  \n",
       "345 0.721 (0.708, 0.728) 0.726 (0.715, 0.736) 0.006 (-0.003, 0.014)  \n",
       "346 0.683 (0.669, 0.702) 0.689 (0.674, 0.708) 0.006 (0.001, 0.011)   \n",
       "347 0.58 (0.55, 0.605)   0.584 (0.553, 0.613) 0.006 (-0.027, 0.026)  \n",
       "348 0.765 (0.755, 0.774) 0.77 (0.76, 0.779)   0.006 (0.001, 0.011)   \n",
       "349 0.554 (0.538, 0.573) 0.561 (0.542, 0.573) 0.006 (-0.01, 0.021)   \n",
       "350 0.722 (0.715, 0.732) 0.728 (0.721, 0.738) 0.006 (0.001, 0.01)    \n",
       "351 0.654 (0.644, 0.667) 0.659 (0.646, 0.673) 0.006 (0.001, 0.01)    \n",
       "352 0.579 (0.571, 0.588) 0.585 (0.578, 0.595) 0.006 (0.001, 0.011)   \n",
       "353 0.65 (0.607, 0.687)  0.655 (0.621, 0.699) 0.006 (-0.025, 0.045)  \n",
       "354 0.547 (0.514, 0.581) 0.551 (0.52, 0.583)  0.006 (-0.027, 0.038)  \n",
       "355 0.637 (0.621, 0.652) 0.642 (0.63, 0.661)  0.006 (-0.004, 0.017)  \n",
       "356 0.678 (0.666, 0.69)  0.684 (0.672, 0.697) 0.006 (0.002, 0.011)   \n",
       "357 0.573 (0.544, 0.607) 0.579 (0.556, 0.611) 0.006 (-0.014, 0.03)   \n",
       "358 0.699 (0.662, 0.734) 0.705 (0.667, 0.739) 0.006 (-0.015, 0.03)   \n",
       "359 0.647 (0.633, 0.664) 0.654 (0.64, 0.674)  0.006 (-0.004, 0.018)  \n",
       "360 0.558 (0.532, 0.586) 0.564 (0.538, 0.587) 0.007 (-0.018, 0.026)  \n",
       "361 0.592 (0.581, 0.606) 0.599 (0.588, 0.61)  0.007 (-0.003, 0.016)  \n",
       "362 0.505 (0.496, 0.514) 0.512 (0.503, 0.521) 0.007 (0.001, 0.014)   \n",
       "363 0.64 (0.61, 0.675)   0.649 (0.614, 0.692) 0.007 (-0.027, 0.052)  \n",
       "364 0.721 (0.713, 0.73)  0.728 (0.719, 0.737) 0.007 (0.001, 0.012)   \n",
       "365 0.769 (0.76, 0.779)  0.776 (0.767, 0.786) 0.007 (0.002, 0.012)   \n",
       "366 0.756 (0.745, 0.771) 0.764 (0.749, 0.779) 0.007 (-0.003, 0.016)  \n",
       "367 0.598 (0.589, 0.613) 0.606 (0.594, 0.622) 0.007 (-0.003, 0.017)  \n",
       "368 0.727 (0.714, 0.738) 0.733 (0.72, 0.746)  0.007 (0, 0.015)       \n",
       "369 0.639 (0.609, 0.669) 0.648 (0.615, 0.681) 0.007 (-0.023, 0.044)  \n",
       "370 0.584 (0.573, 0.596) 0.591 (0.578, 0.602) 0.007 (-0.001, 0.017)  \n",
       "371 0.769 (0.761, 0.78)  0.777 (0.768, 0.787) 0.007 (0.003, 0.013)   \n",
       "372 0.654 (0.625, 0.677) 0.661 (0.639, 0.684) 0.007 (-0.009, 0.026)  \n",
       "373 0.662 (0.652, 0.673) 0.669 (0.658, 0.68)  0.008 (0, 0.014)       \n",
       "374 0.553 (0.51, 0.579)  0.554 (0.534, 0.59)  0.008 (-0.03, 0.046)   \n",
       "375 0.573 (0.564, 0.582) 0.58 (0.569, 0.59)   0.008 (0.002, 0.014)   \n",
       "376 0.724 (0.698, 0.754) 0.731 (0.7, 0.756)   0.008 (-0.006, 0.022)  \n",
       "377 0.559 (0.544, 0.58)  0.568 (0.551, 0.588) 0.008 (-0.006, 0.022)  \n",
       "378 0.693 (0.682, 0.707) 0.701 (0.691, 0.714) 0.008 (-0.001, 0.017)  \n",
       "379 0.581 (0.556, 0.608) 0.591 (0.561, 0.612) 0.008 (-0.016, 0.031)  \n",
       "380 0.601 (0.591, 0.609) 0.609 (0.599, 0.616) 0.008 (0.002, 0.013)   \n",
       "381 0.66 (0.628, 0.692)  0.668 (0.637, 0.687) 0.008 (-0.024, 0.029)  \n",
       "382 0.6 (0.591, 0.609)   0.608 (0.6, 0.616)   0.008 (0.002, 0.013)   \n",
       "383 0.589 (0.553, 0.618) 0.594 (0.564, 0.632) 0.008 (-0.011, 0.026)  \n",
       "384 0.603 (0.588, 0.62)  0.611 (0.597, 0.624) 0.008 (-0.002, 0.019)  \n",
       "385 0.628 (0.616, 0.64)  0.637 (0.625, 0.648) 0.009 (0, 0.015)       \n",
       "386 0.627 (0.618, 0.637) 0.636 (0.626, 0.646) 0.009 (0.002, 0.014)   \n",
       "387 0.6 (0.59, 0.609)    0.609 (0.599, 0.618) 0.009 (0.004, 0.016)   \n",
       "388 0.668 (0.624, 0.714) 0.673 (0.634, 0.724) 0.009 (-0.012, 0.025)  \n",
       "389 0.444 (0.429, 0.469) 0.455 (0.432, 0.473) 0.009 (-0.011, 0.027)  \n",
       "390 0.547 (0.541, 0.554) 0.556 (0.548, 0.562) 0.009 (0.005, 0.013)   \n",
       "391 0.602 (0.591, 0.616) 0.609 (0.601, 0.625) 0.009 (0.001, 0.015)   \n",
       "392 0.577 (0.57, 0.585)  0.586 (0.579, 0.595) 0.009 (0.005, 0.013)   \n",
       "393 0.595 (0.585, 0.605) 0.605 (0.595, 0.613) 0.009 (0.003, 0.015)   \n",
       "394 0.522 (0.509, 0.531) 0.53 (0.517, 0.542)  0.009 (-0.003, 0.019)  \n",
       "395 0.669 (0.638, 0.699) 0.681 (0.645, 0.712) 0.009 (-0.018, 0.037)  \n",
       "396 0.66 (0.64, 0.679)   0.668 (0.65, 0.696)  0.009 (-0.001, 0.024)  \n",
       "397 0.704 (0.695, 0.714) 0.714 (0.702, 0.725) 0.009 (0.002, 0.017)   \n",
       "398 0.614 (0.583, 0.643) 0.624 (0.591, 0.659) 0.009 (-0.014, 0.031)  \n",
       "399 0.669 (0.641, 0.693) 0.68 (0.653, 0.708)  0.01 (-0.009, 0.032)   \n",
       "400 0.507 (0.469, 0.534) 0.511 (0.478, 0.553) 0.01 (-0.022, 0.042)   \n",
       "401 0.662 (0.655, 0.671) 0.671 (0.665, 0.681) 0.01 (0.007, 0.013)    \n",
       "402 0.627 (0.615, 0.641) 0.637 (0.625, 0.65)  0.01 (0.003, 0.017)    \n",
       "403 0.676 (0.636, 0.709) 0.686 (0.652, 0.716) 0.01 (-0.009, 0.032)   \n",
       "404 0.61 (0.587, 0.629)  0.621 (0.6, 0.638)   0.01 (-0.005, 0.027)   \n",
       "405 0.639 (0.629, 0.649) 0.649 (0.64, 0.659)  0.01 (0.004, 0.015)    \n",
       "406 0.69 (0.664, 0.721)  0.701 (0.675, 0.734) 0.01 (-0.008, 0.026)   \n",
       "407 0.606 (0.579, 0.638) 0.619 (0.586, 0.641) 0.01 (-0.016, 0.03)    \n",
       "408 0.591 (0.575, 0.608) 0.6 (0.582, 0.618)   0.01 (-0.004, 0.023)   \n",
       "409 0.647 (0.613, 0.686) 0.659 (0.621, 0.69)  0.01 (-0.015, 0.052)   \n",
       "410 0.57 (0.558, 0.581)  0.58 (0.569, 0.592)  0.01 (0.002, 0.02)     \n",
       "411 0.63 (0.608, 0.658)  0.64 (0.614, 0.67)   0.01 (-0.005, 0.027)   \n",
       "412 0.598 (0.585, 0.615) 0.607 (0.595, 0.625) 0.01 (0, 0.02)         \n",
       "413 0.733 (0.714, 0.747) 0.744 (0.73, 0.76)   0.01 (0.003, 0.022)    \n",
       "414 0.612 (0.604, 0.618) 0.622 (0.614, 0.629) 0.011 (0.005, 0.017)   \n",
       "415 0.689 (0.683, 0.696) 0.701 (0.694, 0.707) 0.011 (0.006, 0.016)   \n",
       "416 0.554 (0.533, 0.567) 0.562 (0.546, 0.581) 0.011 (-0.005, 0.024)  \n",
       "417 0.667 (0.648, 0.689) 0.678 (0.659, 0.699) 0.011 (0.001, 0.019)   \n",
       "418 0.556 (0.546, 0.568) 0.567 (0.556, 0.578) 0.011 (0.003, 0.018)   \n",
       "419 0.741 (0.726, 0.754) 0.752 (0.739, 0.764) 0.011 (0.004, 0.019)   \n",
       "420 0.588 (0.57, 0.602)  0.598 (0.585, 0.613) 0.011 (-0.004, 0.024)  \n",
       "421 0.552 (0.534, 0.57)  0.564 (0.547, 0.58)  0.011 (-0.001, 0.024)  \n",
       "422 0.633 (0.622, 0.642) 0.644 (0.635, 0.654) 0.011 (0.004, 0.019)   \n",
       "423 0.713 (0.688, 0.745) 0.726 (0.689, 0.756) 0.011 (-0.016, 0.033)  \n",
       "424 0.494 (0.467, 0.525) 0.503 (0.471, 0.548) 0.011 (-0.024, 0.039)  \n",
       "425 0.618 (0.6, 0.637)   0.629 (0.611, 0.647) 0.011 (-0.002, 0.02)   \n",
       "426 0.608 (0.586, 0.63)  0.617 (0.602, 0.643) 0.011 (-0.003, 0.026)  \n",
       "427 0.671 (0.646, 0.701) 0.681 (0.653, 0.713) 0.011 (-0.007, 0.027)  \n",
       "428 0.626 (0.612, 0.638) 0.637 (0.621, 0.648) 0.011 (0.002, 0.02)    \n",
       "429 0.625 (0.616, 0.635) 0.636 (0.628, 0.644) 0.011 (0.004, 0.017)   \n",
       "430 0.623 (0.604, 0.641) 0.634 (0.614, 0.648) 0.011 (-0.002, 0.022)  \n",
       "431 0.68 (0.667, 0.69)   0.691 (0.682, 0.704) 0.011 (0.004, 0.018)   \n",
       "432 0.631 (0.585, 0.669) 0.642 (0.603, 0.676) 0.011 (-0.027, 0.047)  \n",
       "433 0.575 (0.566, 0.587) 0.586 (0.576, 0.597) 0.012 (0.004, 0.02)    \n",
       "434 0.643 (0.622, 0.667) 0.655 (0.636, 0.677) 0.012 (-0.002, 0.025)  \n",
       "435 0.608 (0.567, 0.651) 0.622 (0.577, 0.665) 0.012 (-0.025, 0.049)  \n",
       "436 0.57 (0.545, 0.599)  0.584 (0.556, 0.61)  0.012 (-0.009, 0.032)  \n",
       "437 0.682 (0.678, 0.686) 0.694 (0.691, 0.698) 0.012 (0.009, 0.014)   \n",
       "438 0.663 (0.66, 0.667)  0.675 (0.672, 0.679) 0.012 (0.01, 0.014)    \n",
       "439 0.578 (0.56, 0.599)  0.589 (0.572, 0.609) 0.012 (-0.004, 0.026)  \n",
       "440 0.682 (0.678, 0.688) 0.695 (0.69, 0.699)  0.012 (0.01, 0.015)    \n",
       "441 0.682 (0.677, 0.686) 0.694 (0.69, 0.698)  0.012 (0.01, 0.014)    \n",
       "442 0.667 (0.644, 0.687) 0.678 (0.654, 0.701) 0.012 (-0.004, 0.024)  \n",
       "443 0.664 (0.659, 0.667) 0.676 (0.672, 0.679) 0.012 (0.01, 0.014)    \n",
       "444 0.639 (0.63, 0.646)  0.65 (0.642, 0.659)  0.012 (0.007, 0.017)   \n",
       "445 0.673 (0.666, 0.682) 0.686 (0.676, 0.694) 0.012 (0.006, 0.018)   \n",
       "446 0.539 (0.52, 0.56)   0.552 (0.535, 0.571) 0.013 (0.003, 0.021)   \n",
       "447 0.571 (0.556, 0.588) 0.586 (0.567, 0.601) 0.013 (0.001, 0.026)   \n",
       "448 0.506 (0.457, 0.545) 0.515 (0.466, 0.552) 0.013 (-0.039, 0.057)  \n",
       "449 0.626 (0.612, 0.642) 0.64 (0.625, 0.657)  0.013 (0.006, 0.02)    \n",
       "450 0.708 (0.701, 0.715) 0.721 (0.715, 0.728) 0.013 (0.009, 0.017)   \n",
       "451 0.655 (0.64, 0.667)  0.666 (0.651, 0.681) 0.013 (-0.002, 0.022)  \n",
       "452 0.551 (0.522, 0.578) 0.565 (0.535, 0.596) 0.013 (-0.009, 0.031)  \n",
       "453 0.447 (0.428, 0.465) 0.46 (0.44, 0.476)   0.013 (-0.003, 0.033)  \n",
       "454 0.629 (0.598, 0.666) 0.641 (0.604, 0.681) 0.013 (-0.015, 0.038)  \n",
       "455 0.647 (0.621, 0.667) 0.658 (0.64, 0.682)  0.013 (-0.003, 0.028)  \n",
       "456 0.744 (0.737, 0.754) 0.759 (0.75, 0.769)  0.014 (0.008, 0.02)    \n",
       "457 0.681 (0.661, 0.698) 0.694 (0.675, 0.713) 0.014 (0.003, 0.023)   \n",
       "458 0.479 (0.445, 0.508) 0.493 (0.461, 0.522) 0.014 (-0.022, 0.052)  \n",
       "459 0.66 (0.646, 0.676)  0.675 (0.661, 0.691) 0.014 (0.005, 0.025)   \n",
       "460 0.683 (0.655, 0.7)   0.698 (0.67, 0.714)  0.014 (-0.002, 0.03)   \n",
       "461 0.658 (0.642, 0.676) 0.672 (0.648, 0.691) 0.014 (-0.001, 0.024)  \n",
       "462 0.593 (0.551, 0.625) 0.608 (0.572, 0.643) 0.014 (-0.001, 0.039)  \n",
       "463 0.749 (0.716, 0.791) 0.766 (0.738, 0.803) 0.015 (-0.008, 0.038)  \n",
       "464 0.654 (0.633, 0.673) 0.669 (0.651, 0.685) 0.015 (-0.001, 0.029)  \n",
       "465 0.644 (0.629, 0.658) 0.658 (0.643, 0.674) 0.015 (0.003, 0.026)   \n",
       "466 0.588 (0.575, 0.607) 0.604 (0.588, 0.619) 0.015 (0.003, 0.027)   \n",
       "467 0.584 (0.553, 0.604) 0.597 (0.57, 0.625)  0.015 (-0.006, 0.037)  \n",
       "468 0.516 (0.49, 0.546)  0.53 (0.504, 0.563)  0.015 (-0.004, 0.042)  \n",
       "469 0.563 (0.549, 0.575) 0.578 (0.564, 0.587) 0.015 (0.007, 0.021)   \n",
       "470 0.652 (0.648, 0.658) 0.668 (0.662, 0.674) 0.015 (0.011, 0.018)   \n",
       "471 0.515 (0.505, 0.527) 0.531 (0.521, 0.543) 0.015 (0.004, 0.029)   \n",
       "472 0.54 (0.533, 0.545)  0.555 (0.548, 0.561) 0.015 (0.009, 0.022)   \n",
       "473 0.594 (0.576, 0.621) 0.61 (0.588, 0.63)   0.016 (0.001, 0.028)   \n",
       "474 0.533 (0.512, 0.561) 0.549 (0.519, 0.573) 0.016 (-0.008, 0.029)  \n",
       "475 0.535 (0.476, 0.578) 0.551 (0.498, 0.61)  0.016 (-0.013, 0.061)  \n",
       "476 0.503 (0.469, 0.535) 0.515 (0.478, 0.548) 0.016 (-0.021, 0.048)  \n",
       "477 0.575 (0.553, 0.593) 0.591 (0.568, 0.615) 0.016 (-0.01, 0.032)   \n",
       "478 0.556 (0.546, 0.567) 0.573 (0.561, 0.582) 0.016 (0.006, 0.024)   \n",
       "479 0.606 (0.587, 0.622) 0.622 (0.606, 0.639) 0.016 (0.006, 0.024)   \n",
       "480 0.58 (0.572, 0.591)  0.597 (0.588, 0.606) 0.016 (0.009, 0.022)   \n",
       "481 0.619 (0.606, 0.638) 0.637 (0.618, 0.656) 0.016 (0.002, 0.032)   \n",
       "482 0.726 (0.689, 0.759) 0.739 (0.707, 0.769) 0.017 (-0.014, 0.044)  \n",
       "483 0.466 (0.44, 0.498)  0.484 (0.461, 0.512) 0.017 (-0.01, 0.046)   \n",
       "484 0.67 (0.656, 0.682)  0.686 (0.676, 0.7)   0.017 (0.007, 0.027)   \n",
       "485 0.508 (0.476, 0.532) 0.524 (0.489, 0.56)  0.017 (-0.009, 0.041)  \n",
       "486 0.728 (0.689, 0.761) 0.744 (0.714, 0.775) 0.017 (-0.003, 0.035)  \n",
       "487 0.572 (0.556, 0.587) 0.589 (0.573, 0.6)   0.017 (0.005, 0.027)   \n",
       "488 0.73 (0.712, 0.751)  0.747 (0.726, 0.771) 0.017 (0.003, 0.029)   \n",
       "489 0.702 (0.675, 0.724) 0.719 (0.693, 0.743) 0.017 (-0.002, 0.037)  \n",
       "490 0.589 (0.573, 0.606) 0.608 (0.59, 0.622)  0.017 (0.01, 0.028)    \n",
       "491 0.662 (0.643, 0.687) 0.679 (0.662, 0.698) 0.017 (-0.001, 0.031)  \n",
       "492 0.691 (0.675, 0.706) 0.707 (0.696, 0.721) 0.018 (0.004, 0.031)   \n",
       "493 0.622 (0.6, 0.65)    0.641 (0.618, 0.663) 0.018 (-0.007, 0.039)  \n",
       "494 0.567 (0.557, 0.578) 0.586 (0.577, 0.597) 0.018 (0.011, 0.026)   \n",
       "495 0.598 (0.562, 0.632) 0.615 (0.584, 0.646) 0.018 (0, 0.04)        \n",
       "496 0.569 (0.555, 0.581) 0.586 (0.57, 0.6)    0.018 (0.005, 0.028)   \n",
       "497 0.672 (0.655, 0.692) 0.69 (0.673, 0.712)  0.018 (0.003, 0.028)   \n",
       "498 0.752 (0.732, 0.765) 0.768 (0.757, 0.784) 0.018 (0.006, 0.032)   \n",
       "499 0.704 (0.681, 0.728) 0.722 (0.699, 0.744) 0.018 (0.004, 0.033)   \n",
       "500 0.654 (0.624, 0.677) 0.671 (0.643, 0.704) 0.019 (-0.007, 0.041)  \n",
       "501 0.551 (0.535, 0.567) 0.57 (0.556, 0.589)  0.019 (0.007, 0.031)   \n",
       "502 0.662 (0.635, 0.685) 0.68 (0.653, 0.707)  0.019 (-0.003, 0.038)  \n",
       "503 0.503 (0.471, 0.531) 0.519 (0.486, 0.556) 0.019 (-0.016, 0.052)  \n",
       "504 0.591 (0.582, 0.599) 0.609 (0.6, 0.618)   0.019 (0.011, 0.026)   \n",
       "505 0.452 (0.437, 0.469) 0.47 (0.457, 0.489)  0.019 (0.004, 0.035)   \n",
       "506 0.674 (0.667, 0.681) 0.693 (0.686, 0.701) 0.019 (0.013, 0.024)   \n",
       "507 0.623 (0.604, 0.64)  0.643 (0.626, 0.661) 0.019 (0.007, 0.03)    \n",
       "508 0.559 (0.54, 0.572)  0.577 (0.563, 0.592) 0.019 (0.005, 0.033)   \n",
       "509 0.648 (0.636, 0.661) 0.669 (0.653, 0.682) 0.019 (0.011, 0.03)    \n",
       "510 0.577 (0.56, 0.598)  0.597 (0.584, 0.616) 0.019 (0.007, 0.032)   \n",
       "511 0.556 (0.546, 0.568) 0.576 (0.566, 0.583) 0.02 (0.009, 0.027)    \n",
       "512 0.555 (0.546, 0.568) 0.575 (0.565, 0.586) 0.02 (0.009, 0.029)    \n",
       "513 0.492 (0.464, 0.517) 0.511 (0.475, 0.541) 0.02 (-0.004, 0.043)   \n",
       "514 0.619 (0.594, 0.641) 0.637 (0.614, 0.668) 0.02 (-0.001, 0.043)   \n",
       "515 0.679 (0.669, 0.689) 0.699 (0.688, 0.709) 0.02 (0.012, 0.028)    \n",
       "516 0.534 (0.503, 0.555) 0.553 (0.526, 0.58)  0.02 (0, 0.042)        \n",
       "517 0.733 (0.721, 0.745) 0.753 (0.742, 0.764) 0.02 (0.012, 0.027)    \n",
       "518 0.697 (0.683, 0.708) 0.718 (0.705, 0.729) 0.02 (0.012, 0.029)    \n",
       "519 0.593 (0.575, 0.612) 0.612 (0.592, 0.633) 0.02 (0.003, 0.034)    \n",
       "520 0.583 (0.574, 0.593) 0.603 (0.594, 0.612) 0.021 (0.013, 0.028)   \n",
       "521 0.606 (0.579, 0.638) 0.629 (0.599, 0.65)  0.021 (-0.008, 0.045)  \n",
       "522 0.637 (0.607, 0.666) 0.656 (0.626, 0.695) 0.021 (-0.016, 0.067)  \n",
       "523 0.612 (0.567, 0.648) 0.63 (0.595, 0.668)  0.021 (-0.008, 0.05)   \n",
       "524 0.626 (0.592, 0.656) 0.649 (0.607, 0.676) 0.021 (-0.004, 0.047)  \n",
       "525 0.61 (0.58, 0.642)   0.629 (0.603, 0.66)  0.021 (-0.012, 0.052)  \n",
       "526 0.425 (0.406, 0.441) 0.445 (0.426, 0.46)  0.021 (0.008, 0.036)   \n",
       "527 0.656 (0.643, 0.671) 0.677 (0.663, 0.692) 0.021 (0.011, 0.029)   \n",
       "528 0.704 (0.695, 0.712) 0.726 (0.718, 0.734) 0.022 (0.015, 0.028)   \n",
       "529 0.628 (0.616, 0.644) 0.651 (0.637, 0.663) 0.022 (0.011, 0.036)   \n",
       "530 0.578 (0.565, 0.592) 0.6 (0.587, 0.61)    0.022 (0.013, 0.03)    \n",
       "531 0.646 (0.601, 0.689) 0.668 (0.622, 0.718) 0.022 (-0.023, 0.056)  \n",
       "532 0.577 (0.554, 0.602) 0.599 (0.572, 0.628) 0.022 (0.004, 0.043)   \n",
       "533 0.434 (0.381, 0.475) 0.463 (0.423, 0.502) 0.022 (-0.02, 0.088)   \n",
       "534 0.673 (0.648, 0.697) 0.695 (0.673, 0.719) 0.022 (0.003, 0.039)   \n",
       "535 0.603 (0.595, 0.611) 0.626 (0.616, 0.635) 0.022 (0.015, 0.028)   \n",
       "536 0.605 (0.598, 0.611) 0.627 (0.62, 0.634)  0.023 (0.015, 0.029)   \n",
       "537 0.657 (0.633, 0.681) 0.68 (0.656, 0.701)  0.023 (0.004, 0.045)   \n",
       "538 0.656 (0.64, 0.671)  0.679 (0.664, 0.693) 0.023 (0.013, 0.035)   \n",
       "539 0.541 (0.486, 0.581) 0.56 (0.516, 0.609)  0.023 (-0.017, 0.064)  \n",
       "540 0.567 (0.559, 0.58)  0.59 (0.582, 0.603)  0.023 (0.014, 0.032)   \n",
       "541 0.564 (0.553, 0.576) 0.588 (0.575, 0.601) 0.024 (0.01, 0.034)    \n",
       "542 0.506 (0.443, 0.542) 0.53 (0.485, 0.566)  0.024 (-0.019, 0.068)  \n",
       "543 0.549 (0.537, 0.56)  0.573 (0.564, 0.585) 0.024 (0.014, 0.034)   \n",
       "544 0.524 (0.499, 0.549) 0.547 (0.524, 0.573) 0.024 (-0.009, 0.051)  \n",
       "545 0.687 (0.66, 0.721)  0.712 (0.69, 0.737)  0.024 (0.01, 0.037)    \n",
       "546 0.528 (0.52, 0.536)  0.553 (0.546, 0.561) 0.024 (0.017, 0.032)   \n",
       "547 0.64 (0.618, 0.663)  0.667 (0.642, 0.69)  0.024 (0.004, 0.044)   \n",
       "548 0.472 (0.458, 0.484) 0.496 (0.477, 0.51)  0.025 (0.007, 0.038)   \n",
       "549 0.561 (0.542, 0.575) 0.586 (0.567, 0.598) 0.025 (0.007, 0.043)   \n",
       "550 0.734 (0.725, 0.744) 0.757 (0.748, 0.769) 0.025 (0.016, 0.031)   \n",
       "551 0.722 (0.701, 0.746) 0.748 (0.722, 0.77)  0.025 (0.008, 0.044)   \n",
       "552 0.558 (0.544, 0.57)  0.582 (0.568, 0.597) 0.025 (0.015, 0.037)   \n",
       "553 0.586 (0.576, 0.597) 0.611 (0.601, 0.621) 0.025 (0.016, 0.032)   \n",
       "554 0.674 (0.661, 0.688) 0.7 (0.685, 0.713)   0.025 (0.014, 0.036)   \n",
       "555 0.551 (0.538, 0.565) 0.577 (0.565, 0.588) 0.026 (0.013, 0.036)   \n",
       "556 0.559 (0.535, 0.585) 0.586 (0.562, 0.614) 0.026 (0.002, 0.056)   \n",
       "557 0.652 (0.618, 0.677) 0.674 (0.647, 0.704) 0.026 (0.003, 0.039)   \n",
       "558 0.579 (0.567, 0.59)  0.606 (0.593, 0.615) 0.026 (0.016, 0.037)   \n",
       "559 0.73 (0.707, 0.751)  0.758 (0.737, 0.78)  0.026 (0.006, 0.046)   \n",
       "560 0.576 (0.525, 0.616) 0.597 (0.553, 0.647) 0.026 (-0.022, 0.069)  \n",
       "561 0.565 (0.55, 0.579)  0.59 (0.578, 0.607)  0.027 (0.015, 0.037)   \n",
       "562 0.561 (0.533, 0.59)  0.589 (0.559, 0.622) 0.027 (-0.005, 0.069)  \n",
       "563 0.579 (0.568, 0.589) 0.606 (0.595, 0.619) 0.027 (0.021, 0.034)   \n",
       "564 0.606 (0.595, 0.618) 0.633 (0.623, 0.643) 0.027 (0.017, 0.037)   \n",
       "565 0.572 (0.556, 0.59)  0.598 (0.583, 0.617) 0.027 (0.01, 0.047)    \n",
       "566 0.577 (0.568, 0.588) 0.604 (0.592, 0.615) 0.027 (0.016, 0.037)   \n",
       "567 0.531 (0.509, 0.551) 0.558 (0.534, 0.585) 0.027 (0.005, 0.053)   \n",
       "568 0.6 (0.589, 0.608)   0.628 (0.618, 0.636) 0.028 (0.02, 0.035)    \n",
       "569 0.592 (0.582, 0.606) 0.619 (0.612, 0.631) 0.028 (0.018, 0.038)   \n",
       "570 0.58 (0.535, 0.621)  0.607 (0.573, 0.639) 0.028 (-0.004, 0.065)  \n",
       "571 0.629 (0.619, 0.638) 0.656 (0.647, 0.664) 0.028 (0.019, 0.035)   \n",
       "572 0.661 (0.633, 0.689) 0.687 (0.658, 0.712) 0.028 (0.006, 0.042)   \n",
       "573 0.585 (0.566, 0.602) 0.613 (0.593, 0.63)  0.028 (0.008, 0.038)   \n",
       "574 0.575 (0.563, 0.586) 0.604 (0.592, 0.614) 0.028 (0.02, 0.039)    \n",
       "575 0.703 (0.672, 0.745) 0.731 (0.696, 0.759) 0.028 (-0.005, 0.053)  \n",
       "576 0.6 (0.58, 0.621)    0.629 (0.612, 0.648) 0.028 (0.013, 0.043)   \n",
       "577 0.604 (0.578, 0.633) 0.634 (0.608, 0.662) 0.028 (0.009, 0.053)   \n",
       "578 0.649 (0.622, 0.674) 0.679 (0.647, 0.706) 0.028 (0.006, 0.052)   \n",
       "579 0.591 (0.581, 0.601) 0.62 (0.609, 0.628)  0.029 (0.019, 0.038)   \n",
       "580 0.59 (0.58, 0.601)   0.619 (0.609, 0.628) 0.029 (0.021, 0.038)   \n",
       "581 0.581 (0.559, 0.6)   0.609 (0.588, 0.631) 0.029 (0.009, 0.051)   \n",
       "582 0.671 (0.649, 0.688) 0.697 (0.68, 0.722)  0.029 (0.013, 0.044)   \n",
       "583 0.557 (0.533, 0.579) 0.586 (0.561, 0.615) 0.029 (0.005, 0.055)   \n",
       "584 0.581 (0.569, 0.596) 0.61 (0.597, 0.624)  0.029 (0.018, 0.036)   \n",
       "585 0.526 (0.499, 0.574) 0.556 (0.519, 0.598) 0.029 (-0.008, 0.056)  \n",
       "586 0.637 (0.611, 0.657) 0.665 (0.642, 0.692) 0.029 (0.012, 0.049)   \n",
       "587 0.588 (0.557, 0.629) 0.616 (0.577, 0.672) 0.029 (-0.038, 0.094)  \n",
       "588 0.698 (0.68, 0.714)  0.725 (0.709, 0.747) 0.029 (0.013, 0.046)   \n",
       "589 0.563 (0.531, 0.591) 0.594 (0.556, 0.631) 0.029 (-0.011, 0.077)  \n",
       "590 0.683 (0.671, 0.697) 0.713 (0.703, 0.73)  0.03 (0.02, 0.041)     \n",
       "591 0.651 (0.633, 0.665) 0.681 (0.662, 0.698) 0.03 (0.014, 0.042)    \n",
       "592 0.591 (0.571, 0.61)  0.622 (0.606, 0.641) 0.03 (0.019, 0.043)    \n",
       "593 0.572 (0.554, 0.589) 0.602 (0.588, 0.617) 0.03 (0.013, 0.047)    \n",
       "594 0.561 (0.53, 0.595)  0.594 (0.56, 0.635)  0.03 (-0.008, 0.068)   \n",
       "595 0.587 (0.576, 0.597) 0.617 (0.607, 0.628) 0.03 (0.021, 0.04)     \n",
       "596 0.755 (0.74, 0.771)  0.785 (0.767, 0.798) 0.03 (0.014, 0.046)    \n",
       "597 0.513 (0.489, 0.539) 0.548 (0.526, 0.566) 0.03 (0.013, 0.061)    \n",
       "598 0.673 (0.66, 0.687)  0.704 (0.692, 0.718) 0.03 (0.022, 0.039)    \n",
       "599 0.552 (0.534, 0.564) 0.582 (0.565, 0.597) 0.03 (0.018, 0.044)    \n",
       "600 0.723 (0.699, 0.741) 0.752 (0.731, 0.774) 0.03 (0.011, 0.046)    \n",
       "601 0.596 (0.497, 0.701) 0.627 (0.507, 0.734) 0.031 (-0.07, 0.137)   \n",
       "602 0.643 (0.617, 0.669) 0.672 (0.647, 0.714) 0.031 (0.011, 0.056)   \n",
       "603 0.499 (0.481, 0.52)  0.533 (0.51, 0.55)   0.031 (0.012, 0.058)   \n",
       "604 0.59 (0.564, 0.609)  0.621 (0.601, 0.64)  0.031 (0.014, 0.05)    \n",
       "605 0.522 (0.496, 0.549) 0.552 (0.521, 0.576) 0.031 (0.002, 0.053)   \n",
       "606 0.659 (0.633, 0.689) 0.69 (0.661, 0.719)  0.031 (0.011, 0.052)   \n",
       "607 0.58 (0.565, 0.597)  0.612 (0.593, 0.634) 0.031 (0.014, 0.046)   \n",
       "608 0.467 (0.434, 0.504) 0.5 (0.457, 0.534)   0.031 (-0.013, 0.061)  \n",
       "609 0.608 (0.595, 0.625) 0.64 (0.627, 0.652)  0.032 (0.021, 0.043)   \n",
       "610 0.421 (0.389, 0.453) 0.454 (0.423, 0.484) 0.032 (0.014, 0.047)   \n",
       "611 0.49 (0.435, 0.53)   0.521 (0.465, 0.561) 0.032 (-0.006, 0.072)  \n",
       "612 0.567 (0.539, 0.585) 0.594 (0.574, 0.614) 0.032 (0.013, 0.051)   \n",
       "613 0.72 (0.688, 0.757)  0.752 (0.726, 0.787) 0.032 (-0.002, 0.062)  \n",
       "614 0.568 (0.544, 0.613) 0.602 (0.571, 0.633) 0.033 (-0.002, 0.071)  \n",
       "615 0.718 (0.702, 0.734) 0.749 (0.738, 0.765) 0.033 (0.021, 0.045)   \n",
       "616 0.631 (0.587, 0.665) 0.663 (0.631, 0.695) 0.033 (-0.002, 0.064)  \n",
       "617 0.645 (0.635, 0.655) 0.678 (0.669, 0.687) 0.033 (0.024, 0.04)    \n",
       "618 0.506 (0.491, 0.517) 0.539 (0.527, 0.55)  0.033 (0.021, 0.045)   \n",
       "619 0.628 (0.607, 0.649) 0.663 (0.649, 0.683) 0.033 (0.02, 0.05)     \n",
       "620 0.588 (0.576, 0.601) 0.621 (0.608, 0.635) 0.033 (0.021, 0.045)   \n",
       "621 0.638 (0.617, 0.656) 0.67 (0.656, 0.688)  0.034 (0.021, 0.045)   \n",
       "622 0.497 (0.458, 0.532) 0.532 (0.499, 0.562) 0.034 (-0.006, 0.081)  \n",
       "623 0.593 (0.571, 0.615) 0.627 (0.606, 0.649) 0.034 (0.016, 0.056)   \n",
       "624 0.698 (0.678, 0.73)  0.735 (0.709, 0.763) 0.034 (0.009, 0.059)   \n",
       "625 0.519 (0.498, 0.541) 0.552 (0.528, 0.579) 0.034 (0.008, 0.059)   \n",
       "626 0.567 (0.556, 0.579) 0.602 (0.589, 0.613) 0.035 (0.028, 0.043)   \n",
       "627 0.554 (0.524, 0.598) 0.593 (0.56, 0.625)  0.035 (-0.003, 0.075)  \n",
       "628 0.706 (0.69, 0.72)   0.74 (0.726, 0.758)  0.035 (0.022, 0.044)   \n",
       "629 0.67 (0.632, 0.702)  0.708 (0.666, 0.744) 0.035 (0.012, 0.071)   \n",
       "630 0.455 (0.43, 0.476)  0.49 (0.468, 0.507)  0.036 (0.015, 0.062)   \n",
       "631 0.61 (0.592, 0.632)  0.647 (0.627, 0.667) 0.037 (0.025, 0.047)   \n",
       "632 0.591 (0.573, 0.608) 0.626 (0.609, 0.645) 0.037 (0.02, 0.048)    \n",
       "633 0.44 (0.406, 0.492)  0.474 (0.428, 0.521) 0.037 (-0.006, 0.076)  \n",
       "634 0.629 (0.617, 0.652) 0.668 (0.652, 0.686) 0.038 (0.021, 0.051)   \n",
       "635 0.351 (0.331, 0.374) 0.39 (0.367, 0.412)  0.038 (0.021, 0.054)   \n",
       "636 0.629 (0.605, 0.654) 0.666 (0.642, 0.688) 0.038 (0.014, 0.06)    \n",
       "637 0.657 (0.636, 0.68)  0.694 (0.676, 0.714) 0.038 (0.018, 0.055)   \n",
       "638 0.568 (0.528, 0.604) 0.608 (0.566, 0.64)  0.039 (0.016, 0.069)   \n",
       "639 0.439 (0.397, 0.478) 0.479 (0.431, 0.518) 0.039 (0.009, 0.077)   \n",
       "640 0.539 (0.511, 0.569) 0.576 (0.546, 0.603) 0.039 (-0.002, 0.064)  \n",
       "641 0.597 (0.563, 0.625) 0.634 (0.596, 0.666) 0.039 (0.009, 0.073)   \n",
       "642 0.674 (0.659, 0.686) 0.713 (0.699, 0.725) 0.039 (0.027, 0.049)   \n",
       "643 0.631 (0.603, 0.653) 0.67 (0.644, 0.701)  0.04 (0.014, 0.065)    \n",
       "644 0.631 (0.588, 0.666) 0.667 (0.626, 0.709) 0.04 (-0.006, 0.084)   \n",
       "645 0.509 (0.496, 0.522) 0.549 (0.535, 0.564) 0.04 (0.024, 0.056)    \n",
       "646 0.602 (0.573, 0.635) 0.644 (0.606, 0.684) 0.04 (0.015, 0.071)    \n",
       "647 0.52 (0.487, 0.55)   0.559 (0.524, 0.593) 0.04 (0.009, 0.07)     \n",
       "648 0.697 (0.681, 0.716) 0.737 (0.72, 0.759)  0.04 (0.026, 0.054)    \n",
       "649 0.489 (0.47, 0.508)  0.532 (0.511, 0.552) 0.041 (0.021, 0.063)   \n",
       "650 0.742 (0.73, 0.754)  0.785 (0.772, 0.793) 0.041 (0.033, 0.05)    \n",
       "651 0.582 (0.552, 0.608) 0.62 (0.6, 0.656)    0.041 (0, 0.068)       \n",
       "652 0.514 (0.477, 0.557) 0.557 (0.52, 0.605)  0.042 (0.01, 0.083)    \n",
       "653 0.546 (0.513, 0.576) 0.588 (0.552, 0.622) 0.042 (0.011, 0.066)   \n",
       "654 0.577 (0.551, 0.609) 0.619 (0.594, 0.653) 0.043 (0.015, 0.071)   \n",
       "655 0.655 (0.632, 0.675) 0.696 (0.676, 0.716) 0.043 (0.02, 0.064)    \n",
       "656 0.617 (0.589, 0.642) 0.66 (0.635, 0.687)  0.044 (0.022, 0.061)   \n",
       "657 0.554 (0.525, 0.593) 0.598 (0.565, 0.631) 0.044 (0.001, 0.083)   \n",
       "658 0.562 (0.53, 0.592)  0.605 (0.582, 0.63)  0.044 (0.01, 0.076)    \n",
       "659 0.545 (0.508, 0.587) 0.591 (0.542, 0.636) 0.044 (-0.003, 0.083)  \n",
       "660 0.48 (0.466, 0.501)  0.523 (0.51, 0.542)  0.044 (0.028, 0.062)   \n",
       "661 0.492 (0.444, 0.545) 0.535 (0.501, 0.58)  0.045 (-0.011, 0.1)    \n",
       "662 0.631 (0.597, 0.664) 0.676 (0.623, 0.717) 0.045 (0.005, 0.082)   \n",
       "663 0.553 (0.516, 0.587) 0.597 (0.562, 0.633) 0.045 (0.009, 0.083)   \n",
       "664 0.412 (0.383, 0.43)  0.458 (0.428, 0.479) 0.046 (0.024, 0.068)   \n",
       "665 0.453 (0.434, 0.477) 0.501 (0.478, 0.526) 0.046 (0.022, 0.074)   \n",
       "666 0.63 (0.611, 0.649)  0.679 (0.658, 0.694) 0.047 (0.033, 0.066)   \n",
       "667 0.681 (0.673, 0.69)  0.728 (0.718, 0.736) 0.047 (0.039, 0.054)   \n",
       "668 0.592 (0.571, 0.617) 0.639 (0.613, 0.663) 0.048 (0.014, 0.067)   \n",
       "669 0.582 (0.554, 0.604) 0.624 (0.6, 0.653)   0.048 (0.022, 0.068)   \n",
       "670 0.708 (0.697, 0.72)  0.757 (0.746, 0.77)  0.048 (0.039, 0.058)   \n",
       "671 0.676 (0.663, 0.692) 0.724 (0.711, 0.738) 0.049 (0.036, 0.06)    \n",
       "672 0.541 (0.522, 0.564) 0.591 (0.57, 0.612)  0.049 (0.026, 0.069)   \n",
       "673 0.591 (0.568, 0.618) 0.639 (0.616, 0.661) 0.049 (0.029, 0.07)    \n",
       "674 0.643 (0.611, 0.677) 0.696 (0.66, 0.727)  0.049 (0.015, 0.079)   \n",
       "675 0.644 (0.599, 0.683) 0.69 (0.651, 0.732)  0.05 (0.008, 0.086)    \n",
       "676 0.647 (0.616, 0.672) 0.693 (0.669, 0.721) 0.051 (0.028, 0.08)    \n",
       "677 0.695 (0.679, 0.714) 0.748 (0.726, 0.762) 0.051 (0.033, 0.072)   \n",
       "678 0.554 (0.51, 0.596)  0.604 (0.566, 0.653) 0.052 (0.004, 0.093)   \n",
       "679 0.456 (0.439, 0.473) 0.507 (0.486, 0.523) 0.052 (0.03, 0.071)    \n",
       "680 0.617 (0.582, 0.66)  0.67 (0.617, 0.716)  0.052 (0.012, 0.085)   \n",
       "681 0.533 (0.512, 0.548) 0.585 (0.565, 0.597) 0.053 (0.038, 0.071)   \n",
       "682 0.697 (0.688, 0.706) 0.75 (0.739, 0.758)  0.053 (0.044, 0.063)   \n",
       "683 0.622 (0.605, 0.635) 0.675 (0.658, 0.688) 0.053 (0.04, 0.064)    \n",
       "684 0.559 (0.538, 0.583) 0.61 (0.586, 0.637)  0.054 (0.029, 0.076)   \n",
       "685 0.445 (0.4, 0.485)   0.5 (0.461, 0.532)   0.055 (0.014, 0.089)   \n",
       "686 0.616 (0.603, 0.628) 0.67 (0.652, 0.685)  0.055 (0.042, 0.068)   \n",
       "687 0.554 (0.514, 0.598) 0.612 (0.553, 0.647) 0.055 (0.011, 0.097)   \n",
       "688 0.7 (0.676, 0.723)   0.753 (0.736, 0.777) 0.056 (0.033, 0.076)   \n",
       "689 0.503 (0.476, 0.528) 0.556 (0.529, 0.588) 0.056 (0.022, 0.088)   \n",
       "690 0.469 (0.452, 0.486) 0.525 (0.51, 0.538)  0.057 (0.037, 0.071)   \n",
       "691 0.445 (0.397, 0.49)  0.501 (0.451, 0.54)  0.057 (0.01, 0.103)    \n",
       "692 0.62 (0.602, 0.643)  0.679 (0.66, 0.697)  0.058 (0.04, 0.075)    \n",
       "693 0.631 (0.594, 0.675) 0.687 (0.655, 0.724) 0.058 (0.019, 0.09)    \n",
       "694 0.543 (0.532, 0.55)  0.6 (0.592, 0.608)   0.058 (0.051, 0.064)   \n",
       "695 0.407 (0.368, 0.448) 0.465 (0.418, 0.512) 0.059 (0.025, 0.095)   \n",
       "696 0.503 (0.474, 0.53)  0.56 (0.535, 0.582)  0.059 (0.027, 0.086)   \n",
       "697 0.404 (0.36, 0.447)  0.458 (0.428, 0.496) 0.059 (0.011, 0.109)   \n",
       "698 0.545 (0.538, 0.552) 0.605 (0.597, 0.611) 0.059 (0.052, 0.069)   \n",
       "699 0.678 (0.669, 0.686) 0.737 (0.728, 0.747) 0.06 (0.052, 0.069)    \n",
       "700 0.7 (0.674, 0.728)   0.76 (0.74, 0.789)   0.06 (0.033, 0.081)    \n",
       "701 0.556 (0.544, 0.567) 0.616 (0.603, 0.63)  0.061 (0.047, 0.074)   \n",
       "702 0.517 (0.49, 0.546)  0.578 (0.544, 0.604) 0.061 (0.037, 0.088)   \n",
       "703 0.739 (0.734, 0.744) 0.801 (0.796, 0.804) 0.062 (0.057, 0.065)   \n",
       "704 0.561 (0.547, 0.579) 0.624 (0.614, 0.641) 0.063 (0.052, 0.076)   \n",
       "705 0.632 (0.617, 0.654) 0.697 (0.677, 0.715) 0.064 (0.05, 0.083)    \n",
       "706 0.659 (0.629, 0.686) 0.724 (0.708, 0.744) 0.065 (0.036, 0.098)   \n",
       "707 0.504 (0.464, 0.543) 0.568 (0.534, 0.61)  0.066 (0.028, 0.105)   \n",
       "708 0.659 (0.636, 0.683) 0.724 (0.703, 0.745) 0.066 (0.04, 0.091)    \n",
       "709 0.742 (0.737, 0.751) 0.81 (0.804, 0.817)  0.067 (0.061, 0.073)   \n",
       "710 0.627 (0.583, 0.673) 0.691 (0.659, 0.732) 0.068 (0.017, 0.11)    \n",
       "711 0.742 (0.735, 0.749) 0.81 (0.805, 0.817)  0.068 (0.062, 0.075)   \n",
       "712 0.638 (0.61, 0.667)  0.706 (0.675, 0.737) 0.069 (0.04, 0.092)    \n",
       "713 0.68 (0.646, 0.711)  0.75 (0.717, 0.78)   0.07 (0.035, 0.102)    \n",
       "714 0.698 (0.676, 0.721) 0.768 (0.751, 0.789) 0.07 (0.054, 0.086)    \n",
       "715 0.681 (0.638, 0.718) 0.753 (0.714, 0.793) 0.071 (0.031, 0.108)   \n",
       "716 0.544 (0.511, 0.575) 0.613 (0.583, 0.651) 0.071 (0.033, 0.106)   \n",
       "717 0.587 (0.546, 0.625) 0.66 (0.617, 0.697)  0.071 (0.023, 0.113)   \n",
       "718 0.635 (0.627, 0.641) 0.706 (0.7, 0.712)   0.072 (0.065, 0.078)   \n",
       "719 0.451 (0.432, 0.472) 0.521 (0.5, 0.544)   0.072 (0.042, 0.099)   \n",
       "720 0.62 (0.598, 0.641)  0.692 (0.673, 0.707) 0.072 (0.055, 0.087)   \n",
       "721 0.636 (0.631, 0.643) 0.71 (0.705, 0.715)  0.073 (0.068, 0.079)   \n",
       "722 0.541 (0.506, 0.569) 0.612 (0.58, 0.641)  0.074 (0.046, 0.109)   \n",
       "723 0.531 (0.499, 0.573) 0.615 (0.579, 0.658) 0.084 (0.047, 0.122)   \n",
       "724 0.527 (0.491, 0.56)  0.611 (0.576, 0.661) 0.085 (0.046, 0.138)   \n",
       "725 0.565 (0.551, 0.58)  0.652 (0.642, 0.668) 0.089 (0.068, 0.106)   \n",
       "726 0.617 (0.589, 0.652) 0.709 (0.676, 0.751) 0.092 (0.05, 0.128)    \n",
       "727 0.523 (0.515, 0.529) 0.615 (0.608, 0.622) 0.093 (0.084, 0.103)   \n",
       "728 0.523 (0.516, 0.529) 0.618 (0.611, 0.624) 0.095 (0.086, 0.102)   \n",
       "729 0.677 (0.666, 0.69)  0.776 (0.765, 0.786) 0.097 (0.084, 0.109)   \n",
       "730 0.549 (0.513, 0.589) 0.649 (0.607, 0.705) 0.098 (0.057, 0.136)   \n",
       "731 0.318 (0.287, 0.347) 0.417 (0.382, 0.459) 0.099 (0.074, 0.127)   \n",
       "732 0.607 (0.584, 0.633) 0.709 (0.684, 0.729) 0.101 (0.071, 0.127)   \n",
       "733 0.711 (0.687, 0.732) 0.814 (0.795, 0.833) 0.103 (0.085, 0.121)   \n",
       "734 0.525 (0.506, 0.549) 0.63 (0.611, 0.648)  0.105 (0.077, 0.13)    \n",
       "735 0.491 (0.446, 0.539) 0.602 (0.559, 0.638) 0.106 (0.059, 0.141)   \n",
       "736 0.431 (0.404, 0.464) 0.54 (0.505, 0.566)  0.107 (0.067, 0.138)   \n",
       "737 0.427 (0.41, 0.447)  0.536 (0.518, 0.552) 0.108 (0.091, 0.128)   \n",
       "738 0.447 (0.402, 0.474) 0.563 (0.521, 0.613) 0.119 (0.072, 0.169)   \n",
       "739 0.539 (0.531, 0.547) 0.665 (0.657, 0.672) 0.126 (0.116, 0.135)   \n",
       "740 0.646 (0.618, 0.684) 0.77 (0.731, 0.798)  0.126 (0.089, 0.155)   \n",
       "741 0.669 (0.646, 0.696) 0.797 (0.771, 0.815) 0.128 (0.101, 0.155)   \n",
       "742 0.53 (0.521, 0.539)  0.66 (0.652, 0.667)  0.129 (0.119, 0.141)   \n",
       "743 0.598 (0.574, 0.623) 0.727 (0.708, 0.75)  0.129 (0.1, 0.154)     \n",
       "744 0.53 (0.519, 0.537)  0.66 (0.653, 0.665)  0.129 (0.122, 0.14)    \n",
       "745 0.53 (0.498, 0.569)  0.666 (0.635, 0.694) 0.133 (0.097, 0.172)   \n",
       "746 0.528 (0.518, 0.535) 0.666 (0.661, 0.673) 0.138 (0.132, 0.146)   \n",
       "747 0.583 (0.563, 0.618) 0.728 (0.709, 0.752) 0.145 (0.12, 0.171)    \n",
       "748 0.685 (0.655, 0.704) 0.836 (0.822, 0.853) 0.153 (0.135, 0.179)   \n",
       "749 0.325 (0.288, 0.373) 0.488 (0.443, 0.535) 0.156 (0.117, 0.201)   \n",
       "750 0.629 (0.594, 0.67)  0.805 (0.779, 0.829) 0.175 (0.139, 0.204)   \n",
       "751 0.609 (0.59, 0.633)  0.869 (0.858, 0.884) 0.259 (0.239, 0.281)   \n",
       "752 0.602 (0.551, 0.656) 0.868 (0.84, 0.905)  0.265 (0.21, 0.324)    "
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "ukb = fread(\"UKB_SupplTable1_DiscriminativePerformanceAll_CropRatio-0.66.csv\")\n",
    "ukb"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 89,
   "metadata": {},
   "outputs": [],
   "source": [
    "epic_agg <- benchmark_endpoints %>%\n",
    "  filter(score %in% scores_plot) %>%\n",
    "  mutate(score = factor(score, levels = scores_plot)) %>%\n",
    "  mutate(endpoint = factor(endpoint, levels = endpoints_sorted)) %>%\n",
    "  ungroup() %>%\n",
    "  pivot_wider(names_from = score, values_from = cindex) %>% \n",
    "  mutate(id = row_number()) %>%\n",
    "  mutate(delta = `Age+Sex+Retina` - `Age+Sex`) %>%\n",
    "  filter(endpoint %in% endpoints_md$endpoint) %>%\n",
    "  group_by(endpoint, phecode_string, phecode_category) %>%\n",
    "  median_qi(`Age+Sex`, `Age+Sex+Retina`, delta) %>%\n",
    "  mutate(endpoint = fct_reorder(endpoint, delta)) %>%\n",
    "  mutate(phecode_category = factor(phecode_category, levels = categories_sorted))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 90,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "\u001b[1m\u001b[22mAdding missing grouping variables: `endpoint`, `phecode_string`\n"
     ]
    }
   ],
   "source": [
    "epic <- epic_agg %>%\n",
    "  mutate(epic_agesex = glue(\"{round(`Age+Sex`, 3)} ({round(`Age+Sex.lower`, 3)}, {round(`Age+Sex.upper`, 3)})\"),\n",
    "         epic_agesexretina = glue(\"{round(`Age+Sex+Retina`, 3)} ({round(`Age+Sex+Retina.lower`, 3)}, {round(`Age+Sex+Retina.upper`, 3)})\"),\n",
    "         epic_delta = glue(\"{round(delta, 3)} ({round(`delta.lower`, 3)}, {round(`delta.upper`, 3)})\")\n",
    "        ) %>%\n",
    "  select(epic_agesex, epic_agesexretina, epic_delta)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 91,
   "metadata": {},
   "outputs": [],
   "source": [
    "st4 = ukb %>% left_join(epic, by=c(\"endpoint\", \"phecode_string\")) %>% as_tibble()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 92,
   "metadata": {},
   "outputs": [],
   "source": [
    "st4_clean <- st4 %>%\n",
    "  mutate(across(everything(), ~ replace_na(., \"\"), .names = \"{col}\")) %>%\n",
    "  mutate(\n",
    "    delta_lower = as.numeric(sub(\".*\\\\((.*),.*\", \"\\\\1\", delta)),\n",
    "    delta_upper = as.numeric(sub(\".*, (.*)\\\\).*\", \"\\\\1\", delta)),\n",
    "    epic_delta_lower = as.numeric(sub(\".*\\\\((.*),.*\", \"\\\\1\", epic_delta)),\n",
    "    epic_delta_upper = as.numeric(sub(\".*, (.*)\\\\).*\", \"\\\\1\", epic_delta))\n",
    "  ) %>%\n",
    "  mutate(\n",
    "    sign_ukb = case_when(\n",
    "      delta_lower > 0 & delta_upper > 0 ~ \"+\",\n",
    "      delta_lower < 0 & delta_upper < 0 ~ \"-\",\n",
    "      TRUE ~ \"ns\"\n",
    "    ),\n",
    "    sign_epic = case_when(\n",
    "    is.na(epic_delta_lower) | is.na(epic_delta_upper) ~ NA_character_,\n",
    "      epic_delta_lower > 0 & epic_delta_upper > 0 ~ \"+\",\n",
    "      epic_delta_lower < 0 & epic_delta_upper < 0 ~ \"-\",\n",
    "      TRUE ~ \"ns\"\n",
    "    ) \n",
    "  ) %>% \n",
    "    arrange(epic_delta_lower) %>% \n",
    "    select(-delta_lower, -delta_upper, -epic_delta_lower, -epic_delta_upper) %>%\n",
    "    mutate(sign = glue(\"{sign_ukb}|{sign_epic}\"))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 93,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<table class=\"dataframe\">\n",
       "<caption>A grouped_df: 7 × 4</caption>\n",
       "<thead>\n",
       "\t<tr><th scope=col>sign_ukb</th><th scope=col>sign_epic</th><th scope=col>sign</th><th scope=col>n</th></tr>\n",
       "\t<tr><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;glue&gt;</th><th scope=col>&lt;int&gt;</th></tr>\n",
       "</thead>\n",
       "<tbody>\n",
       "\t<tr><td>+ </td><td>+ </td><td>+|+  </td><td>40</td></tr>\n",
       "\t<tr><td>+ </td><td>- </td><td>+|-  </td><td>10</td></tr>\n",
       "\t<tr><td>+ </td><td>ns</td><td>+|ns </td><td>55</td></tr>\n",
       "\t<tr><td>- </td><td>ns</td><td>-|ns </td><td> 3</td></tr>\n",
       "\t<tr><td>ns</td><td>+ </td><td>ns|+ </td><td>15</td></tr>\n",
       "\t<tr><td>ns</td><td>- </td><td>ns|- </td><td> 7</td></tr>\n",
       "\t<tr><td>ns</td><td>ns</td><td>ns|ns</td><td>42</td></tr>\n",
       "</tbody>\n",
       "</table>\n"
      ],
      "text/latex": [
       "A grouped\\_df: 7 × 4\n",
       "\\begin{tabular}{llll}\n",
       " sign\\_ukb & sign\\_epic & sign & n\\\\\n",
       " <chr> & <chr> & <glue> & <int>\\\\\n",
       "\\hline\n",
       "\t +  & +  & +\\textbar{}+   & 40\\\\\n",
       "\t +  & -  & +\\textbar{}-   & 10\\\\\n",
       "\t +  & ns & +\\textbar{}ns  & 55\\\\\n",
       "\t -  & ns & -\\textbar{}ns  &  3\\\\\n",
       "\t ns & +  & ns\\textbar{}+  & 15\\\\\n",
       "\t ns & -  & ns\\textbar{}-  &  7\\\\\n",
       "\t ns & ns & ns\\textbar{}ns & 42\\\\\n",
       "\\end{tabular}\n"
      ],
      "text/markdown": [
       "\n",
       "A grouped_df: 7 × 4\n",
       "\n",
       "| sign_ukb &lt;chr&gt; | sign_epic &lt;chr&gt; | sign &lt;glue&gt; | n &lt;int&gt; |\n",
       "|---|---|---|---|\n",
       "| +  | +  | +|+   | 40 |\n",
       "| +  | -  | +|-   | 10 |\n",
       "| +  | ns | +|ns  | 55 |\n",
       "| -  | ns | -|ns  |  3 |\n",
       "| ns | +  | ns|+  | 15 |\n",
       "| ns | -  | ns|-  |  7 |\n",
       "| ns | ns | ns|ns | 42 |\n",
       "\n"
      ],
      "text/plain": [
       "  sign_ukb sign_epic sign  n \n",
       "1 +        +         +|+   40\n",
       "2 +        -         +|-   10\n",
       "3 +        ns        +|ns  55\n",
       "4 -        ns        -|ns   3\n",
       "5 ns       +         ns|+  15\n",
       "6 ns       -         ns|-   7\n",
       "7 ns       ns        ns|ns 42"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "st4_clean %>% filter(!is.na(sign_epic)) %>% group_by(sign_ukb, sign_epic, sign) %>% tally()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 94,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<table class=\"dataframe\">\n",
       "<caption>A tibble: 40 × 12</caption>\n",
       "<thead>\n",
       "\t<tr><th scope=col>phecode_category</th><th scope=col>endpoint</th><th scope=col>phecode_string</th><th scope=col>Age+Sex</th><th scope=col>Age+Sex+Retina</th><th scope=col>delta</th><th scope=col>epic_agesex</th><th scope=col>epic_agesexretina</th><th scope=col>epic_delta</th><th scope=col>sign_ukb</th><th scope=col>sign_epic</th><th scope=col>sign</th></tr>\n",
       "\t<tr><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;glue&gt;</th><th scope=col>&lt;glue&gt;</th><th scope=col>&lt;glue&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;glue&gt;</th></tr>\n",
       "</thead>\n",
       "<tbody>\n",
       "\t<tr><td>GI           </td><td>phecode_528  </td><td>Nausea and vomiting                                            </td><td>0.601 (0.591, 0.609)</td><td>0.609 (0.599, 0.616)</td><td>0.008 (0.002, 0.013)</td><td>0.624 (0.603, 0.648)</td><td>0.627 (0.605, 0.65) </td><td>0.002 (0.001, 0.004)</td><td>+</td><td>+</td><td>+|+</td></tr>\n",
       "\t<tr><td>Cardio       </td><td>phecode_424  </td><td>Heart failure                                                  </td><td>0.744 (0.737, 0.754)</td><td>0.759 (0.75, 0.769) </td><td>0.014 (0.008, 0.02) </td><td>0.768 (0.754, 0.785)</td><td>0.772 (0.758, 0.79) </td><td>0.003 (0.001, 0.006)</td><td>+</td><td>+</td><td>+|+</td></tr>\n",
       "\t<tr><td>Neuro        </td><td>phecode_350  </td><td>Other symptoms involving nervous system                        </td><td>0.697 (0.683, 0.708)</td><td>0.718 (0.705, 0.729)</td><td>0.02 (0.012, 0.029) </td><td>0.801 (0.784, 0.805)</td><td>0.804 (0.789, 0.808)</td><td>0.003 (0.001, 0.005)</td><td>+</td><td>+</td><td>+|+</td></tr>\n",
       "\t<tr><td>Blood        </td><td>phecode_160  </td><td>Nutritional anemias                                            </td><td>0.6 (0.589, 0.608)  </td><td>0.628 (0.618, 0.636)</td><td>0.028 (0.02, 0.035) </td><td>0.617 (0.61, 0.628) </td><td>0.623 (0.611, 0.636)</td><td>0.005 (0.001, 0.009)</td><td>+</td><td>+</td><td>+|+</td></tr>\n",
       "\t<tr><td>Resp         </td><td>phecode_486  </td><td>Other respiratory disorders                                    </td><td>0.651 (0.633, 0.665)</td><td>0.681 (0.662, 0.698)</td><td>0.03 (0.014, 0.042) </td><td>0.622 (0.583, 0.638)</td><td>0.635 (0.59, 0.653) </td><td>0.009 (0.001, 0.021)</td><td>+</td><td>+</td><td>+|+</td></tr>\n",
       "\t<tr><td>Musc/Skel    </td><td>phecode_703  </td><td>Chrystal arthropathies                                         </td><td>0.765 (0.755, 0.774)</td><td>0.77 (0.76, 0.779)  </td><td>0.006 (0.001, 0.011)</td><td>0.726 (0.697, 0.745)</td><td>0.729 (0.704, 0.749)</td><td>0.004 (0.002, 0.007)</td><td>+</td><td>+</td><td>+|+</td></tr>\n",
       "\t<tr><td>Genitourinary</td><td>phecode_583  </td><td>Chronic kidney disease                                         </td><td>0.721 (0.713, 0.73) </td><td>0.728 (0.719, 0.737)</td><td>0.007 (0.001, 0.012)</td><td>0.746 (0.728, 0.749)</td><td>0.749 (0.734, 0.755)</td><td>0.004 (0.002, 0.006)</td><td>+</td><td>+</td><td>+|+</td></tr>\n",
       "\t<tr><td>Resp         </td><td>phecode_483  </td><td>Pleural effusion                                               </td><td>0.68 (0.667, 0.69)  </td><td>0.691 (0.682, 0.704)</td><td>0.011 (0.004, 0.018)</td><td>0.637 (0.626, 0.653)</td><td>0.642 (0.631, 0.659)</td><td>0.004 (0.002, 0.006)</td><td>+</td><td>+</td><td>+|+</td></tr>\n",
       "\t<tr><td>Cardio       </td><td>phecode_401-1</td><td>Essential hypertension                                         </td><td>0.663 (0.66, 0.667) </td><td>0.675 (0.672, 0.679)</td><td>0.012 (0.01, 0.014) </td><td>0.639 (0.628, 0.651)</td><td>0.643 (0.634, 0.657)</td><td>0.004 (0.002, 0.007)</td><td>+</td><td>+</td><td>+|+</td></tr>\n",
       "\t<tr><td>Cardio       </td><td>phecode_401  </td><td>Hypertension                                                   </td><td>0.664 (0.659, 0.667)</td><td>0.676 (0.672, 0.679)</td><td>0.012 (0.01, 0.014) </td><td>0.637 (0.632, 0.645)</td><td>0.642 (0.637, 0.65) </td><td>0.005 (0.002, 0.006)</td><td>+</td><td>+</td><td>+|+</td></tr>\n",
       "\t<tr><td>Musc/Skel    </td><td>phecode_724  </td><td>Other symptoms and disorders of the soft tissue                </td><td>0.567 (0.557, 0.578)</td><td>0.586 (0.577, 0.597)</td><td>0.018 (0.011, 0.026)</td><td>0.547 (0.518, 0.577)</td><td>0.562 (0.551, 0.594)</td><td>0.022 (0.002, 0.038)</td><td>+</td><td>+</td><td>+|+</td></tr>\n",
       "\t<tr><td>Blood        </td><td>phecode_164-1</td><td>Microcytic anemia                                              </td><td>0.592 (0.582, 0.606)</td><td>0.619 (0.612, 0.631)</td><td>0.028 (0.018, 0.038)</td><td>0.613 (0.595, 0.628)</td><td>0.619 (0.602, 0.632)</td><td>0.005 (0.002, 0.01) </td><td>+</td><td>+</td><td>+|+</td></tr>\n",
       "\t<tr><td>Resp         </td><td>phecode_460-2</td><td>Acute lower respiratory infection                              </td><td>0.645 (0.635, 0.655)</td><td>0.678 (0.669, 0.687)</td><td>0.033 (0.024, 0.04) </td><td>0.716 (0.703, 0.731)</td><td>0.723 (0.709, 0.737)</td><td>0.006 (0.002, 0.011)</td><td>+</td><td>+</td><td>+|+</td></tr>\n",
       "\t<tr><td>Cardio       </td><td>phecode_440  </td><td>Embolism and thrombosis                                        </td><td>0.633 (0.622, 0.642)</td><td>0.644 (0.635, 0.654)</td><td>0.011 (0.004, 0.019)</td><td>0.472 (0.455, 0.493)</td><td>0.489 (0.464, 0.511)</td><td>0.015 (0.003, 0.026)</td><td>+</td><td>+</td><td>+|+</td></tr>\n",
       "\t<tr><td>Resp         </td><td>phecode_468  </td><td>Pneumonia                                                      </td><td>0.674 (0.667, 0.681)</td><td>0.693 (0.686, 0.701)</td><td>0.019 (0.013, 0.024)</td><td>0.73 (0.724, 0.734) </td><td>0.735 (0.728, 0.739)</td><td>0.004 (0.003, 0.007)</td><td>+</td><td>+</td><td>+|+</td></tr>\n",
       "\t<tr><td>Musc/Skel    </td><td>phecode_713  </td><td>Symptoms related to joints                                     </td><td>0.578 (0.565, 0.592)</td><td>0.6 (0.587, 0.61)   </td><td>0.022 (0.013, 0.03) </td><td>0.64 (0.627, 0.658) </td><td>0.647 (0.636, 0.662)</td><td>0.006 (0.003, 0.013)</td><td>+</td><td>+</td><td>+|+</td></tr>\n",
       "\t<tr><td>Blood        </td><td>phecode_164  </td><td>Anemia                                                         </td><td>0.605 (0.598, 0.611)</td><td>0.627 (0.62, 0.634) </td><td>0.023 (0.015, 0.029)</td><td>0.641 (0.621, 0.659)</td><td>0.647 (0.627, 0.665)</td><td>0.006 (0.003, 0.007)</td><td>+</td><td>+</td><td>+|+</td></tr>\n",
       "\t<tr><td>GI           </td><td>phecode_507  </td><td>Lesions of mouth                                               </td><td>0.351 (0.331, 0.374)</td><td>0.39 (0.367, 0.412) </td><td>0.038 (0.021, 0.054)</td><td>0.536 (0.512, 0.576)</td><td>0.545 (0.522, 0.583)</td><td>0.008 (0.003, 0.019)</td><td>+</td><td>+</td><td>+|+</td></tr>\n",
       "\t<tr><td>GI           </td><td>phecode_522  </td><td>Gastrointestinal inflammation                                  </td><td>0.577 (0.571, 0.583)</td><td>0.583 (0.576, 0.589)</td><td>0.005 (0.002, 0.009)</td><td>0.568 (0.557, 0.596)</td><td>0.574 (0.564, 0.602)</td><td>0.006 (0.004, 0.009)</td><td>+</td><td>+</td><td>+|+</td></tr>\n",
       "\t<tr><td>Genitourinary</td><td>phecode_582  </td><td>Acute kidney failure                                           </td><td>0.704 (0.695, 0.712)</td><td>0.726 (0.718, 0.734)</td><td>0.022 (0.015, 0.028)</td><td>0.744 (0.723, 0.749)</td><td>0.75 (0.73, 0.756)  </td><td>0.006 (0.004, 0.009)</td><td>+</td><td>+</td><td>+|+</td></tr>\n",
       "\t<tr><td>Resp         </td><td>phecode_460  </td><td>Acute respiratory infection                                    </td><td>0.629 (0.619, 0.638)</td><td>0.656 (0.647, 0.664)</td><td>0.028 (0.019, 0.035)</td><td>0.707 (0.703, 0.717)</td><td>0.717 (0.711, 0.73) </td><td>0.008 (0.004, 0.014)</td><td>+</td><td>+</td><td>+|+</td></tr>\n",
       "\t<tr><td>Derm         </td><td>phecode_660  </td><td>Infection of the skin                                          </td><td>0.577 (0.568, 0.588)</td><td>0.604 (0.592, 0.615)</td><td>0.027 (0.016, 0.037)</td><td>0.67 (0.639, 0.689) </td><td>0.68 (0.665, 0.695) </td><td>0.014 (0.005, 0.027)</td><td>+</td><td>+</td><td>+|+</td></tr>\n",
       "\t<tr><td>Resp         </td><td>phecode_474-1</td><td>Emphysema                                                      </td><td>0.695 (0.679, 0.714)</td><td>0.748 (0.726, 0.762)</td><td>0.051 (0.033, 0.072)</td><td>0.694 (0.662, 0.718)</td><td>0.731 (0.703, 0.747)</td><td>0.033 (0.009, 0.069)</td><td>+</td><td>+</td><td>+|+</td></tr>\n",
       "\t<tr><td>Derm         </td><td>phecode_686-1</td><td>Pressure ulcer                                                 </td><td>0.718 (0.702, 0.734)</td><td>0.749 (0.738, 0.765)</td><td>0.033 (0.021, 0.045)</td><td>0.785 (0.738, 0.805)</td><td>0.806 (0.766, 0.821)</td><td>0.02 (0.014, 0.028) </td><td>+</td><td>+</td><td>+|+</td></tr>\n",
       "\t<tr><td>Derm         </td><td>phecode_686  </td><td>Chronic ulcer of skin                                          </td><td>0.706 (0.69, 0.72)  </td><td>0.74 (0.726, 0.758) </td><td>0.035 (0.022, 0.044)</td><td>0.774 (0.749, 0.797)</td><td>0.793 (0.769, 0.818)</td><td>0.02 (0.014, 0.029) </td><td>+</td><td>+</td><td>+|+</td></tr>\n",
       "\t<tr><td>Eye          </td><td>phecode_374  </td><td>Disorders of the retina                                        </td><td>0.678 (0.669, 0.686)</td><td>0.737 (0.728, 0.747)</td><td>0.06 (0.052, 0.069) </td><td>0.687 (0.676, 0.71) </td><td>0.712 (0.707, 0.729)</td><td>0.028 (0.015, 0.039)</td><td>+</td><td>+</td><td>+|+</td></tr>\n",
       "\t<tr><td>Resp         </td><td>phecode_474  </td><td>Chronic obstructive pulmonary disease [COPD]                   </td><td>0.681 (0.673, 0.69) </td><td>0.728 (0.718, 0.736)</td><td>0.047 (0.039, 0.054)</td><td>0.685 (0.665, 0.699)</td><td>0.718 (0.692, 0.727)</td><td>0.032 (0.017, 0.039)</td><td>+</td><td>+</td><td>+|+</td></tr>\n",
       "\t<tr><td>Endo         </td><td>phecode_202  </td><td>Diabetes mellitus                                              </td><td>0.635 (0.627, 0.641)</td><td>0.706 (0.7, 0.712)  </td><td>0.072 (0.065, 0.078)</td><td>0.605 (0.586, 0.613)</td><td>0.63 (0.607, 0.642) </td><td>0.023 (0.021, 0.031)</td><td>+</td><td>+</td><td>+|+</td></tr>\n",
       "\t<tr><td>Resp         </td><td>phecode_487  </td><td>Hemorrhage from respiratory passages                           </td><td>0.623 (0.604, 0.64) </td><td>0.643 (0.626, 0.661)</td><td>0.019 (0.007, 0.03) </td><td>0.655 (0.641, 0.682)</td><td>0.685 (0.67, 0.713) </td><td>0.027 (0.023, 0.035)</td><td>+</td><td>+</td><td>+|+</td></tr>\n",
       "\t<tr><td>Resp         </td><td>phecode_479-3</td><td>Respiratory failure                                            </td><td>0.671 (0.649, 0.688)</td><td>0.697 (0.68, 0.722) </td><td>0.029 (0.013, 0.044)</td><td>0.657 (0.607, 0.684)</td><td>0.703 (0.661, 0.726)</td><td>0.043 (0.023, 0.069)</td><td>+</td><td>+</td><td>+|+</td></tr>\n",
       "\t<tr><td>Resp         </td><td>phecode_475  </td><td>Asthma                                                         </td><td>0.54 (0.533, 0.545) </td><td>0.555 (0.548, 0.561)</td><td>0.015 (0.009, 0.022)</td><td>0.498 (0.482, 0.509)</td><td>0.546 (0.534, 0.558)</td><td>0.047 (0.028, 0.074)</td><td>+</td><td>+</td><td>+|+</td></tr>\n",
       "\t<tr><td>Eye          </td><td>phecode_375  </td><td>Abnormal intraocular pressure                                  </td><td>0.697 (0.688, 0.706)</td><td>0.75 (0.739, 0.758) </td><td>0.053 (0.044, 0.063)</td><td>0.633 (0.625, 0.647)</td><td>0.675 (0.664, 0.688)</td><td>0.041 (0.032, 0.047)</td><td>+</td><td>+</td><td>+|+</td></tr>\n",
       "\t<tr><td>Resp         </td><td>phecode_479  </td><td>Pulmonary insufficiency and acute respiratory distress syndrome</td><td>0.656 (0.643, 0.671)</td><td>0.677 (0.663, 0.692)</td><td>0.021 (0.011, 0.029)</td><td>0.657 (0.602, 0.683)</td><td>0.705 (0.662, 0.739)</td><td>0.048 (0.036, 0.065)</td><td>+</td><td>+</td><td>+|+</td></tr>\n",
       "\t<tr><td>Eye          </td><td>phecode_371  </td><td>Cataract                                                       </td><td>0.739 (0.734, 0.744)</td><td>0.801 (0.796, 0.804)</td><td>0.062 (0.057, 0.065)</td><td>0.707 (0.702, 0.712)</td><td>0.756 (0.752, 0.759)</td><td>0.048 (0.045, 0.054)</td><td>+</td><td>+</td><td>+|+</td></tr>\n",
       "\t<tr><td>Metab        </td><td>phecode_236  </td><td>Overweight and obesity                                         </td><td>0.523 (0.516, 0.529)</td><td>0.618 (0.611, 0.624)</td><td>0.095 (0.086, 0.102)</td><td>0.479 (0.447, 0.505)</td><td>0.561 (0.548, 0.59) </td><td>0.09 (0.049, 0.115) </td><td>+</td><td>+</td><td>+|+</td></tr>\n",
       "\t<tr><td>GI           </td><td>phecode_546  </td><td>Other disorders of liver                                       </td><td>0.619 (0.606, 0.638)</td><td>0.637 (0.618, 0.656)</td><td>0.016 (0.002, 0.032)</td><td>0.532 (0.491, 0.568)</td><td>0.612 (0.59, 0.64)  </td><td>0.079 (0.053, 0.099)</td><td>+</td><td>+</td><td>+|+</td></tr>\n",
       "\t<tr><td>Mental       </td><td>phecode_281  </td><td>Substance abuse, dependence, and withdrawl                     </td><td>0.539 (0.531, 0.547)</td><td>0.665 (0.657, 0.672)</td><td>0.126 (0.116, 0.135)</td><td>0.548 (0.517, 0.581)</td><td>0.656 (0.631, 0.683)</td><td>0.102 (0.062, 0.143)</td><td>+</td><td>+</td><td>+|+</td></tr>\n",
       "\t<tr><td>Mental       </td><td>phecode_282  </td><td>Nicotine dependence (current and history of)                   </td><td>0.53 (0.519, 0.537) </td><td>0.66 (0.653, 0.665) </td><td>0.129 (0.122, 0.14) </td><td>0.544 (0.521, 0.561)</td><td>0.652 (0.626, 0.679)</td><td>0.111 (0.08, 0.152) </td><td>+</td><td>+</td><td>+|+</td></tr>\n",
       "\t<tr><td>Mental       </td><td>phecode_281-2</td><td>Substance dependence                                           </td><td>0.528 (0.518, 0.535)</td><td>0.666 (0.661, 0.673)</td><td>0.138 (0.132, 0.146)</td><td>0.546 (0.526, 0.562)</td><td>0.654 (0.635, 0.68) </td><td>0.104 (0.082, 0.139)</td><td>+</td><td>+</td><td>+|+</td></tr>\n",
       "\t<tr><td>Mental       </td><td>phecode_282-1</td><td>Current tobacco use and nicotine dependence                    </td><td>0.53 (0.521, 0.539) </td><td>0.66 (0.652, 0.667) </td><td>0.129 (0.119, 0.141)</td><td>0.538 (0.495, 0.571)</td><td>0.645 (0.62, 0.693) </td><td>0.105 (0.09, 0.154) </td><td>+</td><td>+</td><td>+|+</td></tr>\n",
       "</tbody>\n",
       "</table>\n"
      ],
      "text/latex": [
       "A tibble: 40 × 12\n",
       "\\begin{tabular}{llllllllllll}\n",
       " phecode\\_category & endpoint & phecode\\_string & Age+Sex & Age+Sex+Retina & delta & epic\\_agesex & epic\\_agesexretina & epic\\_delta & sign\\_ukb & sign\\_epic & sign\\\\\n",
       " <chr> & <chr> & <chr> & <chr> & <chr> & <chr> & <glue> & <glue> & <glue> & <chr> & <chr> & <glue>\\\\\n",
       "\\hline\n",
       "\t GI            & phecode\\_528   & Nausea and vomiting                                             & 0.601 (0.591, 0.609) & 0.609 (0.599, 0.616) & 0.008 (0.002, 0.013) & 0.624 (0.603, 0.648) & 0.627 (0.605, 0.65)  & 0.002 (0.001, 0.004) & + & + & +\\textbar{}+\\\\\n",
       "\t Cardio        & phecode\\_424   & Heart failure                                                   & 0.744 (0.737, 0.754) & 0.759 (0.75, 0.769)  & 0.014 (0.008, 0.02)  & 0.768 (0.754, 0.785) & 0.772 (0.758, 0.79)  & 0.003 (0.001, 0.006) & + & + & +\\textbar{}+\\\\\n",
       "\t Neuro         & phecode\\_350   & Other symptoms involving nervous system                         & 0.697 (0.683, 0.708) & 0.718 (0.705, 0.729) & 0.02 (0.012, 0.029)  & 0.801 (0.784, 0.805) & 0.804 (0.789, 0.808) & 0.003 (0.001, 0.005) & + & + & +\\textbar{}+\\\\\n",
       "\t Blood         & phecode\\_160   & Nutritional anemias                                             & 0.6 (0.589, 0.608)   & 0.628 (0.618, 0.636) & 0.028 (0.02, 0.035)  & 0.617 (0.61, 0.628)  & 0.623 (0.611, 0.636) & 0.005 (0.001, 0.009) & + & + & +\\textbar{}+\\\\\n",
       "\t Resp          & phecode\\_486   & Other respiratory disorders                                     & 0.651 (0.633, 0.665) & 0.681 (0.662, 0.698) & 0.03 (0.014, 0.042)  & 0.622 (0.583, 0.638) & 0.635 (0.59, 0.653)  & 0.009 (0.001, 0.021) & + & + & +\\textbar{}+\\\\\n",
       "\t Musc/Skel     & phecode\\_703   & Chrystal arthropathies                                          & 0.765 (0.755, 0.774) & 0.77 (0.76, 0.779)   & 0.006 (0.001, 0.011) & 0.726 (0.697, 0.745) & 0.729 (0.704, 0.749) & 0.004 (0.002, 0.007) & + & + & +\\textbar{}+\\\\\n",
       "\t Genitourinary & phecode\\_583   & Chronic kidney disease                                          & 0.721 (0.713, 0.73)  & 0.728 (0.719, 0.737) & 0.007 (0.001, 0.012) & 0.746 (0.728, 0.749) & 0.749 (0.734, 0.755) & 0.004 (0.002, 0.006) & + & + & +\\textbar{}+\\\\\n",
       "\t Resp          & phecode\\_483   & Pleural effusion                                                & 0.68 (0.667, 0.69)   & 0.691 (0.682, 0.704) & 0.011 (0.004, 0.018) & 0.637 (0.626, 0.653) & 0.642 (0.631, 0.659) & 0.004 (0.002, 0.006) & + & + & +\\textbar{}+\\\\\n",
       "\t Cardio        & phecode\\_401-1 & Essential hypertension                                          & 0.663 (0.66, 0.667)  & 0.675 (0.672, 0.679) & 0.012 (0.01, 0.014)  & 0.639 (0.628, 0.651) & 0.643 (0.634, 0.657) & 0.004 (0.002, 0.007) & + & + & +\\textbar{}+\\\\\n",
       "\t Cardio        & phecode\\_401   & Hypertension                                                    & 0.664 (0.659, 0.667) & 0.676 (0.672, 0.679) & 0.012 (0.01, 0.014)  & 0.637 (0.632, 0.645) & 0.642 (0.637, 0.65)  & 0.005 (0.002, 0.006) & + & + & +\\textbar{}+\\\\\n",
       "\t Musc/Skel     & phecode\\_724   & Other symptoms and disorders of the soft tissue                 & 0.567 (0.557, 0.578) & 0.586 (0.577, 0.597) & 0.018 (0.011, 0.026) & 0.547 (0.518, 0.577) & 0.562 (0.551, 0.594) & 0.022 (0.002, 0.038) & + & + & +\\textbar{}+\\\\\n",
       "\t Blood         & phecode\\_164-1 & Microcytic anemia                                               & 0.592 (0.582, 0.606) & 0.619 (0.612, 0.631) & 0.028 (0.018, 0.038) & 0.613 (0.595, 0.628) & 0.619 (0.602, 0.632) & 0.005 (0.002, 0.01)  & + & + & +\\textbar{}+\\\\\n",
       "\t Resp          & phecode\\_460-2 & Acute lower respiratory infection                               & 0.645 (0.635, 0.655) & 0.678 (0.669, 0.687) & 0.033 (0.024, 0.04)  & 0.716 (0.703, 0.731) & 0.723 (0.709, 0.737) & 0.006 (0.002, 0.011) & + & + & +\\textbar{}+\\\\\n",
       "\t Cardio        & phecode\\_440   & Embolism and thrombosis                                         & 0.633 (0.622, 0.642) & 0.644 (0.635, 0.654) & 0.011 (0.004, 0.019) & 0.472 (0.455, 0.493) & 0.489 (0.464, 0.511) & 0.015 (0.003, 0.026) & + & + & +\\textbar{}+\\\\\n",
       "\t Resp          & phecode\\_468   & Pneumonia                                                       & 0.674 (0.667, 0.681) & 0.693 (0.686, 0.701) & 0.019 (0.013, 0.024) & 0.73 (0.724, 0.734)  & 0.735 (0.728, 0.739) & 0.004 (0.003, 0.007) & + & + & +\\textbar{}+\\\\\n",
       "\t Musc/Skel     & phecode\\_713   & Symptoms related to joints                                      & 0.578 (0.565, 0.592) & 0.6 (0.587, 0.61)    & 0.022 (0.013, 0.03)  & 0.64 (0.627, 0.658)  & 0.647 (0.636, 0.662) & 0.006 (0.003, 0.013) & + & + & +\\textbar{}+\\\\\n",
       "\t Blood         & phecode\\_164   & Anemia                                                          & 0.605 (0.598, 0.611) & 0.627 (0.62, 0.634)  & 0.023 (0.015, 0.029) & 0.641 (0.621, 0.659) & 0.647 (0.627, 0.665) & 0.006 (0.003, 0.007) & + & + & +\\textbar{}+\\\\\n",
       "\t GI            & phecode\\_507   & Lesions of mouth                                                & 0.351 (0.331, 0.374) & 0.39 (0.367, 0.412)  & 0.038 (0.021, 0.054) & 0.536 (0.512, 0.576) & 0.545 (0.522, 0.583) & 0.008 (0.003, 0.019) & + & + & +\\textbar{}+\\\\\n",
       "\t GI            & phecode\\_522   & Gastrointestinal inflammation                                   & 0.577 (0.571, 0.583) & 0.583 (0.576, 0.589) & 0.005 (0.002, 0.009) & 0.568 (0.557, 0.596) & 0.574 (0.564, 0.602) & 0.006 (0.004, 0.009) & + & + & +\\textbar{}+\\\\\n",
       "\t Genitourinary & phecode\\_582   & Acute kidney failure                                            & 0.704 (0.695, 0.712) & 0.726 (0.718, 0.734) & 0.022 (0.015, 0.028) & 0.744 (0.723, 0.749) & 0.75 (0.73, 0.756)   & 0.006 (0.004, 0.009) & + & + & +\\textbar{}+\\\\\n",
       "\t Resp          & phecode\\_460   & Acute respiratory infection                                     & 0.629 (0.619, 0.638) & 0.656 (0.647, 0.664) & 0.028 (0.019, 0.035) & 0.707 (0.703, 0.717) & 0.717 (0.711, 0.73)  & 0.008 (0.004, 0.014) & + & + & +\\textbar{}+\\\\\n",
       "\t Derm          & phecode\\_660   & Infection of the skin                                           & 0.577 (0.568, 0.588) & 0.604 (0.592, 0.615) & 0.027 (0.016, 0.037) & 0.67 (0.639, 0.689)  & 0.68 (0.665, 0.695)  & 0.014 (0.005, 0.027) & + & + & +\\textbar{}+\\\\\n",
       "\t Resp          & phecode\\_474-1 & Emphysema                                                       & 0.695 (0.679, 0.714) & 0.748 (0.726, 0.762) & 0.051 (0.033, 0.072) & 0.694 (0.662, 0.718) & 0.731 (0.703, 0.747) & 0.033 (0.009, 0.069) & + & + & +\\textbar{}+\\\\\n",
       "\t Derm          & phecode\\_686-1 & Pressure ulcer                                                  & 0.718 (0.702, 0.734) & 0.749 (0.738, 0.765) & 0.033 (0.021, 0.045) & 0.785 (0.738, 0.805) & 0.806 (0.766, 0.821) & 0.02 (0.014, 0.028)  & + & + & +\\textbar{}+\\\\\n",
       "\t Derm          & phecode\\_686   & Chronic ulcer of skin                                           & 0.706 (0.69, 0.72)   & 0.74 (0.726, 0.758)  & 0.035 (0.022, 0.044) & 0.774 (0.749, 0.797) & 0.793 (0.769, 0.818) & 0.02 (0.014, 0.029)  & + & + & +\\textbar{}+\\\\\n",
       "\t Eye           & phecode\\_374   & Disorders of the retina                                         & 0.678 (0.669, 0.686) & 0.737 (0.728, 0.747) & 0.06 (0.052, 0.069)  & 0.687 (0.676, 0.71)  & 0.712 (0.707, 0.729) & 0.028 (0.015, 0.039) & + & + & +\\textbar{}+\\\\\n",
       "\t Resp          & phecode\\_474   & Chronic obstructive pulmonary disease {[}COPD{]}                    & 0.681 (0.673, 0.69)  & 0.728 (0.718, 0.736) & 0.047 (0.039, 0.054) & 0.685 (0.665, 0.699) & 0.718 (0.692, 0.727) & 0.032 (0.017, 0.039) & + & + & +\\textbar{}+\\\\\n",
       "\t Endo          & phecode\\_202   & Diabetes mellitus                                               & 0.635 (0.627, 0.641) & 0.706 (0.7, 0.712)   & 0.072 (0.065, 0.078) & 0.605 (0.586, 0.613) & 0.63 (0.607, 0.642)  & 0.023 (0.021, 0.031) & + & + & +\\textbar{}+\\\\\n",
       "\t Resp          & phecode\\_487   & Hemorrhage from respiratory passages                            & 0.623 (0.604, 0.64)  & 0.643 (0.626, 0.661) & 0.019 (0.007, 0.03)  & 0.655 (0.641, 0.682) & 0.685 (0.67, 0.713)  & 0.027 (0.023, 0.035) & + & + & +\\textbar{}+\\\\\n",
       "\t Resp          & phecode\\_479-3 & Respiratory failure                                             & 0.671 (0.649, 0.688) & 0.697 (0.68, 0.722)  & 0.029 (0.013, 0.044) & 0.657 (0.607, 0.684) & 0.703 (0.661, 0.726) & 0.043 (0.023, 0.069) & + & + & +\\textbar{}+\\\\\n",
       "\t Resp          & phecode\\_475   & Asthma                                                          & 0.54 (0.533, 0.545)  & 0.555 (0.548, 0.561) & 0.015 (0.009, 0.022) & 0.498 (0.482, 0.509) & 0.546 (0.534, 0.558) & 0.047 (0.028, 0.074) & + & + & +\\textbar{}+\\\\\n",
       "\t Eye           & phecode\\_375   & Abnormal intraocular pressure                                   & 0.697 (0.688, 0.706) & 0.75 (0.739, 0.758)  & 0.053 (0.044, 0.063) & 0.633 (0.625, 0.647) & 0.675 (0.664, 0.688) & 0.041 (0.032, 0.047) & + & + & +\\textbar{}+\\\\\n",
       "\t Resp          & phecode\\_479   & Pulmonary insufficiency and acute respiratory distress syndrome & 0.656 (0.643, 0.671) & 0.677 (0.663, 0.692) & 0.021 (0.011, 0.029) & 0.657 (0.602, 0.683) & 0.705 (0.662, 0.739) & 0.048 (0.036, 0.065) & + & + & +\\textbar{}+\\\\\n",
       "\t Eye           & phecode\\_371   & Cataract                                                        & 0.739 (0.734, 0.744) & 0.801 (0.796, 0.804) & 0.062 (0.057, 0.065) & 0.707 (0.702, 0.712) & 0.756 (0.752, 0.759) & 0.048 (0.045, 0.054) & + & + & +\\textbar{}+\\\\\n",
       "\t Metab         & phecode\\_236   & Overweight and obesity                                          & 0.523 (0.516, 0.529) & 0.618 (0.611, 0.624) & 0.095 (0.086, 0.102) & 0.479 (0.447, 0.505) & 0.561 (0.548, 0.59)  & 0.09 (0.049, 0.115)  & + & + & +\\textbar{}+\\\\\n",
       "\t GI            & phecode\\_546   & Other disorders of liver                                        & 0.619 (0.606, 0.638) & 0.637 (0.618, 0.656) & 0.016 (0.002, 0.032) & 0.532 (0.491, 0.568) & 0.612 (0.59, 0.64)   & 0.079 (0.053, 0.099) & + & + & +\\textbar{}+\\\\\n",
       "\t Mental        & phecode\\_281   & Substance abuse, dependence, and withdrawl                      & 0.539 (0.531, 0.547) & 0.665 (0.657, 0.672) & 0.126 (0.116, 0.135) & 0.548 (0.517, 0.581) & 0.656 (0.631, 0.683) & 0.102 (0.062, 0.143) & + & + & +\\textbar{}+\\\\\n",
       "\t Mental        & phecode\\_282   & Nicotine dependence (current and history of)                    & 0.53 (0.519, 0.537)  & 0.66 (0.653, 0.665)  & 0.129 (0.122, 0.14)  & 0.544 (0.521, 0.561) & 0.652 (0.626, 0.679) & 0.111 (0.08, 0.152)  & + & + & +\\textbar{}+\\\\\n",
       "\t Mental        & phecode\\_281-2 & Substance dependence                                            & 0.528 (0.518, 0.535) & 0.666 (0.661, 0.673) & 0.138 (0.132, 0.146) & 0.546 (0.526, 0.562) & 0.654 (0.635, 0.68)  & 0.104 (0.082, 0.139) & + & + & +\\textbar{}+\\\\\n",
       "\t Mental        & phecode\\_282-1 & Current tobacco use and nicotine dependence                     & 0.53 (0.521, 0.539)  & 0.66 (0.652, 0.667)  & 0.129 (0.119, 0.141) & 0.538 (0.495, 0.571) & 0.645 (0.62, 0.693)  & 0.105 (0.09, 0.154)  & + & + & +\\textbar{}+\\\\\n",
       "\\end{tabular}\n"
      ],
      "text/markdown": [
       "\n",
       "A tibble: 40 × 12\n",
       "\n",
       "| phecode_category &lt;chr&gt; | endpoint &lt;chr&gt; | phecode_string &lt;chr&gt; | Age+Sex &lt;chr&gt; | Age+Sex+Retina &lt;chr&gt; | delta &lt;chr&gt; | epic_agesex &lt;glue&gt; | epic_agesexretina &lt;glue&gt; | epic_delta &lt;glue&gt; | sign_ukb &lt;chr&gt; | sign_epic &lt;chr&gt; | sign &lt;glue&gt; |\n",
       "|---|---|---|---|---|---|---|---|---|---|---|---|\n",
       "| GI            | phecode_528   | Nausea and vomiting                                             | 0.601 (0.591, 0.609) | 0.609 (0.599, 0.616) | 0.008 (0.002, 0.013) | 0.624 (0.603, 0.648) | 0.627 (0.605, 0.65)  | 0.002 (0.001, 0.004) | + | + | +|+ |\n",
       "| Cardio        | phecode_424   | Heart failure                                                   | 0.744 (0.737, 0.754) | 0.759 (0.75, 0.769)  | 0.014 (0.008, 0.02)  | 0.768 (0.754, 0.785) | 0.772 (0.758, 0.79)  | 0.003 (0.001, 0.006) | + | + | +|+ |\n",
       "| Neuro         | phecode_350   | Other symptoms involving nervous system                         | 0.697 (0.683, 0.708) | 0.718 (0.705, 0.729) | 0.02 (0.012, 0.029)  | 0.801 (0.784, 0.805) | 0.804 (0.789, 0.808) | 0.003 (0.001, 0.005) | + | + | +|+ |\n",
       "| Blood         | phecode_160   | Nutritional anemias                                             | 0.6 (0.589, 0.608)   | 0.628 (0.618, 0.636) | 0.028 (0.02, 0.035)  | 0.617 (0.61, 0.628)  | 0.623 (0.611, 0.636) | 0.005 (0.001, 0.009) | + | + | +|+ |\n",
       "| Resp          | phecode_486   | Other respiratory disorders                                     | 0.651 (0.633, 0.665) | 0.681 (0.662, 0.698) | 0.03 (0.014, 0.042)  | 0.622 (0.583, 0.638) | 0.635 (0.59, 0.653)  | 0.009 (0.001, 0.021) | + | + | +|+ |\n",
       "| Musc/Skel     | phecode_703   | Chrystal arthropathies                                          | 0.765 (0.755, 0.774) | 0.77 (0.76, 0.779)   | 0.006 (0.001, 0.011) | 0.726 (0.697, 0.745) | 0.729 (0.704, 0.749) | 0.004 (0.002, 0.007) | + | + | +|+ |\n",
       "| Genitourinary | phecode_583   | Chronic kidney disease                                          | 0.721 (0.713, 0.73)  | 0.728 (0.719, 0.737) | 0.007 (0.001, 0.012) | 0.746 (0.728, 0.749) | 0.749 (0.734, 0.755) | 0.004 (0.002, 0.006) | + | + | +|+ |\n",
       "| Resp          | phecode_483   | Pleural effusion                                                | 0.68 (0.667, 0.69)   | 0.691 (0.682, 0.704) | 0.011 (0.004, 0.018) | 0.637 (0.626, 0.653) | 0.642 (0.631, 0.659) | 0.004 (0.002, 0.006) | + | + | +|+ |\n",
       "| Cardio        | phecode_401-1 | Essential hypertension                                          | 0.663 (0.66, 0.667)  | 0.675 (0.672, 0.679) | 0.012 (0.01, 0.014)  | 0.639 (0.628, 0.651) | 0.643 (0.634, 0.657) | 0.004 (0.002, 0.007) | + | + | +|+ |\n",
       "| Cardio        | phecode_401   | Hypertension                                                    | 0.664 (0.659, 0.667) | 0.676 (0.672, 0.679) | 0.012 (0.01, 0.014)  | 0.637 (0.632, 0.645) | 0.642 (0.637, 0.65)  | 0.005 (0.002, 0.006) | + | + | +|+ |\n",
       "| Musc/Skel     | phecode_724   | Other symptoms and disorders of the soft tissue                 | 0.567 (0.557, 0.578) | 0.586 (0.577, 0.597) | 0.018 (0.011, 0.026) | 0.547 (0.518, 0.577) | 0.562 (0.551, 0.594) | 0.022 (0.002, 0.038) | + | + | +|+ |\n",
       "| Blood         | phecode_164-1 | Microcytic anemia                                               | 0.592 (0.582, 0.606) | 0.619 (0.612, 0.631) | 0.028 (0.018, 0.038) | 0.613 (0.595, 0.628) | 0.619 (0.602, 0.632) | 0.005 (0.002, 0.01)  | + | + | +|+ |\n",
       "| Resp          | phecode_460-2 | Acute lower respiratory infection                               | 0.645 (0.635, 0.655) | 0.678 (0.669, 0.687) | 0.033 (0.024, 0.04)  | 0.716 (0.703, 0.731) | 0.723 (0.709, 0.737) | 0.006 (0.002, 0.011) | + | + | +|+ |\n",
       "| Cardio        | phecode_440   | Embolism and thrombosis                                         | 0.633 (0.622, 0.642) | 0.644 (0.635, 0.654) | 0.011 (0.004, 0.019) | 0.472 (0.455, 0.493) | 0.489 (0.464, 0.511) | 0.015 (0.003, 0.026) | + | + | +|+ |\n",
       "| Resp          | phecode_468   | Pneumonia                                                       | 0.674 (0.667, 0.681) | 0.693 (0.686, 0.701) | 0.019 (0.013, 0.024) | 0.73 (0.724, 0.734)  | 0.735 (0.728, 0.739) | 0.004 (0.003, 0.007) | + | + | +|+ |\n",
       "| Musc/Skel     | phecode_713   | Symptoms related to joints                                      | 0.578 (0.565, 0.592) | 0.6 (0.587, 0.61)    | 0.022 (0.013, 0.03)  | 0.64 (0.627, 0.658)  | 0.647 (0.636, 0.662) | 0.006 (0.003, 0.013) | + | + | +|+ |\n",
       "| Blood         | phecode_164   | Anemia                                                          | 0.605 (0.598, 0.611) | 0.627 (0.62, 0.634)  | 0.023 (0.015, 0.029) | 0.641 (0.621, 0.659) | 0.647 (0.627, 0.665) | 0.006 (0.003, 0.007) | + | + | +|+ |\n",
       "| GI            | phecode_507   | Lesions of mouth                                                | 0.351 (0.331, 0.374) | 0.39 (0.367, 0.412)  | 0.038 (0.021, 0.054) | 0.536 (0.512, 0.576) | 0.545 (0.522, 0.583) | 0.008 (0.003, 0.019) | + | + | +|+ |\n",
       "| GI            | phecode_522   | Gastrointestinal inflammation                                   | 0.577 (0.571, 0.583) | 0.583 (0.576, 0.589) | 0.005 (0.002, 0.009) | 0.568 (0.557, 0.596) | 0.574 (0.564, 0.602) | 0.006 (0.004, 0.009) | + | + | +|+ |\n",
       "| Genitourinary | phecode_582   | Acute kidney failure                                            | 0.704 (0.695, 0.712) | 0.726 (0.718, 0.734) | 0.022 (0.015, 0.028) | 0.744 (0.723, 0.749) | 0.75 (0.73, 0.756)   | 0.006 (0.004, 0.009) | + | + | +|+ |\n",
       "| Resp          | phecode_460   | Acute respiratory infection                                     | 0.629 (0.619, 0.638) | 0.656 (0.647, 0.664) | 0.028 (0.019, 0.035) | 0.707 (0.703, 0.717) | 0.717 (0.711, 0.73)  | 0.008 (0.004, 0.014) | + | + | +|+ |\n",
       "| Derm          | phecode_660   | Infection of the skin                                           | 0.577 (0.568, 0.588) | 0.604 (0.592, 0.615) | 0.027 (0.016, 0.037) | 0.67 (0.639, 0.689)  | 0.68 (0.665, 0.695)  | 0.014 (0.005, 0.027) | + | + | +|+ |\n",
       "| Resp          | phecode_474-1 | Emphysema                                                       | 0.695 (0.679, 0.714) | 0.748 (0.726, 0.762) | 0.051 (0.033, 0.072) | 0.694 (0.662, 0.718) | 0.731 (0.703, 0.747) | 0.033 (0.009, 0.069) | + | + | +|+ |\n",
       "| Derm          | phecode_686-1 | Pressure ulcer                                                  | 0.718 (0.702, 0.734) | 0.749 (0.738, 0.765) | 0.033 (0.021, 0.045) | 0.785 (0.738, 0.805) | 0.806 (0.766, 0.821) | 0.02 (0.014, 0.028)  | + | + | +|+ |\n",
       "| Derm          | phecode_686   | Chronic ulcer of skin                                           | 0.706 (0.69, 0.72)   | 0.74 (0.726, 0.758)  | 0.035 (0.022, 0.044) | 0.774 (0.749, 0.797) | 0.793 (0.769, 0.818) | 0.02 (0.014, 0.029)  | + | + | +|+ |\n",
       "| Eye           | phecode_374   | Disorders of the retina                                         | 0.678 (0.669, 0.686) | 0.737 (0.728, 0.747) | 0.06 (0.052, 0.069)  | 0.687 (0.676, 0.71)  | 0.712 (0.707, 0.729) | 0.028 (0.015, 0.039) | + | + | +|+ |\n",
       "| Resp          | phecode_474   | Chronic obstructive pulmonary disease [COPD]                    | 0.681 (0.673, 0.69)  | 0.728 (0.718, 0.736) | 0.047 (0.039, 0.054) | 0.685 (0.665, 0.699) | 0.718 (0.692, 0.727) | 0.032 (0.017, 0.039) | + | + | +|+ |\n",
       "| Endo          | phecode_202   | Diabetes mellitus                                               | 0.635 (0.627, 0.641) | 0.706 (0.7, 0.712)   | 0.072 (0.065, 0.078) | 0.605 (0.586, 0.613) | 0.63 (0.607, 0.642)  | 0.023 (0.021, 0.031) | + | + | +|+ |\n",
       "| Resp          | phecode_487   | Hemorrhage from respiratory passages                            | 0.623 (0.604, 0.64)  | 0.643 (0.626, 0.661) | 0.019 (0.007, 0.03)  | 0.655 (0.641, 0.682) | 0.685 (0.67, 0.713)  | 0.027 (0.023, 0.035) | + | + | +|+ |\n",
       "| Resp          | phecode_479-3 | Respiratory failure                                             | 0.671 (0.649, 0.688) | 0.697 (0.68, 0.722)  | 0.029 (0.013, 0.044) | 0.657 (0.607, 0.684) | 0.703 (0.661, 0.726) | 0.043 (0.023, 0.069) | + | + | +|+ |\n",
       "| Resp          | phecode_475   | Asthma                                                          | 0.54 (0.533, 0.545)  | 0.555 (0.548, 0.561) | 0.015 (0.009, 0.022) | 0.498 (0.482, 0.509) | 0.546 (0.534, 0.558) | 0.047 (0.028, 0.074) | + | + | +|+ |\n",
       "| Eye           | phecode_375   | Abnormal intraocular pressure                                   | 0.697 (0.688, 0.706) | 0.75 (0.739, 0.758)  | 0.053 (0.044, 0.063) | 0.633 (0.625, 0.647) | 0.675 (0.664, 0.688) | 0.041 (0.032, 0.047) | + | + | +|+ |\n",
       "| Resp          | phecode_479   | Pulmonary insufficiency and acute respiratory distress syndrome | 0.656 (0.643, 0.671) | 0.677 (0.663, 0.692) | 0.021 (0.011, 0.029) | 0.657 (0.602, 0.683) | 0.705 (0.662, 0.739) | 0.048 (0.036, 0.065) | + | + | +|+ |\n",
       "| Eye           | phecode_371   | Cataract                                                        | 0.739 (0.734, 0.744) | 0.801 (0.796, 0.804) | 0.062 (0.057, 0.065) | 0.707 (0.702, 0.712) | 0.756 (0.752, 0.759) | 0.048 (0.045, 0.054) | + | + | +|+ |\n",
       "| Metab         | phecode_236   | Overweight and obesity                                          | 0.523 (0.516, 0.529) | 0.618 (0.611, 0.624) | 0.095 (0.086, 0.102) | 0.479 (0.447, 0.505) | 0.561 (0.548, 0.59)  | 0.09 (0.049, 0.115)  | + | + | +|+ |\n",
       "| GI            | phecode_546   | Other disorders of liver                                        | 0.619 (0.606, 0.638) | 0.637 (0.618, 0.656) | 0.016 (0.002, 0.032) | 0.532 (0.491, 0.568) | 0.612 (0.59, 0.64)   | 0.079 (0.053, 0.099) | + | + | +|+ |\n",
       "| Mental        | phecode_281   | Substance abuse, dependence, and withdrawl                      | 0.539 (0.531, 0.547) | 0.665 (0.657, 0.672) | 0.126 (0.116, 0.135) | 0.548 (0.517, 0.581) | 0.656 (0.631, 0.683) | 0.102 (0.062, 0.143) | + | + | +|+ |\n",
       "| Mental        | phecode_282   | Nicotine dependence (current and history of)                    | 0.53 (0.519, 0.537)  | 0.66 (0.653, 0.665)  | 0.129 (0.122, 0.14)  | 0.544 (0.521, 0.561) | 0.652 (0.626, 0.679) | 0.111 (0.08, 0.152)  | + | + | +|+ |\n",
       "| Mental        | phecode_281-2 | Substance dependence                                            | 0.528 (0.518, 0.535) | 0.666 (0.661, 0.673) | 0.138 (0.132, 0.146) | 0.546 (0.526, 0.562) | 0.654 (0.635, 0.68)  | 0.104 (0.082, 0.139) | + | + | +|+ |\n",
       "| Mental        | phecode_282-1 | Current tobacco use and nicotine dependence                     | 0.53 (0.521, 0.539)  | 0.66 (0.652, 0.667)  | 0.129 (0.119, 0.141) | 0.538 (0.495, 0.571) | 0.645 (0.62, 0.693)  | 0.105 (0.09, 0.154)  | + | + | +|+ |\n",
       "\n"
      ],
      "text/plain": [
       "   phecode_category endpoint     \n",
       "1  GI               phecode_528  \n",
       "2  Cardio           phecode_424  \n",
       "3  Neuro            phecode_350  \n",
       "4  Blood            phecode_160  \n",
       "5  Resp             phecode_486  \n",
       "6  Musc/Skel        phecode_703  \n",
       "7  Genitourinary    phecode_583  \n",
       "8  Resp             phecode_483  \n",
       "9  Cardio           phecode_401-1\n",
       "10 Cardio           phecode_401  \n",
       "11 Musc/Skel        phecode_724  \n",
       "12 Blood            phecode_164-1\n",
       "13 Resp             phecode_460-2\n",
       "14 Cardio           phecode_440  \n",
       "15 Resp             phecode_468  \n",
       "16 Musc/Skel        phecode_713  \n",
       "17 Blood            phecode_164  \n",
       "18 GI               phecode_507  \n",
       "19 GI               phecode_522  \n",
       "20 Genitourinary    phecode_582  \n",
       "21 Resp             phecode_460  \n",
       "22 Derm             phecode_660  \n",
       "23 Resp             phecode_474-1\n",
       "24 Derm             phecode_686-1\n",
       "25 Derm             phecode_686  \n",
       "26 Eye              phecode_374  \n",
       "27 Resp             phecode_474  \n",
       "28 Endo             phecode_202  \n",
       "29 Resp             phecode_487  \n",
       "30 Resp             phecode_479-3\n",
       "31 Resp             phecode_475  \n",
       "32 Eye              phecode_375  \n",
       "33 Resp             phecode_479  \n",
       "34 Eye              phecode_371  \n",
       "35 Metab            phecode_236  \n",
       "36 GI               phecode_546  \n",
       "37 Mental           phecode_281  \n",
       "38 Mental           phecode_282  \n",
       "39 Mental           phecode_281-2\n",
       "40 Mental           phecode_282-1\n",
       "   phecode_string                                                 \n",
       "1  Nausea and vomiting                                            \n",
       "2  Heart failure                                                  \n",
       "3  Other symptoms involving nervous system                        \n",
       "4  Nutritional anemias                                            \n",
       "5  Other respiratory disorders                                    \n",
       "6  Chrystal arthropathies                                         \n",
       "7  Chronic kidney disease                                         \n",
       "8  Pleural effusion                                               \n",
       "9  Essential hypertension                                         \n",
       "10 Hypertension                                                   \n",
       "11 Other symptoms and disorders of the soft tissue                \n",
       "12 Microcytic anemia                                              \n",
       "13 Acute lower respiratory infection                              \n",
       "14 Embolism and thrombosis                                        \n",
       "15 Pneumonia                                                      \n",
       "16 Symptoms related to joints                                     \n",
       "17 Anemia                                                         \n",
       "18 Lesions of mouth                                               \n",
       "19 Gastrointestinal inflammation                                  \n",
       "20 Acute kidney failure                                           \n",
       "21 Acute respiratory infection                                    \n",
       "22 Infection of the skin                                          \n",
       "23 Emphysema                                                      \n",
       "24 Pressure ulcer                                                 \n",
       "25 Chronic ulcer of skin                                          \n",
       "26 Disorders of the retina                                        \n",
       "27 Chronic obstructive pulmonary disease [COPD]                   \n",
       "28 Diabetes mellitus                                              \n",
       "29 Hemorrhage from respiratory passages                           \n",
       "30 Respiratory failure                                            \n",
       "31 Asthma                                                         \n",
       "32 Abnormal intraocular pressure                                  \n",
       "33 Pulmonary insufficiency and acute respiratory distress syndrome\n",
       "34 Cataract                                                       \n",
       "35 Overweight and obesity                                         \n",
       "36 Other disorders of liver                                       \n",
       "37 Substance abuse, dependence, and withdrawl                     \n",
       "38 Nicotine dependence (current and history of)                   \n",
       "39 Substance dependence                                           \n",
       "40 Current tobacco use and nicotine dependence                    \n",
       "   Age+Sex              Age+Sex+Retina       delta               \n",
       "1  0.601 (0.591, 0.609) 0.609 (0.599, 0.616) 0.008 (0.002, 0.013)\n",
       "2  0.744 (0.737, 0.754) 0.759 (0.75, 0.769)  0.014 (0.008, 0.02) \n",
       "3  0.697 (0.683, 0.708) 0.718 (0.705, 0.729) 0.02 (0.012, 0.029) \n",
       "4  0.6 (0.589, 0.608)   0.628 (0.618, 0.636) 0.028 (0.02, 0.035) \n",
       "5  0.651 (0.633, 0.665) 0.681 (0.662, 0.698) 0.03 (0.014, 0.042) \n",
       "6  0.765 (0.755, 0.774) 0.77 (0.76, 0.779)   0.006 (0.001, 0.011)\n",
       "7  0.721 (0.713, 0.73)  0.728 (0.719, 0.737) 0.007 (0.001, 0.012)\n",
       "8  0.68 (0.667, 0.69)   0.691 (0.682, 0.704) 0.011 (0.004, 0.018)\n",
       "9  0.663 (0.66, 0.667)  0.675 (0.672, 0.679) 0.012 (0.01, 0.014) \n",
       "10 0.664 (0.659, 0.667) 0.676 (0.672, 0.679) 0.012 (0.01, 0.014) \n",
       "11 0.567 (0.557, 0.578) 0.586 (0.577, 0.597) 0.018 (0.011, 0.026)\n",
       "12 0.592 (0.582, 0.606) 0.619 (0.612, 0.631) 0.028 (0.018, 0.038)\n",
       "13 0.645 (0.635, 0.655) 0.678 (0.669, 0.687) 0.033 (0.024, 0.04) \n",
       "14 0.633 (0.622, 0.642) 0.644 (0.635, 0.654) 0.011 (0.004, 0.019)\n",
       "15 0.674 (0.667, 0.681) 0.693 (0.686, 0.701) 0.019 (0.013, 0.024)\n",
       "16 0.578 (0.565, 0.592) 0.6 (0.587, 0.61)    0.022 (0.013, 0.03) \n",
       "17 0.605 (0.598, 0.611) 0.627 (0.62, 0.634)  0.023 (0.015, 0.029)\n",
       "18 0.351 (0.331, 0.374) 0.39 (0.367, 0.412)  0.038 (0.021, 0.054)\n",
       "19 0.577 (0.571, 0.583) 0.583 (0.576, 0.589) 0.005 (0.002, 0.009)\n",
       "20 0.704 (0.695, 0.712) 0.726 (0.718, 0.734) 0.022 (0.015, 0.028)\n",
       "21 0.629 (0.619, 0.638) 0.656 (0.647, 0.664) 0.028 (0.019, 0.035)\n",
       "22 0.577 (0.568, 0.588) 0.604 (0.592, 0.615) 0.027 (0.016, 0.037)\n",
       "23 0.695 (0.679, 0.714) 0.748 (0.726, 0.762) 0.051 (0.033, 0.072)\n",
       "24 0.718 (0.702, 0.734) 0.749 (0.738, 0.765) 0.033 (0.021, 0.045)\n",
       "25 0.706 (0.69, 0.72)   0.74 (0.726, 0.758)  0.035 (0.022, 0.044)\n",
       "26 0.678 (0.669, 0.686) 0.737 (0.728, 0.747) 0.06 (0.052, 0.069) \n",
       "27 0.681 (0.673, 0.69)  0.728 (0.718, 0.736) 0.047 (0.039, 0.054)\n",
       "28 0.635 (0.627, 0.641) 0.706 (0.7, 0.712)   0.072 (0.065, 0.078)\n",
       "29 0.623 (0.604, 0.64)  0.643 (0.626, 0.661) 0.019 (0.007, 0.03) \n",
       "30 0.671 (0.649, 0.688) 0.697 (0.68, 0.722)  0.029 (0.013, 0.044)\n",
       "31 0.54 (0.533, 0.545)  0.555 (0.548, 0.561) 0.015 (0.009, 0.022)\n",
       "32 0.697 (0.688, 0.706) 0.75 (0.739, 0.758)  0.053 (0.044, 0.063)\n",
       "33 0.656 (0.643, 0.671) 0.677 (0.663, 0.692) 0.021 (0.011, 0.029)\n",
       "34 0.739 (0.734, 0.744) 0.801 (0.796, 0.804) 0.062 (0.057, 0.065)\n",
       "35 0.523 (0.516, 0.529) 0.618 (0.611, 0.624) 0.095 (0.086, 0.102)\n",
       "36 0.619 (0.606, 0.638) 0.637 (0.618, 0.656) 0.016 (0.002, 0.032)\n",
       "37 0.539 (0.531, 0.547) 0.665 (0.657, 0.672) 0.126 (0.116, 0.135)\n",
       "38 0.53 (0.519, 0.537)  0.66 (0.653, 0.665)  0.129 (0.122, 0.14) \n",
       "39 0.528 (0.518, 0.535) 0.666 (0.661, 0.673) 0.138 (0.132, 0.146)\n",
       "40 0.53 (0.521, 0.539)  0.66 (0.652, 0.667)  0.129 (0.119, 0.141)\n",
       "   epic_agesex          epic_agesexretina    epic_delta           sign_ukb\n",
       "1  0.624 (0.603, 0.648) 0.627 (0.605, 0.65)  0.002 (0.001, 0.004) +       \n",
       "2  0.768 (0.754, 0.785) 0.772 (0.758, 0.79)  0.003 (0.001, 0.006) +       \n",
       "3  0.801 (0.784, 0.805) 0.804 (0.789, 0.808) 0.003 (0.001, 0.005) +       \n",
       "4  0.617 (0.61, 0.628)  0.623 (0.611, 0.636) 0.005 (0.001, 0.009) +       \n",
       "5  0.622 (0.583, 0.638) 0.635 (0.59, 0.653)  0.009 (0.001, 0.021) +       \n",
       "6  0.726 (0.697, 0.745) 0.729 (0.704, 0.749) 0.004 (0.002, 0.007) +       \n",
       "7  0.746 (0.728, 0.749) 0.749 (0.734, 0.755) 0.004 (0.002, 0.006) +       \n",
       "8  0.637 (0.626, 0.653) 0.642 (0.631, 0.659) 0.004 (0.002, 0.006) +       \n",
       "9  0.639 (0.628, 0.651) 0.643 (0.634, 0.657) 0.004 (0.002, 0.007) +       \n",
       "10 0.637 (0.632, 0.645) 0.642 (0.637, 0.65)  0.005 (0.002, 0.006) +       \n",
       "11 0.547 (0.518, 0.577) 0.562 (0.551, 0.594) 0.022 (0.002, 0.038) +       \n",
       "12 0.613 (0.595, 0.628) 0.619 (0.602, 0.632) 0.005 (0.002, 0.01)  +       \n",
       "13 0.716 (0.703, 0.731) 0.723 (0.709, 0.737) 0.006 (0.002, 0.011) +       \n",
       "14 0.472 (0.455, 0.493) 0.489 (0.464, 0.511) 0.015 (0.003, 0.026) +       \n",
       "15 0.73 (0.724, 0.734)  0.735 (0.728, 0.739) 0.004 (0.003, 0.007) +       \n",
       "16 0.64 (0.627, 0.658)  0.647 (0.636, 0.662) 0.006 (0.003, 0.013) +       \n",
       "17 0.641 (0.621, 0.659) 0.647 (0.627, 0.665) 0.006 (0.003, 0.007) +       \n",
       "18 0.536 (0.512, 0.576) 0.545 (0.522, 0.583) 0.008 (0.003, 0.019) +       \n",
       "19 0.568 (0.557, 0.596) 0.574 (0.564, 0.602) 0.006 (0.004, 0.009) +       \n",
       "20 0.744 (0.723, 0.749) 0.75 (0.73, 0.756)   0.006 (0.004, 0.009) +       \n",
       "21 0.707 (0.703, 0.717) 0.717 (0.711, 0.73)  0.008 (0.004, 0.014) +       \n",
       "22 0.67 (0.639, 0.689)  0.68 (0.665, 0.695)  0.014 (0.005, 0.027) +       \n",
       "23 0.694 (0.662, 0.718) 0.731 (0.703, 0.747) 0.033 (0.009, 0.069) +       \n",
       "24 0.785 (0.738, 0.805) 0.806 (0.766, 0.821) 0.02 (0.014, 0.028)  +       \n",
       "25 0.774 (0.749, 0.797) 0.793 (0.769, 0.818) 0.02 (0.014, 0.029)  +       \n",
       "26 0.687 (0.676, 0.71)  0.712 (0.707, 0.729) 0.028 (0.015, 0.039) +       \n",
       "27 0.685 (0.665, 0.699) 0.718 (0.692, 0.727) 0.032 (0.017, 0.039) +       \n",
       "28 0.605 (0.586, 0.613) 0.63 (0.607, 0.642)  0.023 (0.021, 0.031) +       \n",
       "29 0.655 (0.641, 0.682) 0.685 (0.67, 0.713)  0.027 (0.023, 0.035) +       \n",
       "30 0.657 (0.607, 0.684) 0.703 (0.661, 0.726) 0.043 (0.023, 0.069) +       \n",
       "31 0.498 (0.482, 0.509) 0.546 (0.534, 0.558) 0.047 (0.028, 0.074) +       \n",
       "32 0.633 (0.625, 0.647) 0.675 (0.664, 0.688) 0.041 (0.032, 0.047) +       \n",
       "33 0.657 (0.602, 0.683) 0.705 (0.662, 0.739) 0.048 (0.036, 0.065) +       \n",
       "34 0.707 (0.702, 0.712) 0.756 (0.752, 0.759) 0.048 (0.045, 0.054) +       \n",
       "35 0.479 (0.447, 0.505) 0.561 (0.548, 0.59)  0.09 (0.049, 0.115)  +       \n",
       "36 0.532 (0.491, 0.568) 0.612 (0.59, 0.64)   0.079 (0.053, 0.099) +       \n",
       "37 0.548 (0.517, 0.581) 0.656 (0.631, 0.683) 0.102 (0.062, 0.143) +       \n",
       "38 0.544 (0.521, 0.561) 0.652 (0.626, 0.679) 0.111 (0.08, 0.152)  +       \n",
       "39 0.546 (0.526, 0.562) 0.654 (0.635, 0.68)  0.104 (0.082, 0.139) +       \n",
       "40 0.538 (0.495, 0.571) 0.645 (0.62, 0.693)  0.105 (0.09, 0.154)  +       \n",
       "   sign_epic sign\n",
       "1  +         +|+ \n",
       "2  +         +|+ \n",
       "3  +         +|+ \n",
       "4  +         +|+ \n",
       "5  +         +|+ \n",
       "6  +         +|+ \n",
       "7  +         +|+ \n",
       "8  +         +|+ \n",
       "9  +         +|+ \n",
       "10 +         +|+ \n",
       "11 +         +|+ \n",
       "12 +         +|+ \n",
       "13 +         +|+ \n",
       "14 +         +|+ \n",
       "15 +         +|+ \n",
       "16 +         +|+ \n",
       "17 +         +|+ \n",
       "18 +         +|+ \n",
       "19 +         +|+ \n",
       "20 +         +|+ \n",
       "21 +         +|+ \n",
       "22 +         +|+ \n",
       "23 +         +|+ \n",
       "24 +         +|+ \n",
       "25 +         +|+ \n",
       "26 +         +|+ \n",
       "27 +         +|+ \n",
       "28 +         +|+ \n",
       "29 +         +|+ \n",
       "30 +         +|+ \n",
       "31 +         +|+ \n",
       "32 +         +|+ \n",
       "33 +         +|+ \n",
       "34 +         +|+ \n",
       "35 +         +|+ \n",
       "36 +         +|+ \n",
       "37 +         +|+ \n",
       "38 +         +|+ \n",
       "39 +         +|+ \n",
       "40 +         +|+ "
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "st4_clean %>% filter(!is.na(sign_epic)) %>% filter(sign==\"+|+\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 95,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "0.232558139534884"
      ],
      "text/latex": [
       "0.232558139534884"
      ],
      "text/markdown": [
       "0.232558139534884"
      ],
      "text/plain": [
       "[1] 0.2325581"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "40/172"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "st4_clean %>% filter(!is.na(sign_epic)) "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 52,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<table class=\"dataframe\">\n",
       "<caption>A tibble: 10 × 2</caption>\n",
       "<thead>\n",
       "\t<tr><th scope=col>sign</th><th scope=col>n</th></tr>\n",
       "\t<tr><th scope=col>&lt;glue&gt;</th><th scope=col>&lt;int&gt;</th></tr>\n",
       "</thead>\n",
       "<tbody>\n",
       "\t<tr><td>+ | +  </td><td> 40</td></tr>\n",
       "\t<tr><td>+ | -  </td><td> 10</td></tr>\n",
       "\t<tr><td>+ | NA </td><td>195</td></tr>\n",
       "\t<tr><td>+ | ns </td><td> 55</td></tr>\n",
       "\t<tr><td>- | NA </td><td> 26</td></tr>\n",
       "\t<tr><td>- | ns </td><td>  3</td></tr>\n",
       "\t<tr><td>ns | + </td><td> 15</td></tr>\n",
       "\t<tr><td>ns | - </td><td>  7</td></tr>\n",
       "\t<tr><td>ns | NA</td><td>359</td></tr>\n",
       "\t<tr><td>ns | ns</td><td> 42</td></tr>\n",
       "</tbody>\n",
       "</table>\n"
      ],
      "text/latex": [
       "A tibble: 10 × 2\n",
       "\\begin{tabular}{ll}\n",
       " sign & n\\\\\n",
       " <glue> & <int>\\\\\n",
       "\\hline\n",
       "\t + \\textbar{} +   &  40\\\\\n",
       "\t + \\textbar{} -   &  10\\\\\n",
       "\t + \\textbar{} NA  & 195\\\\\n",
       "\t + \\textbar{} ns  &  55\\\\\n",
       "\t - \\textbar{} NA  &  26\\\\\n",
       "\t - \\textbar{} ns  &   3\\\\\n",
       "\t ns \\textbar{} +  &  15\\\\\n",
       "\t ns \\textbar{} -  &   7\\\\\n",
       "\t ns \\textbar{} NA & 359\\\\\n",
       "\t ns \\textbar{} ns &  42\\\\\n",
       "\\end{tabular}\n"
      ],
      "text/markdown": [
       "\n",
       "A tibble: 10 × 2\n",
       "\n",
       "| sign &lt;glue&gt; | n &lt;int&gt; |\n",
       "|---|---|\n",
       "| + | +   |  40 |\n",
       "| + | -   |  10 |\n",
       "| + | NA  | 195 |\n",
       "| + | ns  |  55 |\n",
       "| - | NA  |  26 |\n",
       "| - | ns  |   3 |\n",
       "| ns | +  |  15 |\n",
       "| ns | -  |   7 |\n",
       "| ns | NA | 359 |\n",
       "| ns | ns |  42 |\n",
       "\n"
      ],
      "text/plain": [
       "   sign    n  \n",
       "1  + | +    40\n",
       "2  + | -    10\n",
       "3  + | NA  195\n",
       "4  + | ns   55\n",
       "5  - | NA   26\n",
       "6  - | ns    3\n",
       "7  ns | +   15\n",
       "8  ns | -    7\n",
       "9  ns | NA 359\n",
       "10 ns | ns  42"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "st4_clean %>% group_by(sign) %>% tally()## %>% filter(sign_ukb==\"\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 97,
   "metadata": {},
   "outputs": [],
   "source": [
    "st4_clean %>% write_csv(\"outputs/SupplTable4_ukbepic_merged.csv\")"
   ]
  }
 ],
 "metadata": {
  "hide_input": false,
  "kernelspec": {
   "display_name": "R [conda env:.conda-r_env]",
   "language": "R",
   "name": "conda-env-.conda-r_env-r"
  },
  "language_info": {
   "codemirror_mode": "r",
   "file_extension": ".r",
   "mimetype": "text/x-r-source",
   "name": "R",
   "pygments_lexer": "r",
   "version": "4.2.3"
  },
  "toc-autonumbering": false
 },
 "nbformat": 4,
 "nbformat_minor": 4
}
